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 Aromatic rings are important molecular components of many pharmaceuticals, 
agrochemicals, organic materials and natural products, and the development of selective 
arene functionalization transformations has been broadly applied in basic and translational 
research. Photoredox catalysis is an invaluable synthetic tool for the activation of organic 
molecules via single electron redox pathways. This synthetic strategy enables the 
construction of carbon-carbon and carbon-heteroatom bonds with orthogonal reactivity to 
classical two-electron pathways. An introduction to both topics is provided in the first two 
chapters. 
The Nicewicz lab has recently developed a variety of transformations that proceed by 
reactive cation radical species. These systems rely on the ability of an acridinium 
photoredox catalyst to promote single electron oxidation of a target organic substrate by 
photoinduced electron transfer. Noting the importance of aromatic molecules, we sought to 
develop photoredox-catalyzed chemo- and site- selective arene functionalizations that 
proceed through arene radical cations. As a result, two general reaction methodologies 
emerged from our investigations into the reactivity of arene radical cations: selective 
aromatic carbon-hydrogen (C–H) bond and carbon-oxygen (C–O) bond functionalizations.  
These photoredox-catalyzed aryl C–H amination and C–H (radio)fluorination 
reactions feature the use of a nitroxyl radical co-catalyst and oxygen to achieve a net 
oxidative transformation, which furnishes aryl amines and radiolabeled fluoroarenes with 






and the application of 18F-labeled aromatics to positron emission tomography (PET) imaging 
was demonstrated. These two projects are covered in Chapters 3 and 5. 
Photoredox-catalyzed aryl C–O functionalizations occur by a complementary strategy 
to nucleophilic aromatic substitution (SNAr). The generation of arene radical cations enables 
an inversion of traditional SNAr selectivities such that electron-rich aromatics are selectively 
functionalized at an electron-donating C–O bond-containing substituent. This reaction mode 
enables the synthesis of aryl amines, fluoroarenes, and [18F]fluoroarenes. Additionally, we 
demonstrate that this reactivity pattern is dependent on the presence of a terminal oxidant, 
wherein its exclusion promotes selective C–O substitution over C–H functionalization. These 
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CHAPTER 1: CHEMO- AND SITE SELECTIVITY IN AROMATIC FUNCTIONALIZATION  
 
1.1. Introduction to Chemoselectivity and Site selectivity 
 Synthetic organic chemists have long been interested in developing reaction 
methodologies that precisely target and replace a desired functional group (FG) in a given 
molecule with minimal impact on the rest of the structure. This goal is driven by a desire to 
alleviate the synthetic demand required for constructing molecular complexity and to enable 
sustainable and efficient transformations of feedstock chemicals to value-added commodity 
chemicals. However, most molecules have a myriad of FGs and distinguishing between them 
can be challenging. Chemists have defined two idealized reaction classes which address the 
level of control over FG manipulation achievable within a molecule, i.e., chemoselectivity 
and site selectivity. The IUPAC defines the former as “the preferential reaction of a chemical 
reagent with one of two or more different FGs”,1 and operationally depends on the 
differences in inherent FG reactivity to obtain high levels of selectivity. For example, the 
chemoselective Kumada-Corriu coupling of aryl iodides from Schoenebeck and co-workers 
illustrates the exquisite differentiation exhibited by the cationic palladium trimer 1.1 for the 
activation of the aryl carbon-iodine (C-I) bond over other aryl halides (Figure 1.1A).2 This 
selectivity arises due to the significantly higher kinetic barriers for the oxidative addition of 
the palladium catalyst to the carbon-bromine (C–Br) and carbon-chlorine (C–Cl) bonds 
(38.8 kcal/mol and 45.3 kcal/mol respectively) relative to the C-I bond (30.7 kcal/mol).2 
 While solving the problem of chemoselectivity is noteworthy, a more significant 
challenge is site selectivity, which is formally defined as the differentiation of reactivity 
between the same kind of FG in different chemical environments.3 This approach takes 
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advantage of the stereoelectronic properties of a substrate and/or a reagent to manipulate 
the differences in the chemical environments of similar FGs. An example is illustrated in the 
site-selective chlorination of (+)-sclareolide reported by Alexanian and co-workers, in which 
a bulky N-chloroamide 1.2 biases chlorination at a secondary (2º) C–H bond (Figure 
1.1B).4 Light-initiated homolysis of the nitrogen chlorine (N–Cl) bond generates a bulky 
electrophilic nitrogen-centered (N-centered) amidyl radical that abstracts a secondary 
hydrogen atom (H atom) at the least sterically-hindered, electron-rich aliphatic 2º C–H 
bond. Because selectivity is influenced by the presence of steric bulk in the substrate, a 
decrease in selectivity between 1º/2º C–H bonds is observed upon the removal of this bias.4 
However, introducing a more hindered aromatic moiety on the N-chloroamide mitigates 2º 
selectivity for an increase in 1º C–H functionalization.5 Consequently, the development of 
reaction methodologies for reagent-directed site selectivity is necessary to complement 
substrate control for the preferential activation of C–H bonds.  
 
Figure 1.1. Examples of chemoselective and site-selective reactions. A) Chemoselective 
Kumada-Corriu coupling for aryl iodides with a cationic palladium trimer 1.1 B) Site-
selective chlorination of sclareolide with N-chloroamide 1.2 
 
An illustrative example is the recent development in catalyst-controlled activation of 
unactivated aliphatic C–H bonds by Davies and co-workers (Figure 1.2).6–8 In order to 





Angew. Chem. Int. Ed. 2019, 58, 211.
MgBr
MeO














































stereoelectronic properties associated with each respective bond (Figure 1.2A). Initial 
reaction development by the Davies lab targeted 2º C–H bonds by introducing steric 
hindrance on the carboxylate ligands of a dimeric rhodium species (Rh-2) such that the 
most accessible 2º site is functionalized (Figure 1.2B) .6 Iterations of their ligand set on 
rhodium introduced 1º and 3º C–H bond selective catalysts (Rh-1)8 and (Rh-3)7, which  
 
Figure 1.2. Considerations for rhodium-catalyzed aliphatic C–H functionalization A) 
Stereoelectronic factors impact C–H bond site selectivity. B) The development of dirhodium-
catalyzed site-selective C–H functionalizations via catalyst design. 
 
were respectively less and more sterically-encumbered than Rh-2. Computational and 
experimental studies suggest that site selectivity arises from the formation of a 
conformational pocket in the rhodium species which uses its steric environment to bias the 















































































A. 1 mol % Rh-1, DCM, reflux; B.1 mol % Rh-2, DCM, reflux; 
C. 1 mol % Rh-3, DCM, -40 ºC





































In summary, the quest for chemoselectivity and/or site selectivity continues to 
inspire the development new reaction methodologies, and one should consider the organic 
structure (e.g. aromatic, aliphatic, etc.) of the substrate, the chemical environment of the 
FGs in consideration, and the rational design of reagents/catalysts in order to achieve that 
end9. 
1.2 Significance of Chemoselectivity and Site selectivity for Aromatic Systems 
Aromatic compounds are typically defined as molecules which fulfill the requirements 
of the quantum mechanically-derived Hückel’s rule (Hückel aromaticity) and they typically 
display remarkable stability due to the resonance stabilization of their pi (p) systems. Their 
significance extends beyond theoretical interest as these scaffolds are ubiquitous in both 
naturally-occurring and synthetic molecules, which presents an opportunity for the 
development of chemoselective and site-selective reactions to synthesize or derivatize 
complex aromatic architectures.10 An excellent case study is the deadly alkaloid strychnine, 
which has long served as an inspiration for the development of new synthetic strategies, 
with Sir Robert Robinson once claiming that “for its molecular size, it is the most complex 
substance known”.11 In 2002, Mori and Nakanishi utilized an intramolecular palladium-
catalyzed asymmetric allylic substitution/reaction to construct an enantioenriched 6,5,6 
fused ring system in excellent yield (Figure 1.3, 1.3 to 1.4).12 The chemoselectivity of the 
palladium catalyst for the aryl bromide enables the efficient formation of the tricyclic 
indoline 1.4, which was then elaborated to the alkaloid in 10 additional steps. This synthesis 
is not an isolated example — the development of chemoselective palladium-catalyzed cross-
coupling has enabled the facile completion of numerous natural products, and serve as 
inspiration for the development of new FG-selective reaction methodologies.13  
Late-stage functionalizations (LSFs) of complex bioactive molecules have become an 
attractive strategy in drug discovery as they facilitate the rapid diversification of 
pharmaceuticals without requiring cumbersome synthetic routes. These analogs would then 
enable the elucidation of structure–activity relationships (SAR) and the optimization of on-
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target potency, selectivity and absorption–distribution–metabolism–excretion (ADME) 
properties — a boon for medicinal chemists.14 In the context of strychnine, diversification of 
the C–H bonds in its arene moiety has historically required harsh oxidative conditions or 
have been limited to halogenation, nitrations and sulfonylations.15,16 However, recent 
developments in LSFs have enabled site-selective amination and thianthrenation (and 
subsequent carbonylation).17,18 The latter example is especially interesting as the aryl-
thianthrene adduct shows promise for diversification beyond the installation of carbonyl FGs. 
Both transformations would have required de novo syntheses with several FG 
interconversions in order to obtain the desired regioisomers of functionalized strychnine. 
Therefore, site selectivity is an important guiding principle for the derivatization of bioactive 
molecules and future discoveries in this field should enhance its applicability to translational 
research. 
 
 Figure 1.3: Chemoselectivity and site selectivity in the synthesis and late-stage 
functionalization of strychnine 
   
Because of the widespread interest in the synthesis of functionalized aromatic 
scaffolds, it is crucial to examine existing reaction manifolds that enable selective bond 
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obtaining chemoselectivity and site selectivity for arene functionalizations, as well as current 
limitations of these methods.  
1.3 Strategies for Chemoselectivity in Arene Functionalizations 
1.3.1 Nucleophilic substitutions 
The innate electronic biases of aromatic systems have long been manipulated to 
direct FG selectivity. The classic example of this substrate-level control is nucleophilic 
aromatic substitution (SNAr), in which substituents located ortho- and para- to electron-
withdrawing p species are selectively exchanged for a nucleophile. These FGs promote 
substitution by stabilizing the putative high-energy, non-aromatic Meisenheimer complex 
(Figure 1.4A, 1.6) that forms upon nucleophilic attack.19 However, recent re-examinations 
of the SNAr mechanism have challenged the universality of this assumption and instead 
propose that concerted addition-elimination pathways are viable alternatives (Figure 
1.4B).20,21 In these examples, nucleofuge identity and structural features of the substrate 
bias the concerted mechanism such that the formation of a Meisenheimer complex becomes 
too energetically unfavorable or the barrier to nucleofuge elimination decreases.  
There are two specialized cases of SNAr worth noting due to their unique mechanistic 
divergence from the stepwise and concerted pathways. The first is termed vicarious SNAr 
(VNS), in which the direct substitution of a C–H bond occurs amid the presence of 
competing halogens (Figure 1.4C).22 The initial stabilization of a Meisenheimer complex by 
ortho- p electron-withdrawing substituents (usually nitro- groups) is similar to the stepwise 
mechanism, however, this reaction is done at very low temperatures, and requires a 
terminal oxidation step (for non-carbon nucleophiles) and a built-in nucleofuge within a 
carbon-based nucleophile for selective C–H substitution. Consequently, this reaction 
manifold is the kinetic pathway for SNAr, wherein nucleophilic attack occurs at the least-
sterically hindered arene; the thermodynamic pathway (concerted/stepwise SNAr) is 
observed when the reaction is run at higher temperatures.23 While this transformation can 
be classified as an example of aromatic C–H functionalization, a thorough survey of these 
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methodologies is reserved for the following section because they serve as the archetype for 
site selectivity considerations. 
 
Figure 1.4. Mechanistically distinct classes of nucleophilic aromatic substitution (SNAr) 
 
The second example of a mechanistically distinct SNAr reaction manifold is radical-
SNAr (SRN1), in which the nucleophile does not react directly with the parent arene but 
rather the aryl radical intermediate formed via reductive cleavage (Figure 1.4D).24  This 
Nucleophilic Aromatic Substitutions (SNAr)
A. Stepwise Mechanism
B. Concerted Mechanism
C. Vicarious SNAr (VNS)










































































transformation requires an initiating electron-transfer (ET) step, which proceeds by an 
outer-sphere process involving ET from the nucleophile. However if ET is kinetically 
unfavorable, the transformation putatively proceeds by a concerted ET-bond heterolysis 
pathway rather than a simple outer-sphere ET.25 Electronically unbiased and electron-rich 
arenes are compatible with SRN1, thus further distinguishing this reaction manifold from the 
other SNAr classes. The only requirement is that ET in the initiation and propagation steps 
are favorable. Otherwise the inclusion of electron accepting groups may be necessary to 
promote reactivity.26 Lastly, these reactions are sensitive to oxygen and unproductive H-
atom transfer (HAT) reactions. The former is a known inhibitor of radical propagation whilst 
the latter can occur with labile solvent/reagent C–H bonds, which yield the reduced 
dehalogenated arene and terminate the radical chain process. 
Overall, the operational simplicity of SNAr makes it an invaluable synthetic tool for 
the chemoselective modification of aromatic ring scaffolds in pharmaceutical and chemical 
research, its major limitation is obvious — electron-rich arenes are generally incompatible 
due to insufficient stabilization of the Meisenheimer complex or of the concerted transition 
state. SRN1 stands as a notable exception to this restriction due to its divergence from polar 
SNAr mechanisms. However, ET rates are sensitive to the FG identities on the arene such 
that certain electron-rich substrates may be incompatible with this system. 
1.3.2 Bond Activations Mediated by Transition Metals 
Chemoselectivity in arene functionalization is not limited to the innate electronics of 
aromatics; a primary motivating goal in organic catalysis is the development of selective 
carbon-heteroatom (C–Het) bond activation. This approach can be traced back to the 
Wurtz-Fittig27 and Ullman reactions28, in which aryl halides were selectively coupled to alkyl 
and aryl electrophiles respectively (Scheme 1.1). In the Wurtz-Fittig reaction, net 
reduction of the aryl halide forms an arylsodium reagent, which directly reacts with the 
electrophile. Although there is precedent for the reaction to proceed via a radical coupling 
mechanism similar to SRN1, most experimental evidence suggests that a polar mechanism is 
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operative.29,30 The Ullman reaction also targets aryl halide bond for activation, however this 
transformation is mechanistically distinct from the Wurtz-Fittig. Upon activation by 
elemental copper, the organometallic species 1.7 can undergo oxidative addition with a 
second equivalent of aryl iodide to yield 1.8, which is primed for reductive elimination to 
yield the homocoupled biaryl product.28 While the formation of 1.7 likely proceeds through 
ET or halogen atom transfer (XAT), mechanistic studies indicate that carbon-carbon (C–C) 
bond formation occurs via inner sphere processes involving CuI/CuIII manifold.31 Despite 
their differences, both share a common limitation — the activating reagent is used in 
stoichiometric or superstoichiometric amounts, which is detrimental to its adoption in 
general synthesis.  
 
Scheme 1.1. General mechanisms for the Wurtz-Fittig and Ullman reactions 
 
Since the seminal work of Wurtz-Fittig and Ullman, the maturation of transition 
metal-catalyzed reactions has enabled an expansion in the range of compatible 
electrophiles, thus allowing for catalytic bond formations between carbon atoms, as well as 
between carbon and numerous other heteroatoms. A prime example is the advancement of 
palladium-catalyzed cross-coupling methods, which are best illustrated by the Nobel Prize-
winning Heck, Negishi and Suzuki reactions for C–C bond formation32 and the Buchwald-
Hartwig amination for carbon-nitrogen (C–N) bond formation33. Aryl halides and 





































these transformations and the reactions follow a derivative of the generalized mechanisms 
shown in Schemes 1.2 and 1.3. 
The Heck reaction typically begins with a Pd(0) species (1.9), which can be 
generated via in-situ reduction of a Pd(II) precatalyst (Scheme 1.2). 1.9 can then undergo 
oxidative addition with an equivalent of aryl halide to form species 1.10. Coordination of 
alkene 1.11 to the arylpalladium 1.10 is followed by syn-insertion of the s-aryl-palladium  
 
Scheme 1.2. General mechanism for a Heck reaction between iodobenzene and methyl 
acrylate 
 
bond into the double bond to form 1.12.32 Internal rotation around the former double bond 
is required to obtain the syn-periplanar orientation with a neighboring ß-hydrogen 
necessary for product formation via ß-hydride elimination (1.13 to 1.14). The resultant 
palladium species can then be turned over via a deprotonation event to reset the catalytic 










































The Suzuki and Negishi reactions (Scheme 1.3A) are mechanistically similar to the 
Heck reaction, but have an additional transmetalation step in order to obtain a reactive 
carbon coupling partner that is either pre-activated or generated in-situ. For example, the 
aryl boron-ate complex (1.16) in Suzuki cross-couplings, formed via the activation of an 
aryl boronic acid or aryl boronic ester with a stoichiometric alkoxide base, is the putative 
species that participates in the transmetalation step with an oxo-palladium intermediate.34 
Recent studies, however, appear to suggest that transmetalation can occur without  
 
Scheme 1.3. General mechanisms for the Suzuki and Negishi reactions (A) and for the 
Buchwald-Hartwig reaction (B). 
 
exogenous base oxo-palladium intermediate when using aryl boronic esters.35 For 
Buchwald-Hartwig aminations (Scheme 1.3B), base-promoted exchange of the halide from 
the oxidative addition species 1.17 for an equivalent amine generates the amino-palladium 
intermediate 1.18, which can then undergo reductive elimination to give the desired 
aminated arene 1.19.36  

























































represent a portion of developments in transition metal-catalyzed cross-coupling as there 
are a plenitude of other redox-active metals and coupling partners to consider. A non-
exhaustive account of notable, named modern cross-coupling reactions is given in Figure 
1.5. A key observation from this list is that chemoselective arene functionalization has been 
traditionally focused on the activation of carbon-halogen bonds. Consequently, current and 
future development in chemoselective aromatic functionalizations mediated by transition 
metals are focused on the selective activation of traditionally inert chemical bonds, which 
can be achieved via polar, radical or a hybrid of polar-radical mechanistic pathways.  
 
Figure 1.5. Several examples of modern cross-coupling transformations  
 
One example is the use of nitroarenes as aryl halide equivalents for the Suzuki 
reaction and Buchwald-Hartwig amination (Figure 1.6).37,38 Nitroarenes are typically 
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synthesized non-selectively from a nitroarene reduction-Sandmeyer sequence.39 The 
mechanisms are proposed to be similar to that in Scheme 1.3, and oxidative addition is 
proposed to be the turnover-limiting step in the transformation, presumably due to the 
difficulty of activating a relatively stronger Ar-NO2 bond.  
 
Figure 1.6. Suzuki (A) and Buchwald-Hartwig (B) reactions with nitroarene substrates 
 
Another example of a contemporary strategy in chemoselective aromatic 
functionalization is the activation of protected phenol moieties. Phenols are more naturally 
abundant than aryl halides40 and their derivatives (Scheme 1.4A) are robust synthetic 
handles capable of complementary reactivity to haloarenes, thus useful intermediates for 
target-oriented syntheses.39,41 Furthermore, protected phenols (e.g., sulfamates and 
carbamates) can be used as directing groups for ortho-metalation prior to cross-coupling, 
thus providing a functional handle capable of dual activation modes.42 While palladium has 
been utilized for this transformation43, most of the advances in this area have relied on 
nickel catalysts.44 While the mechanistic rationale for the superiority of nickel over palladium 
is not fully understood, a recent study on Ni-catalyzed silylation of aryl esters by Martin and 
co-workers propose the formation of a dimeric nickel species as the active catalyst 
(Scheme 1.4B).45,46 This bis-nickel complex 1.20 is formed during the facile oxidative 
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nickel species (1.21). Furthermore, computational and experimental studies suggest that 
transmetalation (1.21 to 1.22) is the turnover-determining step for this transformation.  
 
Scheme 1.4. Cross-coupling via C–O bond activation A) Phenol-derived cross-coupling 
handles. B) Nickel-catalyzed silylation of aryl pivalates 
 
1.4 Strategies for Site selectivity in Arene C–H Functionalizations 
 Site-selective arene C–H functionalization is a unique subset of chemoselective arene 
transformations with the additional challenge of having FGs with nearly identical chemical 
properties.3 For example, anisole (1.23), 3-methylanisole (1.24) 3-methylanisole (1.25) 
respectively have three, four and two different positional C(sp2)-H functionalization sites 
(Figure 1.7). However, the ortho, meta, and para C–H locations relative to each arene FG 
have intrinsic electronic properties that can be exploited to bias reactivity at one aromatic 
C–H bond. Furthermore, the FGs can also play a role in directing reactivity to a neighboring 
C–H site, typically through the use of FG with a Lewis-basic atom such as nitrogen or 
oxygen.47 Finally, the manipulation of electronic and steric effects on the catalyst through 
ligand design plays an important role differentiating the chemical environments around each 
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Figure 1.7. C–H site-selectivities for anisole, 3-methylanisole and 3-methylanisole 
 
1.4.1 Electrophilic Aromatic Substitution 
Like SNAr, electrophilic aromatic substitution (SEAr) relies on the electronics of the 
aromatic system to determine regioselectivity for arene functionalization. Electron-donating 
groups (EDGs) tend to provide ortho and para substituted products, with increasing 
selectivity for the para position achievable through modulation of EDG size and reactivity; 
conversely, electron-withdrawing groups (EWGs) bias substitution at the meta C–H position 
(Figure 1.8A).50 Despite these electronic constraints, SEAr is still widely utilized for the 
nitration, sulfonation, halogenation, acylation (Friedel-Crafts acylation) and alkylation 
(Friedel-Crafts acylation) of aromatic systems (Figure 1.8B).51 The mechanism for SEAr is 
well-studied52, and often proceeds first by catalytic activation of the electrophile 1.26 
(Figure 1.8C). Fast p-complexation of the arene to 1.26, followed by a slower s-bond  
 
Figure 1.8. Electrophilic aromatic substitution (SEAr): selectivities for electron-rich and 






































































































formation generates an arenium ion (1.27). The stability of this s-complex, also known as 
the Wheland intermediate, is dependent on the identities of the EDGs and EWGs within the 
arene. Rapid deprotonation yields the desired aromatic product (1.28) and the catalyst 
(typically a Lewis acid). However, recent mechanistic work suggests that the stepwise 
formation of the arenium ion is not the preferred mechanism for certain SEAr reactions.51 
Instead, a concerted transition state is proposed for halogenations and sulfonylations 
occurring in nonpolar solvents; upon the introduction of a complexing solvent, a stepwise 
SEAr mechanism returns.53,54 Galabov, von R. Schleyer, and co-workers propose a 
theoretical value — the electrophile affinity (Ea) to quantify the reactivity and positional 
selectivity for the stepwise SEAr transformation.55 This value is determined by evaluating the 
energy changes upon the formation of an arenium—electrophile complex.55 Reactivity site 
selectivity is strongly correlated to the arene electrostatic potentials, however this trend 
breaks when steric bulk is introduced within the electrophile. 
1.4.2 Directing Group-Assisted C–H Activation  
 Site selectivity for arene functionalization can be controlled through FG assistance. 
The activation of an arene C–H bond at a metal center requires a proximal relationship 
between the two species, thus a widely-employed strategy is to use nitrogen-, oxygen-, 
sulfur-, and phosphorus-containing directing groups (DGs).56 These DGs enable the 
activation of an ortho- C–H bond to form thermodynamically stable five- and six-membered 
metallacycles that can engage in a subsequent functionalization step.57 Using palladium as a 
representative metal, the formation of the palladacycle 1.29 starts with pre-coordination of 
the Lewis-basic site to the Pd(II) center, followed by arene C–H activation (Scheme 
1.5A).58 At this point, the reaction can undergo variations of elementary steps that lead to 
the desired product and a reduced palladium species. The most common of these pathways 
is a ligand exchange (arene deprotonation in Scheme 1.5A) to form species 1.30, which 




Scheme 1.5. Mechanism of palladium-catalyzed directed ortho arylation: Pathway 
operating via Pd0/PdII species (A); pathway operating via PdII/PdIV species (B). 
 
Oxidation of Pd(0) regenerates the catalytically active species necessary for the 
transformation. Alternatively, a net oxidative Pd(II)/Pd(IV) catalytic cycle may be dominant 
(Scheme 1.5B). The ortho-acetoxylation of phenylpyridine systems59 involves the 
formation of intermediate 1.31, which is oxidized to octahedral Pd(IV) 1.32 by a 
hypervalent iodine reagent. Complex 1.32 then undergoes reductive elimination to generate 
the desired product and the starting catalyst. While this method is synthetically useful,56,58,60 
it suffers from two key problems. First, the directing group are synthetically restrictive, i.e., 
they can be difficult to install and remove. Second, the thermodynamic stability of the 
cyclometalated species may inhibit the success of downstream reactions. 
 An alternative strategy is to use less-coordinating FGs such as ketones, carboxylic 
acids, amides, alkyl amines, and alkyl ethers. These species are not novel DGs in organic 




























































of the parent aryl C–H bond.50 Cyclometalation with Pd(II) leads to a less stable 
intermediate, which in turn, increases its reactivity and allows for the implementation of a 
greater range of compatible reaction partners.57,61 However, these cyclometalated species 
are more conformationally labile because of the weaker metal- DG interactions, which may 
make oxidative addition of the aryl C–H bond at the metal center more difficult. 
 
Figure 1.9. Mechanistic considerations in palladium-catalyzed arene C–H functionalizations 
with strongly-coordinating directing groups (A) and weakly-coordinating directing groups 
(B); Example of complex-induced proximity effect (CIPE) in (C) arene lithiation and (D) 
palladium-catalyzed activation; Equilibration impact of arene carboxylate binding modes on 
cyclopalladation (E). 
 
One way to overcome this limitation is to utilize the concept of complex-induced 
proximity effect (CIPE), in which DGs stabilize geometrically favorable metal-ligand 
interactions that bring reactive groups into proximity of the C–H bond prior to deprotonation 
(Figure 1.9C).62 Biasing the formation of a palladium-DG intermediate also results in a 
higher effective molarity of the reactive species prior to oxidative addition, which in turn 
promotes the C–H activation step (Figure 1.9D).57 Thus, a base-assisted, cyclometalation-
deprotonation (CMD) event leads to the formation of the palladacycle. Problems may arise 
from unproductive intermediates arising from nonsingular binding modes of certain DGs. For 
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the k1-coordination mode primarily leads to cyclometallation (Figure 1.9E). Yu and co-
workers demonstrate that the inclusion of an inorganic counterion is crucial for obtaining the 
o-arylation63 and o-iodination64 of benzoic acids, and enabled the isolation and 
characterization of a carboxylate-based palladacycle.65 Yu and co-workers hypothesize that 
this enhancement arises from tight cationic alkali metal k2-binding to the carboxylate, which 
forces the Pd(II) center to coordinate in a k1 fashion to an oxygen lone pair.57 Furthermore, 
the principles for directed ortho-functionalization have also been applied in the development 
of templating DGs for meta- and para-selective arene C–H activations (Figure 1.10).66 
Meta functionalizations tend to involve energetically demanding 11-12 membered 
metallacycle in which weak end-on coordination of a nitrile to the Pd(II) center induces 
activation of the arene C–H bond (Figure 1.10A).67 Para-selective reactions require longer 
chain lengths — typically forming 17-membered cyclophane-like transition states — to 
enable the requisite proximal interactions between the complexed-Pd(II) and the para C–H 
bond (Figure 1.10B).68 
 
Figure 1.10. Meta (A) and para (B) C–H functionalizations mediated by templating groups 
 
Directed C–H functionalization is not limited to Pd(II) species as Ru(II)69 and 
Rh(III)70 complexes are commonly used catalysts for directed ortho-functionalization of 
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Scheme 1.6. Directed C–H arene functionalization mediated by CpRhIII catalysis 
 
catalyzed C(sp2)-H activation occurs (CMD), similar to Pd(II) systems. Cp*Rh(III) complexes 
are especially used for directed C–H activation due to the enhanced reactivity of the Rh(III)-
carbon(aryl) bond and the privileged properties of the Cp* ligands.70 Correlations of Cp 
substitution identity to Rh(III) C–H insertion rates were recently studied by Rovis and co-
workers, and they found that Cp derivatives with the highest electron density at the Rh 
center displayed the fastest rates of cyclometalation (Scheme 1.6).71 Computational (e.g., 
NPA atomic charges at Rh) and experimental (e.g. !"/$%%/% values for Rh) studies also suggest 
that the electronic contribution of the Rh plays a bigger role than the steric environment in 
accelerating C–H insertion.71 It is also worth noting the use of an iridium catalyst in a recent 
report by Rovis and co-workers, where an Ir(III) species participates in undirected CMD on 
route towards tandem C(sp2)-H and C(sp3)-H bond activations resulting in net alkyne 
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Scheme 1.7. Tandem C(sp2)–H and C(sp3)–H bond activations mediated by CpIrIII catalysis 
 
A unique divergence from ortho-metalation strategies is the use of a DG to induce 
meta-metalation and subsequent arylation, which was first reported by Gaunt and co-
workers (Scheme 1.8A).73 This reaction is complementary to reactivity patterns associated 
with SEAr and Pd-directed arylations74, as meta functionalization of C–H bonds in electron-
donating anilides is observed. The putative mechanism (Scheme 1.8B) proceeds by the 
formation of an electrophilic Cu(III)-aryl intermediate (1.35) from a Cu(I) species and an 
aryliodonium reagent,75 followed by ligand-assisted, dearomative oxy-cupration at the 
meta-position (1.36). Aromatization of 1.36 leads to a formal Cu(III) bis-aryl species 
(1.37), which yields the desired product and the catalyst after reductive elimination. 
However, a recent computational study by Li and Wu contend that the oxy-cupration step is 
energetically unfavorable.76 They propose instead the formation of a Heck-like four-
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Scheme 1.8. Regiodivergent anilide arylations: Ortho arylation observed in palladium 
catalysis whereas meta arylation is observed for copper species (A); Mechanism proposals 
for copper-catalyzed arylation by B) Gaunt and co-workers, and C) Li, Wu and co-workers. 
 
phenyl group (1.39) without any formal arylcupration (Scheme 1.8C). The strategy 
developed by Gaunt and co-workers was also applied towards selective C3 arylations of 
indoles, with the choice of N-protecting group crucial for dictating site selectivity.75 Upon 
switching from N-alkyl- to N-acetylindoles, C2-selective arylation was observed, likely due 
to complexation between the carbonyl moiety and the Cu(III) intermediate. 
1.4.3 Catalyst-Directed C–H Activation 
 In the absence of a directing group on the arene, site selectivity relies on the 
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chelate directed C–H activation were independently reported by the Fagnou77–79 and Itami80 
groups, in which palladium and rhodium catalysts were used to couple aryl halides and 
unactivated arenes (Scheme 1.9). The mechanism for both transformations is illustrated by 
the Pd system developed by Fagnou and co-workers79, in which initial oxidative addition of 
the aryl halide forms an electrophilic Pd(II) intermediate (1.40). Ligand exchange of a 
halide for a pivalate (1.41) is crucial for this transformation as the pivalate assists in CMD 
(1.42) following the coordination of the unactivated arene to the metal center. Ligand 
dissociation and subsequent reductive elimination yields the desired biphenyl product and 
regenerates the active Pd(0) catalyst. Fagnou and co-workers also demonstrate that the key 
CMD step is general for an electronically diverse range of arenes,81 although faster reactions 
are observed for electron-neutral and electron-poor aromatics.82,83 Recent iterations of this  
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transformation84,85 utilize a Ag(I) salt as a co-catalyst for C–H activation of electron-
deficient arenes. Experimental and computational evidence suggest that CMD with a Ag(I) 
carboxylate forms an arylsilver (I) complex that participates in transmetalation to generate 
the bis-aryl Pd(II) intermediate necessary for reductive elimination.  
C–Het bond-forming reactions have also been accomplished using electrophilic metal 
species.86 In particular, C–N bond formation typically involves a nitrene intermediate. One 
notable example is the Rh-catalyzed amination of electron-rich arenes reported by Kürti and 
co-workers (Figure 1.11A).87 N-Methyl-O-tosylhydroxylamine (TsONHMe) activation by a 
dirhodium(II) species (1.43) generates a protonated dirhodium-nitrene complex (1.44), 
which undergoes electrophilic trapping by the arene and subsequent rearomatization to 
provide the desired amination product. Kürti and co-workers note that the electrophilic 
amine identity was crucial for obtaining the desired product (Figure 1.11B) as the less 
acidic trichloroethylsulfamate provides sole benzylic amination (1.45) 88 whereas TsONHMe 
delivers the arene amination adduct (1.46). 
Non-chelate directed arylation strategies have also been applied to rhodium- and 
iridium-catalyzed silylations and borylations of arenes.89 Organoboron and organosilicon 
aromatics are important synthetic intermediates (c.f. Suzuki and Hiyama cross-couplings), 
thus methods for the facile installation of carbon-silicon (C–Si) and carbon-boron (C–B) 
units are valuable. In 2002, the Smith and Hartwig groups independently reported the first 
examples of intermolecular borylations of unactivated arenes using phosphine-iridium90 and 
bpy-iridium91 complexes respectively (Scheme 1.10). Both methods demonstrate meta and  
para selectivity for mono-substituted systems, with no ortho-borylation observed. Excellent 
meta selectivity is observed for 1,3-disubstituted arenes, which suggests that site selectivity 
is highly dependent on the steric demand within the aromatic core.92,93 While the initial 
report by Smith required high reaction temperatures, the bpy-Ir catalyst system developed 
by Hartwig and co-workers enabled room-temperature arene borylations. This remarkable 




Figure 1.11. Arene amination via RhII-nitrene species in which regiodivergence in C–H 
functionalization is dictated by the electrophilic amine source. 
 
(1.47), which was identified as the active catalytic species for the transformation.94 The 
mechanism of the reaction is as follows: dissociation of an alkene from the boryl–Ir(III) 
catalyst (1.48) precedes arene C–H activation, which can occur via s-bond metathesis 
(1.49) or by oxidation addition of the aryl C–H bond (1.50).94 Reductive elimination from 
the Ir(V) intermediate reveals the borylated arene and an Ir(III) intermediate (1.51), which 
undergoes hydride–borolane exchange to turn over the catalytic cycle.  
Furthermore, Hartwig and co-workers reported a rhodium-catalyzed arene C–H 
silylation in 2014, in which hydrosilanes are coupled to a wide range of arenes with good to 
excellent levels of regiocontrol (Scheme 1.11).95 The mechanism for the transformation96 
begins with the formation of Rh(III) silyl dihydride (1.52), which is the resting state species 






















































































Scheme 1.10 Mechanism and regioselectivities of iridium-catalyzed aromatic borylations  
 
generates intermediate 1.53, which then undergoes reductive elimination to afford the 
Rh(I)-silyl species 1.54. Arene C–H activation of benzene generates the Rh(III) species 
1.55, which yields the desired silylarene via reductive elimination, and Rh(I)-hydride 1.56. 
Alternatively, catalytically active 1.53 can also be formed from 1.56 via consecutive 
cyclohexene association, insertion, and silane oxidative addition. Regioselectivity appears to 
be dependent on silane identity, as meta-silylation relative to the OTBS group was observed 
when triethylsilane was used (1.57), whereas the bulky silane HSiMe(OTMS)2 directed 
silylation to the less-sterically encumbered para C–H site (1.58). Iridium complexes were 
later shown to be competent catalysts for arene silylation by Hartwig and co-workers, and 
they display a greater FG tolerance albeit with lower regioselectivities.97 Ligand 
modifications were found to be crucial to extending the reaction scope, as increased steric 
bulk on the phenanthroline core enabled the efficient silylation of electron-rich arenes — a 
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Scheme 1.11. Mechanism and regioselectivities of rhodium-catalyzed aromatic silylations 
 
borylations as alkylrhodium reductive elimination is the turnover-determining step, which 
diverges from observations of slow arene C–H activation in the former systems.96  
Site selectivity for arene C–H activation by electrophilic metalation systems is 
typically controlled by stereoelectronic demands of the substrate, thus ligand design has 
emerged as a strategy to bias regioselectivity of C–H activation. Yu and co-workers report a 
ligand-accelerated arene C–H functionalization in which electron-poor pyridone 1.59 
stabilizes the active palladium catalyst and participate in the CMD step (Figure 1.12).99 
Site-selectivities are modest to excellent for their C–H olefination transformation, displaying 
preferential meta selectivity relative to the most proximal FG. This reaction mode is 
complementary to the ortho selectivities observed in Fujiwara-Moritani palladation 
pathways.100 Lastly, this transformation also uses arene as a limiting agent, a current 
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Figure 1.12. Pyridone ligand-accelerated aromatic C–H functionalization  
 
1.5 The Catellani Reaction: Palladium/Norbornene Cooperative Catalysis  
 The Catellani reaction stands as a notable example of being both a chemoselective 
and a site-selective transformation. This reactivity arises because two catalytically-active 
species — palladium metal and norbornene (NBE) — enable access to three different 
palladium oxidation states [Pd(0)/Pd(II)/Pd(IV)]. In their initial report, Catellani and co-
workers demonstrate the regioselective bis-alkylation and olefination of aryl halides  
(Scheme 1.11).101 Oxidative addition of the aryl iodide to Pd(0) generates the Pd(II) 
intermediate 1.60, which can undergo migratory insertion into the NBE olefin to generate 
1.61. Deprotonation of an ortho arene C–H bond generates palladacycle 1.62 that engages 
in oxidative addition of an alkyl halide to form the Pd(IV) species 1.63. 1.63 then 
undergoes reductive elimination to afford the ortho-functionalized arene-palladium complex 
1.64. A second round of arene ortho-alkylation continues via similar elementary steps  
(1.65 to 1.67) to yield the bis-functionalized palladium-arene complex 1.67. NBE-
deinsertion forms the active Pd(II) species (1.68) that undergoes a Heck-reaction with an 
olefin to generate the observed product.102 In the presence of an ortho-functionalized aryl 
halide, only mono-alkylation is observed.103 The key to the success of this transformation is 
the privileged role of NBE as a co-catalyst. Four features of NBE explain its crucial role in 
driving the Catellani reaction — 1) Its inability to undergo ß-hydride elimination, 2) fast NBE 
migratory insertion with the Pd(II) oxidative addition complex, 3) rigidity-enhanced 
CO2Me
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palladacycle formation and 4) facile NBE deinsertion upon ortho bis-functionalization of the 
arene.104 Lautens and co-workers measured the rate of NBE migratory insertion into 
arylpalladium(II) complex 1.60 to be between 17–18 kcal/mol as this elementary step 
relieves thermodynamic ring strain (21.6 kcal/mol)105 through a kinetically-favorable 
pyramidized transition state.106  
 
Scheme 1.12 A catalytic cycle for the Catellani reaction involving double o-alkylation-Heck 
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Furthermore, the rigidity of the NBE skeleton facilitates h2 arene-metal precoordination and 
shortens the Pd(II) arene C–H bond interaction,107 thereby favoring palladacycle formation. 
Finally, because NBE elimination is promoted by the steric interactions between the metal 
and arene, NBE extrusion is most kinetically favorable when both ortho positions of the 
arene are substituted.104 
 Since the initial report by Catellani, palladium/NBE cooperative catalysis has evolved 
to include a range of nucleophiles and electrophiles102,104 but the transformation has been 
limited by the ortho-constraint, in which monofunctionalization is only applicable to ortho-
substituted aryl halides. Dong and co-workers developed a solution to this problem in 2018 
by introducing bridgehead-substituted NBEs (e.g. 1.69 and 1.70) to induce steric 
repulsions that favor NBE deinsertion following the initial ortho C–H functionalization 
(Figure 1.13A).17 The C–H metalation transition state (TS) with an unsubstituted NBE 
(1.71) is favored over the ß-carbon elimination pathway (Figure 1.13B) because the latter 
TS (1.72) would require a energetically-demanding pseudo-perpendicular relationship 
between the aryl ring plane and the bridgehead C–H bond.105 However, the metalation 
pathway can be disfavored (1.73) by replacing the bridgehead C–H bonds with bulky alkyl 
groups (Figure 1.13C), which would introduce steric strain between the new arene 
substituent and the bridgehead FG (1.74). Monosubstituted NBE (1.69) displays excellent 
regioselectivity control for meta-subtituted aryl iodides while an NBE with unsymmetrical 
bridgehead di-substitution (1.70) is necessary for biasing mono-amination on unsubstituted 
or para-substituted iodoarenes (Figure 1.13D). This advance also enables arene 
functionalizations with complementary selectivities to SEAr. When coupled with a hydride 
source (1.75) and 4-benzoyloxymorpholine, 3-substituted and 4-substitued aryl amines 
were obtained for electron-rich and electron-poor iodoarenes respectively, thus overriding 




Figure 1.13 Overcoming the ortho constraint of Pd/NBE catalysis: Bridgehead-substituted 
NBEs enable selective functionalization of 3- and 4- substituted aryl halides (A); further C–H 
metalation is favored with unsubstituted NBEs (B), while substituted NBEs favor the ß-
carbon elimination pathway (C); regiocontrol afforded by NBE 1.70 (D) and SEAr-orthogonal 
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CHAPTER 2: PHOTOREDOX CATALYSIS 
 
2.1 Introduction 
 Visible-light photoredox catalysis is a fast-growing field in organic chemistry that 
focuses on light-activated transformations of substrate redox states for bond formation. 
These transformations utilize single electron radical intermediates in reaction pathways 
complementary to closed-shell, two-electron mechanisms. The key electron mediator in this 
reaction process is the photoredox catalyst, which is usually unreactive in its ground state, 
but acts as either an electron-donor or an electron-acceptor upon photoexcitation at the 
appropriate wavelength. This one-electron redox process, commonly referred to as 
photoinduced electron transfer (PET), serves as the underlying mechanism for substrate 
activation. 
One advantage afforded by photoredox catalysis is its compatibility with overall 
redox-neutral reactions. In such reactions, both single-electron oxidation and reduction 
occur with the substrate, but at different points in the mechanism such that there is no net 
change in the oxidation state between the substrate and the products.1 Attempts to 
replicate this system with stoichiometric reductants and oxidants run into the problem of 
reagent incompatibility. Furthermore, photoredox catalysis can also enable access to radical 
ion species, which operate with umpolung reactivity compared to their ground state 
counterparts.2 Generating cation radicals and anion radicals has historically been 
experimentally cumbersome, often requiring the use of stoichiometric reductants and 
oxidants, or the use of electrochemistry. However, the relative operational ease of 
photoredox catalysis streamlines the generation of these radical ion species and should 
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enable further developments in this field such that their adoption in organic synthesis 
becomes a more attractive proposition. 
In summary, the resurgence of interest in radical chemistry positions photoredox 
catalysis as an exciting entry point into either the generation of new open-shell species 
capable of participating in known chemical space or the discovery of novel reaction 
manifolds inaccessible by two-electron pathways. The following sections aim to provide a 
brief overview into 1) the physical behavior of the photocatalyst excited states (Section 
2.2), 2) the general reaction mechanisms invoked in photoredox catalysis (Section 2.3), 3) 
classes of photoredox catalysts used (Section 2.4) and 4) reaction manifolds successfully 
established for photoredox catalysis (Section 2.5).  
2.2 Photophysical and Electrochemical Considerations. 
 The photophysics of the photoredox catalyst is arguably the most important factor in 
determining photochemical reactivity. The behavior of the electronically excited molecule 
dictates the feasibility and rates of ET, which in turn impacts substrate activation. Thus, any 
improvements to the efficiencies of reaction methodologies,3,4 or developments in catalyst 
design5,6 usually stem from a thorough analysis and understanding of photochemical 
mechanisms. A discussion of the photophysics associated with a generalized photocatalyst A 
is illustrated in a simplified state energy diagram (Figure 2.1). A is electronically excited 
upon absorption of light (+hn), which then promotes an electron from its ground state (S0) 
to a higher energy singlet state. Vibrational equilibration of the promoted electron by non-
radiative pathways leads to the lowest energy singlet excited state (S1) of A (1A). The fate 
of 1A electron in the S1 energy level is dependent on its radiative (light emission) and 
nonradiative (heat emission) pathways.7 Relaxation of the S1 via the fluorescence (radiative, 
–hn) or internal conversion (non-radiative) returns the excited electron to S0. Alternatively, 
the 1A electron can transition to a lower energy triplet excited state (T1) by a spin-
forbidden, nonradiative process called intersystem crossing (ISC). Because ISC is a spin-
forbidden transition, the lifetime for the triplet state of A (3A) is usually longer than 1A. 
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However, both decay to S1 via similar radiative (phosphorescence) and non-radiative 
pathways.  
When these principles are evaluated through the lens of photoredox catalysis, the 
motivating factor for effective substrate activation is the optimization of PET. An empirical 
generalization is that the longer the lifetime of 1A and 3A, the greater likelihood that A will 
undergo PET. This relationship can be quantified through the determination of fluorescence 
and ISC quantum yields (ff and fISC respectively), which are a general approximation for the 
lifetime of A in the productive S1 or T1 states since ET occurs on faster time scales than 
nonradiative pathways.7  
 
Figure 2.1. Photophysical (I) and electrochemical (II) processes of photocatalyst A. 
Diagram adapted from Romero and Nicewicz7 
  
The excited state energies for photoredox catalysts do not provide the full picture for 
PET; in order to quantify the thermodynamic favorability of PET for A, both the excited state 
and the ground state energies must be considered. 
 Electrochemistry is an invaluable tool for measuring ground-state redox potentials of 
organic and inorganic species. The free energy of electron transfer in the ground state is 
given by equation 2.1, where !	is the Faraday constant (23.061 kcal V–1 mol–1), and 

























A is an excited state reductant if E*ox (A•+/A*) < 0
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single electron acceptor A and single electron donor D. By this convention, the oxidation 
potential refers to the half reaction D•+® D while the reduction potential refers to the half 
reaction A ® A•– as single electron reduction of A is thermodynamically unfavorable whereas 
the reduction of D•+ is usually energetically favorable.7 
Equation 2.1. 
DGET = –!(E1/2(A/A•–) – E1/2(D•+/D))    
With an understanding of both the photophysical and electrochemical properties of 
photocatalyst A, a generalized equation incorporating both factors can be used to determine 
the thermodynamic favorability of PET for A. Equation 2.2, better known as the “Gibbs 
energy of photoinduced electron transfer”, considers both the excited state (E0,0) and 
ground state (Eº) energies of the species involved in photoinduced electron transfer. The 
excited state energy of the S1 state can be experimentally obtained by determining either 1) 
the intersection or 2) the midpoint between the absorption and emission spectra. The 
excited state energy of the T1 state is less trivial to determine and is often estimated using 
the phosphorescence maximum obtained under cryogenic temperatures.7 The work term 
(w) in equation 2.2 considers the solvent-dependent Coulombic attractions, but is typically 
omitted due to its numerical insignificance. Consequently, a good first approximation of 
DGPET can be obtained through this relationship between ground and excited state redox 
properties. 
Equation 2.2. 
DGPET = –!(Eº (D•+/D) – Eº (A/A•–)) – w – E0,0 
In photoredox catalysis, the excited state chromophore (A*) acts as either an 
oxidant or as a reductant, thus it is important to obtain its excited state reduction and 
oxidation potentials. These values can be derived from equations 2.3 and 2.4, which 




E*red (A*/A•–) = Ered (A/A•–) + E0,0 
 
Equation 2.4. 
E*ox (A•+/A*) = Eox (A•+/A) – E0,0 
 With E*red (A*/A•–) and E*ox (A•+/A*), we can finally determine the thermodynamic 
favorability of PET in photoredox catalysis. For A* and a generic substrate B, equation 2.4 
can be further generalized for the two redox events. Equations 2.5 and 2.6 describe the 
free energy of PET for an excited state photooxidant and photoreductant respectively. If 
photoinduced oxidation of B is favorable, then |E*red (A*/A•–)| > |Eox (B•+/B)|. Similarly, if 
photoinduced reduction of B is to be thermodynamically allowed, then |E*ox (A•+/A*)| > | 
Ered (B/B•–)|.  
Equation 2.5. 
DGPET = –!(E*red (A*/A•–) – Eox (B•+/B))  
Equation 2.6. 
DGPET = –!(Ered (B/B•–) – E*ox (A•+/A*))   
 
2.3 General Mechanisms in Photoredox Catalysis 
 Photoredox catalyst C can either participate in a single electron oxidative or 
reductive quenching pathways (Scheme 2.1). In the former mechanism (Scheme 2.1A), 
photoexcitation of C to C* generates an excited state reductant capable of donating an 
electron to an equivalent of substrate S or an oxidant O. The oxidized catalyst C•+ can then 
be turned over via ET from another equivalent of S or a reductant R. The reductive 
quenching cycle (Scheme 2.1B) follows a similar pathway, where photoexcitation of C to C* 
generates an excited state oxidant capable of abstracting an electron from an equivalent of 
S or R. C is then regenerated via oxidation of C•– with an equivalent of S or O. In both 
mechanisms, substrate activation via PET generates ion radical pairs (S•– and S•+) capable 




Scheme 2.1. Oxidative (A) and reductive (B) quenching cycles of a generic photoredox 
catalyst C 
 
 Furthermore, photoredox reactions tend to fall into three redox categories — net 
oxidative, net reductive and net redox-neutral (Figure 2.2). In the first two, the 
stoichiometric oxidant and reductant respectively serve as electron sinks (Figure 2.2A) and 
sources (Figure 2.2B) for the PET step or the catalyst turnover step. However, the net 
redox-neutral reaction usually involves ET with the oxidized or reduced forms of the 
catalyst, and may require a redox-active co-catalyst for efficient turnover (Figure 2.2C).7 
As a result, no stoichiometric oxidant or reductant is required, and no change in substrate 
oxidation state is observed.  
2.4 Photoredox Catalysts 
There are two general classes of photoredox catalysts used in organic synthesis— 
transition metal photocatalysts and organic dyes (Table 2.1). A key differentiating feature 
between the two types of photocatalysts is the mechanisms by which PET occur. Visible-
light excitation of transition metal photocatalysts such as Ru(bpy)3 (2.1) and 
Ir[dF(CF3)ppy]2-(dtbpy) (2.2) promotes an electron from a metal-centered orbital to a 
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(MLCT), creates an excited state species capable of undergoing PET either as a photooxidant 
or photoreductant. In the former, an electron from the substrate’s highest occupied  
 
Figure 2.2. Oxidative (A), reductive (B) and redox-neutral (C) photoredox reactions 
 
molecular orbital (HOMO) can fill the newly-created singly occupied molecular orbital 
(SOMO) at the metal whereas in the latter situation, the excited electron can be donated 
into the substrate’s lowest occupied molecular orbital (LUMO). On the other hand, organic 
photocatalysts such as the acridinium (2.3) and phenothiazine dyes (2.4) engage in PET via 
excited state redox changes on the organic framework. In the cases of 2.3 and 2.4, these 
species have specific excited state behavior, and thus do not participate in their respective 
diametrically opposite redox reactions (i.e. excited state reduction and oxidation). 
 The efficiency of a photoredox catalyst is highly dependent on the stability of the 
chromophore. Covalent modifications on the ligands for the transition metal or on the 
organic core of dyes can inhibit MLCT or PET. Thus, it is crucial to consider potential 
deactivation pathways when designing new photocatalysts. The development of acridinium 
photocatalysts serves a case study, as structural modifications have improved catalyst 






































effectively utilized in a myriad of photoredox transformations7, however the N-methyl 
moiety on the acridinium is a potential liability in the presence of a strong nucleophile.8  
 
Table 2.1. Photophysical properties of several transition metal and organic photoredox 
catalysts 
 
Demethylation results in net deactivation of the photooxidant, thus resulting in an 
ineffective catalyst. Substitution of the methyl for a phenyl group and increasing 
substitution on the aromatic core results in a more stable photocatalyst 2.6 that is able to 
catalyze anti-Markovnikov alkene hydrofunctionalizations with mineral acids.9 However, 2.6 
is still prone to covalent functionalization by polar or radical mechanisms at the 3 and 6 
positions of the aromatic core. Substituting the 2,7-dimethyl groups for 3,6-di-tert-butyl 
groups (2.3) prevents substitution at these electrophilic sites and yields a more robust 
catalyst. Instead, catalyst modification occurs at mesityl group, which is activated when the 
acridinium ion is in its charge-transfer excited singlet state.10,11 These post-modified species 
do exhibit photocatalytic activity under irradiation, thus indicating that they may not be 
catalytic dead ends.12 In summary, the evolution of the acridinium photocatalyst scaffold 
has yielded derivatives that demonstrate greater tolerance to reactive radical or polar 









































B. Organic Photoredox CatalystsA. Transition Metal Photoredox Catalysts




Figure 2.3. Structural changes to acridinium-based photoredox catalysts improve their 
stabilities towards reactive species. 
 
2.5 Selected Examples of Photoredox-Catalyzed Reactions 
 Having covered the basics of photoredox catalysis, it is instructive to highlight 
several notable examples in the context of synthetic chemistry. A common theme among 
these reactions is that substrate activation by either an excited state photooxidant or 
photoreductant generates a reactive organic radical or radical ion. Thus, the following 
subsections cover the different uses of these species in either reaction methodology 
development or total synthesis.  
2.5.1 Metallophotoredox Catalysis 
 The merger of photoredox and transition metal catalysis, termed “metallophotoredox 
catalysis” takes advantage of the unique substrate activation modes provided by visible-
light photocatalysis and the well-developed catalytic cycles of transition metals. One key 
highlight is the first example of a C(sp2)–C(sp3) cross-coupling between alkyl radicals and  






















































2014.13,14 In MacMillan and Doyle’s transformation (Scheme 2.2A), an alpha amino radical 
(2.7) is generated from photoredox-catalyzed decarboxylation of the parent amino acid with 
excited state Ir(III) photooxidant 2.8. 2.7 then enters the catalytic cycle by  
 
Scheme 2.2. Metallophotoredox-catalyzed C(sp2)–C(sp3) cross-couplings of a-amino 
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combining with the nickel (II) complex 2.9, which is generated in situ from oxidative  
addition of an aryl halide to a Ni(0) species. Reductive elimination of the Ni(III) 
intermediate 2.10 yields the desired cross-coupled product and a Ni(I) complex, the latter 
of which is simultaneously turned over by oxidizing the Ir(II) species 2.11 to ground state 
2.8. The Molander example (Scheme 2.2B), which is a formal C(sp2)–C(sp3) cross-coupling 
between benzyl trifluoroborates and aryl halides, follows a similar mechanism to MacMillan 
and Doyle’s report, with the key exception being the use of the excited state Ir(III) species 
2.12 to generate benzyl radicals 2.13 from the parent trifluoroborates 2.14. 
 Since these initial reports, significant investment has gone into using the oxidative 
and reductive platforms provided by photoredox catalysis for the diversifying the pool of 
applicable alkyl radicals15,16 and for the activation of traditionally organometallic 
intermediate cul-de-sacs.17,18 Future directions for this area should also see its application to 
biologically relevant systems19 with the goal of enabling bioorthogonal methodologies for in 
vitro and in vivo systems.20 
2.5.2 Proton-Coupled Electron Transfer 
 The selective generation of carbon- and heteroatom- centered radicals is an 
important strategy for the discovery of new reaction methodologies proceeding by open- 
shell pathways and their application in total synthesis.21,22 One method for generating these 
reactive intermediates is HAT from C–H and heteroatom–hydrogen (Het–H) bonds to an 
appropriate H-atom acceptor. While the catalytic activation and functionalization of aliphatic 
C–H bonds is well-studied23–25, there is a relative lack of analogous insights into the 
homolytic cleavage of Het–H bonds (e.g. O–H, N–H bonds).26 This gap in the literature 
primarily stems from thermochemical difficulties of selective HAT from O–H and N–H bonds 
in the presence of weaker C–H bonds.27,28 One strategy for circumventing this problem is 
the use of proton-coupled electron transfer (PCET), which is an elementary step by which  
concerted transfer of an electron and a proton occur such that a formal HAT is obtained.29   
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For example, the formation of an amidyl radical via HAT of an amide N–H bond is 
thermodynamically challenging [BDFE(N–H) ~ 100 kcal/mol] (Figure 2.4A). However,  
 
Figure 2.4. Proton-coupled electron transfer (PCET) activates traditionally strong amide N–
H bonds (A); The application of PCET to total synthesis of (–)-calycanthidine (B) 
 
electron-transfer from the N–H bond to a metal single electron oxidant coupled to a 
deprotonation event enables favorable amidyl radical formation.30 While a ground state 
oxidant might be too reactive in the presence of labile C–H bonds, a photoactivated oxidant 
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photoredox-catalyzed PCET strategy (Figure 2.4B), in which an excited state Ir(III) 
photooxidant 2.15 and an enantioenriched phosphate 2.16 engage in PCET with a 
tryptamine derivative (2.17) to provide a phosphate-stabilized indole radical cation 
(2.18).31 Intermediate 2.18 then undergoes enantioselective trapping of TEMPO and 
subsequent amino-cyclization of iminium ion 2.19 to yield the enantioenriched product 
2.20. An equivalent of TEMPO then turns over the catalytic cycle by regenerating the 
ground state 2.15. Knowles and co-workers then elaborate 2.20 to the pyrroloindoline 
natural product (–)-calycanthidine in three additional steps.  
2.5.3 Ion Radicals in Photoredox Catalysis 
 The chemistry of cation radicals and anion radicals is relatively underappreciated in 
comparison to the well-studied systems of polar intermediates or neutral radicals.2 A key 
reason for their underutilization in organic synthesis is a historical lack of straightforward 
methods for generating these reactive species. However, recent advances in 
electrochemistry and photochemistry have revitalized an interest in ion radicals by 
improving access to these intermediates. The following three examples highlight the 
application of three different cation radicals generated by the oxidative photoredox catalysis 
manifold. For brevity’s sake, a discussion of reductive photoredox catalysis is omitted, but 
their utility in organic synthesis is noteworthy.2,7,32 
 The catalytic addition of heteroatoms to olefins are an important organic 
transformation and thus have been studied in great detail.33,34 Markovnikov selectivity — 
nucleophilic addition to the most substituted carbon — is often observed due to the innate 
polarization of the alkene. Subverting this functionalization pattern thus requires a polarity 
reversal of alkene character. One approach to this problem is the single electron oxidation 
of olefins to generate reactive alkene radical cations.35 Photoredox catalysis can be used for 
the formation of alkene radical cations, which proceeds via PET from an electron-rich alkene 
to a photooxidant.36,37 These intermediates display umpolung reactivity patterns, such as 
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the anti-Markovnikov addition of nucleophiles to olefins. This reaction mode was utilized by 
Stephenson and co-workers in 2018, where a formal anti-Markovnikov amino arylation was  
 
Scheme 2.3. Photoredox-catalyzed anti-Markovnikov amino-arylation of styrene derivatives 
with arylsulfonylacetamides. 
 
achieved using electron-rich alkenes and arylsulfonylacetamides (Scheme 2.3).38 The 
alkene cation radical 2.22 of anethole (2.21) is formed via PET from the olefin to the 
excited state Ir(III) photocatalyst 2.23. Intermolecular trapping of 2.22 with an 
arylsulfonylacetamide equivalent 2.24 occurs at the terminal position, thus generating the 
more stabilized benzyl radical 2.25. This intermediate can then undergo a Smiles–Truce 
1,5-aryl shift,39 followed by concurrent reduction and catalyst turnover to provide the 
desired amino-arylated product 2.26. This transformation is highly diastereoselective and 
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the methyl and para-methoxyphenyl (PMP) substituents is adopted prior to the 1,5-aryl 
shift.38 This conformation avoids unfavorable interactions between the methyl and PMP 
groups that would arise from the transition state (2.28) leading to the minor diastereomer. 
 The amine cation radical motif has gained interest in the synthetic community due to 
its heightened electrophilicity relative to the parent amine or a neutral aminyl radical, which 
in turn enables the discovery of new reaction manifolds.40 One particularly useful outcome 
of these species is the formation of an α-amino radical, which is obtained after 
deprotonation of a C–H bond adjacent to the amine cation radical. Electron-rich amines 
were initially required for PET as excited-state Ru- and Ir-based photocatalysts41–43 were 
inefficient photooxidants for carbonyl-protected amines, however Nicewicz and co-workers 
have recently reported the use of highly-oxidizing acridinium dyes have enabled PET from  
 
Figure 2.5. Photoredox-catalyzed a-functionalization of carbamates mediated by acridinium 
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carbamate-protected amines (Figure 2.5A).44 A representative example is given in Figure 
2.5B, wherein N-Boc protected piperidine undergoes single electron oxidation with excited  
state acridinium 2.29 to generate amine cation radical 2.30. Intermediate 2.30 then 
undergoes facile deprotonation to generate the α-carbamyl radical 2.31, which is a 
competent trap for methyl vinyl ketone. The intermediate 2.32 generated from radical 
recombination turns over acridine 2.33 to provide the desired product and restart the 
catalytic cycle. Furthermore, this transformation can be applied in the total synthesis of  
monomorine I (2.34). Using enantioenriched (S)-N-Boc-2-methylpiperidine, efficient α-
functionalization with butyl vinyl ketone affords intermediate 2.35, which was elaborated to 
2.34 by a facile two-step deprotection-reductive cyclization procedure. This sequence 
affords the desired natural product as a single diastereomer in good yield (Figure 2.5A). 
 Amine cation radicals have also been utilized in the translational research, namely 
the development of isotopically-labeled pharmaceuticals. The introduction of hydrogen 
isotopes — deuterium (2H, D) and tritium (3H, T) — into drug candidates is routinely used in 
the medicinal chemistry to study the absorption, distribution, metabolism and excretion 
(ADME) properties of drug candidates,45,46 as well as their in vivo localization via 
autoradiography.47 The synthesis of these isotopically-labeled molecules is typically 
accomplished using transition metal-catalyzed methods and has been limited to the 
deuteration and tritiation of aromatic C–H bonds.48,49 In 2017, MacMillan and co-workers 
reported a photoredox-catalyzed method for the deuteration and tritiation of amine 
containing pharmaceuticals (Figure 2.6A).50 Substituted amines are ubiquitous motifs in 
pharmaceuticals51 and natural products,52 thus making them viable candidates for 2H- and 
3H-labeling via α-amino radical intermediates. Amine cation radicals are generated via PET 
of substituted amines to excited state organic photooxidant 1,2,3,5-tetrakis(carbazol-9-yl)-
4,6-dicyanobenzene (2.36, 4Cz-IPN) and are subsequently converted to α-amino radicals 
(2.37) after deprotonation (Figure 2.6B). D- and T-atom transfer from a deuterated or 
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tritiated triisopropylsilanethiol (2.38) yields the respective 2H- and 3H- labeled products. 
The resultant thiyl radical (2.39) turns over the reduced photocatalyst (4Cz-IPN•, 2.40)  
 
Figure 2.6. Deuteration and tritiation of amine-based molecules via photoredox catalysis  
 
with concurrent reduction to the thiolate (2.41); 2.38 is then regenerated with a respective 
equivalent of D2O/T2O. Deuterated/tritiated thiol 2.38 can also be obtained from the parent 
2.42 by D–H or T–H exchange. While pure D2O is readily available, appreciable amounts of 
high molar activity, H2O-less T2O were obtained in-situ from T2 gas (2.43, 1.0 Ci scale) and 
PtO2 in N-methyl-2-pyrrolidone (NMP) (Figure 2.6C). In the representative example of the 
antidepressant Clomipramine (2.44), moderate to high selectivity is observed for 2H- and 
3H- labeling of α-carbons in tertiary amines motifs over other functional groups (2.45 and 
2.46). Some competitive deuteration and tritiation is observed at weak benzylic C–H bonds, 
which presumably occurs through D/T-atom exchange with the thiyl/thiolate moieties53. 
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CHAPTER 3: SITE-SELECTIVE C–H AMINATION VIA ORGANIC PHOTOREDOX 
CATALYSIS 
 
Adapted from Romero, N. A. Margrey, K. A.; Tay, N. E.; Nicewicz, D. A. Science 2015, 349 
(6254), 1326–1330. Copyright 2015 by the American Association for the Advancement of 
Science. 
 
3.1 Background: Arene Amination 
Arene functionalizations are arguably one of the most important transformations 
developed within the past century. Its importance in organic synthesis is paramount; aryl 
C–C and C–Het bonds are ubiquitous in the aromatic backbone of many pharmaceuticals, 
agrochemicals and natural products synthesized on the milligram to ton scale. 
Consequently, chemists have sought methods of forming these bonds selectively within 
aromatic molecules. The continued relevance of aryl functionalizations serves as a 
testament to their efforts, with classical examples such as the SNAr and SEAr reactions 
setting the path forward for contemporary transition metal catalysis. Recent advances in the 
selectivity and efficiency of metal-catalyzed coupling reactions have thus established it as a 
cornerstone of aryl C–Het bond formation.  
Among the myriad of aryl C–Het forming transformations, C–N bonds are among the 
most valuable. Arylamines are ubiquitous in pharmaceuticals, natural products, 
agrochemicals, pigments, and optoelectronic materials.1,2 Modern transition-metal catalysis 
has provided numerous ways of accessing aryl C–N bond formation, the most prominent of 
which are the Ullmann-type, Buchwald-Hartwig and Chan-Lam aminations (Figure 3.1A).2–4 
While cross-coupling remains the gold standard for aryl C–N bond formation, its use of pre-
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waste. Furthermore, late-stage installation of an appropriate cross-coupling handle may be 
difficult, which would thus lead to a less efficient synthetic route. Consequently, there has 
been a great interest in developing analogous aryl aminations that target unactivated 
aromatic C–H bonds. 
Aryl C–H functionalization promises more efficient, streamlined and sustainable 
syntheses; however, regioselective activation of relatively inert C–H bonds is still a major 
challenge. Intermolecular ortho C–H amination has been realized via DG controlled 
transition-metal catalysis. Representative examples of work in this area include methods 
developed by Yu, Carretero, and Chang5–7 in which carbonyl-appended groups direct ortho-
selective installation of C–N bonds within aromatic systems (Figure 3.1B). 
 
Figure 3.1. Selected examples of aryl C–N bond formation 
 
Transition-metal catalyzed, non-directed methods for aryl C–N bond formation with 
imides have been developed by Ritter, Baran and Itami (Figure 3.1C).8–10 While moderate 
to excellent yields are typically observed, high regioselectivity is limited to heteroaromatic 
molecule as regioisomeric mixtures are often observed in non-heteroaromatic systems. 
Researchers have also explored aryl C–N forming methods without transition metals. Work 
by Chang, DeBoef, and Sanford illustrate the successes of this approach, albeit its limitation 
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to C–H imidation (Figure 3.1C).11–13 These transformations operate via the formation of N-
centered phthalimidyl species which recombine with arenes non-selectively to give a 
mixture of aminated products. 
3.2 Strategies for Reaction Development 
In developing a method for arene C–H amination, we were interested in using arene 
cation radicals as the electrophile for nucleophilic substitution. The immediacy of arene 
cation radical species has been implicated in the enzymatic degradation of lignin,14 while 
Kochi and co-workers first extensively studied the cation radical’s stability in aromatic 
systems.15,16 Furthermore, anodic oxidation has been used to generate aryl radical cations, 
which are then trapped by range of nucleophiles.17–19 Most notably, Yoshida and co-workers 
have recently developed two electrochemical methods for aryl amination, forming N-aryl 
imidazoles20 and anilines21 respectively (Figure 3.1D). However, over-oxidation is a 
persistent problem in many of these examples, as the high concentrations of stationary 
radical cations lead to undesirable reactivity.22 An alternative method of generating cation 
radicals would be through photoredox catalysis, which allows for greater selectivity and 
control in producing open-shell species.  
 
Figure 3.2. Anti-Markovnikov alkene hydrofunctionalization protocol (A) and the proposed 
aryl C–H functionalization sequence (B). 
 
 Research in the Nicewicz lab has centered on the use of organic dyes as oxidative 
photoredox catalysts. Utilizing Fukuzumi’s 9-mesityl-10-methylacridinium (Mes-Acr+),23 we 































The proposed mechanism proceeds via single-electron oxidation of an alkene by excited-
state Mes-Acr (Mes-Acr*+) to generate a transient alkene radical cation species, which is 
then trapped by an amine before subsequent HAT from an hydrogen atom donor, affording 
the anti-Markonikov hydroamination product (3.1). With the success of our alkene 
hydrofunctionalization method, we were interested to apply the same functionalization 
strategy to aromatic molecules (Figure 3.2B) via the analogous aryl cation radical (3.2). 
Fukuzumi and co-workers have proposed the formation of aryl radical cations in prior 
photocatalytic arene bromination and fluorination protocols.26,27 Thus, we anticipated the 
feasibility of generating the arene cation radical via photoinduced electron transfer (PET) 
and trapping it with a nucleophile before subsequent deprotonation and oxidation to provide 
the functionalized arene (3.3). We proposed that an arene cation radical could serve as a 
key reactive intermediate in a direct, intermolecular C–H aryl amination. We believed that 
an amine could form s-adduct 3.5 with an arene cation radical 3.4, generated upon 
photoinduced electron transfer (PET) from the arene to an excited-state photoredox catalyst 
(cat*) (Fig. 3.3).25,28–31 The subsequent deprotonation of distonic cation radical 3.5, 
followed by oxidative aromatization of intermediate 3.6, would deliver the desired aminated 
arene. As this process constitutes a two-electron and two-proton loss, an equivalent of a 
two-electron oxidant would be required for each photocatalyst turnover. We identified  
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dioxygen (O2) as a suitable terminal oxidant that would both regenerate cat* and 
rearomatize 3.6, thus turning over the catalytic cycle and furnishing the desired product.  
In the initial screens for reactivity, commercially available acridinium catalysts 3.7A 
and 3.7B were used (Table 3.1) as they have highly positive excited-state reduction 
potentials (E*red = +2.20 and +2.09 V vs. SCE respectively) and are robust in the presence 
of strong nucleophiles. Pyrazole (3.8) and anisole (3.9) were selected as a representative 
azole nucleophile and arene coupling partner. Under the conditions given in Table 3.1, only 
2% of the C–N–coupled arene adduct (3.10a and 3.10b) was observed in the absence of 
oxygen. However, when the reaction was run under a balloon of O2, a combined 47% yield 
of 3.10a and 3.10b was observed, with good para:ortho selectivity (ratio of 6.7:1). 
Subsequent first-pass optimization efforts involving changes to catalyst, concentration, 
solvent, or other oxidants produced no yield improvements (Table 3.1, entries 3-9). This 
plateau in yield can be traced to several causes. First, aryl amine products 3.10a and 
3.10b (Ep/2 = +1.50 V vs. SCE) possess lower oxidation potentials than anisole does (Ep/2 = 
+1.87 V vs. SCE), thus 3.10a and 3.10b could competitively reduce excited-state 
acridinium (cat+*), resulting in product inhibition. Second, analysis of the reaction mixture 
revealed that phenyl formate was the major byproduct, indicating that, in addition to 
product inhibition, undesirable oxidative side reactions with the arene were competing with 
the desired reaction pathway. Third, after failing to detect catalyst A or B in crude 1H NMR 
spectra, we questioned the stability of the catalyst under the reaction conditions.  
Since both anisole (3.8) and acridinium are susceptible to degradation in the 
presence of oxygen-centered radicals;32 we surveyed a number of additives that could 
mitigate the formation of any highly reactive radical intermediates, such as peroxyl radicals. 
We found that 10 mol % of 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) improved the 
yield of 3.10a and 3.10b to 65%. We also observed that the remaining mass balance was 
almost entirely unreacted anisole. Increased equivalents of TEMPO afforded a yield of 74% 
that decreased with higher loadings (Table 3.1, entry 12). As an additional measure to 
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prolong the viability of the acridinium catalyst, we modified the acridinium structure to 
confer stability against undesirable addition of nucleophiles or radicals (9-mesityl-3,6-di-
tert-butyl-10-phenylacridinium tetrafluoroborate, 3.7C). The use of this catalyst provided 
the best results to date, producing 3.10a and 3.10b in 88% yield (6.9:1 p-/o-) after 20 
hours. A 97% yield was achieved under an atmosphere of air after irradiation for 3 days 
(Table 3.1, entry 16). With these results in hand, an examination of compatible arenes and 
azoles was undertaken. 
3.3  Arene and Azole Scope for Photoredox-catalyzed C–H Arene Amination 
The optimized conditions were successfully extended to the coupling of pyrazole with 
a variety of monosubstituted aromatics, including MOM–, TBS–protected phenols and 
biphenyl (3.10 to 3.14, 3.17; Figure 3.4). Halogenated anisole derivatives were excellent 
substrates for the transformation and afforded N-arylpyrazoles 3.18 and 3.19, with 
complete regioselectivity para to the methoxy substituent. Likewise, regiochemical 
discrimination is possible on biaryls bearing electronically distinct aromatic groups. Despite 
the availability of eight unique aryl C–H bonds in 2-chloro-2'-methoxy-1,1'-biphenyl, biaryl 
3.20 was formed in 75% yield, with completely site-selective addition para to the methoxy 
group, which is reflective of the electronic influences on this arene manifold. Heterocycles 
bearing electron-releasing substitution are competent substrates: Dimethoxypyridine 3.21 
and methoxyquinoline 3.22 were isolated in modest yields but as single products. 
Heterocyclic motifs such as quinazoline dione, 1-methyl indazole, and dihydrocoumarin 
readily underwent C–H amination with pyrazole to produce adducts 3.23 to 3.25. In all 
cases, regioselectivity ratios of >15:1 were observed.  
One of the challenges associated with the oxidative functionalization of arenes is the 
presence of weak benzylic C–H bonds, which have a documented propensity for H-atom 
and/or proton loss at these positions in arene cation radicals.22 For example, under the 
electrochemical oxidation conditions,20 alkyl-substituted arenes undergo benzylic amination 
over aryl amination. Initial attempts at applying the previously optimized conditions to the 
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coupling of pyrazole with mesitylene were hampered by competitive benzylic oxidation to 
the aryl aldehyde, a reaction pathway which has been previously  
 
Table 3.1. Reaction optimization table for site-selective C–H arene amination of anisole 
with pyrazole. 
 
Documented.33 Excluding O2 suppressed benzylic oxidation and increasing the TEMPO 
loading to 1.0 equivalent enabled the addition of pyrazole to the aromatic ring of 
mesitylene, forming 3.15 in excellent yield (82%) with no products resulting from benzylic 
oxidation observed. Likewise, m-xylene reacted under these conditions, albeit in lower 
yields (36%); the remainder of the mass balance was identified as unreacted starting 
material. Modest yields are notable given the oxidation potential of m-xylene (Ep/2 = +2.28 

















3.7A; R = R' = H; E*red = +2.20 V
3.7B; R = Me; R' = H; E*red = +2.09 V








entry additive catalyst solvent [M] yield 3.10a:3.10b
none 3.7A DCE [0.25] 47% 6.7:12
none 3.7B DCE [0.25] 37% 3.6:16
PhI(OAc)2 (1.0 equiv) 3.7B DCE [0.25] 20% 4.1:17
BQ (1.0 equiv) 3.7B DCE [0.25] 18% 6.9:18











TEMPO (0.1 equiv) 3.7B DCM[0.25] 65% 6.7:110
TEMPO (0.2 equiv) 3.7B DCM[0.25] 74% 6.2:111
TEMPO (0.5 equiv) 3.7B DCM[0.25] 45% 6.3:112
TEMPO (0.2 equiv) 3.7A DCM[0.1] 61% 6.8:113
TEMPO (0.2 equiv) 3.7B DCM[0.1] 79% 6.7:114
TEMPO (0.2 equiv) 3.7C DCM[0.1] 88% 6.9:115
TEMPO (0.2 equiv) (air)* 3.7C DCM[0.1] 97% 7.5:116
33 °C, O2 (1 atm)
none 3.7A MeCN [0.25] 6% 2.0:13
none 3.7A MeOH [0.25] 4% 1:2.94




no O2 3.7A DCM [0.25] 2% –1
Reactions run with 1.0 equiv of anisole and 2.0 equiv of pyrazole. *Reaction run for 68 h. E*red values for 3.7A-C vs. SCE
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acidity of alkylbenzene cation radicals (pKa [PhMe]+• = –20, where Ka is the acid 
dissociation constant34), it is remarkable that productive aryl C–H amination occurs for 
mesitylene and m-xylene.  
 
Figure 3.4. Arene scope for site-selective C–H amination with pyrazole. 
 
Azoles are a privileged structural unit in pharmacologically active compounds35,36 and in the 
architectures of transition metal–catalysts and organocatalysts. Yet the most reliable 
methods for constructing aryl-azoles require at least two synthetic steps. We found that a 
diverse range of N-heterocyclic nucleophiles could be directly coupled to an arene by our 
reaction protocol. In addition to pyrazoles (3.26 to 3.28), we found that 1,2,3- and 1,2,4-
triazoles (3.29, 3.31), tetrazole (3.30), imidazole and benzimidazole (3.32 and 3.35), 
benzotriazole (3.33), and tetrahydroindazole (3.34) produced good to excellent yields of 
the C–N adducts (53 to 85%). A di-Boc–protected adenine gave nearly quantitative yields 
(99%) of purines (3.36) in a 1.1:1 N-regioisomeric ratio. Furthermore, the successful 
synthesis of 3.37 from the coupling of Boc-histidine methyl ester with 3.9 offers a new 
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3.11 R = –OMOM; 52% yield; 7.8:1 p:o
3.12; R = –OTBS; 74% yield; 9.3:1 p:o
3.13; R = –Ot-Bu; 63% yield; 6:1 p:o
3.173.10; R = –OMe; 88% yield; 8.8:1 p:o
3.14 R = –OPh; 86% yield; 11:1 p:o
3.16 (R = –H)
3.18 3.19
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strategy for the modification of biologically relevant structures containing this amino acid 
motif. 
 
Figure 3.5 Azole scope for site-selective C–H amination with anisole. Parenthetical ratios 
refer to para:ortho (p:o) selectivity for the given N-isomer.  
 
To evaluate whether this catalyst system could be applied to late-stage 
functionalization, we tested the C–N bond–forming protocol with the representative complex 
molecules, shown in Figure 3.6. When reacted with pyrazole, O-acetylcapsaicin, naproxen 
methyl ester, and dihydroquinidine·trifluoroacetic acid (DHQD·TFA) were transformed into 
single regioisomers of the adducts (3.38 to 3.40). Despite heteroatom substitution at the 
benzylic position, no oxidation of the benzylic C–H bonds was observed in either O-
acetylcapsaicin or DHQD·TFA in the reactions forming 3.38 and 3.40, respectively. 
Likewise, naproxen methyl ester contains a sensitive benzylic C–H bond that remains 
undisturbed in the coupling reaction. Overall, the successful coupling of a wide range of 
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AZOLES | ARENE = anisole
3:1 p:o 1:1 N1 (10:1):N2 (>20:1) 5:1 p:o
85% yield; 7.5:1 p:o
73% yield; 3.6:1 N1 (6:1):N2 (8:1)
1.1:1 N4 (4:1): N1 (4.5:1)
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arenes and azoles demonstrates the mildness and practicality of this arene amination 
protocol.  
 
Figure 3.6. Complex molecule derivatization with pyrazole. 
 
3.4  Aniline Synthesis via Photoredox-catalyzed C–H Arene Amination 
Traditional methods for aniline synthesis have involved either nitration-
hydrogenation sequence or SNAr via a benzyne species. A C–H amination protocol of 
benzene with ammonia, developed by DuPont, employs a NiO-ZrO2 catalyst system at 350 
°C and 300-400 atm, furnishing aniline in a 14% maximum yield.37,38 More recently, aniline 
syntheses via transition metal catalysis have been reported, where aryl halides are coupled 
with either ammonia or ammonium salts.39–41 Anodic oxidation has also been used to 
generate anilines, where pyridine is used as the C–N aryl coupling partner before a Zincke 
reaction with piperidine affords the products21. Given this precedent, we were interested in 
applying our C–H amination method to aniline synthesis. Starting with 5 mol% of 9-mesityl-
2,7-dimethyl-10-phenylacridinium tetrafluoroborate (3.7B, Table 3.2), 20 mol% of 
2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) in DCE under aerobic conditions, we 
obtained a combined GC yield of 23% for p-anisidine (3.41a) and o-anisidine (3.41b) from 
3.9 and ammonium fluoride. Encouraged by this result, we initiated an optimization of this 
transformation. An initial screen of commercially available ammonium salts led to an 
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evaluation of the basicity of the ammonium counterion, as well as the solubility of the salts 
in DCE. Since controlling the equilibrium between free and protonated ammonia is crucial in 
generating an effective concentration of nucleophile, we hypothesized it would be  
 
Table 3.2 Reaction optimization table for anisidine synthesis from anisole 
 
reasonable to correlate availability of free ammonia with counterion basicity. However, we 
only observed a weak correlation between counterion basicity and the anisidine yield (Table 
3.2, entries 1-5). Next, the solubility of the ammonium species was explored due to their 
relative insolubility in DCE. Ethereal and polar aprotic solvents were able to solubilize 
ammonium carbonate more effectively, yet they did not improve the reaction as the 
observed yields were lower than those in DCE (Table 3.2, cf. entries 3, 6, 7; cf. 4 and 8).  
However, when a solvent mixture of 10:1 DCE:H2O was used, an increase in yield 


















3.7B; R = Me; R' = H




entry ammonia source catalyst solvent [M] yield† 3.41a:3.41b
3.7B DCE [0.10]  15% 1:12
3.7B DCE:H2O [0.10]* 43% 1.6:19
3.7C DCE:H2O [0.10]* 45% 1.5:111
23 °C, O2 (1 atm)
3.7B DCE [0.10] 26% 1:1.53
3.7B DCE [0.10] 35% 1:14


















Reactions were performed using anisole (0.460 mmol), catalyst Mes-Acr A or Mes-Acr B (5 mol %), TEMPO (0.2 equiv)
* A 10:1 ratio of DCE:H2O was utilized as the solvent system.
†Yields determined by gas chromatography analysis using 3-bromotoluene as the internal standard
X refers to the respective ammonium countertion for each entry
3.7B DCE [0.10] 0% NA5 (NH4)2SO4, 2 equiv







3.7B THF [0.10] 6% 1:1.36 NH4HCO3, 2 equiv
3.7B TFT [0.10] 19% 1:1.37 NH4HCO3, 2 equiv
3.7C DCE:H2O [0.10]* 58% 1.4:114 NH4O2CNH2, 4 equiv
3.7B DCE:H2O [0.10]* 47% 1.4:112 NH4O2CNH2, 4 equiv
3.7C DCE:H2O [0.10]* 40% 1.2:113 (NH4)2CO3, 4 equiv






solubilizing the ammonium salts and effective solvent medium is necessary. Increasing the 
equivalents of ammonium carbonate did not have a significant impact on the yield (Table 
3.2, cf. entries 10 and 12), thus alternative sources of ammonia were examined. An 
examination of ammonium carbonate’s industrial origins reveals that commercial supplies 
are mixtures of ammonium bicarbonate and ammonium carbamate.42 No dramatic change in 
yields were observed with switching from the carbonate moiety to ammonium carbamate 
(43% vs. 46% cf. entries 9 and 10). However, a permanent switch to ammonium carbamate 
as the primary aminating source was made with an intent to maintain reagent purity 
throughout the transformation.  
 
Figure 3.7. Hypothesized effect of acridinium-substitution on catalyst stability. 
 
Throughout our studies, we were concerned about the stability of 3.7B during the 
reaction. Nucleophilic attack at the 3- or 6- positions of the acridinium would irreversibly 
deactivate the catalyst or form an inactive off-cycle species (Figure 3.7).43 The discovery of 
catalyst 3.7C was crucial as we theorized that the relative steric bulk of the tert-butyl 
groups would either inhibit nucleophilic approach at the 2- or 7- positions or mitigate any 
potential lifetime as an off-cycle covalent species. With 3.7C in hand, we examined its 
impact on the reaction yield. At lower loadings of ammonium carbamate (2.0 equiv), we 
observed little difference in yields (Table 3.2, cf. entries 10 and 11), but upon doubling the 
amount of nucleophile a significant increase in yield was observed (47% to 58%, Table 3.2 
cf. entries 12 and 14) thus substantiated our catalyst stability hypothesis. Upon final 
optimization, we obtained a 58% yield of 3.41a and 3.41b from 3.9 in a 1.4:1 ratio (Table 


































 Throughout the optimization process, we observed incomplete conversion of the 
starting material to the product. This could indicate potential product inhibition, as the 
anisidine formed could reversibly deactivate the catalyst. Alternatively, the products could 
compete with the substrate for PET with excited-state 3.7C. Since the anilines formed are 
more oxidizable than the parent anisole [Ep/2(anisidine) < Ep/2 (anisole)] competitive PET 
pathways should emerge as ratio of product to substrate increases (Figure 3.8).  
 
Figure 3.8. Electrochemical rationale for potential product inhibition via competitive PET. 
 
 
Table 3.3. Hypothesized product inhibition by 3.41a or 3.41b on the amination of 3.9. 
 
We tested this hypothesis by adding increasing amounts of either 3.41a and 3.41b 





































Ep/2 ~ 0.8 V


















entry 3.41a or b (mol %) yield 3.41a (%)† yield 3.41b (%)† total yield (%)†
12% 11% 23%1
trace 9.5% 9.5%3





Reactions were performed using anisole (0.460 mmol), catalyst  (5 mol %), TEMPO (0.20 equiv); *A 10:1 ratio of DCE:H2O
†Yields determined by gas chromatography analysis using 3-bromotoluene as the internal standard
14% trace 14%6 B (100)
16% 11% 27%4 B (20)
21% 7.9% 28%5 B (50)
3.2% 9.6% 13%2 A (50)
3.41a
3.41b


















whereas the effect is less pronounced with 3.41b (Table 3.3, cf. entries 1–3 with entries 
4–6). One possible explanation for the observed inhibition selectivity with 3.41b is its 
relative nucleophilicity to 3.41a. Given the relative steric bulk of 3.41b, 3.41a might be 
more likely to covalently deactivate the photocatalyst, however we currently do not have 
any evidence for this hypothesis. Nevertheless, product inhibition is observed for both 
3.41a and 3.41b, indicating that product inhibition is limiting the full conversion of 
substrate to product. 
 Upon the conclusion of reaction optimization, a representative set of oxidizable 
arenes was used to demonstrate the generality of the amination protocol. Aryl ethers, 
protected phenols and biphenyl (Figure 3.9, 3.41 to 3.45) were found to be good coupling 
partners and the chromatographically-inseparable products were obtained with modest 
selectivity for the p-isomer. Higher regioselectivities and good yields were observed for the 
aminated products of 2-chloroanisole, N-methylindazole, and 6-methoxyquinoline (Figure 
3.9, 3.46 to 3.48). While the substrate scope is not as extensive as that reported for C–H  
 













63% yield; 2.1:1 p:o 44% yield; 3.9:1 p:o 62% yield; 2.9:1 p:o 59% yield; 1.6:1 p:o









1.0 equiv 4.0 equiv
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(0.20 equiv)






























3.41 3.42 3.43 3.44
3.45 3.46 3.47 3.48
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amination reaction with azoles, this amination protocol should be translatable to the other 
substrates reported. The origins of the regioselectivity observed are currently unknown and 
warrant further study. Qualitative arguments for regioselectivity posited by Yoshida and 
Fukuzumi suggest that nucleophilic attack preferentially occurs at the site with the more 
stabilized radical cation, as respectively shown by lowest unoccupied molecular orbital 
(LUMO) or relative atomic charge models of radical cation.21,26 However, their explanations 
do not account for steric effects and may not hold for more complex systems. Thus, future 
mechanistic studies will attempt to elucidate the origins of regioselectivity. 
 A proposed mechanism (Scheme 3.1) for the reaction is as follows. Photoexcitation 
of Mes-Acr+ generates excited state (Mes-Acr+*), which oxidizes the arene via PET to 
generate the arene radical cation (3.2). Reduced Mes-Acr (Mes-Acr•) can then be oxidized 
back to Mes-Acr+ by molecular oxygen O2 to form superoxide. Trapping of the radical cation 
by ammonia (3.49) followed by deprotonation at the nitrogen leads to a radical 
Meisenheimer-like complex (3.50). This species can either undergo HAT with TEMPO to 
yield the aniline (3.51) and TEMPO-H, or rearomatization via the trapping of 3.50 with O2 to 
form 3.52, which can undergo subsequent intramolecular HAT to generate 3.51 and 
hydroperoxyl radical.44 TEMPO-H is regenerated upon reacting with superoxide, yielding a 
hydroperoxyl anion that can be protonated to form hydrogen peroxide. Other potential 
methods of regenerating TEMPO from TEMPO-H include HAT with either O2 or hydroperoxyl. 
Further mechanistic studies should clarify the catalytic role of several reagents as well as 
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CHAPTER 4: CATION RADICAL ACCELERATED NUCLEOPHILIC AROMATIC 
SUBSTITUTION VIA ORGANIC PHOTOREDOX CATALYSIS 
 
Reproduced with permission from Tay, N. E. S.; Nicewicz, D. A. J. Am. Chem. Soc. 2017, 
139 (45), 16100-16104. Copyright 2017 American Chemical Society. 
 
4.1 Introduction 
One of the most direct means of benzenoid functionalization is nucleophilic aromatic 
substitution (SNAr). Mechanistically, this transformation occurs by an addition–elimination 
sequence via a Meisenheimer complex and allows for selective cleavage of C–F or C–Cl 
bonds (Figure 1). Despite its prevalence in medicinal chemistry,1 the utility of SNAr is limited 
to select aromatics and heteroaromatics, as the formation of the Meisenheimer complex is 
highly endergonic and its stabilization requires electron-withdrawing groups at either the 
ortho or para positions of the arene.2 
We have established a research program studying the reactivity of arene cation 
radicals, generated by organic photooxidation catalysts, that undergo a series of  formal C–
H functionalization reactions with nucleophiles such as azoles, ammonia and cyanide.3,4 
These reactions proceed via photoinduced electron transfer (PET) from the aromatic 
substrate to an excited-state acridinium photooxidant to generate arene cation radicals. The 
natural population analysis (NPA) of anisole, a prototypical substrate in the aforementioned 
reactions, reveals a buildup of charge density in the cation radical at the methoxy-bearing 
carbon atom as well as the para- and ortho-carbon atoms (Figure 4.1).5 Cation radical 4.1 
is anticipated to be susceptible to reversible nucleophilic attack at either the ipso-, para- or 
ortho- positions relative to the methoxy group. We hypothesized that if a terminal oxidant is 
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omitted, ipso σ-complex 4.2 could undergo rearomatization after methanol extrusion to give 
an overall inverse electron-demand SNAr affording 4.3. This is in contrast to the previous C–
H functionalization pathways that occur via the para- or ortho-addition intermediates, as a 
second, irreversible oxidation step is required to form these adducts.3 Herein, we describe 
the development of a general means for activation of alkoxy arenes toward SNAr via single 
electron oxidation. Current methods for C–O bond functionalization of aryl methyl ethers 
rely primarily on nickel catalysis,6,7 with notable exceptions utilizing harsh acidic8 or basic 
conditions.9 Our proposed transformation presents an alternative paradigm for C–O bond 
functionalization via mild, transition metal-free catalysis. 
 
Figure 4.1. Challenges to using alkoxy arenes in SNAr chemistry (A) and a proposal for a 
photoredox-catalyzed cation radical-accelerated SNAr (B).  
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4.2 Results and Discussion  
We began our studies with 2,4-dichloroanisole as the aromatic substrate and 
imidazole as the nucleophilic coupling partner, using the acridinium photocatalyst A 
previously utilized in our arene C–H amination3 and cyanation4 protocols (Table B.1, 
Appendix B). Successful formation of the desired aminated arene 4.4 in a 95% yield 
(isolated yield = 79%) was realized with an excess of imidazole in an equivolume mixture of 
2,2,2-trifluoroethanol (TFE) and 1,2-dichloroethane (DCE) under anaerobic conditions. 
Control experiments established the importance of acridinium photocatalyst A as the 
amination product was not formed in the absence of light and photocatalyst, and decreased 
yields were observed with less structurally robust acridinium derivatives (catalysts B and 
C).10 Additionally, we reasoned that formation of the ipso product was promoted by the 
exclusion of oxygen from the system, as downstream aryl aromatization and deprotonation 
pathways for C–H amination would be eliminated. As anticipated, conducting the reaction 
under aerobic conditions displayed the sensitivity of the system to oxygen, as decreased 
yields were observed. 
The optimized conditions were then successfully applied to a range of halogenated 
methoxyarenes, a substrate limitation under current nickel-catalyzed conditions.11 2,4-Di-
halogenated anisoles were successfully transformed to corresponding N-arylimidazoles (4.5 
to 4.8) in good yield, with a tolerance for brominated and fluorinated anisoles observed 
(Figure 4.2). Interestingly, substitutive defluorination for 4.7 and 4.8 was observed under 
our reaction conditions, but its extent was substitution-dependent and an independent SNAr 
pathway for this competitive transformation was ruled out as defluorinative SNAr was not 
observed in the absence of light or acridinium (Table B.6, Appendix B).  
Mono-chlorinated, 2,4-substituted anisoles were also excellent substrates for this 
transformation, yielding the corresponding chlorinated N-arylimidazoles 4.9 and 4.10 in 
excellent yield. We were pleased to find that mono-substituted 4-chloroanisole and 2-
chloroanisole, as well as unsubstituted anisole provided the ipso-aminated products in 
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excellent to moderate yields (4.11 to 4.13). The latter two results are especially interesting 
as they display complementary selectivity to our previously reported C–H amination 
protocol. We were also able to transform several substituted methoxynaphthalenes to their 
N-naphthylimidazole counterparts, as 1-chloro-2-(1-imidazolyl)naphthalene 4.14 and 1-
cyano-2-(1-imidazolyl)naphtalene 4.15 were obtained in good and excellent yields 
respectively. Additionally, we discovered the amenability of benzyl aryl ethers as 
nucleofuges in this transformation, with 1-(benzyloxy)-2,4-dichlorobenzene affording the  
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4.21: R = OBn; 80% yield
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Arene = N-phthaloyl-O-methyltyrosine methyl ester
Amine = Boc-histidine methyl ester
Arene = N-phthaloyl-tyrosinemethyl ester
Arene = N-phthaloyl-4-methoxy-3-pivaloyl L-DOPA methyl ester
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4.4; R1 = Cl; R2 = Cl; 79% yield
4.5; R1 = Cl; R2 = Br; 57% yield
4.6; R1 = Br; R2 = Cl; 78% yield
4.7; R1 = Cl; R2 = F; 30% yielda
4.8; R1 = F; R2 = Cl; 56% yieldb
4.9; R1 = Cl; R2 = tBu; 87% yield
4.10; R1 = Cl; R2 = Ph; 99% yield
4.11; R1 = H; R2 = Cl; 93% yield
4.12; R1 = Cl; R2 = H; 64% yield




MeO 4.17; R = CO2Me; 92% yield (7:1 C4:C3)
4.18; R = CN; 99% yield (15:1 C4:C3)
4.19; R = OTf; 76% yield (2:1 C4:C3)
4.20; R = CHO; 44% yield (1:8 C4:C3)c
4
3
Reactions were run in a 1:1 mixture of 1,2-dichloroethane (DCE) and 2,2,2-trifluoroethanol (TFE) at [0.1 M] with respect to the arene. a26% of defluorinative 
amination product observed, see Appendix B for details. bTwo side products (11% combined) observed, see Appendix B for details. c10 mol % catalyst A 
used. d9:1 DCE:TFE solvent system. ‡Loss of –OBn.
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adduct 4.16 in excellent yield. Guaiacol and veratrole are monomeric units obtained from 
lignin valorization processes12,13 and their catechol core is prevalent in numerous plant and 
animal metabolites. Despite their structural ubiquity in natural and synthetic molecules, 
selective O-alkyl C–O substitutions in these motifs are elusive. Upon applying our reaction 
conditions to methyl veratrate, we observed a 92% yield for the aminated products 4.17 
with a 7:1 C4:C3 selectivity. Veratronitrile, 3,4-dimethoxyphenyl triflate, and 
veratraldehyde also provided the desired N-arylimidazoles (4.18 to 4.20). While OMe-
substitution at C4 was typically favored in accordance with computationally predicted NPA 
values, we observed a regioselectivity switch for veratraldehyde. We hypothesize that this 
divergence results from hemiacetal formation in the presence of TFE, for which NPA values 
predict a regioselectivity preference for C3 over C4.  
Triisopropylsilyl (TIPS) and benzyl-protected methyl isovanillate underwent selective 
ipso-OMe amination to yield 4.21 and 4.22 in excellent yield. Interestingly, selective OMe- 
substitution was observed for 3-(benzyloxy)-4-methoxyphenyl triflate when using a 9:1 
DCE:TFE solvent mixture (4.23). Selective C3 amination was observed for O-benzylvanillin 
isomers (4.24 and 4.25), which corroborates the regioselectivity preferences for 
veratraldehyde. Benzyl-protected acetovanillone and isoacetovanillone were also aminated 
in excellent yields (4.26 to 4.29), albeit with limited C4:C3 selectivity. We hypothesize that 
the absence of regioselectivity in these examples may arise from increased difficulty of 
hemiacetal formation for the acetophenones. Heterocycles containing the veratrole core 
were also selectively aminated with imidazole at the 7-position, yielding single regioisomers 
for 4-chloro-6,7-dimethoxyquinoline 4.30 and 6,7-dimethoxyisoquinoline 4.31. 
We then sought to probe the applicability of this system to the late-stage functionalization 
of complex molecules. A protected methoxynoradrenalone derivative was converted to the 
3- and 4-(1-imidazolyl) noradrenalone derivatives 4.32 and 4.33 respectively, with partial 
selectivity for C3-substitution as predicted by NPA values. Tyrosine and L-DOPA methyl 
ester derivatives were regioselectively transformed to the aminated adducts 4.34 and 4.35 
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in moderate to good yields. We also demonstrate the first example of selective aryl C–N 
formation between the imidazole moiety of Boc-histidine methyl ester and the 
methoxyarene component of Phth-O-methyltyrosine methyl ester 4.36.  
 
Table 4.1. Nucleophile scope of cation radical-accelerated SNAr.  
 
A range of N-heterocyclic nucleophiles were found to be competent coupling partners 
for our transformation. Pyrazoles successfully formed the C–N adduct with 2,4 
dichloroanisole in moderate to excellent yields (Table 4.1, 4.37 to 4.41). Interestingly, we 
observed the formation of a single regioisomer (4.39, 4.40) when using 3-methylpyrazole 
as the nucleophile, and confirmed its identity as the less hindered C–N adduct 4.40 by X-
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Reactions run in a 1:1 mixture of DCE:TFE [0.1 M] with respect to the arene. a0.10 equiv of 
catalyst A. bTrifluorotoluene (TFT) as solvent. cReaction run in a 1:1 DCE:TFT. dReaction run 




furnishing N-arylbenzimidazoles (NAB) 4.42 and 4.43 in moderate yields. The formation of 
the unsymmetrial NABs 4.43 are especially interesting, as the azole component is a key 
feature of a potential therapeutic for neurodegenerative diseases;14 thus our synthetic 
method would enable arene diversification of the parent benzimidazole. Boc-histidine methyl 
ester was also a compatible nucleophile, affording the C–N adduct 4.44 as a single 
regioisomer in moderate yield. Lastly, triazoles were competent coupling partners as the 
unsubstituted and amino acid derived triazoles furnished the desired products 4.45 and 
4.46. The product regioselectivities for 4.44 and 4.46 suggest a spatial preference for the 
unhindered azole tautomer, and future work will elucidate the nature of this selectivity. 
Two non-N-heterocyclic nucleophiles were found to be competent coupling partners. Aniline 
synthesis was accomplished using ammonium carbamate under an anaerobic version of our 
previously reported arene amination conditions,3 generating 4.47 in a moderate yield. 
Additionally, we report the suitability of TFE as a nucleophile under our conditions. The 
incorporation of trifluoroethyl groups into pharmaceuticals is known to increase their 
lipophilicity and metabolic stability,15 and methods for generating trifluoroethylarylethers 
proceed via copper-catalysis with aryl halides15 or tetrafluoroborates16 as the coupling 
partners. We display the first example (to the best of our knowledge) of methoxyarene 
coupling with trifluoroethanol, as 2,4-dichloroanisole was converted to the 
trifluoroethylarylether 4.48 in 44% yield in the presence of the exogenous base 1,1,3,3-
tetramethylguanidine.  
Sequential C–H functionalization and SNAr reactions were possible using naproxen 
methyl ester to first afford a cyanation adduct (S4.30, Appendix B) followed by the SNAr 
conditions with imidazole to give 4.49, thus displaying the complementarity of our arene 
functionalization protocols for late-stage modifications of complex arenes (Figure 4.3A). 
Finally, we also display an example of selective C–O bond cleavage in a β-O-4’ lignin model 
substrate S4.32 (Appendix B), where highly selective O-4’ cleavage furnishes 4.50 in a 




Figure 4.3 Sequential complementary photoredox-catalyzed arene functionalizations. (A) 
Selective O-4’ C–O bond cleavage in a β-O-4’ lignin model substrate (B). Proposed 
mechanism (C). 
 
deuterated analog S4.41 (Appendix B), which provided 4.51 in a comparable yield. This 
selectivity complements current redox-neutral lignin depolymerization methods involving 
photoredox catalysis, in which β-O-4’ linkages are common cleavage targets.17 While the 
mechanism of this transformation is currently under examination, we were interested in 
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aforementioned proposal. Since both 2,4-dichloroanisole and imidazole [Ep/2 = +2.04 V and 
Ep/2 = +1.15 V vs. SCE, respectively, Figure S8, Appendix B]18 are capable of reductively 
quenching catalyst A (E*red = +2.15 V), product formation could potentially occur via the 
arene or imidazole radical cation. Substituting acridinium A for a less oxidizing iridium-based 
photocatalyst D (E* [IrIII*/IrII] = +1.68 V vs. SCE)19 yielded no desired product (Table S1, 
Appendix B, entry 16). This result indicates that an electrophilic aromatic substitution-like 
mechanism involving the methoxyarene and an open shell imidazole species is unlikely, and 
that the arene radical cation is crucial for arene amination. We were also interested in 
probing the identity of the nucleofuge upon arene aromatization. When 1-(benzyloxy)-2,4-
dichlorobenzene was subjected to reaction conditions, we observed the presence of benzyl 
alcohol as the only by-product of the reaction, indicating that the nucleofuge is unaltered 
upon expulsion from arene (Figs. B.9 -B.11, Appendix B). Lastly, we note the presence of 
a solvent effect with TFE. When 3-(benzyloxy)-4-methoxyphenyl triflate was subjected to a 
1:1 DCE:TFE solvent system (Fig. B.12, Appendix B), the product of C3-substitution, 
4.19b was observed in addition to the aforementioned C4-substitution adduct 4.23 in a 
2.5:1 C4:C3 ratio. We hypothesize that increasing the concentration of the highly ionizing 
and polar TFE20 stabilizes the radical cation resonance forms such that the two most stable 
cationic sites are available for nucleophilic attack. Given these observations, we proposed 
that Mes-Acr+* oxidizes the anisole derivative leading to 4.52 (Figure 4.3C). Addition of 
the nucleophile at the methoxy-bearing carbon gives rise to 4.53, which undergoes loss of 
MeOH and is reduced by Mes-Acr•, leading to the final SNAr adduct.  
4.3 Conclusion 
Overall, we have demonstrated the applicability and practicality of cation-accelerated 
SNAr for the formation of N-arylazoles, anilines and trifluoroethylarylethers from the parent 
methoxyarenes and benzyloxyarenes. The accessibility of guaiacol and veratrole moieties 
should enable the functionalization of lignin-based substrates as well as late-stage 
diversification of complex molecules with these motifs. Together, our photoredox-catalyzed 
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strategy offers a new approach to C–O bond functionalization and we anticipate that the 
mildness of this protocol will enable adoption for a range of applications. 
4.4 Associated Content 
Appendix B: Experimental procedures and spectral data 
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CHAPTER 5: DIRECT ARENE C–H FLUORINATION WITH 18F– VIA ORGANIC 
PHOTOREDOX CATALYSIS  
 
Adapted from Chen, W.†; Huang, Z.†; Tay, N. E. S.†; Giglio, B.; Wang, M.; Wang, H.; Wu, 
Z.; Nicewicz, D. A.; Li, Z. Science 2019, 364, 1170. Copyright 2019 by the American 
Association for the Advancement of Science. 
†These authors contributed equally to this work. The sequence is determined by last name only and does not 
represent the contribution to the research. 
 
5.1 Background: Radiofluorination of Aromatic Systems 
Fluorine-18 (18F) is one of the most important radioisotopes in the 
radiopharmaceutical industry, because it has a relatively long half-life (t1/2 = 110 min) and 
decays with high efficiency by positron emission (97%).1 A primary application of this 
radioisotope is in the form of 2-[18F]fluorodeoxyglucose ([18F]FDG), which is used for 
oncological diagnoses, neuroimaging, and studying glucose metabolism.2 Uptake of [18F]FDG 
and other 18F-labeled agents is monitored by positron emission tomography (PET) imaging, 
which quantifies spatial distributions and metabolic perturbations, as well as site-specific 
chemical reactivity and ensuing in vivo biological processes.3 
Many small molecule pharmaceuticals and therapeutics contain aromatic or 
heteroaromatic systems within their framework, thus presenting a common organic subunit 
for the installation of radioisotopes to yield radiotracers with imaging utility. In particular, 
the direct conversion of arene C–H into C–18F bonds is ideal owing to the prevalence of 
aromatic C–H bonds and the increasing importance of C(sp2)–F bonds in small molecule 
therapeutics and probes.4,5 Direct 18F-fluorination of aromatics currently requires the use of 
electrophilic fluorine sources, the simplest of which is [18F]F2; however this gaseous 
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reagent is incompatible with many common organic functional groups and suffers from low 
molar activity (the measured radioactivity per mole of compound) as a result of its 
production methods.6–8 Most modern methods for C–H to C–HF bond conversion require 
electrophilic fluorine in the form of relatively expensive but bench-stable reagents such as 
N-fluorobenzenesulfonimide (NFSI) and 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo-
[2.2.2]octane-bis(tetra-fluoroborate) (Selectfluor). However, their utility for 18F 
radiolabeling via electrophilic fluorination is diminished because [18F]NFSI and 
[18F]Selectfluor are prepared from [18F]F2,9 which results in even lower molar activities of 
the 18F-labeled tracers. Therefore, a method for direct conversion of a C–H to C–18F bond via 
a nucleophilic arene fluorination strategy is highly attractive because the synthesis of 18F-
radiolabeled pharmaceutical compounds can be accomplished with high molar activity 
fluoride ([18F]F-). Furthermore, direct C–H to C–18F conversion should alleviate synthetic 
burdens associated with the synthesis of radiotracer precursors10 and allow for the recovery 
of precious, unreacted starting material. However, the primary hurdle for this approach is 
the lack of reactivity for a majority of simple aromatics with [18F]F-.  
Nucleophilic aromatic substitution of electron-deficient arenes has been the standard 
method for [18F]F- incorporation,1 but pre-functionalization of the aromatic subunit with 
electron withdrawing groups is required for this strategy.3 Thus, modern radiofluorination 
methods have sought to generalize the arene scope for this transformation. Current 
strategies include 18F-deoxyfluorination of phenols via uronium11 and N-arylsydnone12 
intermediates; displacement of sulfonium salts;13 fluorodemetalation of pre-formed 
palladium or nickel arene complexes from the requisite aryl halides or boronic acids;14,15 and 
copper-mediated cross-coupling of preformed or in situ–generated aryliodoniums,16,17 aryl 
boronic acids18, esters,19 and arylstannanes20 (Figure 5.1A). Despite the advances in 
radiofluorination, these approaches can be technically challenging for radiochemists. 
Moreover, the use of metal reagents, especially in stoichiometric or superstoichiometric 
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amounts, can complicate the quality control process for translational studies because 
additional analysis on residual metal levels is required.  
 
Figure 5.1. An organic photoredox approach to 18F labeling of arenes for PET studies. (A) 
Prior work relies on the isolation of aryl organometallic species. (B) This study obviates the 
need for metalation by using organic photoredox catalysis. 
 
5.2 Results and Discussion 
With these challenges in mind, we sought to develop an arene C–H fluorination 
method compatible with [18F]F– (Figure 5.1B). The Nicewicz lab has developed a research 
program using organic single electron photooxidants to catalytically generate arene radical 
cations as reactive intermediates for arene C–H functionalization reactions. Thus, we applied 
this strategy for direct C–H to C–18F bond conversion. Considering the low molar amount of 
no-carrier-added [18F]F-, radiation exposure, and the potentially high cost of [18F]F- 
production, we decided to first use 19F-fluoride for the development of a photoredox-
catalyzed method for arene C–H fluorination. Using diphenyl ether as the aromatic 
substrate, we were able to obtain 17% of fluorinated adducts in a 13:1 para:ortho ratio 
using an acridinium-based photooxidant (5.1), cesium fluoride (CsF), the phase transfer 
reagent tetrabutylammonium bisulfate (TBA-HSO4) and 2,2,6,6-tetramethyl-1-piperidine 1-
oxyl (TEMPO) as a redox co-mediator under aerobic conditions for 24 h (Figure 5.2 and 
Table C.1, Appendix C). We attribute the low yields to the relative recalcitrance of 
fluoride, which is a Brønsted base and can form strong hydrogen bonds in aqueous 
environments.21 Despite lower yields for the aryl C–H fluorination with 19F–, C–H fluorination 
was feasible and thus we decided to extend our method to radiofluorination. 
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In this new system, [18F]F- is employed as the limiting reagent and we envisioned 
that the relatively higher concentration of arene radical cation would efficiently capture 
[18F]F-. Transitioning from F- to [18F]F- necessitated a re-examination of fluoride sources and 
irradiation method while aiming to achieve reasonable 18F labeling yields on 30 min to 1 h 
timescales, given the fleeting half-life of the fluorine radioisotope. High molar activity 
aqueous [18F]F- is prepared via proton bombardment of [18O]water and subsequent elution 
of 18F-fluoride with tetrabutylammonium bicarbonate to form [18F]TBAF or with potassium 
carbonate complexed with the aminopolyether cryptand Kryptofix 2.2.2 to form [18F]KF-
K2221. In both of these systems, excess tetrabutylammonium bicarbonate and potassium 
carbonate are present. Although the initial radiochemical yields (RCYs) were relatively low 
(0.57%), [18F]TBAF was the most effective 18F-fluorinating agent in the synthesis of [18F]5.2 
(see Appendix C, section C.5.5). Initial RCYs using 455 nm light-emitting diodes were 
relatively low (0.57%), which prompted us to re-evaluate the light flux for the 
transformation. Using top-down irradiation with a 3.5 W laser (450 nm)22 for 30 minutes 
(cooled to 0 ºC to prevent solvent loss from laser-generated heat) under an aerobic 
atmosphere afforded a significant increase in the yields of the 18F-fluorinated adducts of 
diphenyl ether (25.8 and 2.0% for the para- and ortho- adducts, respectively). After 
extensive optimization (see Appendix C, section C.5.5), we identified a system that 
afforded the para and ortho fluorinated adducts (37.1 and 2.0% yield respectively), but 
observed a drop in the molar activity of [18F]–TBAF. We attributed this inconsistency to the 
exchange of [18F]F- with fluoride from the BF4- counterion of the acridinium catalyst, which 
in turn lowers the net molar activity of [18F]–TBAF. To circumvent this problem, we 
synthesized an acridinium containing a perchlorate (ClO4-) counterion and found that 18F-
labeled diphenyl ether (5.2) adducts could be isolated with a molar activity of 1.37 Ci/µmol 
(compared with. 0.39 Ci/µmol with BF4- counterion) and comparable RCYs of 38.2% and 
1.8% for the para- and ortho-products respectively.  
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Having identified the optimal catalytic conditions for the transformation, we turned 
our attention to evaluating the scope of this method with a range of aromatic and 
heteroaromatic substrates. Biphenyl (5.3) and naphthalene (5.4) were fluorinated at the 4- 
and 1- positions, respectively, in good RCY. 2-Substituted methoxyarenes (5.5 to 5.11) 
were also efficiently fluorinated at the C–H site para to the methoxy group, following a 
similar trend to the amination23 and cyanation24 methods from our laboratory. Halogenated 
and pseudohalogenated methoxyarenes 2-bromoanisole (5.5), 2-chloroanisole (5.6) and 2-
OTf-anisole (5.7) were all fluorinated at the 4-position in good RCY, thus demonstrating the 
compatibility of halogenated and pseudohalogenated arenes with our system, as these 
functional groups are typically susceptible to oxidative addition in transition metal–catalyzed 
methods. A range of carbonyl-containing functional groups such as esters (5.8), ketones 
(5.9), nitriles (5.10), aldehydes (5.11), and amides (5.12) were all compatible with this 
method, affording single regioisomers of the 18F adducts. Methoxy-substituted biphenyl 
systems (5.13 and 5.14) were also competent substrates for fluorination, affording the 
single regioisomers in moderate RCY. We did not observe significant ortho fluorination for 2-
substituted anisoles, which we attribute to a greater gain in positive charge density on the 
para position of the arene cation radical25 and potential steric hindrance. Thus, we were 
curious to explore the amenability of our radiofluorination protocol to methoxyarenes 
bearing substitution at the para position. We found that these 4-substituted congeners 
(5.15 to 5.19) were compatible fluorination partners although the RCYs observed were 
significantly lower than their 2-substituted counterparts. Nevertheless, the isolated yields 
for these 4-substituted methoxyarenes are acceptable for PET imaging applications. 
Preliminary computational studies (Appendix C, Figures. C.9 and C.10) suggest that 
there is little correlation between the calculated electrophilicities of the cation radical for the 
2- and 4-substituted arenes and the observed yields, thus suggesting a greater contribution 
of steric effects in determining site selectivity. When 3-methoxyacetophenone was 
subjected to the radiofluorination conditions, a 2:1 ratio of 18F-labeled adducts was obtained 
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with a preference for fluorination para to the methoxy group (5.20). Computational studies 
suggest that the 6-position gains the most electrophilic character relative to the 2- and 4- 
positions (Appendix C, Figure C.11) upon single electron oxidation; however only the 
latter products are observed. Taken together, these results demonstrate a strong preference 
for the para functionalization of methoxyarenes except in cases where the para position is 
occupied, and they suggest that steric effects may play a role in dictating site-selectivity for 
C–H fluorination.  
 Arenes containing guaiacol motifs are found in numerous plant and animal 
metabolites, thus the application of our C–H radiofluorination strategy could enable the 
facile synthesis of 18F radiotracers from renewable sources. We found that ethylguaiacol 
(5.21), vanillylamine (5.22), nonivamide (5.23) and zingerone (5.24) derivatives were all 
successfully fluorinated to provide single regioisomers of the 18F analogs. Furthermore, this 
reaction is not limited to methoxyarenes, as demonstrated by mesitylene undergoing 
fluorination (<9 %) under aerobic conditions to give 5.25. This isolated RCY was improved 
to 50% by employing a modified anaerobic system (using TEMPO as a net oxidant in MeCN 
with N2 bubbling). Fluorinated heterocycles are privileged and highly-desirable motifs in 
pharmaceutical and agrochemical research, and substantial resources are directed toward 
measuring the pharmacokinetics of these compounds.26 Our radiofluorination protocol was 
applied to several heterocyclic classes: We found that 2,5-dimethoxypyridine (5.26), 2-
chloro-6-methoxyquinoline (5.27), and N,N-dihexylquinazolinedione (5.28) were all 
successfully fluorinated in good to moderate RCY. Benzazoles common to many therapeutics 
such as N-methylindazole (5.29), benzoxazole (5.30), and benzimidazole (5.31) all 
underwent fluorination at the most electrophilic positions of their respective cation radicals. 
Selective late-stage arene C–H fluorination is an attractive synthetic strategy as it 




Figure 5.2. Reaction scope of 18F fluorination of aromatics. All RCYs are decay corrected 
and are averaged over 3 experiments unless otherwise noted. *Yield averaged over 5 
experiments. †24.8% RCY of the 2-fluoro dechlorinated product is formed. ‡ RCYs listed are 
based on the product deprotection yields (see section C.5.6 of supplemental information). 
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and enables the straightforward conversion of bioactive molecules and drugs into PET 
agents for in vitro companion diagnosis or for pharmacodynamic and pharmacokinetic 
studies.  
We chose to apply our 18F radiofluorination method to several non steroidal anti-
inflammatory drugs (NSAIDs), which are an important class of pharmaceuticals that 
alleviate pain and inflammation by inhibiting the activity of cyclooxygenase enzymes (COX-1 
and COX-2). Although there have been recent advances in the radiolabeling of COX-1 and 
COX-2 inhibitors, many examples use 11C as the radionuclide, which has the disadvantage of 
a shorter half-life (t1/2 = 20.2 minutes) than 18F.27 Existing 18F-labeled COX inhibitors 
typically incorporate 18F in the radioprobe as part of a phenol-appended fluorinated alkyl 
chain.28 However, these functional groups are prone to metabolic degradation and thus may 
be less effective radiotracers.27,29 Fluorination of the aromatic ring is a strategy typically 
used to study drug metabolism, as fluorine is a hydrogen bioisostere and its substitution 
slows the metabolic degradation of drug molecules by cytochrome P450.29 Fluorinated 
aromatics can also act as metabolic tracers because hydroxylated fluoroarene metabolites 
undergo a 1,2-fluoride shift (NIH shift), thus allowing for the detection and quantification of 
metabolic byproducts.30,31 Furthermore, the introduction of fluorine into the aromatic system 
can improve the potency and cell permeability of drug molecules through non-covalent 
interactions.5 The development of the NSAID celecoxib is an instructive example, in which 
the substitution of various aryl C–H bonds for aryl C–F bonds was used to bias in vitro COX-
2 selectivity.32 However, routes for the analogous synthesis of C(sp2)–18F bonds in COX 
inhibitors with aromatic moieties are underexplored because of difficulties with designing 
late-stage precursors for 18F radiolabeling.33 Thus, we envisioned that our method would 
enable the introduction of 18F into known COX inhibitors. The NSAID derivatives fenoprofen 
methyl ester (5.32), flurbiprofen methyl ester (5.33), and O-methyl methyl salicylate (5.8) 
were all fluorinated in good to moderate RCYs. Given the ubiquitous use of these 
commercial NSAIDs.34 the synthesis of their radiotracer counterparts could provide 
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researchers with a method for visualizing their immediate in vivo metabolic fates that is 
complementary to the longitudinal metabolism studies enabled by 3H- and 14C– labeling 
strategies.35  
The hypolipidemic agents clofibrate (5.34) and fenofibrate (5.35), as well as a 
derivative of the biological neurotransmitter precursor DL-DOPA (5.36) were selectively 
fluorinated in moderate RCY after 30 minutes. We found that the fluorination protocol was 
influenced by reaction times, as extending the run time to 1 h increased the RCY of the 
fluorinated DOPA derivative to 21.2%. This result is especially noteworthy because 
[18F]DOPA is an important radioprobe for the PET imaging of CNS disorders,36 but published 
routes to it typically require extensive and sensitive synthesis with 18F precursors37 or the 
fluorination of pre-functionalized DOPA analogs.16,19 This fluorinated DOPA derivative was 
then subjected to facile global deprotection to yield [18F]–DOPA (5.37) in 12.3% RCY. Other 
aromatic amino acids such as the protected variants of O-Me-ortho-tyrosine and 4-phenyl-
phenylalanine were also successfully radiofluorinated (5.38 and 5.40 respectively) and their 
deprotected forms (5.39 and 5.41 respectively) were accessed with relative ease.  
A major objective of our synthetic methodology was to develop clinically-relevant 
PET tracers from readily available bioactive molecules without first requiring arene 
prefunctionalization. To test this concept, we examined the feasibility of converting the 
NSAID fenoprofen into a PET agent by direct C–H fluorination. Fenoprofen has notable anti-
inflammatory activity,38 but there have been minimal studies with its fluorinated analogs. 
Given the widely exploited hydrogen bioisosterism of fluorine in medicinal chemistry,5 we 
were interested in examining the viability of the radiofluorinated analog for PET studies. 
[18F]–Fenoprofen (5.42) was readily accessed from 5.32, which was then used to detect 
inflammation induced by 12-o-tetradecanoylphorbol-13-acetate (TPA) in mouse ears 
(Figures 5.3A and C.6.) (see Appendix C for more details).39 Preliminary ex vivo PET 
studies (Figure 5.3A) show significantly higher uptake of [18F]–fenoprofen in the ear 
inflammation model relative to the control 30 minutes after intravenous introduction of the 
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radioprobe. These data suggest 5.42 is a potential PET agent that demonstrates preferential 
accumulation in inflamed tissue. Additional biological evaluations for 5.42 are needed, but 
are currently beyond the scope of this Report.  
Another application of our C–H radiofluorination method is rapid radioligand 
screening in drug discovery and development. We chose to highlight synthetic aromatic 
amino acids as a class of bioactive metabolites owing to their applicability for oncological 
PET imaging.40–42 We are especially interested in the tyrosine scaffold as fluorination on the 
aromatic ring is an important functionalization mode for developing PET probes. We selected 
O-Me-ortho-tyrosine and 4-phenyl-phenylalanine as the working examples and our method 
provides facile access to radiofluorinated 5.39 and 5.41. In vivo PET studies of mice 
containing MCF-7 (breast cancer) and U87MG (glioblastoma) tumor xenografts demonstrate 
prominent uptake of 5.39 with minimal accumulation in other organs except the pancreas 
and bladder (Figures 5.3B and C.7) (see Appendix C for more details). Conversely, 5.41 
displayed low uptake in similar tumor models with significantly higher retention in the 
mouse circulatory system. On the basis these preliminary studies, 5.39 shows promise as a 
selective amino acid radioprobe for tumor detection and further studies will be needed to 
examine its biological activity and pharmacology. These results further demonstrate the 
potential of our radiofluorination method for the discovery of new PET agents that 
circumvents the need for prefunctionalized (hetero)arenes. 
5.3 Conclusions 
18F radiolabeling is an important tool for noninvasive studies of biological systems 
and we anticipate that the applicability of our radiofluorination method to commercial 
pharmaceuticals and metabolites will enable direct access to new classes of translationally-
relevant 18F-radiotracers, either as diagnostic agents or as target probes for elucidating the 




Figure 5.3. Application examples of PET tracers synthesized via arene C–H 
radiofluorination. Maximum intensity projection (MIP) PET images of [18F]Fenoprofen (5.42) 
demonstrate higher uptake in TPA-treated mouse ear (A-1) compared with control (A-2) 
mouse ear (A). PET/CT images demonstrate preferential tumor (MCF-7) accumulation of 
5.39, compared with longer blood circulation and higher non-specific binding of 5.41 at 1 
hour post-injection(B). Structures of the tracers used in the preceding panels are shown 
(C). 
 
5.4 Associated Content 
Appendix C. Experimental procedures, additional data, and analysis are included 
Data for PET and PET/CT images in Figures 5.3 and C.6 and C.7 have been submitted to 
Zenodo43–47. 
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CHAPTER 6: CATION RADICAL ACCELERATED NUCLEOPHILIC AROMATIC 
DEOXYFLUORINATION WITH 19F– AND 18F– VIA ORGANIC PHOTOREDOX CATALYSIS 
 
6.1 Introduction 
 General methods for site selective and facile installation of fluorine (19F) and its 
radioisotope (18F) in functionalized aromatic molecules are highly desirable. The ubiquity 
and value of fluorinated molecules in market pharmaceuticals1,2 and agrochemicals3 are 
well-documented, and 18F is an important radioisotope used in the synthesis of 
radiopharmaceuticals for positron emission tomography (PET)4,5 imaging. Nucleophilic 
aromatic substitution (SNAr) is a cornerstone of organic reaction methodology and has been 
used for the construction of arene C–F bonds with 19F–6 and 18F–7 (Figure 6.1A). However, 
traditional stepwise SNAr methods are typically constrained to arenes possessing ortho- 
and/or para- electron-withdrawing substituents, which can stabilize a negatively-charged 
Meisenheimer complex upon nucleophile attack. Concerted SNAr variants undergo direct 
substitution at an sp2 carbon8,9 but the rates of nucleofuge extrusion diminish upon the 
introduction of electron-rich groups.9 Transition metal catalysis with nucleophilic fluoride is 
another highly valuable transformation for the synthesis of C–F bonds (Figure 6.1B). These 
reactions historically rely on palladium, copper or silver catalysis alongside aryl 
(pseudo)halides,10,11 boron electrophiles,12,13 or activated nucleofuges14,15 for successful C–
19F and C–18F bond formation.4,7,16 However, the synthesis of specialized ligands and high 
catalyst loadings are potential roadblocks for its widespread adoption. 
Photoredox catalysis has recently emerged as an important synthetic tool for enabling 
novel modes of substrate activation through photogenerated oxidants or reductants.17,18 
These reactive catalytic species generate cation radical or radical anion intermediates via the 
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respective oxidation and reduction of traditionally stable molecules, which in turn enable site 
selective bond functionalization.19 We have recently studied and reported the reactivity of 
arene radical cations generated by photoinduced electron transfer (PET) from stable aromatic 
substrates to a highly-oxidizing photoexcited state acridinium dye. In particular, we were 
interested in the substitution of C–O bonds for C–F bonds. Transition metal catalysis10 and 
concerted SNAr9,20,21 methods have been utilized for the direct fluorination of activated C–O 
bonds, but there is a dearth of methods for site selective arene deoxyfluorinations with 
relatively unactivated nucleofuges. Furthermore, deoxyfluorination methods with nucleophilic 
18F are currently limited to high reaction temperatures and an activated uronium nucleofuge 
prone to decomposition with electron-rich phenols.9,22 With these challenges in mind, we 
sought to develop a strategy that would allow for site selective  
 
Figure 6.1. Strategies for arene fluorination via SNAr (A), transition metal catalysis (B), and 
photoredox catalysis (C). 
 
arene deoxyfluorination on electron-rich (hetero)aromatics. We recently disclosed a 
photoredox-catalyzed cation-radical accelerated SNAr transformation which selectively 
aminates methoxy- and benzyloxy- nucleofuges.23 In this report, arene radical cations 
catalytically generated by organic single electron photooxidants are utilized as reactive 
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intermediates for C–O substitution. Thus, we envisioned that this reactivity could be 
translated to a variety of fluoride sources. 
6.2 Results and Discussion 
We took inspiration from our recent report on arene C–H [18F]radiofluorination, in 
which we used cesium fluoride (CsF), a commonly used nucleophilic fluorine source, in tandem 
with tetrabutylammonium bisulfate (TBAHSO4), a phase transfer reagent, to install fluoride in 
several (hetero)arenes.24 Unfortunately, initial attempts at using fluoride as a nucleophile 
were unsuccessful when using 4-phenylanisole as the substrate, either providing returned 
starting material or observable substrate de-methylation. We hypothesize that the increased 
acidity of O-methyl C–H bonds for the resultant aryl methyl ether cation radical may lead to 
unproductive deprotonation under basic conditions.25 Thus, we decided to explore alternative 
nucleofuges that would circumvent the problem of acidic alkyl C–H bonds without significantly 
altering arene electronics. Aryloxy groups fulfill this requirement whilst being utilized in 
traditional SNAr for electron-poor aromatics,6,26 and displaying higher rates of expulsion 
relative to alkoxides.6 An important consideration upon adoption of aryloxy groups is arene 
site selectivity as substitution may occur on either aromatic ring. In our reaction manifold, we 
envisioned that photoinduced electron transfer from an unsymmetrical biaryl ether to a 
photoexcited acridinium would generate the arene radical cation (Figure 6.1C). This 
electrophilic species  has two potential sites of functionalization, but the formation of the 
cation radical on the arene with the lower oxidation potential is thermodynamically 
preferred.27 Because electron-rich arenes are easier to ionize, choosing a suitable aryloxy 
nucleofuge should bias deoxyfluorination on the more electron-rich arene. 
We chose 4-(4-chlorophenoxy)-1,1'-biphenyl (S2) as a model substrate and after 
optimization (see Appendix D, Table D.1) found that using an acridinium-based 
photooxidant (6.1), CsF, and TBAHSO4 with a biphasic dichloromethane water solvent system, 
we obtained 4-phenylfluorobenzene in excellent yield with minimal formation of 4-chloro-
fluorobenzene. The phase transfer reagent and biphasic solvent system was crucial for 
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obtaining appreciable yields as significantly diminished yields were observed when 
modifications were made (entries 4 to 5, 11 to 12 in Appendix D, Table D.1). Greater 
flexibility in fluoride source was observed as simple alkali-metal fluorides could be used, with 
potassium fluoride being a competent substitute for cesium fluoride with little to no change 
in the overall yield; however, better reproducibility was observed with CsF. Finally, 
photocatalyst 6.1 was necessary for the reaction as minimal conversion was observed with 
its exclusion. 
With the optimized conditions in hand, we sought to extend this method to a range of 
(hetero)aromatic systems. 4-Chlorophenoxy-substituted biphenyls were competent 
substrates as 6.2 to 6.5 furnished the respective fluorinated arenes in good yield. Cross-
coupling handles for nickel-catalysis were also compatible with our method, as (4-
chlorophenoxy)-phenyl pivalate and 4-chlorophenoxy-4-chlorobenzene were converted to 
their fluorinated analogs (6.6 and 6.7) in good to moderate yield. Electron-rich bis-
oxygenated arenes are typically poor substrates for SNAr and have limited reactivity under 
uronium-20 and fluorosulfonate-21 based deoxyfluorination conditions. However, ethylguaiacol 
analogs were successfully fluorinated selectively at the phenoxy positions using our method 
to furnish 6.8 and 6.9, with 4-substitution of the ethyl moiety relative to the nucleofuge 
furnishing higher yields than the respective 3-substituted isomer. 4-Bromo-1-(4-
chlorophenoxy)-2-methoxybenzene and 4-chloro-1-(4-chlorophenoxy)-2-methoxybenzene 
were converted to their respective aryl fluorides (6.10 and 6.11) in excellent yield. 4-Chloro-
1-(4-chlorophenoxy)-2-methoxybenzene regioisomers are also competent substrates, 
yielding 6.12 and 6.13 in moderate yield. Electron-withdrawing substituents such as 
carbonyls, nitriles, and ethylacryolyl groups were tolerated under reaction conditions, 
providing the desired fluorinated arenes (6.14 to 6.18) in moderate to excellent yield. 
Dioxygenated benzyl alcohol and phenyl 2-butanone were also successfully converted to the 
respective desired fluorinated products 6.19 and 6.20; however, a precipitous drop in yield 
was observed for the 4-substituted mono-oxygenated benzyl alcohol (6.21). This result thus 
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prompted a brief examination of compatible functional groups. Arylsulfonamide (6.22), 
pyridine (6.23), and pyrimidine (6.24) were fluorinated in moderate to good yield, while 
cyclohexyl (6.25), CBz-protected piperidine 6.26), and tetrahydropyran (6.27) were 
converted to their fluorinated analogs albeit with greater difficulty. 
 
Figure 6.2. Reaction scope of 19F fluorination of aromatics. 19F-NMR yields are denoted by 
brackets.  
Additionally, tri-oxygenated aromatics are typically too electron-rich to be fluorinated 
by traditional SNAr strategies, thus the facile synthesis of fluorinated 6.28 and 6.29 from 
their phenyloxy counterparts demonstrates the complementarity of our arene substitution 
5 mol % 6.1
TBAHSO4 (0.75 equiv)
DCM:H2O (0.1 M, 25:1)
+














































6.10 X = Br; (74%)











6.14 R = H; (36%)
6.15 R = Me; (38%)



























6.36 R- (13% )





























































6.39 NR2 = NPhth; (29%)










6.31 X=OMe, Y=H (30%)





method. Heterocycles were also compatible as competent substrates for this transformation 
as carbazole (6.30), pyridines (6.31-6.34), and pyrimidine (6.35) were successfully 
fluorinated. The synthesis of 6.35 is particularly interesting as it can be deprotected under 
mild acidic conditions28 to reveal fluorouracil, an important antineoplastic drug. Bioactive 
molecules such as the antidiabetic nateglinide (6.36) and its diastereomer (6.37) were 
successfully obtained alongside fluorinated phenylalanines (6.38 to 6.40) and O-methyl 
tyrosines (6.41 and 6.42). Bisprotection of the amine as a pthalimide appeared to improve 
the yield, thus suggesting that unproductive pathways involving the monoprotected amine 
may be responsible for the observed decreases in yield. Additionally, substitution of the 
phenoxy nucleofuge relative to the glycine group appears important as a higher yield was 
observed for 6.41 than 6.42. 
Noting successful site selective C–19F bond formation via our deoxyfluorination 
method, we wanted to extend this method to 18F. We recently disclosed a method for C–H 
radiofluorination with [18F]-tetrabutylammonium fluoride ([18F]TBAF) as the limiting reagent 
relative to the arene.24 Minor adaptation of those conditions (Figure 6.3) enabled a seamless 
translation for nucleophilic fluorination when switching from 19F sources to ([18F]TBAF. While 
our fluorination method with 19F- displays substrate-dependent variability, greater generality 
is observed for radiofluorination as the 18F-labeled congeners are obtained in moderate to 
excellent yield, often in similar or greater yield than their 19F counterparts. We hypothesize 
that the relatively higher arene concentration enables more efficient [18F]F- capture while  
minimizing substrate sensitivity to the more basic reaction conditions used for 19F-
deoxyfluorination. One notable highlight is the highly efficient radiofluorination of the PET 
radiopharmaceutical [18F]fluorouracil29 precursor ([18F] 6.35), which stands as a major 
improvement over reported routes involving spirocylic hypervalent iodoniums30 or 
stoichiometric aryl nickel complexes.28 
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Despite the successes of our (radio)fluorination methods, we recognized that the 
synthesis of diarylethers substrates may be challenging. Thus, we explored several potential 
alternative nucleofuges (Figure 6.4). Electron-poor arenes (S43 to S46) showed excellent  
 
Figure 6.3. Reaction scope of 18F fluorination of aromatics. All RCYs are decay corrected and 
are averaged over 3 experiments (n=3) unless otherwise noted. 
 
selectivity for deoxyfluorination on the more electron-rich arene albeit with reduced 
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could also be utilized as nucleofuges. While the fluorination yields are lower for S43 to S48, 
they are easier to access than the 4-chlorophenoxy nucleofuge. A greater range of 
alternative nucleofuges can be utilized with our radiofluorination method; electron-poor 
phenoxides (S43, S44, and S49), carbonates (S47 to S52), thiocarbonate (S48) and acyl 
(S53) furnished [18F]4-fluorobiphenyl with modest to excellent isolated RCY. However, the 
aryl mesylate (S54), tosylate (S55) and methyl ether (S56) were ineffective substrates. 
Because these nucleofuges can be accessed via traditional SNAr or nucleophilic acylation 
methods from the parent phenol, they serve as alternative functional handles to the 4-
chlorophenoxy group despite their potentially lower RCYs. 
 
Figure 6.4. Nucleofuge scope for the synthesis of 4-fluorobiphenyl (6.2) or [18F]4-
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During our studies, we observed significant formation of 4-chlorofluorobenzene for 
several of our substrates (6.5, 6.14, 6.21, 6.34 and 6.40), which may arise from competitive 
deoxyfluorination (Figure 6.5). Because the formation of 4-chlorofluorobenzene is minimal 
for more electron-rich substrates, we hypothesized that differences in the thermodynamic 
stability of resultant arene cation radicals may be responsible for deoxyfluorination bias. For 
example, a 0.27 V difference in Ep/2 between the arene portions of S2 results in highly selective 
deoxyfluorination whereas a separation of 0.06V between the two halves of S21 leads to an 
almost equal mixture of 6.21 and 6.6. However, when a more electron-rich variant of S21 
(S19) is used, a high degree of deoxyfluorination bias returns for the dioxygenated arene. 
Thus, deoxyfluorination site selectivity appears to be determined by differences in Ep/2, in 
which the more electron-rich arene possesses a greater degree of partial positive charge in 
the cation radical, and thus is preferentially fluorinated. We anticipate that this reactivity 
pattern can be used to guide future attempts at improving site selectivity. 
 
Figure 6.5 Electrochemical differences influence site selectivity for arene fluorination  
 
The mechanism for this transformation is as follows (Figure 6.6). Photoinduced 
electron transfer from the unsymmetrical diphenyl ether 6.43 to 6.1* generates the radical 
cation 6.44, in which the more electron rich arene is oxidized. Trapping 6.44 with an 
equivalent of fluoride yields the intermediate 6.45, which can turnover the catalyst by 
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chlorophenoxide to deliver the desired fluoroarene 6.46. For non-ether substrates (S47, 
S48, S50 to S55) the absence of a competing arene species limits the potential byproducts 
that may be formed. 
 
Figure 6.6 Putative mechanism for cation radical accelerated nucleophilic aromatic 
deoxyfluorination of asymmetrical diphenyl ethers.  
 
In summary, we have developed a photoredox-catalyzed cation radical accelerated 
SNAr method that enables the deoxy(radio)fluorination of electron-rich arenes that are 
typically nonreactive under traditional SNAr conditions. This transformation reverses the 
traditional polarity requirement for SNAr and enables the fluorination of electron-rich arenes 
through the displacement of an aryloxy nucleofuge. We expect that this transformation will 
enable the development and synthesis of new 18F-radiotracers with therapeutic value. 
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APPENDIX A: SUPPORTING INFORMATION FOR “SITE-SELECTIVE C–H AMINATION 
VIA ORGANIC PHOTOREDOX CATALYSIS 
 
A.1 General Information: Materials and Methods 
A.1.1 Materials 
Commercially available reagents were purchased from Sigma-Aldrich, Acros, Alfa 
Aesar, or TCI, Matrix Scientific, Chem Impex International, and Fisher Scientific and were 
used as received unless otherwise noted. Diethyl ether (Et2O), dichloromethane (DCM), 
tetrahydrofuran (THF), toluene, and dimethylformamide (DMF) were dried by passing 
through activated alumina under nitrogen prior to use. Other common solvents and 
chemical reagents were purified by standard published methods as noted. The following 
compounds employed as reagents in the C–H amination reactions were obtained from 
commercial vendors and used as received: 2,2,6,6-Tetramethyl-1-piperidinyloxy (TEMPO), 
polystyrene-divinylbenzene-bound TEMPO, diacetoxyiodobenzene, potassium persulfate, 
benzoquinone, (diacetoxyiodo)benzene, anisole, diphenyl ether, biphenyl, 2-chloroanisole, 
3-bromoanisole, mesitylene, m-xylene, 2,6-dimethoxypyridine, 6-methoxyquinoline, 3,4-
dihydrocoumarin, 4-methyl pyrazole, 3-methyl pyrazole, 1,2,3-triazole, 5-methyltetrazole, 
1,2,4-triazole, 1,2,3-benzotriazole, 4,5,6,7-tetrahydro-1H-indazole, benzimidazole, and 
imidazole. 
A.1.2 General Methods 
Proton, carbon, and fluorine nuclear magnetic resonance spectra (1H NMR,13C NMR, 19F 
NMR) were recorded on a Bruker Avance 400 (1H NMR at 400 MHz, 13C NMR at 100 MHz, 
and 19F NMR at 376 MHz) or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 
151 MHz) spectrometer. Chemical shifts for protons are reported in parts per million 
downfield from tetramethylsilane and are referenced to residual protium in the solvent (1H 
NMR: CHCl3 at 7.26 ppm). Chemical shifts for carbon signals are reported in parts per 
million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent peak (13C NMR: CDCl3 at 77.16 ppm). Fluorine chemical shifts are referenced to 
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trichlorofluoromethane as an external standard at 0 ppm. 1H NMR data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, hept = 
heptet, dd = doublet of doublets, ddd = doublet of doublet of doublets, m = multiplet, br s 
= broad singlet, app = apparent), coupling constants (Hz), and integration. Infrared (IR) 
spectra were obtained using a Jasco 260 Plus Fourier transform infrared spectrometer. High 
Resolution Mass Spectra (HRMS) were obtained using a Thermo LTqFT mass spectrometer 
with electrospray ionization in positive mode. Thin layer chromatography (TLC) was 
performed on SiliaPlate 250 µm thick silica gel plates provided by Silicycle. Visualization was 
accomplished with short wave UV light (254 nm), or development with iodine, ninhydrin 
stain, cerium ammonium molybdate or potassium permanganate solution followed by 
heating. Column chromatography was performed using SiliaFlash P60 silica gel (40-63 µm) 
purchased from Silicycle. Unless noted all reactions were run under an atmosphere of 
oxygen in flame-dried glassware with magnetic stirring. Irradiation of photochemical 
reactions was carried out using a PAR38 Royal Blue aquarium LED lamp (Model #6851) 
fabricated with high-power Cree XR-E LEDs as purchased from Ecoxotic (www.ecoxotic.com) 
with standard borosilicate glass vials purchased from Fischer Scientific. For all photolyses, 
reactions were stirred using a PTFE coated magnetic stir bar on a magnetic stir plate. Gas 
chromatography (GC) was performed on an Agilent 6850 series instrument equipped with a 
split- mode capillary injection system and Agilent 5973 network mass spec detector (MSD). 
Yield refers to isolated yield of analytically pure material unless otherwise noted. NMR yields 
were determined using hexamethyldisiloxane as an internal standard. All other reagents 
were obtained from commercial sources and used without further purification unless 
otherwise noted.  
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A.1.3 Photoreactor Configuration.  
Reactions were irradiated using a simple photoreactor consisting of two Par38 Royal Blue 
Aquarium LED lamps (Model #6851) is shown in which four reactions (2 dram vials) are 
irradiated simultaneously with a foil barrier preventing irradiation by two lamps. In order to 
ensure that the reactions are run near room temperature, a simple cooling fan was installed 
above the reactor to aid in dissipating the heat generated from both nonradiative decay 
pathways of the excited state catalysts and the heat generated from high power LEDs. An 
equilibrium temperature of 33 oC was measured with a standard alcohol thermometer. While 
a number of other blue LED sources are effective, we have found that LED emitters with 
high luminous flux and narrow viewing angle give the best results. 
 
Figure A.1. Photoreactor configuration for aryl amination reactions. 
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A.2 Additional Optimization Studies 
Table A.1. Alkyl Substrate Optimization. 
 
 
A.3 Synthetic Procedures 
A.3.1 Preparation of Acridinium Photocatalysts 
 
9-Mesityl-10-phenyl acridinium tetrafluoroborate (3.7A). 
The title compound was prepared as previously reported by our laboratory.1 The spectral 









9-Mesityl-2,7-dimethyl-10-phenylacridinium tetrafluoroborate (3.7B). 
The title compound was prepared as previously reported by our laboratory.1 The spectral 
data matched the values reported in the literature.  
 
4-(tert-Butyl)-2-((3-(tert-butyl)phenyl)amino)benzoic acid (S1). To a flame dried 2-
neck round bottom flask equipped with a condenser was added potassium carbonate (9.0 g, 
65.3 mmol, 1.4 equiv), copper (594 mg, 9.34 mmol, 0.2 equiv) and 2-bromo-4-(tert-
butyl)benzoic acid (12 g, 46.7 mmol, 1.0 equiv). The setup was evacuated and back filled 
with nitrogen gas three times for 15 minutes each cycle. m-tert-Butyl aniline (10.3 mL, 65.3 
mmol, 1.4 equiv) and 1-pentanol (72 mL) were both sparged with nitrogen for 15 minutes. 
Pentanol was added to the reaction flask followed by the aniline. The solution was heated to 
140 ˚C for 16 hours. The solution was cooled to room temperature and diluted with water 
(100 mL), washed with 3M HCl (100 mL) and extracted with dichloromethane (3 x 100 mL). 
The organic layer was washed with ammonium chloride (100 mL), brine (100 mL) and dried 
over sodium sulfate. The organic solution was concentrated to afford a brown solid. The 
crude product was recrystallized from methanol to afford the desired aryl amine (10.1 g, 
67% yield). 1H NMR (600 MHz, CDCl3): δ 11.74 (br s, 1H), 9.32 (s, 1H), 8.00 (d, J = 9 Hz, 
1H), 7.36-7.35 (m, 2H), 7.32 (t, J = 7.8 Hz, 1H), 7.16 (d, J = 8.4 Hz, 1H), 7.07 (dd, J = 
7.8 Hz, J = 0.6 Hz, 1H), 6.83 (dd, J = 8.4 Hz, J = 1.2 Hz, 1H), 1.35 (s, 9H), 1.27 (s, 9H); 










119.6, 119.5, 115.1, 111.0, 108.0, 35.3, 34.8, 31.4, 30.8. IR (thin film): 3340.10, 
2963.09, 2569.68, 2360.44, 1659.45, 1565.92, 1416.46, 1242.90, 963.27, 700.99. HRMS: 
Calculated for (M+Na)+: 348.1940; found: 348.1932. 
 
 
3,6-Di-tert-butylacridin-9(10H)-one (S2). To an Erlenmeyer flask equipped with a stir 
bar was added sulfuric acid (38 mL), which was heated to 100 ˚C. 4-(tert-Butyl)-2-((3-
(tert-butyl)phenyl)amino)benzoic acid (5.1 g, 15.7 mmol) was added to the sulfuric acid in 
portions and stirred for 3 hours at 100 ˚C. The solution was cooled to room temperature 
and the acidic solution was then poured into water at 0 ˚C, forming a yellow precipitate. 
Ammonium hydroxide was added until an alkaline pH persisted. The yellow solid was then 
filtered over a medium fritted funnel to afford the desired product along with the undesired 
regioisomer in an 8:1 mixture. Hot filtration from methanol removed insoluble salts, 
followed by a recrystallization from methanol and dichloromethane to afford the desired 
acridone (3.6 g, 76% yield). 1H NMR (400 MHz, 3:1 CDCl3:MeOD) δ 8.12 (d, J = 8.9 Hz, 
2H), 7.26 (d, J = 1.8 Hz, 2H), 7.29-7.18 (m, 2H), 3.15 (br. s, 1H), 1.16 (d, J = 2.5 Hz, 
18H). 13C NMR (151 MHz, CDCl3) δ 178.26, 157.33, 141.19, 125.73, 119.82, 118.44, 
112.70, 48.73, 35.02, 30.51. IR (thin film): 3087.48, 2962.13, 2321.87, 1632.45, 1594.84, 




3,6-Di-tert-butyl-10-phenylacridin-9(10H)-one (S3). To a flame-dried round bottom 
flask was added 3,6-di-tert-butylacridin-9(10H)-one (3.75 g, 12.2 mmol, 1 equiv), copper 
(I) iodide (232 mg, 1.22 mmol, 0.1 equiv) and potassium carbonate (3.37 g, 24.4 mmol, 
2.0 equiv). Iodobenzene (1.48 mL, 13.3 mmol, 1.1 equiv) and 2,2,6,6-tetramethylheptane-
3,5-dione (0.51 mL, 2.44 mmol, 0.2 equiv) were added in a nitrogen-filled glovebox along 
with dimethylformamide (62 mL). The solution was heated to 130 ˚C for 48 hours. The 
solution was then cooled to room temperature and quenched with 3M HCl (50 mL). The 
aqueous solution was extracted with dichloromethane (3x 100 mL). The combined organic 
layers were washed with sodium bicarbonate (150 ml), ammonium chloride (150 mL), brine, 
dried over sodium sulfate and then concentrated. The final pale yellow solid (2.95 g, 63% 
yield) was obtained after flash chromatography (20% EtOAc/Hexanes). 1H NMR (400 MHz, 
CDCl3) δ 8.50 (d, J = 8.5 Hz, 2H), 7.72 (t, J = 7.5 Hz, 2H), 7.66 (d, J = 7.3 Hz, 1H), 7.40-
7.37 (m, 2H), 7.33 (dd, J = 8.5, 1.6 Hz, 2H), 6.71 (d, J = 1.6 Hz, 2H), 1.20 (s, 18H). 13C 
NMR (151 MHz, CDCl3) δ177.73, 156.93, 143.38, 139.30, 131.01, 130.21, 129.59, 126.98, 
119.94, 119.77, 113.03, 35.46, 31.01. IR (thin film): 3049.87, 2964.05, 2868.59, 1606.41, 
1452.14, 1307.50, 1197.58, 997.02, 867.81, 682.68; HRMS: Calculated for (M+H)+: 
384.2327; found: 384.2319. 
 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium tetrafluoroborate (3.7C). To a 
flame dried round bottom flask equipped with a stir bar was added 3,6-di-tert-butyl-10-
phenylacridin-9(10H)-one (1.5 g, 3.91 mmol, 1.0 equiv). The acridone was dissolved in dry 










added dropwise and the solution was stirred at room temperature for 24 hours. The solution 
was then heated to 50 ˚C for 72 hours. The red solution was cooled and quenched with 
sodium bicarbonate (100 mL). The aqueous layer was extracted with DCM (3x 100 mL) 
followed by a brine wash, drying over sodium sulfate and concentration to afford a red oil. 
The oil was dried on high vacuum for 4 hours. The oil was then dissolved in ether (67 mL) 
and tetrafluoroboric acid diethyl ether complex (0.65 mL, 4.7 mmol, 1.2 equiv) in ether 
(12.5 mL) was added dropwise and the solution was stirred for 1 hour, during which a 
precipitate quickly appeared with the addition of acid. The yellow solid that precipitated out 
was then filtered and washed with ether (200 mL) to afford the final 3,6-di-tert-butyl-9-
mesityl-10-phenylacridin-10-ium tetrafluoroborate (2.05 g, 92% yield).1H NMR (400 MHz, 
CDCl3) δ 7.99-7.93 (m, 2H), 7.93-7.89 (m, 1H), 7.78 (q, J = 1.6 Hz, 3H), 7.77-7.70 (m, 
2H), 7.41 (d, J = 3.2 Hz, 2H), 7.26 (s, 1H), 7.16 (d, J = 2.7 Hz, 2H), 2.48 (s, 3H), 1.86 (d, 
J = 3.5 Hz, 6H), 1.29 (d, J = 3.5 Hz, 9H). 13C NMR (151 MHz, CDCl3) δ 163.72, 162.44, 
142.25, 140.31, 136.95, 136.25, 131.96, 131.75, 129.40, 129.07, 128.41, 128.12, 127.60, 
124.16, 115.19, 36.80, 30.34, 21.42, 20.36. IR (thin film): 2965.02, 2863.77, 1615.09, 
1540.85, 1436.71, 1252.54, 1055.84, 915.06, 780.06, 728.96; HRMS: Calculated for (M-
BF4)+: 486.3161; found: 486.3158. 
 
A.3.2 Preparation of Arene Substrates 
 
 
(Methoxymethoxy)benzene (S4) was prepared according to a published procedure; 
spectral data were in agreement with literature values.2 
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tert-Butyldimethyl(phenoxy)silane (S5) was prepared according to a published 
procedure; spectral data were in agreement with literature values.3 
 
 
tert-Butoxybenzene (S6) was prepared according to a published procedure; spectral data 
were in agreement with literature values.4 
 
 
2-Chloro-2'-methoxy-1,1'-biphenyl. (S7) Under an inert atmosphere, 173 mg 
Tetrakis(triphenylphosphine)palladium(0) (0.15 mmol, 0.03 equiv) was added to a flame-
dried round bottom flask containing a magnetic stir bar, along with 938 mg (2-
chlorophenyl)boronic acid (6.0 mmol, 1.2 equiv) and 1.38 g K2CO3 (10. mmol, 2.0 equiv). 
Separately, a 9:1 (v/v) mixture of THF/H2O was sparged with nitrogen, then added to the 
flask containing palladium, boronic acid, and carbonate. The mixture was warmed to 50 oC 
for 10 minutes while 2-bromoanisole was sparged with nitrogen in a separate vial. 2-
Bromoanisole was added, and the reaction was heated at reflux for 26 hours. After cooling 
to room temperature, 20 mL H2O was added, along with 10 mL saturated aqueous NH4Cl. 
The layers were separated, and the aqueous phase was extracted twice with diethyl ether. 
The combined extracts were washed with brine and dried with MgSO4. After filtration and 
concetration in vacuo, the crude oil was dissolved in pentanes and crystallization occurred 
when cooled in a -20 oC freezer. The white crystals were collected by vacuum filtration, 
washed with cold pentanes, and dried in vacuo to give 930 mg pure material. The spectral 




1-Methyl-1H-indazole (S8). The title compound was prepared by the published 
procedure.6 The material was recrystallized from a mixture of ethyl acetate and hexanes 
and dried in vacuo. The 1H NMR spectrum matches the reported data. 
 
 
(S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate (S9) was prepared according to 
a published procedure; spectral data were in agreement with literature values.7 
 
 
Bis-Boc-adenine (S10) Prepared according to a published procedure.8 The material was 
recrystallized from a mixture of ethyl acetate and hexanes and dried in vacuo. Spectral data 
were in agreement with literature values. 
 
 
Methyl (tert-butoxycarbonyl)-L-histidinate (S11). The title compound was prepared by 
the published procedure.9 The material was recrystallized from a mixture of ethyl acetate 




1,3-Dihexylquinazoline-2,4(1H,3H)-dione (S12). Benzoyleneurea (1 g, 6.2 mmol, 1.0 
equiv) was dissolved in dry DMF and potassium carbonate was added (2.8 g, 20.1 mmol, 
3.3 equiv). Hexyl bromide (3.5 mL, 24.7 mmol, 4.0 equiv) was added dropwise and the 
solution was stirred for 84 hours. The solution was concentrated and then diluted with 
dichloromethane. The organic solution was washed with water (50 mL), and the aqueous 
layer was extracted with CH2Cl2 (3x 50 mL). The combined organic layers were washed with 
brine, dried over sodium sulfate and concentrated to give a pale yellow solid. The crude 
product was purified by flash chromatography (0-20% EtOAc/Hex) to afford the desired pale 
yellow oil (1.1 g, 54% yield). 1H NMR (600 MHz, CDCl3) δ 8.24 (dd, J = 7.9, 1.7 Hz, 1H), 
7.66 (ddd, J = 8.7, 7.2, 1.7 Hz, 1H), 7.33-7.12 (m, 2H), 4.17-4.04 (m, 4H), 1.77-1.61 (m, 
4H), 1.42-1.23 (m, 11H), 0.95-0.79 (m, 7H). 13C NMR (151 MHz, CDCl3) δ 161.79, 150.80, 
139.89, 134.94, 129.19, 122.68, 115.88, 113.57, 43.84, 42.05, 31.63, 31.63, 31.58, 
27.88, 27.37, 26.78, 26.59, 22.69, 22.67, 14.15, 14.11; IR (thin film): 2956.34, 2930.31, 
2857.99, 2357.55, 1704.76, 1660.41, 1608.34, 1483.96, 1352.82, 757.89. HRMS: 
Calculated for (M+H)+: 331.2385; found: 331.2379. 
 
 
(E)-2-Methoxy-4-((8-methylnon-6-enamido)methyl)phenyl acetate (S13/S13’). 
The title compound was synthesized from capsaicin, which was obtained from Sigma-Aldrich 
as a 2:1 mixture of capsaicin ((E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-
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enamide) and dihydrocapsaicin (N-(4-hydroxy-3-methoxybenzyl)-8-methylnonanamide). 
The capsaicin was used as received and acylated by the following procedure: 750 mg 
capsaicin (2.5 mmol, 1.0 equiv) was cooled to 0 oC in 11 mL DCM, and 262 µL acetyl 
chloride was added (3.7 mmol, 1.5 equiv), followed by 693 µL trimethylamine. The mixture 
was stirred for 1 hour at 0 oC, then at ambient temperature for an additional 1 hour. The 
mixture was diluted with 25 mL DCM and washed with brine, dilute HCl, then saturated 
aqueous NaHCO3. The organic phase was again washed with brine and dried with MgSO4. 
After concentrating in vacuo, the crude tan solid was recrystallized from a mixture of EtOAc 
and hexanes, and collected by vacuum filtration, yielding 813 mg of a white solid. The 
proton NMR spectra indicates that the ratio between O-acetyl capsaicin S13 and O-acetyl 
dihydrocapsaicin S13’ is identical to the starting material. Note: the indicated proton 
resonances refer to the title compound; see the included 1H NMR spectrum below for the 
resonances of the saturated compound. The carbon resonances listed include the 
resonances for both the unsaturated and saturated compounds in the mixture. 1H NMR 
(600 MHz, CDCl3) δ 6.98 (d, J = 8.0 Hz, 1H), 6.90 (s, 1H), 6.84 (d, J = 8.0 Hz, 1H), 5.68 
(s, 1H), 5.41 – 5.28 (m, 2H), 4.42 (d, J = 5.7 Hz, 2H), 3.82 (s, 3H), 2.31 (s, 3H), 2.21 (t, J 
= 7.4 Hz, 2H), 1.99 (q, J = 7.0 Hz, 2H), 1.67 – 1.63 (m, 2H), 1.51 (hept, J = 6.7 Hz, 1H), 
1.39 (p, J = 7.6 Hz, 2H), 0.95 (d, J = 6.7 Hz, 6H). ; 13C NMR (151 MHz, CDCl3) δ 172.96, 
169.29, 151.35, 139.21, 138.25, 137.53, 126.60, 123.01, 120.19, 112.29, 100.12, 56.04, 
43.60, 39.10, 37.00, 36.84, 32.38, 31.12, 29.45, 28.09, 27.39, 25.93, 25.40, 22.80, 20.82. 
IR (thin film): 3287.07, 2928.38, 2359.48, 1766.48, 1642.09, 1511.92, 1388.25, 1272.79, 
1195.54, 1035.59. HRMS: Calculated for (M+Na)+: 370.1995 and 372.2151; found: 




(9S)-10,11-Dihydro-6’-methoxycinchonan-9-ol·2,2,2-trifluoroacetic acid (S14). 
The title compound was prepared by stirring 1.0 g dihydroquinidine (3.1 mmol, 1.0 equiv) in 
a 15:1 (v/v) mixture of Et2O/MeOH at 0 oC and adding 237 µL trifluoroacetic acid (3.1 
mmol, 1.0 equiv) slowly. The mixture was stirred for 2 hours and concentrated in vacuo. 
The crude white foam was recrystallized by dissolving in hot toluene and cooling. The tan 
solid was collected by vacuum filtration and washed with toluene. The solid was dried in 
vacuo to give quantitative yield of the salt. 1H NMR (600 MHz, CDCl3) δ 12.34 (s, 1H), 8.69 
(d, J = 4.5 Hz, 1H), 7.86 (d, J = 9.3 Hz, 1H), 7.62 (d, J = 4.4 Hz, 1H), 7.18 (s, 1H), 6.98 
(s, 1H), 6.37 (s, 1H), 5.66 (s, 1H), 4.16 – 3.91 (m, 1H), 3.83 (s, 3H), 3.54 – 3.22 (m, 3H), 
3.18 (s, 1H), 2.39 – 2.24 (m, 1H), 1.95 (s, 1H), 1.86 – 1.51 (m, 5H), 1.02 – 0.88 (m, 4H). 
13C NMR (151 MHz, CDCl3) δ 162.93 (q, J = 34.9 Hz), 158.20, 146.85, 144.30, 143.27, 
131.19, 125.16, 122.30, 118.36, 116.71 (q, J = 292.7 Hz), 99.36, 66.40, 60.23, 55.79, 
50.03, 49.38, 35.26, 25.16, 24.30, 23.93, 17.68, 11.50. 19F NMR (376 MHz, CDCl3) δ -
75.34. IR (thin film): 3249.47 (br), 2964.05, 2556.18, 2360.44, 1672.95, 1509.99, 
1433.82, 1242.90, 1199.51, 834.06. HRMS: Calculated for (M-C2O2F3)+: 327.2072; found: 
327.2067. 
 
A.3.3 Procedures for the Photoredox-Catalyzed Synthesis of Aryl Amines 
Notes: All isolated yields and regioisomeric ratios reported are the average of duplicate 
experiments. For inseparable mixtures of regioisomers, analytical data was collected for the 




A.3.3.1 General Method A: Synthesis of 3.10-3.14, 3.17-3.31, 3.33-3.36, 3.38-3.40  
The synthesis of aryl pyrazoles 3.10a and 3.10b from anisole 3.9 and pyrazole 3.8 is 
representative of the following general procedure using conditions from Table 3.2:  
To a 2 dram vial containing a Teflon-coated magnetic stir bar was added 25 µmol of catalyst 
C (0.05 equiv), 68 mg of pyrazole (1.0 mmol, 2 equiv), and 16 mg of (2,2,6,6- 
tetramethylpiperidin-1-yl)oxyl (0.1 mmol, 0.2 equiv). Dichloromethane or 1,2-
Dichloroethane was added (5.0 mL), followed by the arene (0.5 mmol, 1.0 equiv). The vial 
was sealed with a Teflon-lined septum screw cap. The septum was pierced with a disposable 
steel needle connected to an oxygen-filled balloon. A vent needle was inserted and the 
reaction medium was sparged for 5 minutes by bubbling oxygen through the mixture. The 
vent needle was removed, and the oxygen balloon was maintained, providing approximately 
1 atm of oxygen to the vial headspace for the course of the reaction. The vial was 
positioned on a stir plate approximately 10 cm from a Par38 LED lamp supplying blue light 
(λ = 440-460 nm). After irradiation for 20 hours, the reaction mixture was analyzed by GC-
MS or concentrated in vacuo and purified by column chromatography on silica gel with 
hexanes/ethyl acetate (or with the eluent noted for each substrate). For reaction 
optimization as shown in Table 3.2, crude reaction mixtures were analyzed by GC-MS by 
the following modification to General Method A: reactions were run under concentrations 
given in Table 3.2 relative to anisole on a 0.5 mmol scale. Following irradiation for 20 
hours, 33 µL 1,3-dimethoxybenzene (0.25 mmol, 0.5 equiv) was added to the reaction 
mixture, which was passed through a short pad of silica gel and rinsed with an equal volume 
of dichloromethane. Samples were analyzed using an Agilent 5973 GC-MS system, wherein 
product yields and anisole conversions were calculated relative to the internal standard 
according to the instrument response factors, which were determined separately by 
construction of calibration curves.  
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1-(4-Methoxyphenyl)-1H-pyrazole (3.10a), 1-(2-methoxyphenyl)-1H-pyrazole 
(3.10b). The title compounds were prepared according to General Method A with an 
irradiation time of 20 hours. The crude residue was purified by column chromatography on 
silica gel with an eluent of 10% to 20% EtOAc/hexanes to yield a pale yellow oil in 88% as 
an inseparable mixture of 3.10a and 3.10b. The para:ortho ratio of the inseparable mixture 
was 6.7:1 as determined by 1H NMR of the isolated product. The NMR data were consistent 
with literature values. 
 
3.10a11: 1H NMR (400 MHz, CDCl3) δ 7.82 (s, 1H), 7.69 (s, 1H), 7.59 (d, J = 8.9 Hz, 2H), 
6.97 (d, J = 8.9 Hz, 2H), 6.43 (s, 1H), 3.84 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 158.25, 
140.64, 134.06, 126.85, 120.91, 114.54, 107.21, 55.60. 
 
3.10b12: 1H NMR (400 MHz, CDCl3) δ 8.03 (s, 1H), 7.72 (m, 1H), 7.69 (m, 2H), 7.30 (m, 
1H), 7.06 (m, 1H), 6.43 (s, 1H), 3.87 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 151.36, 

















1-(4-(Methoxymethoxy)phenyl)-1H-pyrazole (3.11a) and 1-(2-
(methoxymethoxy)phenyl)-1H-pyrazole (3.11b). The title compounds were prepared 
from S4 and pyrazole according to General Method A with an irradiation time of 20 hours. 
The crude residue was purified by column chromatography on silica gel with an eluent of 
10% to 20% EtOAc/hexanes to yield a pale yellow solid in 52% as an inseparable mixture of 
3.11a and 3.11b. The para:ortho ratio of the mixture was 7.8:1 as determined by 1H NMR 
of the isolated product.  
 
3.11a. 1H NMR (600 MHz, CDCl3) δ 7.83 (d, J = 2.4 Hz, 1H), 7.69 (d, J = 1.7 Hz, 1H), 7.59 
(d, J = 9.0 Hz, 2H), 7.11 (d, J = 9.0 Hz, 2H), 6.43 (d, J = 2.2 Hz, 1H), 5.19 (s, 2H), 3.49 
(s, 3H). 13C NMR (151 MHz, CDCl3) δ 155.91, 140.80, 135.03, 126.88, 120.84, 117.08, 
107.35, 94.75, 56.15. 
 
3.11b. 1H NMR (600 MHz, CDCl3) δ 8.03 (dd, J = 2.4, 0.8 Hz, 1H), 7.74-7.70 (m, 2H), 
7.28-7.25 (m, 3H), 6.43 (d, J = 2.2 Hz, 1H), 5.19 (s, 2H), 3.42 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 149.10, 140.24, 135.03, 131.58, 128.16, 125.55, 116.41, 106.38, 95.44, 
56.43. 
 
IR (thin film): 3452.67, 3124.12, 2955.38, 1597.73, 1523.49, 1396.21, 1311.36, 1237.11, 










1-(4-((tert-Butyldimethylsilyl)oxy)phenyl)-1H-pyrazole (3.12a) and 1-(2-((tert-
butyldimethylsilyl) oxy)phenyl)-1H-pyrazole (3.12b). The title compounds were 
prepared from S5 and pyrazole according to General Method A with an irradiation time of 
20 hours. The crude residue was purified by column chromatography on silica gel with an 
eluent of 10% to 20% EtOAc/hexanes to yield a pale yellow oil in 74% as an inseparable 
mixture of 3.12a and 3.12b. The para:ortho ratio of the mixture was 9.3:1 as determined 
by 1H NMR of the isolated product.  
 
3.12a. 1H NMR (600 MHz, CDCl3) δ 7.83 (s, 1H), 7.70 (s, 1H), 7.56-7.54 (d, J = 8.1 Hz, 
2H), 6.93-6.92 (d, J = 8.1 Hz, 2H), 6.44 (d, J = 2.1 Hz, 1H), 1.02 (s, 9H), 0.24 (s, 6H). 13C 
NMR (151 MHz, CDCl3) δ154.11, 140.37, 134.26, 126.57, 120.56, 120.51, 106.93, 25.45, 
18.00, -4.65. 
 
3.12b. 1H NMR (600 MHz, CDCl3) δ 7.93 (d, J = 2.0 Hz, 1H), 7.70 (s, 1H), 7.63 (d, J = 7.9 
Hz, 1H), 7.25-7.19 (m, 1H), 7.10-7.05 (m, 1H), 6.99 (dt, J = 8.1, 1.3 Hz, 1H), 6.43 (s, 
1H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (151 MHz, CDCl3) δ147.58, 139.79, 132.08, 
131.30, 127.79, 125.88, 121.81, 120.86, 105.79, 25.38, 17.91, -5.02. 
 
IR (thin film): 2956.34, 2930.31, 2857.99, 1596.77, 1521.56, 1471.42, 1395.25, 1266.04, 











1-(4-(tert-Butoxy)phenyl)-1H-pyrazole (3.13a) and 1-(2-(tert-butoxy)phenyl)-1H-
pyrazole (3.13b). The title compounds were prepared from S6 and pyrazole according to 
General Method A with an irradiation time of 20 hours. The crude residue was purified by 
column chromatography on silica gel with an eluent of 10% to 20% EtOAc/hexanes to yield 
a pale yellow solid in 63% as an inseparable mixture of 3.13a and 3.13b. The para:ortho 
ratio of the mixture was 6:1 as determined by 1H NMR of the isolated product.  
 
3.13a. 1H NMR (400 MHz, CDCl3) δ 7.90 (s, 1H), 7.74 (s, 1H), 7.62 (d, J = 8.4 Hz, 2H), 
7.11 (d, J = 8.4 Hz, 2H), 6.48 (s, 1H), 1.41 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 153.49, 
140.43, 135.70, 126.47, 124.62, 119.65, 106.97, 78.58, 28.42. 
 
3.13b. 1H NMR (400 MHz, CDCl3) δ 8.12 (s, 1H), 7.74 (s, 1H), 7.25 (d, J = 7.8 Hz, 2H), 
7.22-7.19 (m, 2H), 6.46 (s, 1H), 1.17 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 146.78, 
139.72, 135.32, 131.47, 126.86, 125.03, 124.00, 105.73, 80.56, 27.82. 
 
IR (thin film): 3122.19, 2976.59, 2933.20, 2360.44, 1521.56, 1394.28, 1240.00, 1161.90, 
1046.19, 892.88, 750.17; HRMS: Calculated for (M+Na)+: 239.1160; found: 239.1152. 
 
 
1-(4-Phenoxyphenyl)-1H-pyrazole (3.14a) and 1-(2-phenoxyphenyl)-1H-pyrazole 
(3.14b). The title compounds were prepared from diphenyl ether and pyrazole according to 
General Method A with an irradiation time of 20 hours. The crude residue was purified by 








a pale yellow solid in 86% as an inseparable mixture of 3.14a and 3.14b. The para:ortho 
ratio of the mixture was 11:1 as determined by 1H NMR of the isolated product.  
 
3.14a. 1H NMR (600 MHz, CDCl3) δ 7.88 (d, J = 2.4 Hz, 1H), 7.73 (d, J = 1.8 Hz, 1H), 7.66 
(d, J = 8.9 Hz, 2H), 7.37 (dd, J = 8.5, 7.3 Hz, 2H), 7.14 (td, J = 7.4, 1.1 Hz, 1H), 7.11 (d, J 
= 8.8 Hz, 2H), 7.07-7.03 (m, 2H), 6.47 (t, J = 2.1 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 
157.18, 155.80, 141.03, 136.0, 129.96, 126.92, 123.61, 120.98, 119.74, 118.92, 107.60. 
 
3.14b. 1H NMR (600 MHz, CDCl3) δ 8.10 (d, J = 2.3 Hz, 1H), 7.94-7.90 (m, 1H), 7.70 (d, J 
= 1.7 Hz, 1H), 7.32 (dd, J = 8.5, 7.3 Hz, 2H), 7.27 (d, J = 3.7 Hz, 2H), 7.14 (td, J = 7.4, 
1.1 Hz, 1H), 7.11 (d, J = 8.8 Hz, 1H), 6.98 (dd, J = 7.6, 1.1 Hz, 2H), 6.38 (d, J = 2.1 Hz, 
1H). 13C NMR (151 MHz, CDCl3) δ 156.73, 147.88, 140.55, 132.36, 131.26, 129.61, 
127.91, 125.39, 124.60, 120.98, 118.24, 115.54, 106.92. 
 
IR (thin film): 3056.62, 2359.48, 1589.06, 1521.56, 1488.78, 1395.25, 1236.15, 1046.19, 
936.27, 841.78; HRMS: Calculated for (M+H)+: 237.1028; found: 237.1020. 
 
 
1-([1,1'-Biphenyl]-4-yl)-1H-pyrazole (3.17a) and 1-([1,1'-biphenyl]-2-yl)-1H-
pyrazole (3.17b). The title compounds were prepared from biphenyl and pyrazole 
according to General Method A with an irradiation time of 20 hours. The crude residue was 
purified by column chromatography on silica gel with an eluent of 10% to 20% 








3.17b. The para:ortho ratio of the mixture was 7.9:1 as determined by 1H NMR of the 
isolated product.  
 
3.17a. 1H NMR (600 MHz, CDCl3) δ 7.97 (s, 1H), 7.79-7.76 (m, 3H), 7.69 (dd, J = 8.7, 1.9 
Hz, 2H), 7.64-7.62 (m, 2H), 7.48-7.45 (m, 2H), 7.39-7.36 (m, 1H), 6.50 (s, 1H). 13C NMR 
(151 MHz, CDCl3) δ 141.29, 140.22, 139.49, 139.44, 128.99, 128.17, 127.61, 127.08, 
126.81, 119.5, 107.83. 
 
3.17b. 1H NMR (600 MHz, CDCl3) δ 7.65-7.60 (m, 1H), 7.50-7.44 (m, 2H), 7.32-7.28 (m, 
3H), 7.26 (m, 2H), 7.13-7.12 (dd, J = 6.7, 2.7 Hz, 2H), 7.08 (m, 1H), 6.20 (q, J = 1.9 Hz, 
1H). 13C NMR (151 MHz, CDCl3) δ 140.36, 138.68, 136.78, 131.43, 131.13, 128.64, 
128.55, 128.47, 128.35, 127.53, 126.67, 106.48. 
 
IR (thin film): 3130.87, 3107.72, 2358.52, 1607.38, 1530.24, 1486.85, 1394.28, 1050.05, 
836.96, 743.42; HRMS: Calculated for (M+H)+: 221.1079; found: 221.1072. 
 
 
1-(3-Chloro-4-methoxyphenyl)-1H-pyrazole (3.18). The title compound was prepared 
from 2-chloroanisole and pyrazole according to General Method A with an irradiation time 
of 44 hours. The crude residue was purified by column chromatography on silica gel with an 
eluent of 10% to 20% EtOAc/hexanes to give 3.18 as a pale yellow solid in 70% yield.  
1H NMR (600 MHz, CDCl3) δ 7.80 (d, J = 2.4 Hz, 1H), 7.73 (d, J = 2.6 Hz, 1H), 7.68 (d, J = 
1.8 Hz, 1H), 7.53 (dd, J = 9.0, 2.6 Hz, 1H), 6.96 (d, J = 8.8 Hz, 1H), 6.43 (s, 1H), 3.91 (s, 






118.59, 112.40, 107.71, 56.51; IR (thin film): 3124.12, 2965.02, 2839.67, 2359.48, 
1585.20, 1504.20, 1397.17, 1278.57, 1062.59, 750.17; HRMS: Calculated for (M+Na)+: 
231.0301; found: 231.0294. 
 
 
1-(2-Bromo-4-methoxyphenyl)-1H-pyrazole (3.19). The title compound was prepared 
from 3-bromoanisole and pyrazole according to General Method A with an irradiation time 
of 44 hours. The crude residue was purified by column chromatography on silica gel with an 
eluent of 10% to 20% EtOAc/hexanes to give 3.19 as a white solid in 54% yield. 1H NMR 
(600 MHz, CDCl3) δ 7.71 (dd, J = 11.3, 2.1 Hz, 2H), 7.39 (d, J = 8.9 Hz, 1H), 7.20 (d, J = 
2.5 Hz, 1H), 6.93 (dd, J = 8.7, 2.5 Hz, 1H), 6.43 (t, J = 2.3 Hz, 1H), 3.83 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 153.71, 141.10, 134.21, 126.85, 123.24, 121.77, 118.62, 112.43, 
107.73, 56.55. IR (thin film): 3101.94, 2965.02, 2837.74, 1602.56, 1521.56, 1396.21, 




1-(2'-Chloro-6-methoxy-[1,1'-biphenyl]-3-yl)-1H-pyrazole (3.20). The title 
compound was prepared from S7 and pyrazole according to General Method A with an 
irradiation time of 20 hours. The crude residue was purified by column chromatography on 










yield. 1H NMR (600 MHz, CDCl3) δ 7.86 (d, J = 2.4 Hz, 1H), 7.72 – 7.68 (m, 1H), 7.68 (d, J 
= 2.8 Hz, 1H), 7.52 (d, J = 2.8 Hz, 1H), 7.49 – 7.44 (m, 1H), 7.37 – 7.29 (m, 3H), 7.05 (d, 
J = 8.9 Hz, 1H), 6.45 (t, J = 2.0 Hz, 1H), 3.83 (s, 3H);; 13C NMR (151 MHz, CDCl3) δ 
155.51, 140.85, 136.88, 133.95, 133.70, 131.69, 129.51, 129.43, 129.09, 126.97, 126.69, 
122.54, 120.44, 111.64, 107.41, 56.17. IR (thin film): 3055.66, 2934.16, 2835.81, 
1593.88, 1518.67, 1400.07, 1253.50, 1141.65, 1046.19, 750.17; HRMS: Calculated for 
(M+Na)+: 307.0614; found: 307.0606. 
 
 
2,6-Dimethoxy-3-(1H-pyrazol-1-yl)pyridine (3.21). The title compound was prepared 
from 2,6-dimethoxypyridine and pyrazole according to General Method A with an 
irradiation time of 72 hours. The crude residue was purified by column chromatography on 
silica gel with an eluent of hexanes to 10% EtOAc/hexanes to give 3.21 as a white solid in 
45% yield. 1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 2.4 Hz, 1H), 7.93 (d, J = 8.4 Hz, 1H), 
7.68 (d, J = 1.6 Hz, 1H), 6.45 – 6.37 (m, 2H), 4.02 (s, 3H), 3.96 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 161.15, 154.17, 140.22, 136.29, 131.06, 117.65, 106.33, 101.58, 54.02, 
53.95. IR (thin film): 3103.87, 2949.59, 1592.91, 1591.63, 1486.85, 1392.35, 1230.36, 













6-Methoxy-5-(1H-pyrazol-1-yl)quinoline (23). The title compound was prepared from 
6-methoxyquinoline and pyrazole according to General Method A with an irradiation time 
of 20 hours. The crude residue was purified by column chromatography on silica gel with an 
eluent of 50% to 100% EtOAc/Hexanes to give a yellow oil in 60% yield. 1H NMR (600 
MHz, CDCl3) δ 8.79 (dt, J = 4.1, 2.1 Hz, 1H), 8.21 (d, J = 9.4 Hz, 1H), 7.85 (t, J = 2.1 Hz, 
1H), 7.72-7.62 (m, 2H), 7.58 (d, J = 9.4 Hz, 1H), 7.33 (m, 1H), 6.54 (m, 1H), 3.89 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 152.42, 148.91, 143.37, 140.87, 133.16, 132.07, 131.01, 
127.29, 116.62, 106.30, 56.92. IR (thin film): 311640, 2941.88, 1618.95, 1506.13, 
1398.14, 1325.82, 1267.97, 1091.51, 908.31, 827.31; HRMS: Calculated for (M+H)+: 
226.0980; found: 226.0974. 
 
 
1,3-Dihexyl-6-(1H-pyrazol-1-yl)quinazoline-2,4(1H,3H)-dione (3.23). The title 
compound was prepared from S12 and pyrazole according to General Method A with an 
irradiation time of 20 hours. The crude residue was purified by column chromatography on 
silica gel with an eluent of 10% to 20% EtOAc/hexanes to yield a pale yellow oil in 43% as 
an inseparable mixture of pyrazole addition at the 6 and 8 positions. The ratio of 6-pyrazolyl 
to 8-pyrazolyl products was determined by 1H NMR of the isolated product to be greater 
than 15:1. 1H NMR (600 MHz, CDCl3) δ 8.36 (d, J = 3.0 Hz, 1H), 8.18-8.17 (m, 1H), 8.00 
(d, J = 2.9 Hz, 1H), 7.73 (s, 1H), 7.27-7.26 (m, 1H), 6.49 (s, 1H), 4.14-4.07 (m, 4H), 
1.73-1.68 (m, 4H), 1.44-1.32 (m, 12H), 0.97-0.84 (m, 6H). 13C NMR (151 MHz, CDCl3) δ 
161.22, 150.43, 141.43, 137.96, 135.49, 126.77, 126.43, 117.76, 116.27, 115.05, 108.17, 










film): 3122.19, 2930.31, 2857.99, 1703.80, 1659.45, 1524.45, 1480.10, 1394.28, 
1045.23, 752.10; HRMS: Calculated for (M+Na)+: 419.2423; found: 419.2416. 
 
 
1-Methyl-3-(1H-pyrazol-1-yl)-1H-indazole (3.24). The title compound was prepared 
from 1-methylindazole (S8) and pyrazole according to General Method A with an 
irradiation time of 24 hours. The crude residue was purified by column chromatography on 
silica gel with an eluent of 10% to 75% EtOAc/hexanes to give 3.24 as a pale yellow oil in 
43%. 1H NMR (600 MHz, CDCl3) δ 8.32 (dt, J = 8.3, 1.0 Hz, 1H), 8.25 (d, J = 2.5 Hz, 1H), 
7.81 (d, J = 2.0 Hz, 1H), 7.45 (ddd, J = 8.3, 6.8, 1.1 Hz, 1H), 7.36 (d, J = 8.6 Hz, 1H), 
7.24-7.16 (m, 1H), 6.49 (t, J = 2.1 Hz, 1H), 4.05 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
141.68, 141.42, 127.84, 127.58, 122.63, 121.37, 115.20, 109.01, 107.01, 35.65. IR (thin 
film): 3124.12, 3063.37, 2936.09, 1617.98, 1549.52, 1397.17, 1256.40, 1043.30, 919.88, 
743.43; HRMS: Calculated for (M+Na)+: 221.0803; found: 221.0796. 
 
 
6-(1H-Pyrazol-1-yl)chroman-2-one (3.25). The title compound was prepared according 
to General Method A with the following modifications to the procedure: 2 equivalents of 
3,4-dihydrocoumarin (1.0 mmol) and 1 equivalent of pyrazole (0.5 mmol) with Catalyst B 
(0.025 mmol) in DCE (0.1 M) without a cooling fan and with an irradiation time of 44 hours. 
The title compound was purified by column chromatography on silica gel (25% to 50% 










= 2.5 Hz, 1H), 7.71 (d, J = 1.7 Hz, 1H), 7.60 (d, J = 2.6 Hz, 1H), 7.51 (dd, J = 8.7, 2.6 Hz, 
1H), 7.11 (d, J = 8.7 Hz, 1H), 6.47 (t, J = 2.2 Hz, 1H), 3.06 (dd, J = 8.3, 6.3 Hz, 2H), 2.81 
(dd, J = 8.3, 6.2 Hz, 2H). 13C NMR (151 MHz, CDCl3) δ 168.06, 150.33, 141.28, 136.73, 
126.86, 123.94, 119.25, 118.90, 117.85, 107.90,, 29.03, 23.93.; IR (thin film): 3127.01, 
2918.73, 1769.37, 1600.63, 1502.28, 1395.25, 1343.18, 1217.83, 1144.55, 899.63; 




methyl-1H-pyrazole (3.26b). The title compounds were prepared from anisole and 4-
methylpyrazole according to General Method A with an irradiation time of 20 hours. The 
crude residue was purified by column chromatography on silica gel with an eluent of 
hexanes to 20% EtOAc/hexanes to yield a colorless solid in 68% as an inseparable mixture 
of 3.26a and 3.26b in a ratio of 8:1. 
 
3.26a. 1H NMR (600 MHz, CDCl3) δ 7.59 (s, 1H), 7.54 (d, J = 9.0 Hz, 2H), 7.49 (s, 1H), 
6.94 (d, J = 9.0 Hz, 2H), 3.82 (s, 3H), 2.14 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 157.96, 
141.30, 134.23, 125.55, 120.44, 117.84, 114.52, 55.61, 9.03. 
3.26b. 1H NMR (600 MHz, CDCl3) δ 7.80 (s, 1H), 7.68 (dd, J = 7.9, 1.5 Hz, 1H), 7.51 (s, 
1H), 7.27 – 7.24 (m, 1H), 7.06 – 7.00 (m, 2H), 3.86 (s, 3H), 2.16 (s, 3H). 13C NMR (151 













IR (thin film): 2966.95, 2839.67, 1519.63, 1455.03, 1261.22, 1181.19, 1041.37, 953.63, 




3,5-dimethyl-1H- pyrazole (3.27b). The title compounds were prepared from anisole 
and 4-methylpyrazole according to General Method A with an irradiation time of 20 hours. 
The crude residue was purified by column chromatography on silica gel with an eluent of 
hexanes to 15% EtOAc/hexanes to yield an oily solid in 85% as an inseparable mixture of 
3.27a and 3.27b in a ratio of 7.5:1.  
3.27a13. 1H NMR (600 MHz, CDCl3) δ 7.32 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.9 Hz, 2H), 
5.96 (s, 1H), 3.84 (s, 3H), 2.29 (s, 3H), 2.24 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 158.87, 
148.63, 139.57, 133.22, 126.49, 114.21, 106.35, 55.64, 13.64, 12.28. 
3.27b14. 1H NMR (600 MHz, CDCl3) δ 7.38 (td, J = 8.0, 1.7 Hz, 1H), 7.33 – 7.32 (m, 1H), 
7.04 – 6.99 (m, 2H), 5.96 (s, 1H), 3.79 (s, 3H), 2.30 (s, 3H), 2.09 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 154.77, 149.03, 141.56, 130.00, 129.37, 128.79, 120.90, 111.97, 105.27, 
















methyl-1H-pyrazole (3.28b), 1-(4-methoxyphenyl)-5-methyl-1H-pyrazole (3.28c), 
1-(2-methoxyphenyl)-5-methyl-1H-pyrazole (3.28d). The title compounds were 
prepared from anisole and 3-methylpyrazole according to General Method A with an 
irradiation time of 20 hours. The crude residue was purified by column chromatography on 
silica gel with an eluent of hexanes to 50% EtOAc/hexanes from which were isolated two 
sets of fractions. The first contained an inseparable mixture of N2 isomers 3.28a and 3.28b 
in 57% yield and a 6:1 ratio. The second contained an inseparable mixture of N3 isomers 
3.28c and 3.28d in 16% yield and a 8:1 ratio. The spectral data for the known compounds 
3.28b14, 3.28c15, and 3.28d16 were consistent with the literature reports. 
3.28a. 1H NMR (600 MHz, CDCl3) δ 7.70 (s, 1H), 7.54 (d, J = 8.9 Hz, 2H), 6.94 (d, J = 8.9 
Hz, 2H), 6.20 (s, 1H), 3.82 (s, 3H), 2.37 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 157.86, 
150.00, 134.09, 127.43, 120.53, 114.43, 106.99, 55.53, 13.72.  
3.28b . 1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 2.2 Hz, 1H), 7.72 – 7.69 (m, 1H), 7.26 – 
7.22 (m, 1H), 7.07 – 6.99 (m, 2H), 6.21 – 6.20 (m, 1H), 3.85 (s, 3H), 2.38 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 151.16, 149.33, 132.31, 129.79, 127.54, 125.07, 121.13, 
112.16, 106.14, 55.89, 13.67. 
 
IR (thin film): 3459.67, 2932.23, 1646.91, 1515.77, 1456.96, 1363.43, 1247.72, 1181.19, 



















3.28c. 1H NMR (600 MHz, CDCl3) δ 7.54 (d, J = 1.6 Hz, 1H), 7.34 (d, J = 8.9 Hz, 2H), 6.97 
(d, J = 8.9 Hz, 2H), 6.17 (d, J = 1.3 Hz, 1H), 3.85 (s, 3H), 2.29 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 159.09, 139.59, 138.82, 133.17, 126.53, 114.27, 106.42, 55.66, 12.34.  
 
3.28d. 1H NMR (600 MHz, CDCl3) δ 7.59 (d, J = 1.6 Hz, 1H), 7.43 – 7.39 (m, 1H), 7.33 – 
7.31 (m, 1H), 7.07 – 7.01 (m, 2H), 6.17 – 6.16 (m, 1H), 3.79 (s, 3H), 2.15 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 154.81, 140.75, 140.00, 130.26, 129.24, 120.92, 112.12, 




triazole (3.29b). The title compounds were prepared from anisole and 1,2,3-triazole 
according to General Method A with an irradiation time of 20 hours. The crude residue was 
purified by column chromatography on silica gel with an eluent of hexanes to 15% 
EtOAc/hexanes to yield a colorless solid in 71% as an inseparable mixture of 3.29a and 
3.29b in a ratio of 3.5:1. The analytical data matches those reported in the literature for 
3.29a and 3.29b17. 
3.29a. 1H NMR (600 MHz, CDCl3) δ 7.91 (s, 1H), 7.83 (s, 1H), 7.64 (d, J = 8.8 Hz, 2H), 
7.03 (d, J = 8.8 Hz, 2H), 3.88 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 159.95, 134.42, 
122.46, 121.98, 114.91, 112.38, 55.77.  
3.29b . 1H NMR (600 MHz, CDCl3) δ 8.12 (s, 1H), 7.81 (s, 1H), 7.78 (d, J = 7.9 Hz, 1H), 
7.43 (t, J = 7.9 Hz, 1H), 7.14 – 7.05 (m, 2H), 3.89 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 













methyl-2H-tetrazole (3.30b), 1-(4-methoxyphenyl)-5-methyl-1H-tetrazole 
(3.30c), 1-(2-methoxyphenyl)-5-methyl-1H-tetrazole (3.30d). The title compounds 
were prepared from anisole and 5-methyltetrazole according to General Method A with an 
irradiation time of 20 hours and the modification that 1.25 equiv 5-methyltetrazole were 
employed. The crude residue was purified by column chromatography on silica gel with an 
eluent of hexanes to 50% EtOAc/hexanes to EtOAc from which were isolated two sets of 
fractions. The first contained an inseparable mixture of N2 isomers 3.30a and 3.30b in 
23% yield and a 1.7:1 ratio. The second contained an inseparable mixture of N3 isomers 
3.30c and 3.30d in 39% yield and 2.1:1 ratio. The spectral data for the known compounds 
3.30a18, 3.30c19, and 3.30d19 are consistent with the literature reports.  
3.30a. 1H NMR (600 MHz, CDCl3) δ 8.00 (d, J = 9.1 Hz, 2H), 7.03 (d, J = 9.1 Hz, 2H), 3.88 
(s, 3H), 2.62 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 163.11, 160.48, 130.61, 121.40, 
114.77, 55.79, 11.13.  
3.30b . 1H NMR (600 MHz, CDCl3) δ 7.58 – 7.46 (m, 2H), 7.18 – 7.06 (m, 2H), 3.87 (s, 
3H), 2.66 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 162.96, 153.55, 132.00, 127.12, 126.51, 
120.84, 112.80, 56.38, 11.16. 
IR (thin film): 2943.80, 2840.63, 1732.73, 1646.91, 1507.10, 1456.96, 1418.39, 1254.47, 






















3.30c. 1H NMR (600 MHz, CDCl3) δ 7.35 (d, J = 7.4 Hz, 2H), 7.05 (d, J = 7.3 Hz, 2H), 3.87 
(s, 3H), 2.55 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 160.93, 151.78, 126.54, 126.16, 
115.07, 55.80, 9.71. 
3.30d. 1H NMR (600 MHz, CDCl3) δ 7.54 (t, J = 8.0 Hz, 1H), 7.35 – 7.32 (m, 1H), 7.12 – 
7.09 (m, 2H), 3.81 (s, 3H), 2.42 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 153.72, 153.41, 




triazole (3.31b), 4-(4-methoxyphenyl)-4H-1,2,4-triazole (3.31c), 4-(2-
methoxyphenyl)-4H-1,2,4-triazole (3.31d). The title compounds were prepared from 
anisole and 1,2,4-triazole according to General Method A with an irradiation time of 20 
hours. The crude residue was purified by column chromatography on silica gel with an 
eluent of 50% EtOAc/hexanes to 5% MeOH/EtOAc from which were isolated two sets of 
fractions. The first contained a mixture of N1 isomers 3.31a and 3.31b in 36% yield and a 
4.5:1 ratio, but which was separable by additional chromatography. The second contained 
an inseparable mixture of N4 isomers 3.31c and 3.31d in 40% yield and a 4:1 ratio. The 
spectral data for the known compounds 3.31a20 and 3.31b20 are consistent with the 
literature reports. Although 3.31c was reportedly synthesized21, the analytical data 
provided by the authors appeared identical to those reported for compound 3.31a. We 

















3.31a. 1H NMR (600 MHz, CDCl3) δ 8.44 (s, 1H), 8.07 (s, 1H), 7.56 (d, J = 8.9 Hz, 2H), 
7.00 (d, J = 8.9 Hz, 2H), 3.85 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 159.56, 152.48, 
140.90, 130.56, 121.98, 114.92, 55.74. 
3.31b . 1H NMR (600 MHz, CDCl3) δ 8.74 (s, 1H), 8.07 (s, 1H), 7.77 (dd, J = 7.9, 1.3 Hz, 
1H), 7.39 – 7.32 (m, 1H), 7.10 – 7.07 (m, 2H), 3.92 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
151.40, 151.04, 144.71, 129.21, 126.44, 124.66, 121.45, 112.31, 56.11. 
 
3.31c. 1H NMR (600 MHz, CDCl3) δ 8.38 (s, 2H), 7.29 (d, J = 8.9 Hz, 2H), 7.01 (d, J = 8.9 
Hz, 2H), 3.85 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 160.20, 142.01, 126.78, 124.15, 
115.41, 55.82. 
3.31d. 1H NMR (600 MHz, CDCl3) δ 8.40 (s, 2H), 7.44 – 7.41 (m, 1H), 7.28 – 7.27 (m, 
1H), 7.09 – 7.05 (m, 2H), 3.85 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 152.42, 143.02, 
130.55, 125.26, 121.35, 112.58, 56.04.  
 
IR (thin film): 3438.46, 3139.54, 1536.99, 2836.77, 1457.92, 1269.90, 1256.40, 1097.30, 




1H-benzo[d][1,2,3]triazole (3.33b). The title compounds were prepared from anisole 
and 1,2,3-benzotriazole according to General Method A with an irradiation time of 20 










eluent of 5% EtOAc/hexanes to 10% EtOAc/hexanes to yield a colorless solid in 57% yield 
as an inseparable mixture of 3.33a and 3.33b in a ratio of 3:1. The analytical data matches 
those reported in the literature for 3.33a22. 
3.33a. 1H NMR (600 MHz, CDCl3) δ 8.14 (d, J = 8.4 Hz, 1H), 7.68 (app d, J = 8.9 Hz, 3H), 
7.54 (t, J = 8.0 Hz, 1H), 7.43 (t, J = 7.6 Hz, 1H), 7.12 (d, J = 8.9 Hz, 2H), 3.92 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 159.88, 146.36, 132.70, 130.04, 128.10, 124.67, 124.32, 
120.25, 115.04, 110.33, 55.75. 
3.33b . 1H NMR (600 MHz, CDCl3) δ 8.12 (d, J = 8.2 Hz, 1H), 7.55 – 7.49 (m, 2H), 7.49 – 
7.44 (m, 1H), 7.37 (app t, J = 7.4 Hz, 2H), 7.17 – 7.12 (m, 2H), 3.79 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 153.75, 145.74, 134.14, 131.11, 128.19, 127.62, 125.35, 123.92, 
121.16, 119.91, 112.43, 111.27, 55.88. 
 
IR (thin film): 3064.33, 2934.16, 2358.52, 1613.16, 1517.70, 1454.06, 1253.50, 1067.41, 





4,5,6,7-tetrahydro-1H-indazole (3.34c). The title compounds were prepared from 
anisole and 4,5,6,7-tetrahydroindazole according to General Method A with an irradiation 
time of 20 hours. The crude residue was purified by column chromatography on silica gel 













sets of fractions. The first contained an inseparable mixture of N2 isomers 3.34a and 3.34b 
in 25% yield and a 10:1 ratio. The second contained N1 isomer 3.34c as a single compound 
in 26% yield. The spectral data for the known compound 3.34c23 are consistent with the 
literature report. 
3.34a. 1H NMR (600 MHz, CDCl3) δ 7.54 – 7.49 (m, 3H), 6.93 (d, J = 9.0 Hz, 2H), 3.82 (s, 
3H), 2.77 (t, J = 6.3 Hz, 2H), 2.61 (t, J = 6.2 Hz, 2H), 1.93 – 1.81 (m, 2H), 1.81 – 1.72 
(m, 2H).; 13C NMR (151 MHz, CDCl3) δ 157.72, 150.82, 134.46, 123.93, 120.37, 117.84, 
114.50, 55.64, 23.63, 23.61, 20.80.  
 
3.34b. 1H NMR (600 MHz, CDCl3) δ 7.72 (s, 1H), 7.68 (dd, J = 7.9, 1.6 Hz, 1H), 7.25 – 
7.21 (m, 1H), 7.04 – 6.99 (m, 2H), 3.87 (s, 2H), 2.80 – 2.74 (m, 2H), 2.64 – 2.58 (m, 2H), 
1.87 – 1.83 (m, 2H), 1.79 – 1.75 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 151.09, 150.18, 
130.19, 128.64, 127.27, 125.02, 121.23, 116.86, 112.15, 55.98, 23.66, 23.58, 20.85.  
 
IR (thin film): 2932.23, 2853.17, 1517.70, 1456.96, 1377.89, 1254.47, 1023.05, 837.92; 
HRMS: Calculated for (M+H)+: 251.1160; found: 251.1154. 
 
3.34c. 1H NMR (600 MHz, CDCl3) δ 7.43 (s, 1H), 7.38 (d, J = 8.9 Hz, 2H), 6.95 (d, J = 8.9 
Hz, 2H), 3.84 (s, 3H), 2.66 (t, J = 5.8 Hz, 2H), 2.58 (t, J = 5.7 Hz, 2H), 1.82 – 1.75 (m, 
4H). 13C NMR (151 MHz, CDCl3) δ 158.46, 138.40, 138.29, 133.56, 124.84, 117.34, 






benzo[d]imidazole (3.35b). The title compounds were prepared from anisole and 
benzimidazole according to General Method A with an irradiation time of 20 hours. The 
crude residue was purified by column chromatography on silica gel with an eluent of 25% 
EtOAc/hexanes to 75% EtOAc/hexanes to yield a colorless solid in 72% yield as an 
inseparable mixture of 3.35a and 3.35b in a ratio of 5:1. The analytical data matches those 
reported in the literature for 3.35a24 and 3.35b24. 
3.35a. 1H NMR (600 MHz, CDCl3) δ 8.04 (s, 1H), 7.88 – 7.86 (m, 1H), 7.45 – 7.44 (m, 
1H), 7.40 (d, J = 8.9 Hz, 2H), 7.28 – 7.33 (m, 2H), 7.06 (d, J = 8.9 Hz, 2H), 3.87 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 159.37, 143.90, 142.62, 134.29, 129.20, 125.77, 123.57, 
122.63, 120.55, 115.17, 110.40, 55.71. 
3.35b . 1H NMR (600 MHz, CDCl3) δ 8.07 (s, 1H), 7.88 – 7.86 (m, 1H), 7.45 – 7.42 (m, 
1H), 7.41 – 7.39 (m, 1H), 7.33 – 7.27 (m, 3H), 7.13 – 7.08 (m, 2H), 3.78 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 154.00, 143.39, 134.50, 129.78, 127.31, 124.84, 123.29, 122.37, 















The title compounds were prepared from anisole and Boc2-adenine S10 according to 
General Method A with an irradiation time of 20 hours and the modification that 1.25 
equiv S10 were employed. The crude residue was purified by column chromatography on 
silica gel with an eluent of hexanes to 50% EtOAc/hexanes to EtOAc from which were 
isolated two sets of fractions. The first contained an inseparable mixture of N9 isomers 
3.36a and 3.36b in 47% yield and a 3:1 ratio. The second contained an inseparable 
mixture of N7 isomers 3.36c and 3.36d in 52% yield and 4:1 ratio. 
3.36a. 1H NMR (600 MHz, CDCl3) δ 8.91 (s, 1H), 8.28 (s, 1H), 7.59 (d, J = 8.9 Hz, 2H), 
7.10 (d, J = 8.9 Hz, 2H), 3.89 (s, 3H), 1.49 (s, 18H). 13C NMR (151 MHz, CDCl3) δ 159.66, 
153.69, 153.49, 153.10, 152.61, 152.45, 150.64, 150.49, 150.33, 143.94, 130.52, 129.01, 
128.41, 127.47, 126.86, 125.18, 122.29, 121.08, 115.06, 112.33, 83.79, 83.68, 55.61, 
27.75, 27.74. 
3.36b. 1H NMR (600 MHz, CDCl3) δ 8.87 (s, 1H), 8.28 (s, 1H), 7.57 (d, J = 5.9 Hz, 1H), 
7.48 (t, J = 7.9 Hz, 1H), 7.18 – 7.11 (m, 2H), 3.80 (s, 3H), 1.48 (s, 18H). 13C NMR (151 
MHz, CDCl3) δ 153.69, 153.49, 152.45, 150.33, 145.86, 130.52, 128.41, 126.86, 125.12, 




























IR (thin film): 2979.48, 2935.13, 1790.58, 1758.76, 1595.81, 1519.63, 1455.99, 1340.28, 
1140.69; HRMS: Calculated for (M+H)+: 442.2090; found: 442.2087. 
 
3.36c. 1H NMR (600 MHz, CDCl3) δ 9.08 (s, 1H), 8.28 (s, 1H), 7.33 (d, J = 8.8 Hz, 2H), 
6.99 (d, J = 8.8 Hz, 2H), 3.87 (s, 3H), 1.30 (s, 18H). 13C NMR (151 MHz, CDCl3) δ 163.68, 
160.48, 153.06, 149.84, 148.71, 144.26, 127.70, 126.88, 121.51, 115.00, 84.15, 55.83, 
27.93. 
3.36d . 1H NMR (600 MHz, CDCl3) δ 9.06 (s, 1H), 8.33 (s, 1H), 7.48 (t, J = 8.0 Hz, 1H), 
7.36 – 7.33 (m, 1H), 7.10 – 7.04 (m, 2H), 3.79 (s, 3H), 1.30 (s, 18H). 13C NMR (151 MHz, 
CDCl3) δ 163.49, 153.79, 152.77, 150.13, 144.08, 131.04, 127.65, 125.32, 123.49, 121.34, 
121.03, 112.41, 83.94, 55.92, 27.85. 
 
IR (thin film): 3077.83, 2980.45, 2935.13, 2237.99, 1739.48, 1768.40, 1613.16, 1515.77, 




acetate (3.38/3.38’). The title compounds were prepared from anisole and O-
acetylcapsaicin S13/S13’ according to General Method A with the modification that 1.25 
equiv S13 were employed for an irradiation time of 40 hours. The crude residue was 
purified by column chromatography on silica gel with an eluent of hexanes to 75% 
EtOAc/hexanes giving a white solid in 66% yield. Note: The product contains the same ratio 





















provided proton NMR peak list below refers only to the unsaturated product 3.38; see 
spectrum for peaks corresponding to saturated product 3.38’. 
1H NMR (600 MHz, CDCl3) δ 7.70 (s, 1H), 7.64 (d, J = 2.3 Hz, 1H), 7.19 (d, J = 1.9 Hz, 
1H), 7.01 (s, 1H), 6.92 (t, J = 6.0 Hz, 1H), 6.45 (t, J = 2.1 Hz, 1H), 5.38 – 5.28 (m, 2H), 
4.23 (d, J = 6.3 Hz, 2H), 3.87 (s, 3H), 2.32 (s, 3H), 2.20 – 2.14 (m, 2H), 1.97 (q, J = 7.0 
Hz, 2H), 1.62 – 1.58 (m, 2H), 1.50 (hept, J = 6.7 Hz, 1H), 1.36 (p, J = 7.6 Hz, 2H), 0.94 
(d, J = 6.7 Hz, 6H). 13C NMR (151 MHz, CDCl3) δ 172.95, 172.83, 168.87, 151.09, 140.87, 
138.84, 138.08, 133.08, 132.50, 130.75, 126.75, 119.88, 115.31, 107.11, 100.12, 56.47, 
40.00, 39.10, 37.10, 36.96, 32.41, 31.11, 29.77, 29.46, 29.42, 28.09, 27.39, 25.76, 25.27, 
22.80, 22.78, 20.75. 
 
IR (thin film): 3288.04. 2928.38, 2865.70, 1768.40, 1649.80, 1521.56, 1368.25, 1206.26, 
1039.44, 755.00; HRMS: Calculated for (M+Na)+: 436.2213 and 438.2369; found: 
436.2200 and 438.2363. 
 
 
(S)-Methyl 2-(6-methoxy-5-(1H-pyrazol-1-yl)naphthalen-2-yl)propanoate (3.39). 
The title compounds were prepared from pyrazole and naproxen methyl ester S9 according 
to General Method A with an irradiation time of 20 hours and the modification that 4.0 
equiv of pyrazole were employed. The crude residue was purified by column 
chromatography on silica gel (25% to 50% EtOAc/Hexanes) to yield a yellow solid in 26%. 
1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 9.1 Hz, 1H), 7.86 (d, J = 2.0 Hz, 1H), 7.72 (d, J = 








J = 2.3 Hz, 1H), 3.87 (s, 3H), 3.65 (s, 3H), 1.56 (d, J = 7.3, 3H). 13C NMR (151 MHz, 
CDCl3) δ 174.98, 152.61, 140.70, 136.66, 133.06, 131.47, 130.65, 128.97, 127.94, 
125.97, 123.24, 122.83, 113.97, 106.10, 57.00, 52.24, 45.39, 18.57. IR (thin film): 
2949.59, 2844.49, 1732, 1606.41, 1455.99, 1341.25, 1278.57, 1196.61, 1071.26, 755.96; 
HRMS: Calculated for (M+Na)+: 333.1216; found: 333.1207. 
 
 
(9S)-10,11-Dihydro- 6’-methoxy-5’-(1H-pyrazol-1-yl)cinchonan-9-ol · 2,2,2-
trifluoroacetic acid (3.40). The title compound was prepared from S14 using Method A 
with an irradiation time of 40 hours. The crude residue was purified by column 
chromatography on silica gel (0% to 5% MeOH/DCM to 5% MeOH/DCM/0.05% TFA) to yield 
the desired product in 53% as a glassy orange-tinted solid. 
1H NMR (600 MHz, CDCl3) δ 10.85 (br s, 1H), 8.83 (d, J = 4.5 Hz, 1H), 8.34 (d, J = 9.4 Hz, 
1H), 7.97 (d, J = 4.5 Hz, 1H), 7.94 (d, J = 1.8 Hz, 1H), 7.58 (d, J = 9.4 Hz, 1H), 7.38 (d, J 
= 2.2 Hz, 1H), 6.89 (br s, 1H), 6.52 (t, J = 2.0 Hz, 1H), 4.36 (s, 1H), 3.87 (s, 3H), 3.81 (t, 
J = 10.5 Hz, 2H), 3.68 (t, J = 9.8 Hz, 1H), 3.16 – 3.09 (m, 1H), 2.99 (q, J = 9.3 Hz, 1H), 
1.81 – 1.59 (m, 5H), 1.52 – 1.36 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H), 0.41 (dt, J = 13.7, 7.7 
Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 162.54 (q, J = 35.2 Hz), 156.32, 148.37, 143.69, 
143.37, 142.21, 134.37, 134.30, 123.76, 122.24, 121.13, 116.76 (q, J = 292.3 Hz), 
115.56, 108.15, 66.00, 60.59, 57.02, 51.03, 48.45, 35.46, 25.68, 24.20, 23.68, 18.68, 
11.56. 
IR (thin film): 3213.79, 2963.09, 2241.84, 1671.02, 1508.06, 1464.67, 1268.93, 1201.43, 
















A.3.3.2 General Method B: Synthesis of Alkyl-Substituted Arenes 3.15 and 3.16 and 
Imidazoles 3.32 and 3.37.  
The synthesis of aryl pyrazole 3.15 from mesitylene and pyrazole 3.8 is representative of 
the following general procedure:  
To a 2 dram vial containing a Teflon-coated magnetic stir bar was added 25 µmol of Catalyst 
C (0.05 equiv), 34 mg of pyrazole (0.5 mmol, 1 equiv), and 16 mg of (2,2,6,6- 
tetramethylpiperidin-1-yl)oxyl (0.1 mmol, 0.2 equiv). Dichloromethane or 1,2-
Dichloroethane was added (5.0 mL), followed by addition of alkyl arene (1.0 mmol, 2 
equiv). The vial was sealed with a Teflon-lined septum screw cap. The septum was pierced 
with a disposable steel needle connected to a nitrogen-filled balloon. A vent needle was 
inserted and the reaction medium was sparged for 5 minutes by bubbling nitrogen through 
the mixture. The vent needle was removed, and the nitrogen line was maintained, providing 
approximately 1 atm of nitrogen to the vial headspace for the course of the reaction. The 
vial was irradiated as described in General Method A for 44 hours, and the reaction 
mixture was analyzed by GC-MS or concentrated in vacuo and purified by column 
chromatography on silica gel with the eluent noted for each substrate.  
 
 
1-Mesityl-1H-pyrazole (3.15). The title compound was prepared using General Method 
B with an irradiation time of 44 hours. The title compound was purified by column 
chromatography on silica gel (5% to 10% EtOAc/Hexanes) to yield a yellow oil in 82%. 1H 
NMR (400 MHz, CDCl3) δ 8.17 (s, 1H), 7.86 (d, J = 2.3 Hz, 1H), 7.40 (s, 2H), 6.88 (s, 1H), 






130.93, 128.85, 105.83, 21.19, 17.30. IR (thin film): 3103.87, 2921.63, 2358.52, 1594.84, 
1516.74, 1393.32, 1190.83, 1044.26, 852.38, 751.14; HRMS: Calculated for 
(M+H)+:187.1235; found: 187.1228. 
 
 
1-(2,4-Dimethylphenyl)-1H-pyrazole (3.16a) and 1-(2,6-dimethylphenyl)-1H-
pyrazole (3.16b). The title compounds were prepared from m-xylene and pyrazole using 
Method B with an irradiation time of 44 hours. The title compound was purified by column 
chromatography on silica gel (5% to 10% EtOAc/Hexanes) to yield a yellow oil in 36%. The 
ratio of the inseparable mixture was >15:1 as determined by 1H NMR of the isolated 
product. 
 
3.16a. 1H NMR (400 MHz, CDCl3) δ 8.00 (s, 1H), 7.85 (s, 1H), 7.51 (d, J = 7.4 Hz, 1H), 
7.42 (s, 1H), 7.37 (d, J = 7.4 Hz, 1H), 6.72 (s, 1H), 2.68 (s, 3H), 2.50 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 136.07, 134.08, 133.47, 129.32, 127.74, 126.68, 123.05, 121.93, 
102.03, 17.13, 13.90. 
 
3.16b. 1H NMR (400 MHz, CDCl3) δ 8.04 (s, 1H), 7.74 (s, 1H), 7.25 (s, 3H), 6.75 (s, 1H), 
2.31 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 136.03, 135.21, 132.07, 126.81, 124.91, 
124.07, 101.89, 13.28. 
 
IR (thin film): 3103.94, 2972.73, 2936.09, 287052, 1670.05, 1507.10, 1464.67, 1395.25, 











1-(4-Methoxyphenyl)-1H-imidazole (3.32a), 1-(2-methoxyphenyl)-1H-imidazole 
(33.2b), and 1-phenyl-1H-imidazole (3.32c).  
. The title compounds were prepared using General Method B with the following 
modifications: 1.0 equiv anisole and 2.0 equiv imidazole were irradiated for 20 hours 
without nitrogen sparging or a balloon of nitrogen over the course of the reaction. Note: 
General Method A was incompatible with imidazole as a substrate, leading to complete 
suppression of product under the aerobic conditions. The crude residue was purified by 
column chromatography on silica gel with an eluent of 75% EtOAc/hexanes to EtOAc to 5% 
MeOH/EtOAc giving an inseparable mixture of 3.32a and 3.32b in a ratio of 4:1 in 55% 
yield, along with the product of ipso-substitution, 3.32c in 7% yield. The spectral data 
match the literature report for compounds 3.32a, 3.32b, and 3.32c25. 
 
3.32a. 1H NMR (600 MHz, CDCl3) δ 7.76 (s, 1H), 7.30 (d, J = 8.9 Hz, 2H), 7.20 (s, 1H), 
7.18 (s, 1H), 6.98 (d, J = 8.8 Hz, 2H), 3.85 (s, 3H).  
3.32b . 1H NMR (600 MHz, CDCl3) δ 7.78 (s, 1H), 7.37 – 7.34 (m, 1H), 7.29 – 7.28 (m, 
1H), 7.21 (s, 1H), 7.16 (s, 1H), 7.07 – 7.02 (m, 2H), 3.85 (s, 3H).  
3.32c . 1H NMR (600 MHz, CDCl3) δ7.86 (s, 1H), 7.48 (t, J = 7.8 Hz, 2H), 7.41 – 7.36 (m, 
3H), 7.27 (s, 1H), 7.21 (s, 1H). 
 
13C NMR (151 MHz, CDCl3) δ 158.92, 152.58, 137.81, 137.35, 135.86, 135.58, 130.69, 
130.40, 130.03, 129.89, 128.96, 128.79, 127.49, 126.50, 125.53, 123.20, 121.47, 121.00, 













Methyl Nα-(tert-butoxycarbonyl)-Nτ-(4-methoxyphenyl)-L-histidinate (3.37a), 
methyl Nα-(tert-butoxycarbonyl)-Nτ-(2-methoxyphenyl)-L-histidinate (3.37b), 
methyl Nα-(tert-butoxycarbonyl)-Nπ-(4-methoxyphenyl)-L-histidinate (3.37c), 
methyl Nα-(tert-butoxycarbonyl)-Nπ-(2-methoxyphenyl)-L-histidinate (3.37d). The 
title compounds were prepared using General Method B with the following modifications: 
1.0 equiv anisole and 2.0 equiv histidine S11 were irradiated for 20 hours without nitrogen 
sparging or a balloon of nitrogen over the course of the reaction. Note: General Method A 
was incompatible with imidazole as a substrate, leading to complete suppression of product 
under the aerobic conditions. The crude residue was purified by column chromatography on 
silica gel with an eluent of 75% EtOAc/hexanes to EtOAc to 5% MeOH/EtOAc, from which 
were isolated 2 sets of fractions. The first set contained 3.37a and 3.37b in 24% yield and 
8:1 ratio. The second set contained 3.37c and 3.37d in 24% yield and 5:1 ratio. 
3.37a. 1H NMR (600 MHz, CDCl3) δ 7.66 (s, 1H), 7.25 (d, J = 8.9 Hz, 2H), 6.96 (d, J = 9.0 
Hz, 3H), 5.90 (d, J = 8.1 Hz, 1H), 4.65 – 4.53 (m, 1H), 3.84 (s, 3H), 3.72 (s, 3H), 3.15 
(dd, J = 14.8, 5.6 Hz, 1H), 3.08 (dd, J = 14.7, 4.8 Hz, 1H), 1.43 (s, 9H). 13C NMR (151 
MHz, CDCl3) δ 172.73, 159.00, 155.75, 138.41, 135.62, 130.64, 123.07, 116.42, 115.01, 

























3.37b . 1H NMR (600 MHz, CDCl3) δ 7.69 (s, 1H), 7.35 – 7.32 (m, 1H), 7.25 – 7.22 (m, 
1H), 7.05 – 7.00 (m, 2H), 6.97 (s, 1H), 5.56 (d, J = 8.2 Hz, 1H), 4.61 – 4.57 (m, 1H), 3.83 
(s, 3H), 3.72 (s, 3H), 3.02 (dd, J = 15.0, 5.0 Hz, 1H), 2.90 (dd, J = 15.7, 4.4 Hz, 1H), 1.44 
(s, 9H). 
13C NMR (151 MHz, CDCl3) δ 171.59, 152.52, 137.66, 130.01, 129.00, 127.57, 126.46, 
125.41, 121.14, 117.98, 112.46, 80.52, 55.92, 53.74, 52.32, 30.39, 28.40. 
 
IR (thin film): 3369.07, 2976.59, 2841.60, 1746.23, 1705.73, 1517.70, 1366.32, 1251.58, 
1166.72, 1021.12; HRMS: Calculated for (M+H)+:376.1872; found: 376.1863. 
 
3.37c. 1H NMR (600 MHz, CDCl3) δ 7.51 (s, 1H), 7.20 (d, J = 8.8 Hz, 2H), 6.99 (d, J = 8.8 
Hz, 2H), 6.92 (s, 1H), 4.95 (d, J = 7.9 Hz, 1H), 4.39 – 4.34 (m, 1H), 3.86 (s, 3H), 3.62 (s, 
3H), 3.06 (dd, J = 15.4, 5.2 Hz, 1H), 2.97 (dd, J = 15.5, 6.7 Hz, 1H), 1.39 (s, 9H). 13C 
NMR (151 MHz, CDCl3) δ 171.98, 159.89, 155.04, 138.59, 129.01, 128.50, 127.73, 
121.10, 114.88, 80.21, 55.71, 52.72, 52.57, 28.39, 27.14. 
  
3.37d . 1H NMR (600 MHz, CDCl3) δ 7.46 – 7.42 (m, 2H), 7.22 – 7.18 (m, 1H), 7.07 – 7.04 
(m, 2H), 6.93 (s, 1H), 5.00 (d, J = 7.6 Hz, 1H), 4.41 – 4.33 (m, 1H), 3.81 (s, 3H), 3.63 (s, 
3H), 2.94 – 2.90 (m, 2H), 1.39 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.13, 160.77, 
154.66, 153.68, 138.73, 130.78, 128.86, 128.08, 127.76, 127.41, 112.25, 80.11, 55.87, 
52.89, 52.50, 28.42, 26.83.  
 
IR (thin film): 3421.10, 2976.59, 1732.73, 1683.55, 1652.70, 1518.67, 1363.43, 1249.65, 
1166.72, 1024.98; HRMS: Calculated for (M+H)+:376.1872; found: 376.1863. 
  
 169 
A.3.3.3 General Method C: Synthesis of Anilines 3.41-3.48  
To a vial containing a Teflon-coated magnetic stir bar was added Catalyst B or C (0.05 
equiv), ammonium carbamate (4.0 equiv), and TEMPO (0.2 equiv). A 10:1 solvent mixture 
of 1,2-dichloroethane/water was added (0.1M), followed by the arene (1.0 equiv). The vial 
was sealed with a Teflon-lined septum screw cap, and the reaction mixture was sparged 
with O2 and irradiated in the same fashion as General Method A. 
 
p-Anisidine (3.41a) and o-anisidine (3.41b). The title compounds were prepared from 
anisole using General Method C with an irradiation time of 24 hours. The reaction was run 
through a plug of silica, concentrated and the reaction was purified by column 
chromatography on silica gel (20% EtOAc/Hexanes) to afford a dark-purple solid in 36% 
yield (3.41a) and a dark brown liquid in 22% yield (3.41b). The spectral data were in 
agreement with previously reported literature values.26 
 
3.41a. 1H NMR (600 MHz, CDCl3) δ 6.76 (d, J = 8.8 Hz, 1H), 6.66 (d, J = 8.8 Hz, 1H), 3.76 
(s, 3H), 3.44 (br s, 2H); 13C NMR (151 MHz, CDCl3) δ 152.95, 140.03, 116.56, 114.94, 
55.88. 
 
3.41b. 1H NMR (600 MHz, CDCl3) δ 6.85 - 6.78 (m, 2H), 6.78 - 6.70 (m, 2H), 3.86 (s, 3H), 









4-(Methoxymethyl)aniline (3.42a) and 2-(methoxymethyl)aniline (3.42b). The title 
compounds were prepared from S4 using General Method C with an irradiation time of 24 
hours. The reaction was run through a plug of silica, concentrated and the reaction was 
purified by column chromatography on silica gel (20% to 50% EtOAc/Hexanes) to afford a 
brown oil in 43% yield (3.42a) and a yellow oil in 21% yield (3.42b). The spectral data 
were in agreement with previously reported literature values.27,28  
3.42a. 1H NMR (600 MHz, CDCl3) δ 6.87 (d, J = 8.8 Hz, 2H), 6.63 (d, J = 8.8 Hz, 2H), 5.08 
(s, 3H), 3.47 (s, 5H). 13C NMR (151 MHz, CDCl3) δ 150.32, 141.33, 117.98, 116.32, 95.62, 
55.93. 
 
3.42b. 1H NMR (600 MHz, CDCl3) δ 7.03 (dd, J = 8.1, 1.3 Hz, 1H), 6.85 (td, J = 7.6, 1.3 
Hz, 1H), 6.77 – 6.67 (m, 2H), 5.20 (s, 2H), 3.82 (br s, 2H), 3.51 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 144.93, 136.88, 122.61, 118.65, 115.60, 114.89, 95.21, 56.20. 
 
 
4-((tert-Butyldimethylsilyl)oxy)aniline (3.43a) and 2-((tert-
butyldimethylsilyl)oxy)aniline (3.43b). The title compound was prepared from S5 using 













plug of silica, concentrated and the reaction was purified by column chromatography on 
silica gel (10 to 20% EtOAc/Hexanes) to afford a brown solid in 35% yield (3.43a) and a 
yellow oil in 9% yield (3.43b). The spectral data were in agreement with previously 
reported literature values.29,30 
3.43a. 1H NMR (600 MHz, CDCl3) δ 6.67 (m, 2H), 6.59 (m, 2H), 3.41 (br s, 2H), 0.98 (s, 
9H), 0.16 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 148.34, 140.39, 120.80, 116.43, 29.85, 
25.89, 18.33, -4.35. 
 
3.43b. 1H NMR (600 MHz, CDCl3) δ 6.79 (td, J = 7.5, 1.4 Hz, 1H), 6.76 – 6.71 (m, 2H), 
6.63 (ddd, J = 7.9, 7.3, 1.7 Hz, 1H), 3.70 (br s, 2H), 1.03 (s, 9H), 0.25 (s, 6H); 13C NMR 
(151 MHz, CDCl3) δ 143.05, 138.27, 121.95, 118.61, 118.53, 115.78, 25.97, 18.38, -4.10. 
IR (thin film): 3445.17, 2955.38, 2929.34, 2857.02, 1646.91, 1519.63, 1275.68, 1226.50, 
923.74, 832.13. HRMS: Calculated for (M+H)+: 224.1470; found: 224.1464. 
 
 
4-Phenoxyaniline (3.44a) and 2-phenoxyaniline (3.44b). The title compounds were 
prepared from diphenyl ether using General Method C with an irradiation time of 24 hours. 
The reaction was run through a plug of silica, concentrated and the reaction was purified by 
column chromatography on silica gel (20% EtOAc/Hexanes) to afford a light brown solid in 
46% yield (3.44a)31 and a yellow oil in 16% yield (3.44b)32. The spectral data were in 







3.44a. 1H NMR (600 MHz, CDCl3) δ 7.32 - 7.26 (m, 2H), 7.05 - 6.99 (m, 1H), 6.97 - 6.92 
(m, 2H), 6.92 - 6.85 (m, 2H), 6.72 - 6.67 (m, 2H), 3.59 (br s, 2H); 13C NMR (151 MHz, 
CDCl3) δ 159.02, 148.72, 142.80, 129.65, 122.19, 121.27, 117.34, 116.37. 
3.44b. 1H NMR (600 MHz, CDCl3) δ 7.34 – 7.28 (m, 2H), 7.06 (tt, J = 7.3, 1.1 Hz, 1H), 
7.01 – 6.95 (m, 3H), 6.88 (dd, J = 8.0, 1.4 Hz, 1H), 6.83 (dd, J = 7.9, 1.6 Hz, 1H), 6.72 
(td, J = 7.7, 1.6 Hz, 1H), 3.80 (br s, 2H); 13C NMR (151 MHz, CDCl3) δ 157.61, 143.19, 
138.86, 129.84, 125.03, 122.76, 120.40, 118.92, 117.23, 116.61. 
 
 
[1,1'-Biphenyl]-4-amine (3.45a) and [1,1'-biphenyl]-2-amine (3.45b). The title 
compounds were prepared using General Method C with an irradiation time of 24 hours. 
The reaction was run through a plug of silica, concentrated and the reaction was purified by 
column chromatography on silica gel (20% EtOAc/Hexanes) to afford a brown crystalline 
solid in 42% yield (3.45a) and a brown solid in 11% yield (3.45b). The spectral data were 
in agreement with previously reported literature values.26  
3.45a.1H NMR (600 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 2H), 7.48 - 7.35 (m, 4H), 7.33 - 
7.24 (m, 1H), 6.78 (d, J = 8.4 Hz, 2H), 3.74 (br s, 2H); 13C NMR (151 MHz, CDCl3) δ 
145.93, 141.26, 131.68, 128.76, 128.12, 126.51, 126.36, 115.49. 
3.45b.1H NMR (600 MHz, CDCl3) δ 7.49 – 7.42 (m, 4H), 7.38 – 7.33 (m, 1H), 7.20 – 7.12 
(m, 2H), 6.84 (td, J = 7.4, 1.2 Hz, 1H), 6.78 (dd, J = 8.0, 1.1 Hz, 1H), 3.76 (br s, 2H). 13C 
NMR (151 MHz, CDCl3) δ 143.62, 139.64, 130.59, 129.22, 128.94, 128.62, 127.77, 









3-Chloro-4-methoxyaniline (3.46). The title compound was prepared using General 
Method C with an irradiation time of 48 hours. The reaction was run through a plug of 
silica, concentrated and the reaction was purified by column chromatography on silica gel 
(50% EtOAc/Hexanes) to afford a brown solid in 33% yield.  
1H NMR (600 MHz, CDCl3) δ 6.78 (d, J = 8.7 Hz, 1H), 6.76 (d, J = 2.8 Hz, 1H), 6.56 (dd, J 
= 8.7, 2.8 Hz, 1H), 3.83 (s, 3H), 3.47 (br s, 2H); 13C NMR (151 MHz, CDCl3) δ 148.31, 
140.86, 123.32, 117.53, 114.39, 114.15, 57.06. IR (thin film): 3421.10, 3361.32, 3219.58, 
2931.27, 2835.81, 1634.38, 1505.17, 1439.60, 1272.79, 1229.40. HRMS: Calculated for 
(M+H)+: 158.0373; found: 158.0366. 
 
 
1-Methyl-1H-indazol-3-amine (3.47). The title compound was prepared using General 
Method C with an irradiation time of 24 hours. The reaction was run through a plug of 
silica, concentrated and the reaction was purified by column chromatography on silica gel 
(50% to 70% EtOAc/Hexanes) to afford a pink-red crystalline solid in 33% yield. The 
spectral data were in agreement with previously reported literature values.33  
1H NMR (600 MHz, CDCl3) δ 7.55 (d, J = 8.1 Hz, 1H), 7.36 (dd, J = 8.1, 6.9 Hz, 1H), 7.22 
(d, J = 8.6, 1H), 7.03 (dd, J = 7.8, 6.9, 1H), 4.04 (br s, 2H), 3.86 (s, 3H); 13C NMR (151 













6-Methoxy-quinolin-5-amine (3.48). The title compound was prepared using General 
Method C with an irradiation time of 32 hours along with Catalyst B. The reaction was run 
through a plug of silica, concentrated and the reaction was purified by column 
chromatography on silica gel (70% EtOAc/Hexanes) to afford a green solid in 36% yield. 
The spectral data were in agreement with previously reported literature values.33 
1H NMR (600 MHz, CDCl3) δ 8.78 (dd, J = 4.1, 1.6 Hz, 1H), 8.14 (d, J = 8.6, 1H), 7.61 (d, 
J = 9.1, 1H), 7.45 (d, J = 9.1 Hz, 1H), 7.32 (dd, J = 8.6, 4.1 Hz, 1H), 4.27 (br s, 2H), 4.00 
(s, 3H); 13C NMR (151 MHz, CDCl3) δ 148.38, 144.17, 142.72, 129.41, 129.11, 119.79, 







A.4 Electrochemical Measurements  
Electrochemical half peak redox potentials (Ep/2) were estimated from cyclic voltammograms 
obtained by the method described previously34. Measurements were performed in 
acetonitrile with tetrabutylammonium hexafluorophosphate (0.1 M) as the electrolyte, and 
the cyclic voltammograms were collected using a glassy carbon working electrode, a 
platinum wire counter electrode, and an Ag/AgCl reference electrode in saturated NaCl. The 
observed half peak potential was referenced to SCE by addition of 30 mV to the value 
obtained vs. Ag/AgCl. For a typical measurement, the potential was increased from an initial 
potential of 0.5 V to a vertex potential of 2.8 V, then returning to a final potential of 0.5 V. 
With these parameters, all compounds listed in Table A.2 exhibited irreversible oxidation 
waves. Excited state reduction potentials for Catalysts A-C are estimated as described in the 
aforementioned reference from the ground state reduction potentials (Catalyst A: E1/2 = -
0.47 V vs. SCE, Catalyst B: E1/2 = -0.58 V vs. SCE, Catalyst C: E1/2 = -0.52 V vs. SCE) and 




Table A.2. Electrochemical Half Peak Potentials for (Ep/2) for the arenes and select amine 
nucleophiles employed. 
substrate Ep/2 (V vs. SCE) substrate 
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APPENDIX B: SUPPORTING INFORMATION FOR “CATION RADICAL ACCELERATED 
NUCLEOPHILIC AROMATIC SUBSTITUTION VIA ORGANIC PHOTOREDOX 
CATALYSIS” 
 
B.1 General Information: Materials and Methods 
B.1.1 General Reagent Information 
Commercially available reagents were purchased from Sigma-Aldrich, Acros, Alfa 
Aesar, or TCI, Matrix Scientific, Combi-Blocks, Oakwood Chemical, Chem Impex 
International, and Fisher Scientific and were used as received unless otherwise noted. 
Diethyl ether (Et2O), dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and 
dimethylformamide (DMF) were dried by passing through activated alumina under nitrogen 
prior to use. Other common solvents and chemical reagents were purified by standard 
published methods as noted or used as received. All catalyst and substrate syntheses were 
run under a nitrogen atmosphere unless specified otherwise. A sample of the photocatalyst 
[Ir(dF(CF3)ppy) 2(5,5′-d(CF3)bpy)]PF6 was gifted to us from the Alexanian lab at the 
University of North Carolina at Chapel Hill. A gift of benzyl (S)-2-((tert-
butoxycarbonyl)amino)hex-5-ynoate used for the synthesis of S43 was provided by the 
Baran lab at the Scripps Research Institute. The following compounds employed as reagents 
in the photoredox-catalyzed cation radical accelerated nucleophilic aromatic substitution 
reactions were obtained from commercial vendors and used as received: 2-bromo-4-
chloroanisole, 2-bromo-4-fluoroanisole, 4-chloroanisole, 2-chloroanisole, anisole, 3,4-
dimethoxybenzonitrile, 3,4-dimethoxybenzaldehyde, imidazole, pyrazole, 4-methyl pyrazole, 
3-methyl pyrazole, 3,5-dimethyl pyrazole, 1,2,3-triazole, benzimidazole, ammonium 
carbamate, 2,2,2-trifluoroethanol, and 1,1,3,3-tetramethylguanidine.  
B.1.2 General Analytical Information 
 Proton, carbon, and fluorine nuclear magnetic resonance spectra (1H NMR, 13C NMR, 
19F NMR) were recorded on a Bruker Avance 400 (1H NMR at 400 MHz, 13C NMR at 100 MHz, 
and 19F NMR at 376 MHz) or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 
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151 MHz) spectrometer. Chemical shifts for protons are reported in parts per million 
downfield from tetramethylsilane and are referenced to residual protium in the solvent (1H 
NMR: CHCl3 at 7.26 ppm). Chemical shifts for carbon signals are reported in parts per 
million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent peak (13C NMR: CDCl3 at 77.16 ppm). 1H NMR data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, hept = heptet, 
dd = doublet of doublets, ddd = doublet of doublet of doublets, m = multiplet, br s = broad 
singlet, app = apparent), coupling constants (Hz), and integration. Attenuated total 
reflectance FTIR spectra were recorded on a Bruker Alpha FTIR Spectrometer with the 
Plantinum ATR attachment. Spectra were averaged over 24 scans with a spectral resolution 
of 4 cm-1. Data processing was performed using Bruker's OPUS spectroscopy software. High 
Resolution Mass Spectra (HRMS) were obtained via direct infusion using a Thermo LTQ FT 
mass spectrometer with positive mode electrospray ionization, via gas chromatography 
using an Exactive GC gas chromatographic system in positive mode chemical ionization, 
equipped with a Trace 1300 SSL injector and TriPlus RSH autosampler, or via liquid 
chromatography using Waters Acquity H-class liquid chromatograph system coupled to a 
Thermo LTQ FT mass spectrometer with positive mode electrospray ionization. The 
instrumental control, data aion and data processing for HRMS were performed with 
Thermo's Xcalibur and TraceFinder software packages. Low Resolution Mass Spectra (LRMS) 
were obtained using gas chromatography mass spectrometry (GC-MS) (Agilent 6850 series 
GC equipped with Agilent 5973 network Electron Impact-MSD). The instrumental control, 
data acquisition and data processing for LRMS were performed with Agilent GC/MSD 
ChemStation. Additional data processing and visualization for LRMS was performed with 
OpenChrom® Community Edition (open source). Optical rotations were measured using a 2 
mL cell with a 1 dm path length on a Jasco DIP 1000 digital polarimeter. Electrochemical 
potentials were obtained with a standard set of conditions to main internal consistency. 
Cyclic voltammograms were collected with a Pine WaveNow Potentiostat. Data was analyzed 
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using MATLAB by subtracting a background current prior to identifying the maximum 
current (Cp) and determining the potential (Ep/2) at half this value (Cp/2). The obtained value 
was referenced to Ag/AgCl and converted to SCE by subtracting 0.03 V. Thin layer 
chromatography (TLC) was performed on SiliaPlate 250 µm thick silica gel plates provided 
by Silicycle. Visualization was accomplished with short wave UV light (254 nm), or 
development with iodine, ninhydrin solution, cerium ammonium molybdate or potassium 
permanganate solution followed by heating. Column chromatography was performed using 
SiliaFlash P60 silica gel (40-63 µm) purchased from Silicycle. Unless noted all reactions 
were run under an atmosphere of nitrogen in flame-dried glassware with magnetic stirring. 
Irradiation of photochemical reactions was carried out using a PAR38 Royal Blue aquarium 
LED lamp (Model #6851) fabricated with high-power Cree XR-E LEDs as purchased from 
Ecoxotic (www.ecoxotic.com) or a SynLED Parallel Photoreactor from Millipore Sigma with 
standard borosilicate glass vials purchased from Fischer Scientific. For all photolyses, 
reactions were stirred using a PTFE coated magnetic stir bar on a magnetic stir plate. GC 
quantitation experiments were performed on an Agilent 6850 series instrument equipped 
with a split- mode capillary injection system and Agilent 5973 network mass spec detector 
(MSD). Yield refers to isolated yield of analytically pure material unless otherwise noted. GC 
yields were determined using 1,3-dimethoxybenzene as an internal standard. All other 
reagents were obtained from commercial sources and used without further purification 
unless otherwise noted. X-ray diffraction was performed by Dr. Peter S. White at the 
University of North Carolina at Chapel Hill. 
B.1.3 Photoreactor Configuration 
Reactions were irradiated using a simple photoreactor consisting of two Par38 Royal 
Blue Aquarium LED lamps (Model #6851) is shown in which one reaction (2 dram vial) is 
irradiated with a foil barrier preventing irradiation by two lamps. In order to ensure that the 
reactions are run near room temperature, a simple cooling fan was installed perpendicular 
to the reactor to aid in heat dissipation (generated from both nonradiative decay pathways 
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of the excited state catalysts and the heat generated from high power LEDs). The vial was 
positioned on a stir plate approximately 3-4 cm from a Par38 LED lamp supplying blue light 
(λ = 440–460 nm). An equilibrium temperature of 33 °C was measured with a standard 
alcohol thermometer. While a number of other blue LED sources are effective, we have 
found that LED emitters with high luminous flux and narrow viewing angle give the best 
results. Reaction optimizations were performed on a 16-well proprietary photoreactor with 
the following parameters. 
 
Basic Parameters:  
 
Input: AC 100 – 240 V 50/60 Hz  
Output: 12 W  
Light-emitting angle: 45º  
Pulse current: 700 mA 
Lumens (LM): 130 -140 LM 
Wavelength: 465-470 nm; Max wavelength: 467.5 nm  
Working temperature: –10 – +60 ºC 
LED lifetime100000 hours 

















Figure B.1. Side-on (top left) and top-down (top right) views of the simple photoreactor. A 
proprietary 16-well photoreactor used for reaction optimizations (bottom center). 
  
 187 
B.2. Optimization Studies 
 
Table B.1. Reaction optimization and control experiments. 
  
entry catalyst solvent [M] yield
A TFT [0.10] 6%2
A DCE:TFE (1:1) [0.10] 95%6
N/A DCE:TFE (1:1) [0.10] 0%7
A DCE:TFE (1:1) [0.10] 0%8
A DCE:TFE (1:1) [0.10] 84%9
A DCE:TFE (1:1) [0.20] 65%10
A DCE:TFE (1:1) [0.05] 90%11
A DCE:TFE (1:1) [0.10] 66%12
A DCE:TFE (1:1) [0.10] 88%13
B DCE:TFE (1:1) [0.10] 27%14
C DCE:TFE (1:1) [0.10] 65%15
D DCE:TFE (1:1) [0.10] 0%16
A DCE:TFE (1:1) [0.10] 18%17
A MeOH [0.10] 13%3
A TFE [0.10] 87%4
A DCE:TFE (9:1) [0.10] 23%5




















N 33 °C, N2 (1 atm)






A;  R = H; R' = t-Bu; R'' = Ph; E*red = +2.15 V
B; R = R' = H; R'' = Me; E*red = +2.18 V































D:  E1/2Ir*(III)/Ir(II) = +1.61 V
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B.3 Experimental Procedures: Catalyst and Substrate Synthesis 
B.3.1 Preparation of Acridinium Photocatalysts 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium tetrafluoroborate (Catalyst A) was 
prepared according to a published procedure; spectra data were in agreement with 
literature values.1 
 
9-Mesityl-10-methylacridinium tetrafluoroborate (Catalyst B) was prepared 
according to a published procedure; spectra data were in agreement with literature values.2 
 
9-Mesityl-10-phenyl acridinium tetrafluoroborate (Catalyst C) was prepared 























B.3.2 Preparation of Arene Substrates  
 
2,4-Dichloro-1-methoxybenzene (S1) 2,4-Dichlorophenol (6.52 g, 40.0 mmol, 1.0 
equiv) was added to a flame-dried round bottom flask charged with a magnetic stir bar, 
along with 8.29 g K2CO3 (60.0 mmol, 1.5 equiv). The solid reagents were then dissolved in 
40 mL (1.0 M) dry acetone under N2. Dimethyl sulfate (5.70 mL, 60.0 mmol, 1.5 equiv) was 
then added dropwise to the reaction mixture. The reaction was then refluxed overnight. At 
the end of the reaction, the mixture was cooled before 40 mL of H2O and 40 mL of EtOAc 
were added. The layers were separated and the aqueous layer was extracted twice with 
EtOAc (2 x 20 mL). The organic layers were then combined and subsequently washed with 2 
M NaOH solution and brine before being dried over sodium sulfate and concentrated to 
provide a pale yellow liquid. The crude product was purified by flash chromatography 
(hexanes to 5% EtOAc:Hex) to afford a colorless liquid (6.47 g, 91% yield). The spectra 
data were in agreement with literature values.3 
 
 
4-Bromo-2-chloro-1-methoxybenzene (S2) was prepared according to a published 
procedure; spectra data were in agreement with literature values.4 
 
 
4-Chloro-2-fluoro-1-methoxybenzene (S3) 4-Chloro-2-fluorophenol (1.30 mL, 12.5 
mmol, 1.0 equiv) was added to a flame-dried round bottom flask charged with a magnetic 








dissolved in 12.5 mL (1.0 M) dry acetone under N2. Iodomethane (1.20 mL, 18.7 mmol, 1.5 
equiv) was then added dropwise to the reaction mixture. The reaction was then refluxed 
overnight. At the end of the reaction, the mixture was cooled before 20 mL of H2O and 20 
mL of EtOAc were added. The layers were separated and the aqueous layer was extracted 
twice with EtOAc (2 x 10 mL). The organic layers were then combined and subsequently 
washed with 2 M NaOH solution and brine before being dried over sodium sulfate and 
concentrated to provide a pale liquid. The crude product was purified by flash 
chromatography (hexanes) to afford a colorless liquid (6.47 g, 91% yield).  
1H NMR (600 MHz, CDCl3) δ 7.10 (dd, J = 10.8, 2.5 Hz, 1H), 7.06 (ddd, J = 8.8, 2.5, 1.6 
Hz, 1H), 6.88 (t, J = 8.8 Hz, 1H), 3.87 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 152.25 (d, J = 
249.3 Hz), 146.71 (d, J = 10.7 Hz), 125.33 (d, J = 8.9 Hz), 124.34 (d, J = 3.8 Hz), 117.00 
(d, J = 21.5 Hz), 114.14 (d, J = 2.3 Hz), 56.57. 19F NMR (376 MHz, CDCl3) δ -132.26.  
 
IR (thin film): 2841.13, 1499.61, 1266.15, 1209.85, 1129.25, 1024.83, 893.15, 893.15, 
857.25, 799.70, 760.20, 644.63, 580.29; LRMS: Calculated for (M)+: 160.01; found: 
160.00. 
 
4-(tert-butyl)-2-Chloro-1-methoxybenzene (S4) 4-(tert-butyl)-2-Chlorophenol (1.74 
g, 9.42 mmol, 1.0 equiv) was added to a flame-dried round bottom flask charged with a 
magnetic stir bar, along with 1.95 g K2CO3 (14.13 mmol, 1.5 equiv). The solid reagents 
were then dissolved in 9.4 mL (1.0 M) dry acetone under N2. Iodomethane (0.88 mL, 14.13 
mmol, 1.5 equiv) was then added dropwise to the reaction mixture. The reaction was then 
refluxed overnight. At the end of the reaction, the mixture was cooled before 20 mL of H2O 
and 20 mL of EtOAc were added. The layers were separated and the aqueous layer was 
extracted twice with EtOAc (2 x 10 mL). The organic layers were then combined and 




sulfate and concentrated to provide a pale liquid. The crude product was purified by flash 
chromatography (5% EtOAc:Hex) to afford a colorless liquid (1.48 g, 79% yield).  
1H NMR (600 MHz, CDCl3) δ 7.38 (d, J = 2.4 Hz, 1H), 7.23 (dd, J = 8.6, 2.4 Hz, 1H), 6.86 
(d, J = 8.6 Hz, 1H), 3.88 (s, 3H), 1.29 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 152.75, 
144.66, 127.58, 124.55, 121.88, 111.74, 56.28, 34.32, 31.50.  
 
IR (thin film): 2959.98, 1505.98, 1493.19, 1260.29, 1065.23, 1022.75, 807.37, 713.59; 
LRMS: Calculated for (M)+: 198.08; found: 198.10. 
 
3-Chloro-4-methoxy-1,1'-biphenyl (S5) 2-Chloro-4-phenylphenol (1.62 g, 8.26 mmol, 
1.0 equiv) was added to a flame-dried round bottom flask charged with a magnetic stir bar, 
along with 1.71 g K2CO3 (12.4 mmol, 1.5 equiv). The solid reagents were then dissolved in 
33 mL (0.33 M) dry acetone under N2. Iodomethane (0.77 mL, 1.5 mmol, 1.5 equiv) was 
then added dropwise to the reaction mixture. The reaction was then refluxed overnight. At 
the end of the reaction, the mixture was cooled before 30 mL of H2O and 30 mL of EtOAc 
were added. The layers were separated and the aqueous layer was extracted twice with 
EtOAc (2 x 15 mL). The organic layers were then combined and subsequently washed with 2 
M NaOH solution and brine before being dried over sodium sulfate and concentrated to 
provide a pale solid. The crude product was purified by flash chromatography (20% 
EtOAc:Hex) to afford a colorless solid (1.63 g, 90% yield). The spectra data were in 








1-Chloro-2-methoxynaphthalene (S6) was prepared according to a published 
procedure; spectra data were in agreement with literature values.6 
 
 
2-Methoxy-1-naphthonitrile (S7) was prepared according to a published procedure; 
spectra data were in agreement with literature values.7 
 
 
1-(Benzyloxy)-2,4-dichlorobenzene (S8) was prepared following a published procedure 
for 4-chlorophenol8; spectra data were in agreement with literature values.9 
 
 
Methyl 3,4-dimethoxybenzoate (S9) was prepared according to a published procedure; 












3,4-Dimethoxyphenyl trifluoromethanesulfonate (S10) was prepared according to a 
published procedure; spectra data were in agreement with literature values.11 
 
 
Methyl 3-(benzyloxy)-4-methoxybenzoate (S11) was prepared according to a 
published procedure; spectra data were in agreement with literature values.12 
 
 
Methyl 4-methoxy-3-((triisopropylsilyl)oxy)benzoate (S12) 3-Hydroxy-4-
methoxybenzoate (1.00 g, 5.49 mmol, 1.0 equiv) was added to a flame-dried round bottom 
flask charged with a magnetic stir bar, along with 934.1 mg imidazole (13.7 mmol, 2.5 
equiv). The solid reagents were then dissolved in 34 mL (0.16 M) dry DCM under N2. 
Triisopropylsilyl chloride (1.41 mL, 6.59 mmol, 1.2 equiv) was then added dropwise to the 
reaction mixture. The reaction was then stirred overnight. At the end of the reaction, the 
stir bar was removed and the mixture was concentrated by rotary evaporation. The crude 
solid was then reconstituted in 30 mL of EtOAc before 30 mL of H2O was added. The layers 
were separated and the aqueous layer was extracted twice with EtOAc (2 x 15 mL). The 




















brine before being dried over sodium sulfate and concentrated to provide a liquid. The crude 
product was purified by flash chromatography (5% EtOAc:Hex) to afford a pale light yellow 
liquid (1.67 g, 90% yield).  
1H NMR (600 MHz, CDCl3) δ 7.64 (dd, J = 8.5, 2.1 Hz, 1H), 7.53 (d, J = 2.1 Hz, 1H), 6.84 
(d, J = 8.5 Hz, 1H), 3.87 (s, 3H), 3.85 (s, 3H), 1.26 (hept, J = 7.4 Hz, 3H), 1.09 (d, J = 7.4 
Hz, 18H). 13C NMR (151 MHz, CDCl3) δ 167.07, 155.13, 145.14, 124.04, 122.64, 121.44, 
110.93, 55.54, 52.05, 18.01, 12.94.  
 
IR (thin film): 2944.95, 2866.40, 1718.02, 1511.32, 1420.58, 1292.04, 1276.87, 1219.57, 
1131.32, 1098.17, 999.31, 881.47, 828.23, 764.07, 678.79; HRMS: Calculated for 
(M+H)+: 339.1986; found: 339.1978. 
 
 
3-(Benzyloxy)-4-methoxyphenol (S13) was prepared according to a published 
procedure; spectra data were in agreement with literature values.13 
 
 
3-(Benzyloxy)-4-methoxyphenyl trifluoromethanesulfonate (S14) 3-(Benzyloxy)-4-
methoxyphenol (2.42 g, 10.5 mmol, 1.0 equiv) was added to a flame-dried round bottom 
flask charged with a magnetic stir bar. The phenol was then dissolved in 21 mL (0.16 M) dry 
DCM under N2. Pyridine (1.69 mL, 21.0 mmol, 2.0 equiv) was then added to the reaction 











mmol, 1.2 equiv) was then added dropwise to the mixture at 0 °C and then reaction was 
then allowed to warm to room temperature. The mixture was then stirred overnight. The 
reaction was then diluted with DCM (15 mL) and water (30 mL). The layers were separated 
and the aqueous layer was extracted twice with DCM (2 x 15 mL). The organic layers were 
then combined and subsequently washed with 10% HCl solution and brine before being 
dried over sodium sulfate and concentrated to provide a pale yellow solid. The crude 
product was purified by flash chromatography (5% EtOAc:Hex) to afford a light yellow 
crystalline solid (3.52 g, 93% yield).  
1H NMR (600 MHz, CDCl3) δ 7.45 – 7.30 (m, 5H), 6.88 (d, J = 8.9 Hz, 1H), 6.84 (dd, J = 
8.9, 2.7 Hz, 1H), 6.80 (d, J = 2.7 Hz, 1H), 5.14 (s, 2H), 3.90 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 149.54, 148.80, 142.78, 135.97, 128.86, 128.41, 127.54, 118.80 (q, J = 321.2 
Hz), 113.58, 111.52, 107.74, 71.47, 56.41. 19F NMR (376 MHz, CDCl3) δ -72.70.  
 
IR (thin film): 2963.98, 1506.73, 1415.39, 1221.71, 1198.37, 1135.52, 1135.52, 1120.61, 
957.29, 861.58, 834.24, 596.06; HRMS: Calculated for (M+Na)+: 385.0328; found: 
385.0332. 
 
3-(Benzyloxy)-4-methoxybenzaldehyde (S15) was prepared according to a published 









4-(Benzyloxy)-3-methoxybenzaldehyde (S16) was prepared according to a published 
procedure; spectra data were in agreement with literature values.15 
 
 
1-(4-(Benzyloxy)-3-methoxyphenyl)ethan-1-one (S17) was prepared according to a 
published procedure; spectra data were in agreement with literature values.16 
 
 
1-(3-(Benzyloxy)-4-methoxyphenyl)ethan-1-one (S18) was prepared according to a 
published procedure; spectra data were in agreement with literature values.17 
 
 
4-Chloro-6,7-dimethoxyquinoline (S19) was prepared according to a published 




















6,7-Dimethoxyisoquinoline (S20) was prepared according to a published procedure; 
spectra data were in agreement with literature values.19 
 
 
1-(3-(Benzyloxy)-4-methoxyphenyl)-2-bromoethan-1-one (S21) was prepared 




(3-(Benzyloxy)-4-methoxyphenyl)-2-bromoethan-1-one (0.95 g, 2.83 mmol, 1.0 equiv) was 
added to a flame-dried round bottom flask charged with a magnetic stir bar. The solid was 
then dissolved in 5 mL (0.56 M) dry DMF under N2. Phthalimide potassium salt (0.55 g, 2.98 
mmol, 1.05 equiv) was then added and the reaction mixture was stirred overnight. The 
reaction was then diluted with EtOAc (15 mL) and water (30 mL). The layers were 
separated and the aqueous layer was extracted twice with EtOAc (2 x 15 mL). The organic 
layers were then combined and subsequently washed with saturated LiCl solution, 10% HCl 
solution and brine before being dried over sodium sulfate and concentrated to provide a 
solid. The crude product was purified by flash chromatography (20% EtOAc:Hex to 30% 















1H NMR (600 MHz, CDCl3) δ 7.90 (dd, J = 5.4, 3.0 Hz, 2H), 7.75 (dd, J = 5.4, 3.1 Hz, 2H), 
7.66 (dd, J = 8.4, 2.0 Hz, 1H), 7.56 (d, J = 2.0 Hz, 1H), 7.45 (d, J = 7.0 Hz, 2H), 7.37 (t, J 
= 7.5 Hz, 2H), 7.34 – 7.28 (m, 1H), 6.96 (d, J = 8.4 Hz, 1H), 5.18 (s, 2H), 5.06 (s, 2H), 
3.97 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 189.47, 168.13, 154.73, 148.42, 136.42, 
134.24, 132.37, 128.81, 128.29, 127.62, 127.51, 123.67, 123.21, 112.67, 110.67, 71.09, 
56.32, 43.95.  
 
IR (thin film): 2975.14, 2932.14, 1709.19, 1692.27, 1417.42, 1257.83, 715.36; HRMS: 
Calculated for (M+Na)+: 424.1155; found: 424.1164. 
 
 
Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-hydroxyphenyl)propanoate (S23) was 




Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-methoxyphenyl)propanoate (S24) 
Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-hydroxyphenyl)propanoate (4.01 g, 12.3 
mmol, 1.0 equiv) was added to a flame-dried round bottom flask charged with a magnetic 
stir bar, along with 4.25 g of K2CO3 (30.8 mmol, 2.5 equiv). The solids were then dissolved 
in 31 mL (0.40 M) dry acetone under N2. Dimethyl sulfate (1.75 mL, 18.5 mmol, 1.5 equiv) 














cooled and diluted with EtOAc (30 mL) and water (40 mL). The layers were separated and 
the aqueous layer was extracted twice with EtOAc (2 x 20 mL). The organic layers were 
then combined and subsequently washed with 2 M NaOH solution and brine before being 
dried over sodium sulfate and concentrated to provide a white solid. The crude product was 
purified by flash chromatography (30% EtOAc:Hex to 40% EtOAc:Hex) to afford a white 
crystalline solid (3.74 g, 90% yield).  
1H NMR (600 MHz, CDCl3) δ 7.78 (dd, J = 5.4, 3.1 Hz, 2H), 7.69 (dd, J = 5.5, 3.0 Hz, 2H), 
7.07 (d, J = 8.6 Hz, 2H), 6.71 (d, J = 8.7 Hz, 2H), 5.11 (dd, J = 11.4, 5.3 Hz, 1H), 3.78 (s, 
3H), 3.70 (s, 4H), 3.53 (dd, J = 14.5, 5.3 Hz, 1H), 3.48 (dd, J = 14.4, 11.4 Hz, 1H). 13C 
NMR (151 MHz, CDCl3) δ 169.55, 167.62, 158.46, 134.23, 131.71, 129.97, 128.73, 
123.63, 114.07, 55.26, 53.54, 53.03, 33.89.  
 
IR (thin film): 2955.63, 2917.78, 1708.14, 1513.65, 1391.22, 1244.53, 717.18, 515.28; 




(S25) Under glovebox conditions, anhydrous titanium tetrachloride [TiCl4] (3.63 mL, 33.0 
mmol, 3.0 equiv) was added to a flame-dried round bottom flask and sealed with a rubber 
septum. The flask was then brought outside the glovebox and diluted with 6.3 mL of dry 
DCM (5.3 M) under N2. Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4 
methoxyphenyl)propanoate (3.74 g, 11.0 mmol, 1.0 equiv) was added to a separate flame-
dried round bottom flask charged with a magnetic stir bar. The solid was then dissolved in 









α,α−Dichloromethyl methyl ether (2.0 mL, 22.0 mmol, 2.0 equiv) was then added to this 
solution dropwise. After the addition of the ether was complete, the TiCl4 solution was then 
added via cannula, with an additional 10 mL of dry DCM added to the transferring vessel to 
ensure complete transfer of TiCl4. The reaction was then allowed to warm to room 
temperature and then stirred overnight. At the end of the reaction, the mixture was 
quenched over ice water and diluted with DCM (20 mL). The layers were separated and the 
aqueous layer was extracted twice with DCM (2 x 15 mL). The organic layers were then 
combined and subsequently washed with brine before being dried over sodium sulfate and 
concentrated to provide a pale-tan solid. The crude product was purified by flash 
chromatography (50% EtOAc:Hex) to afford a white solid (4.01 g, 99% yield).  
1H NMR (600 MHz, CDCl3) δ 10.31 (s, 1H), 7.78 (dd, J = 5.5, 3.1 Hz, 2H), 7.70 (dd, J = 
5.5, 3.0 Hz, 2H), 7.59 (d, J = 2.4 Hz, 1H), 7.36 (dd, J = 8.6, 2.5 Hz, 1H), 6.83 (d, J = 8.6 
Hz, 1H), 5.08 (dd, J = 11.3, 5.0 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.56 (dd, J = 14.5, 5.0 
Hz, 1H), 3.49 (dd, J = 14.5, 11.3 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 189.56, 169.22, 
167.52, 160.80, 136.37, 134.34, 131.58, 129.15, 129.05, 124.70, 123.71, 112.08, 55.74, 
53.28, 53.10, 33.77. 
 
IR (thin film): 2950.79, 2875.74, 1739.96, 1707.78, 1677.53, 1387.82, 1251.46, 718.76; 




methoxyphenyl)propan-oate (S26) Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(3-formyl-
4-methoxyphenyl)-propanoate (4.01 g, 10.9  mmol, 1.0 equiv) was added to a flame-dried 
round bottom flask charged with a magnetic stir bar. The solid was then dissolved in 73 mL 
(0.15 M) dry DCM under N2 before meta-chloroperbenzoic acid (mCPBA, ≤ 77%, 5.65 g, 
32.7 mmol, 3.0 equiv) was added. The reaction was stirred overnight at room temperature 
and concentrated in vacuo upon completion. The residue was reconstituted in EtOAc (40 
mL) and quenched with saturated Na2SO3 solution (3 x 20 mL), saturated NaHCO3 solution 
(2 x 20 mL) and brine sequentially. The organic layer was then dried over sodium sulfate 
and concentrated to provide a white solid. The crude product was purified by flash 
chromatography (30% EtOAc:Hex) to afford a yellow, gummy solid (3.72 g, 89% yield). 
1H NMR (600 MHz, CDCl3) δ 8.12 (s, 1H), 7.78 (dd, J = 5.5, 3.1 Hz, 2H), 7.69 (dd, J = 5.5, 
3.0 Hz, 2H), 7.05 (dd, J = 8.4, 2.2 Hz, 1H), 6.88 (d, J = 2.2 Hz, 1H), 6.82 (d, J = 8.4 Hz, 
1H), 5.10 (dd, J = 11.3, 5.3 Hz, 1H), 3.76 (s, 3H), 3.73 (s, 3H), 3.54 (dd, J = 14.6, 5.3 Hz, 
1H), 3.47 (dd, J = 14.6, 11.3 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 169.24, 167.56, 
159.03, 149.67, 138.57, 134.29, 131.57, 129.48, 127.68, 123.65, 123.17, 112.66, 55.92, 
53.11, 53.06, 33.76.  
 
IR (thin film): 2956.20, 1738.76, 1708.15, 1385.73, 1262.46, 1129.90, 1088.01, 717.70; 













methoxyphenyl)propanoate (S27) Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(3-
(formyloxy)-4-methoxyphenyl)-propanoate (4.18 g, 10.9 mmol, 1.0 equiv) was added to a 
flame-dried round bottom flask charged with a magnetic stir bar. The solid was then 
dissolved in 73 mL (0.15 M) dry DCM under N2 before ammonia in methanol (2 M, 7.3 mL, 
14.5 mmol, 1.33 equiv) was added. The reaction was stirred overnight at room temperature 
and concentrated in vacuo upon completion to afford a tan solid. The crude product was 
purified by flash chromatography (50% EtOAc:Hex) to afford a pale yellow crystalline solid 
(2.51 g, 65% yield).  
1H NMR (600 MHz, CDCl3) δ 7.77 (dd, J = 5.4, 3.0 Hz, 2H), 7.67 (dd, J = 5.4, 3.0 Hz, 2H), 
6.72 (d, J = 2.0 Hz, 1H), 6.64 (d, J = 8.2 Hz, 1H), 6.62 (dd, J = 8.3, 2.0 Hz, 1H), 5.56 (s, 
1H), 5.09 (dd, J = 11.5, 5.0 Hz, 1H), 3.76 (s, 3H), 3.75 (s, 3H), 3.49 (dd, J = 14.4, 5.0 Hz, 
1H), 3.43 (dd, J = 14.4, 11.5 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 169.50, 167.59, 
145.53, 145.47, 134.18, 131.67, 129.89, 123.59, 120.37, 115.15, 110.73, 55.86, 53.52, 
52.98, 34.08.  
 
IR (thin film): 3423.63, 2951.79, 1746.27, 1715.23, 1511.52, 1391.86, 1264.45, 1176.12, 












pivalate (S28) Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(3-hydroxy-4-methoxyphenyl)-
propanoate (0.70 g, 1.97 mmol, 1.0 equiv) was added to a flame-dried round bottom flask 
charged with a magnetic stir bar, along with 48.1 mg 4-(dimethylamino)pyridine (60.0 
mmol, 1.5 equiv). The solid reagents were then dissolved in 7 mL (0.3 M) dry DCM under 
N2. Dry triethylamine (0.33 mL, 2.36 mmol, 1.2 equiv) was then added to the reaction 
before trimethylacetyl chloride (0.79 mL, 2.36 mmol, 1.2 equiv) was added dropwise to the 
reaction mixture. The reaction was then stirred at room temperature overnight. At the end 
of the reaction, the mixture was quenched with saturated NaHCO3 solution and the layers 
were separated. The aqueous layer was then extracted twice with DCM (2 x 15 mL). The 
organic layers were then combined, dried over sodium sulfate and concentrated to provide a 
pale solid. The crude product was purified by flash chromatography (10-20% EtOAc:Hex) to 
afford a white translucent solid (0.58 g, 67% yield).  
1H NMR (600 MHz, CDCl3) δ 7.79 (dd, J = 5.5, 3.1 Hz, 2H), 7.69 (dd, J = 5.5, 3.0 Hz, 2H), 
6.98 (dd, J = 8.4, 2.2 Hz, 1H), 6.78 (d, J = 2.2 Hz, 1H), 6.76 (d, J = 8.4 Hz, 1H), 5.10 (dd, 
J = 11.3, 5.2 Hz, 1H), 3.77 (s, 3H), 3.70 (s, 3H), 3.53 (dd, J = 14.6, 5.2 Hz, 1H), 3.46 (dd, 
J = 14.5, 11.3 Hz, 1H), 1.28 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 176.50, 169.41, 167.63, 
150.16, 140.06, 134.20, 131.72, 129.19, 126.85, 123.67, 123.47, 112.49, 55.93, 53.29, 
53.05, 39.06, 33.83, 27.27.  
 
IR (thin film): 2972.62, 1775.34, 1711.90, 1385.22, 1262.84, 1124.41, 1105.94, 717.87; 










Methyl (S)-2-(6-methoxynaphthalen-2-yl)propanoate (S29) was prepared according 
to a published procedure; spectra data were in agreement with literature values.1 
 
 
Methyl (S)-2-(5-cyano-6-methoxynaphthalen-2-yl)propanoate (S30) was prepared 
according to a published procedure, with minor modifications to the scale and nucleophile 
equivalents to obtain 90.6 mg of the desired product (67% yield); spectra data were in 
agreement with literature values.22 
 
 
2-Bromo-1-(3,4-dimethoxyphenyl)ethan-1-one (S31) was prepared according to a 
published procedure; spectra data were in agreement with literature values.23 
 
  
2-(4-Acetyl-2-methoxyphenoxy)-1-(3,4-dimethoxyphenyl)ethan-1-one (S32) To a 
clean, flame-dried round bottom flask equipped with a stir bar was added acetovanillone 






















mixture was then dissolved in acetone (10 mL). 2-Bromo-1-(3,4-dimethoxyphenyl)ethan-1-
one (0.5643 g, 2.17 mmol, 1.0 equiv) was then added to the reaction solution and the 
resulting mixture was stirred overnight at room temperature. Upon completion of the 
reaction, the mixture was concentrated by rotary evaporation, reconstituted in EtOAc (20 
mL). H2O (20 mL) was then added to the mixture. The layers were separated and the 
aqueous layer was extracted twice with EtOAc (2 x 15 mL). The organic layers were then 
combined and subsequently washed with water and brine before being dried over sodium 
sulfate and concentrated to provide a tan solid. The crude product was purified by flash 
chromatography (40 to 50% EtOAc:Hex) to afford a tan crystalline solid (0.608 g, 81% 
yield).  
1H NMR (600 MHz, CDCl3) δ 7.65 (dd, J = 8.4, 2.0 Hz, 1H), 7.56 (d, J = 2.0 Hz, 1H), 7.54 
(d, J = 2.0 Hz, 1H), 7.47 (dd, J = 8.3, 2.0 Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 6.76 (d, J = 
8.4 Hz, 1H), 5.40 (s, 2H), 3.95 (s, 3H), 3.94 (s, 3H), 3.92 (s, 3H), 2.53 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 196.88, 192.23, 154.15, 151.76, 149.41, 149.39, 131.42, 127.48, 
123.01, 122.78, 112.22, 110.83, 110.30, 110.24, 71.23, 56.28, 56.17, 56.12, 26.39.  
 
IR (thin film): 3003.80, 2954.77, 2935.70, 2835.82, 1686.23, 1667.29, 1585.43, 1511.08, 
1414.87, 1262.02, 1244.30, 1215.20, 1200.89, 1148.70, 1084.46, 1029.64, 1017.75, 




1-(5-Chloro-2-methoxyphenyl)-1H-imidazole (S34) was prepared using a modified 
procedure from Ma et al. 24 To a clean, dry 3 dram vial containing a Teflon-coated magnetic 




mmol, 0.1 equiv), L-proline (92.1 mg, 0.8 mmol, 0.2 equiv), 326.7 mg of imidazole (4.6 
mmol, 1.2 equiv) and K2CO3 (1.38 g, 10.0 mmol, 2.5 equiv). The vial containing the solids 
were then transferred to the glovebox, where anhydrous DMSO (8 mL, 0.5 M) was added 
and the vial was subsequently sealed with a Teflon-lined septum screw cap. The reaction 
mixture was then refluxed at 90 °C for 36 h. The mixture was then cooled and added to a 
mixture of EtOAc (20 mL) and water (20 mL). The layers were separated and the organic 
layer was washed with water (20 mL x 3) to remove residual DMSO. The organic layer was 
then washed with saturated ammonium chloride solution (20 mL x 3) to remove residual 
copper salts. The organic layer was washed with brine, dried over sodium sulfate and 
concentrated to provide a solid. The crude product was purified by flash chromatography 
(70-80% EtOAc:Hex) to afford a light-brown crystalline solid (0.13 g, 15% yield).  
1H NMR (600 MHz, CDCl3) δ 7.75 (s, 1H), 7.27 (dd, J = 8.8, 2.6 Hz, 1H), 7.24 (d, J = 2.6 
Hz, 1H), 7.15 (s, 1H), 7.13 (s, 1H), 6.95 (d, J = 8.8 Hz, 1H), 3.80 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 151.23, 137.68, 129.20, 128.50, 127.32, 125.77, 125.38, 120.01, 113.46, 
56.20. 
 
IR (thin film): 3113.66, 3021.02, 2998.70, 2838.29, 1516.06, 1465.36, 1455.69, 1245.07, 
1105.82, 1024.30, 901.65, 827.41, 794.33, 744.35, 696.08, 645.15, 626.06; HRMS: 
Calculated for (M)+: 208.0403; found: 208.0394. 
 
 
Methyl (tert-butoxycarbonyl)-L-histidinate (S35) was prepared according to a 







Methyl Nα-(tert-butoxycarbonyl)-Nτ-(2,4-dichlorophenyl)-L-histidinate (S36) was 
prepared by using a modified procedure from Allerton et al. 27. Phenylboronic acid (0.382 g, 
2.0 mmol, 2.0 equiv), copper acetate (0.272 g, 1.5 mmol, 1.5 equiv), 4 Å molecular sieves 
(0.470 g) and methyl (tert-butoxycarbonyl)-L-histidinate [S35] (0.269 g, 1.0 mmol, 1.0 
equiv) were added to a dry, clean 3 dram vial. Dry DCM (6 ml, 0.17 M) and pyridine (0.16 
ml, 2.0 mmol, 2.0 equiv) were then added in subsequent fashion. The reaction mixture was 
then sparged for 15 minutes with a balloon of O2 and stirred at room temperature while 
keeping the reaction under a balloon of O2 for 2 days. At the end of the reaction, a solution 
of ethylenediaminetetraacetic acid (0.497 g, 1.7 mmol, 1.7 equiv) in saturated sodium 
bicarbonate solution (20 ml) was added and the mixture stirred at room temperature for 30 
minutes. The organic layer was then separated from the aqueous layer, which was extracted 
with DCM (2 x 20 ml), and the combined organic layers were dried over Na2SO4 and 
concentrated by rotary evaporation. The crude product was then purified by flash 
chromatography (60% EtOAc:Hex to 80% EtOAc:Hex) to yield a gummy tan-red solid (31.4 
mg, 8% yield).  
1H NMR (600 MHz, CDCl3) δ 7.56 (s, 1H), 7.55 (d, J = 1.8 Hz, 1H), 7.35 (dd, J = 8.5, 1.9 
Hz, 1H), 7.25 (d, J = 8.0 Hz, 1H), 6.90 (s, 1H), 5.87 (d, J = 8.4 Hz, 1H), 4.61 (dt, J = 9.5, 
5.3 Hz, 1H), 3.71 (s, 3H), 3.16 (dd, J = 14.8, 5.6 Hz, 1H), 3.09 (dd, J = 14.9, 4.8 Hz, 1H), 
1.43 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.59, 155.69, 138.11, 137.30, 135.15, 
133.70, 130.81, 130.75, 128.40, 128.28, 118.09, 79.83, 53.53, 52.42, 30.39, 28.47.  
 
IR (thin film): 2977.79, 2931.46, 1743.55, 1705.29, 1496.48, 1365.07, 1160.61, 1051.92, 








4-(Benzyloxy)-3-methoxybenzoic acid (S37) was prepared according to a published 
procedure; spectra data were in agreement with literature values.28 
 
 
4-(Benzyloxy)-N, 3-dimethoxy-N-methylbenzamide (S38) was prepared following a 
modified procedure from Liao et al.29. To a clean, flame-dried round bottom flask equipped 
with a stir bar were added 4-(benzyloxy)-3-methoxybenzoic acid (5.17 g, 20.0 mmol, 1.0 
equiv) and N,O-dimethylhydroxyamine hydrochloride (2.93 g, 30.0 mmol, 1.5 equiv). 53 mL 
of DCM (0.38 M) was then added to the solids, followed by dry triethylamine (4.18 mL, 30.0 
mmol, 1.5 equiv) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (3.6 mL, 20.2 
mmol, 1.01 equiv). The mixture was then stirred at room temperature overnight. The 
reaction was then diluted with DCM (50 mL) and water (50 mL) and the layers were 
separated. The aqueous layer was then extracted twice with DCM (2 x 15 mL). The organic 
layers were then combined and subsequently washed with water and brine before being 
dried over sodium sulfate and concentrated to provide an oil. The crude product was purified 
by flash chromatography (50% EtOAc:Hex) to afford a colorless oil (3.56 g, 59% yield).  
1H NMR (600 MHz, CDCl3) δ 7.45 – 7.40 (m, 2H), 7.36 (t, J = 7.6 Hz, 2H), 7.34 – 7.27 (m, 
3H), 6.86 (d, J = 8.3 Hz, 1H), 5.19 (s, 2H), 3.90 (s, 3H), 3.56 (s, 3H), 3.34 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 169.28, 150.25, 148.86, 136.63, 128.68, 128.06, 127.29, 













IR (thin film): 2963.11, 2933.77, 1632.27, 1599.34, 1579.54, 1512.55, 1454.52, 1417.00, 
1372.38, 1259.62, 1134.87, 1001.81, 813.79, 787.08, 743.48, 697.36, 510.64; HRMS: 
Calculated for (M+H)+: 302.1387; found: 302.1383. 
 
 
1-(4-(Benzyloxy)-3-methoxyphenyl)ethan-1-one-2,2,2-d3 (S39) To a clean, flame-
dried three-neck round bottom flask equipped with a stir bar and a condenser were added 
magnesium turnings (345.2 mg, 14.2 mmol, 1.22 equiv), dry diethyl ether (8 mL, 1.75 M) 
and dry THF (8 mL, 1.75 M). Iodomethane-d3 (≥ 99.5% atom % D, 0.87 mL, 13.9 mmol, 
1.20 equiv) was then added dropwise and the reaction mixture was allowed to stir for 30 
min. at room temperature. A separate, clean, flame-dried round bottom flask equipped with 
a stir bar was added 4-(benzyloxy)-N,3-dimethoxy-N-methylbenzamide (3.49 g, 11.6 mmol, 
1.0 equiv) and the solid was dissolved in dry diethyl ether (11.6 mL, 1.0 M) and dry THF 
(11.6 mL, 1.0 M). The Grignard reaction flask was then cooled to 0 °C and the benzamide 
was added slowly via cannula. The reaction mixture was then warmed to room temperature 
and stirred overnight. 2 M HCl solution (10 mL) was then added to quench the reaction 
mixture followed by the addition of EtOAc (50 mL). The layers were separated and the 
aqueous layer was extracted twice with EtOAc (2 x 15 mL). The organic layers were then 
combined and subsequently washed with water and brine before being dried over sodium 
sulfate and concentrated to provide a white solid. The crude product was purified by flash 
chromatography (20% EtOAc:Hex) to afford a white crystalline solid (3.01 g, 76% yield).  
1H NMR (600 MHz, CDCl3) δ 7.51 (d, J = 2.0 Hz, 1H), 7.44 (dd, J = 8.4, 2.0 Hz, 1H), 7.40 
(d, J = 7.2 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.27 (t, J = 7.4 Hz, 1H), 6.85 (d, J = 8.4 Hz, 
1H), 5.16 (s, 2H), 3.87 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 196.77, 152.19, 149.24, 







IR (thin film): 3037.16, 2969.62, 2937.53, 2872.14, 2099.20, 1660.28, 1578.66, 1511.86, 
1463.19, 1411.94, 1268.62, 1247.37, 1219.18, 1173.22, 1142.66, 1097.34, 1028.26, 
1004.24, 988.08, 861.53, 853.11, 796.40, 787.06, 755.77, 744.98; HRMS: Calculated for 
(M+H)+: 260.1363; found: 260.1349. 
 
 
1-(4-Hydroxy-3-methoxyphenyl)ethan-1-one-2,2,2-d3 (S40) To a clean, flame-dried 
round bottom flask equipped with a stir bar were added 1-(4-(benzyloxy)-3-
methoxyphenyl)-ethan-1-one-2,2,2-d3 (1.90 g, 7.32 mmol, 1.0 equiv) and palladium on 
carbon (10 wt. % [dry], 77.7 mg, 0.73 mmol, 0.10 equiv). Ethanol (73 mL, 0.1 M) and dry 
THF (15 mL) were added to the solid mixture under N2, and the suspension was purged and 
backfilled three times with N2. A balloon of H2 was then added to the reaction vessel and the 
mixture was purged and backfilled three times with H2. The reaction was then allowed to stir 
overnight. Upon completion of the reaction, the mixture was run through a Celite® plug and 
the eluent was concentrated to provide a white solid. No further purification was required 
(1.22 g, 99% yield). 
1H NMR (600 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H), 6.95 (d, J = 8.6 Hz, 1H), 6.11 (s, 1H), 
3.95 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 197.13, 150.49, 146.71, 130.32, 124.16, 
113.86, 109.72, 56.20. 
 
IR (thin film): 3285.22, 3010.55, 2939.93, 2840.41, 2114.13, 1652.35, 1573.20, 1514.43, 
1464.68, 1450.56, 1418.04, 1288.99, 1213.22, 1188.71, 1155.32, 1112.91, 1026.80, 
998.69, 890.44, 836.68, 820.05, 786.67, 671.68; HRMS: Calculated for (M+H)+: 








2,2,2-d3 (S41) To a clean, flame-dried round bottom flask equipped with a stir bar was 
added 1-(4-hydroxy-3-methoxyphenyl)ethan-1-one-2,2,2-d3 (0.677 g, 4.0 mmol, 1.0 equiv) 
and K2CO3 (1.11 g, 8.0 mmol, 2.0 equiv). The reaction mixture was then dissolved in 
acetone (12 mL). 2-Bromo-1-(3,4-dimethoxyphenyl)ethan-1-one (1.04 g, 4.0 mmol, 1.0 
equiv) was then added to the reaction solution and the resulting mixture was stirred 
overnight at room temperature. Upon completion of the reaction, the mixture was 
concentrated by rotary evaporation, reconstituted in EtOAc (20 mL). H2O (20 mL) was then 
added to the mixture. The layers were separated and the aqueous layer was extracted twice 
with EtOAc (2 x 15 mL). The organic layers were then combined and subsequently washed 
with and brine before being dried over sodium sulfate and concentrated to provide a white 
solid. The crude product was purified by flash chromatography (40 to 50% EtOAc:Hex) to 
afford an white crystalline solid (1.01 g, 73% yield).  
1H NMR (600 MHz, CDCl3) δ 7.62 (dd, J = 8.4, 1.9 Hz, 1H), 7.53 (d, J = 2.0 Hz, 1H), 7.51 
(d, J = 1.9 Hz, 1H), 7.44 (dd, J = 8.4, 2.0 Hz, 1H), 6.88 (d, J = 8.4 Hz, 1H), 6.74 (d, J = 
8.4 Hz, 1H), 5.39 (s, 2H), 3.93 (s, 3H), 3.92 (s, 3H), 3.90 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 196.95, 192.13, 154.06, 151.68, 149.31, 149.28, 131.30, 127.38, 122.94, 
122.70, 112.11, 110.70, 110.17, 71.10, 56.21, 56.08, 56.04. 
 
IR (thin film): 3080.56, 3000.72, 2937.69, 2839.28, 2101.17, 1664.55, 1584.18, 1508.79, 
1461.54, 1415.35, 1259.09, 1219.45, 1202.56, 1167.76, 1148.00, 1130.53, 1100.87, 











N-(2-Chlorobenzyl)-1H-benzo[d]imidazole-5-carboxamide (S42). To a clean, flame-
dried round bottom flask equipped with a stir bar was added 5-benzimidazolecarboxylic acid 
(0.811 g, 5.0 mmol, 1.0 equiv) and O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium 
hexafluorophosphate (HBTU, 1.90 g, 5.0 mmol, 1.0 equiv). The reaction mixture was then 
dissolved in DMF (10 mL, 0.5 M). Triethylamine (0.84 mL, 6.0 mmol, 1.2 equiv) was then 
added to the reaction mixture, which clarified upon addition. 2-Chlorobenzylamine (0.65 
mL, 5.5 mmol, 1.1 equiv) was then added and the resulting mixture was stirred overnight at 
room temperature. Upon completion of the reaction, the mixture was concentrated by 
vacuum distillation, reconstituted in 10% MeOH:EtOAc (40 mL). The solution was then 
washed with water (2 x 40 mL) and 10% LiCl solution (40 mL). 20 mL of 2 M NaOH solution 
was then added to remove residual 5-benzimidazole-carboxylic acid from the organic layer, 
which was subsequently washed with brine before being dried over sodium sulfate and 
concentrated to provide a pale off-white solid. The crude product was purified by flash 
chromatography (5% to 15% MeOH:DCM) to afford an white solid (1.21 g, 85% yield). 
1H NMR (600 MHz, DMSO-d6) δ 12.77 (s, 1H), 9.09 (t, J = 5.7 Hz, 1H), 8.37 (s, 1H), 8.25 
(s, 1H), 7.83 (dd, J = 8.4, 1.7 Hz, 1H), 7.66 (d, J = 8.4 Hz, 1H), 7.45 (dd, J = 7.8, 1.4 Hz, 
1H), 7.38 (dd, J = 7.6, 1.8 Hz, 1H), 7.32 (td, J = 7.5, 1.4 Hz, 1H), 7.28 (td, J = 7.6, 1.9 
Hz, 1H), 4.57 (d, J = 5.7 Hz, 2H). 13C NMR (151 MHz, DMSO-d6) δ 167.01, 144.05, 136.70, 
131.95, 129.15, 128.53, 127.94, 127.23, 121.59, 114.99, 40.70 [benzidazole C–H and 4° 
carbons are difficult to assign and distinguish due to N-H equilibration]. 
 
IR (thin film): 3066.86, 2978.69, 2896.97, 1618.58, 1534.99, 1470.68, 1443.28, 1411.86, 
1355.20, 1310.24, 1288.22, 1240.66, 1038.20, 744.67, 676.35; HRMS: Calculated for 











(S43). To a clean, dry pressure tube equipped with a stir bar was added benzyl (S)-2-
((tert-butoxycarbonyl)amino)hex-5-ynoate (1.03 g, 3.3 mmol, 1.0 equiv) and copper iodide 
(31.2 mg, 0.16 mmol, 0.05 equiv). The vessel was then capped with a rubber septum 
before being purged and backfilled with nitrogen three times. The solids were then dissolved 
in a dry 10% MeOH:DMF (5.9 mL DMF, 0.6 mL MeOH, 0.5 M) before azidotrimethylsilane 
(0.65 mL, 4.9 mmol, 1.5 equiv) was added slowly. The vessel was then sealed completely 
with a back seal and heated to 95 °C for 24 h. At the end of the reaction, the vessel was 
then cooled completely to room temperature before being unsealed. The mixture was 
diluted with EtOAc (30 mL). The solution was then washed with water (2 x 20 mL), 10% LiCl 
solution (20 mL), ammonium chloride solution (20 mL) and brine before being dried over 
sodium sulfate and concentrated to provide a red-brown solid. The crude product was 
purified by flash chromatography (50 to 60% EtOAc:Hex) to afford a yellow gummy solid 
(0.807 g, 69% yield). 
1H NMR (600 MHz, CDCl3) δ 7.48 (s, 1H), 7.37 – 7.30 (m, 5H), 5.38 (d, J = 8.5 Hz, 1H), 
5.21 – 5.07 (m, 2H), 4.38 (td, J = 8.9, 4.5 Hz, 1H), 2.86 – 2.74 (m, 2H), 2.17 (tt, J = 13.2, 
5.8 Hz, 1H), 1.98 (dq, J = 14.5, 7.5 Hz, 1H), 1.44 (s, 9H), [triazole NH peak not detected]. 
13C NMR (151 MHz, CDCl3) δ 172.32, 156.04, 135.16, 131.22, 128.77, 128.69, 128.59, 
128.51, 80.69, 67.51, 52.82, 50.95, 32.80, 28.41, 20.64. 
 
IR (thin film): 2975.75, 2932.55, 1688.00, 1499.57, 1366.10, 1249.25, 1212.88, 1157.52, 








B.4 Experimental Procedures: Methods for Photoredox-Catalyzed Cation Radical 
Accelerated Nucleophilic Aromatic Substitution 
B.4.1 Experimental Conditions for Reaction Optimization (Table B.1)  
To a clean, dry 1 dram vial containing a Teflon-coated magnetic stir bar was added 
0.005 mmol of catalyst (0.05 equiv), 13.6 or 27.2 mg of imidazole (0.20 or 0.40 mmol, 2 or 
4 equiv respectively). 2,4-Dichloroanisole (0.1 mmol, 1.0 equiv) was added, followed by 
solvent (5.0 mL, 0.1 M). The vial was then sealed with a Teflon-lined septum screw cap. The 
septum was pierced with a disposable steel needle connected to a drying tube containing 
positive nitrogen pressure. A vent needle was inserted and the reaction medium was 
sparged for 15 minutes by bubbling nitrogen through the mixture. The vent and sparging 
needles were removed and the vials were sealed with Teflon tape to maintain an anaerobic 
atmosphere. The vial was then placed in one of the photoreactor wells and irradiated 
bottom-up for 24 hours. The crude reaction mixture was then eluted through a silica plug 
(with ethyl acetate) and collected in a clean 20 mL scintillation vial.13.1 µL of 1,3 
dimethoxybenzene was then added as the internal standard and the sample was analyzed 
using an Agilent 5973 GC-MS system, wherein product yields and 2,4-dichloroanisole 
conversions were calculated relative to the internal standard according to the instrument 
response factors, which were determined separately by construction of calibration curves.  
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B.4.2 General Method A (Synthesis of 4 – 11, 13, 14, 16) 
To a clean, dry 2 dram vial containing a Teflon-coated magnetic stir bar was added 
0.025 mmol of catalyst A (0.05 equiv), 137.2 mg of imidazole (2.0 mmol, 4 equiv). The 
arene (0.5 mmol, 1.0 equiv) was added, followed by solvent (5.0 mL, 0.1 M). The vial was 
then sealed with a Teflon-lined septum screw cap. The septum was pierced with a 
disposable steel needle connected to a drying tube containing positive nitrogen pressure. A 
vent needle was inserted and the reaction medium was sparged for 15 minutes by bubbling 
nitrogen through the mixture. The vent needle was removed and the positive nitrogen 
pressure was maintained. The vial was positioned on a stir plate approximately 3-4 cm from 
a Par38 LED lamp supplying blue light (λ = 440-460 nm) and irradiated for a designated 
time. The crude reaction mixture was then concentrated in vacuo and purified by column 
chromatography on silica gel with hexanes/ethyl acetate (or with the eluent noted for each 
substrate). 
B.4.3 General Method B (Synthesis of 12, 15, 17 – 35, 49 – 51) 
To a clean, dry 1 dram vial containing a Teflon-coated magnetic stir bar was added 
0.0125 mmol of catalyst A (0.05 equiv), 68.1 mg of imidazole (1.0 mmol, 4 equiv). The 
arene (0.25 mmol, 1.0 equiv) was added, followed by solvent (2.5 mL, 0.1 M). The vial was 
then sealed with a Teflon-lined septum screw cap. The septum was pierced with a 
disposable steel needle connected to a drying tube containing positive nitrogen pressure. A 
vent needle was inserted and the reaction medium was sparged for 15 minutes by bubbling 
nitrogen through the mixture. The vent needle was removed and the positive nitrogen 
pressure was maintained. The vial was positioned on a stir plate approximately 3-4 cm from 
a Par38 LED lamp supplying blue light (λ = 440-460 nm) and irradiated for a designated 
time. The crude reaction mixture was then concentrated in vacuo and purified by column 




B.4.4 General Method C (Synthesis of 36 – 48) 
Note: brackets designate respective equivalents for a 0.5 mmol reaction scale. To a 
clean, dry 1 [2] dram vial containing a Teflon-coated magnetic stir bar was added 0.0125 
[0.025] mmol of catalyst A (0.05 equiv), nucleophile (1.0 mmol [2.0 mmol], 4 equiv unless 
noted otherwise). 2,4-Dichloroanisole (0.25 mmol [0.50 mmol], 1.0 equiv) was added, 
followed by solvent (2.5 mL [5.0 mL], 0.1 M). The vial was then sealed with a Teflon-lined 
septum screw cap. The septum was pierced with a disposable steel needle connected to a 
drying tube containing positive nitrogen pressure. A vent needle was inserted and the 
reaction medium was sparged for 15 minutes by bubbling nitrogen through the mixture. The 
vent needle was removed and the positive nitrogen pressure was maintained. The vial was 
positioned on a stir plate approximately 3-4 cm from a Par38 LED lamp supplying blue light 
(λ = 440-460 nm) and irradiated for a designated time. The crude reaction mixture was 
then concentrated in vacuo and purified by column chromatography on silica gel with 
hexanes/ethyl acetate (or with the eluent noted for each substrate). 
 
 
1-(2,4-Dichlorophenyl)-1H-imidazole (4.4). The title compound was prepared from S1 
according to General Method A with an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (50% EtOAc/hexanes) to afford a tan solid 
in 79% yield. The NMR data were consistent with literature values30. 
1H NMR (600 MHz, CDCl3) δ 7.63 (s, 1H), 7.53 (d, J = 2.3 Hz, 1H), 7.33 (dd, J = 8.5, 2.3 
Hz, 1H), 7.25 (d, J = 8.4 Hz, 1H), 7.16 (s, 1H), 7.09 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 









1-(4-Bromo-2-chlorophenyl)-1H-imidazole (4.5). The title compound was prepared 
from S2 according to General Method A with an irradiation time of 24 hours. The crude 
residue was purified by column chromatography on silica gel (50% EtOAc/hexanes) to 
afford a white solid in 57% yield.  
1H NMR (600 MHz, CDCl3) δ 7.70 (d, J = 2.2 Hz, 1H), 7.65 (s, 1H), 7.50 (dd, J = 8.4, 2.1 
Hz, 1H), 7.20 (d, J = 8.5 Hz, 1H), 7.19 (s, 1H), 7.11 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 
137.45, 134.31, 133.55, 131.19, 130.96, 129.80, 128.73, 122.65, 120.39. 
 
IR (thin film): 3150.61, 3095.21, 3058.04, 3023.10, 1498.65, 1388.48, 1265.83, 1239.88, 
1071.29, 1050.75, 956.53, 827.71, 779.50, 734.58, 656.76, 559.44, 499.81; LRMS: 
Calculated for (M)+: 225.94; found: 225.90. 
 
 
1-(2-Bromo-4-chlorophenyl)-1H-imidazole (4.6). The title compound was prepared 
from 2-bromo-4-chloroanisole according to General Method A with an irradiation time of 24 
hours. The crude residue was purified by column chromatography on silica gel (50% 
EtOAc/hexanes) to afford a yellow-tan solid in 82% yield.  
1H NMR (600 MHz, CDCl3) δ 7.72 (d, J = 2.3 Hz, 1H), 7.62 (s, 1H), 7.39 (dd, J = 8.4, 2.3 
Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 7.18 (s, 1H), 7.08 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 













IR (thin film): 3058.74, 3094.07, 3022.32, 1498.33, 1386.33, 1304.76, 1265.20, 1238.73, 
1064.91, 1044.02, 868.30, 828.23, 778.94, 733.81, 655.02, 560.34, 528.44; HRMS: 
Calculated for (M+H)+: 256.9476; found: 256.9470 
 
 
1-(2-Chloro-4-fluorophenyl)-1H-imidazole (4.7) and 1-(3-chloro-4-
methoxyphenyl)-1H-imidazole (4.7a). The title compounds were prepared from 2-
chloro-4-fluoroanisole according to General Method A with an irradiation time of 24 hours. 
The crude residue was purified by column chromatography on silica gel (80% 
EtOAc/hexanes to EtOAc) to afford 4.7 as an off-white solid in 30% yield and the byproduct 
4.7a as a pale orange solid in 26% yield.  
 
4.7. 1H NMR (600 MHz, CDCl3) δ 7.64 (s, 1H), 7.33 (dd, J = 8.8, 5.4 Hz, 1H), 7.29 (dd, J = 
8.1, 2.8 Hz, 1H), 7.19 (s, 1H), 7.13 – 7.06 (m, 2H). 13C NMR (151 MHz, CDCl3) δ 161.98 
(d, J = 252.7 Hz), 137.71, 131.63 (d, J = 3.7 Hz), 131.44 (d, J = 11.0 Hz), 129.65, 129.03 
(d, J = 9.4 Hz), 120.69, 118.20 (d, J = 25.9 Hz), 115.15 (d, J = 22.5 Hz). 19F NMR (376 
MHz, CDCl3) δ -109.78. 
 
IR (thin film): 3106.41, 3068.05, 3026.29, 2925.23, 1508.99, 1485.73, 1301.21, 1272.29, 
1249.17, 1202.98, 1111.64, 1064.89, 1043.70, 966.26, 891.67, 863.80, 846.50, 832.09, 











4.7a. 1H NMR (600 MHz, CDCl3) δ 7.77 (s, 1H), 7.42 (d, J = 2.6 Hz, 1H), 7.25 (dd, J = 8.8 
Hz, 2.6 Hz, 1H), 7.21 - 7.16 (m, 2H), 7.00 (d, J = 8.8 Hz, 1H), 3.94 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 154.58, 135.84, 130.92, 130.35, 124.14, 123.59, 121.28, 118.74, 112.65, 
56.59. 
 
IR (thin film): 3116.28, 2937.71, 2840.59, 1506.81, 1460.05, 1440.81, 1285.13, 1247.21, 





trifluoroethoxy)-phenyl)-1H-imidazole (4.8a) and 1-(5-chloro-2-methoxyphenyl)-
1H-imidazole (4.8b). 
The title compounds were prepared from S3 according to General Method A with an 
irradiation time of 24 hours. The crude residue was purified by column chromatography on 
silica gel (60 to 80% EtOAc/hexanes) to afford 4.8 as an tan-white solid in 56% yield, the 
byproduct 4.8a as a off-white solid in 6% yield and the byproduct 4.8b as a yellow solid 
alongside 4.8 in 5% yield. The yield for 4.8b was determined by 1H NMR of the isolated 
mixture of 4.8 and 4.8b (2.3:1 ratio of 4.8b to 4.8). The spectra for 4.8b matches S34. 
 
4.8. 1H NMR (600 MHz, CDCl3) δ 7.79 (s, 1H), 7.33 (t, J = 8.5 Hz, 1H), 7.30 (dd, J = 10.3, 
2.2 Hz, 1H), 7.25 (ddd, J = 8.6, 2.3, 1.1 Hz, 1H), 7.23 – 7.19 (m, 2H). 13C NMR (151 MHz, 












1.2 Hz), 125.62 (d, J = 3.9 Hz), 124.37 (d, J = 11.6 Hz), 119.59, 118.14 (d, J = 23.3 Hz). 
19F NMR (376 MHz, CDCl3) δ -121.20.  
 
IR (thin film): 3104.18, 3082.39, 3033.72, 3016.83, 1510.23, 1416.94, 1307.20, 1278.96, 
1258.01, 1221.62, 1059.85, 961.63, 885.21, 865.11, 848.33, 829.88, 735.69, 654.27, 
559.86; LRMS: Calculated for (M)+: 196.02; found: 196.00. 
 
4.8a. 1H NMR (600 MHz, CDCl3) δ 7.77 (s, 1H), 7.29 (d, J = 8.4 Hz, 1H), 7.20 (m, 2H), 
7.17 (dd, J = 8.4, 2.1 Hz, 1H), 7.06 (d, J = 2.1 Hz, 1H), 4.35 (q, JHF = 7.8 Hz, 2H). 13C 
NMR (151 MHz, CDCl3) δ 150.65, 137.56, 134.51, 129.67, 126.92, 126.15, 123.64, 
120.22, 115.08, 66.67 (q, J = 36.5 Hz). 19F NMR (376 MHz, CDCl3) δ -73.70. 
 
IR (thin film): 3019.33, 2950.99, 2923.05, 2852.57, 1517.07, 1289.32, 1259.45, 1232.07, 
1156.97, 1134.13, 1052.82, 960.67, 900.15, 810.25, 739.14, 658.18; LRMS: Calculated 
for (M)+: 276.03; found: 275.90. 
 
4.8b. 1H NMR (600 MHz, CDCl3) δ 7.80 (s, 1H), 7.32 (dd, J = 8.8, 2.5 Hz, 1H), 7.29 (d, J = 
2.6 Hz, 1H), 7.19 (s, 1H), 7.18 (s, 1H), 6.98 (d, J = 8.8 Hz, 1H), 3.84 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 151.33, 137.83, 129.22, 128.66, 127.36, 125.89, 125.54, 120.16, 
113.50, 56.30.  
 





1-(4-(tert-Butyl)-2-chlorophenyl)-1H-imidazole (4.9). The title compound was 
prepared from S4 according to General Method A with an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (40% EtOAc/hexanes) to 
afford a yellow solid in 87% yield.  
1H NMR (600 MHz, CDCl3) δ 7.66 (s, 1H), 7.53 (d, J = 2.1 Hz, 1H), 7.37 (dd, J = 8.3, 2.1 
Hz, 1H), 7.25 (d, J = 8.3 Hz, 1H), 7.18 (s, 1H), 7.13 (s, 1H), 1.34 (s, 9H). 13C NMR (151 
MHz, CDCl3) δ 153.63, 137.71, 132.49, 129.47, 129.36, 127.92, 127.26, 125.00, 120.64, 
77.16, 35.01, 31.20. 
 
IR (thin film): 3098.28, 3061.38, 2959.54, 2903.11, 2868.35, 1511.12, 1460.35, 1391.27, 
1364.86, 1308.21, 1113.54, 1070.55, 1049.01, 903.39, 827.20, 816.44, 780.84, 659.87, 
627.95; LRMS: Calculated for (M)+: 234.09; found: 234.10. 
 
 
1-(3-Chloro-[1,1'-biphenyl]-4-yl)-1H-imidazole (4.10). The title compound was 
prepared from S5 according to General Method A with an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (40% EtOAc/hexanes) to 











1H NMR (600 MHz, CDCl3) δ 7.76 (d, J = 2.0 Hz, 1H), 7.73 (s, 1H), 7.59-7.57 (m, 2H), 
7.57 (dd, J = 8.1, 2.1 Hz, 1H), 7.50-7.46 (m, 2H), 7.45-7.39 (m, 1H), 7.39 (d, J = 8.1 Hz, 
1H), 7.23 (s, 1H), 7.19 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 143.07, 138.51, 137.66, 
133.99, 130.11, 129.56, 129.34, 129.20, 128.56, 127.89, 127.16, 126.47, 120.59. 
 
IR (thin film): 3102.41, 3064.98, 3033.59, 1522.50, 1495.05, 1478.61, 1246.98, 1069.60, 




1-(4-chlorophenyl)-1H-imidazole (4.11). The title compound was prepared from 4-
chloro-anisole according to General Method A with an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (50% EtOAc/hexanes) to 
afford a yellow solid in 93% yield. The NMR data were consistent with literature values31. 
1H NMR (600 MHz, CDCl3) δ 7.79 (s, 1H), 7.41 (d, J = 8.7 Hz, 2H), 7.29 (d, J = 8.7 Hz, 
2H), 7.21 (s, 0H), 7.17 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 135.86, 135.51, 133.13, 
130.72, 130.02, 122.67, 118.18. 
 
 
1-(2-Chlorophenyl)-1H-imidazole (4.12). The title compound was prepared from 2-










crude residue was purified by column chromatography on silica gel (50 to 70% 
EtOAc/hexanes) to afford a pale yellow oil in 64% yield. 1H NMR (600 MHz, CDCl3) δ 7.70 
(s, 1H), 7.59 – 7.52 (m, 1H), 7.38 (m, 2H), 7.38-7.32 (m, 1H), 7.21 (s, 1H), 7.16 (s, 1H). 
13C NMR (151 MHz, CDCl3) δ 137.69, 135.24, 130.99, 130.01, 129.80, 129.55, 127.97, 
127.81, 120.63. 
 
IR (thin film): 3113.49, 1499.42, 1439.94, 1305.07, 1239.90, 1104.11, 1067.51, 1051.01, 




1-Phenyl-1H-imidazole (13). The title compound was prepared from anisole according to 
General Method A with an irradiation time of 24 hours. The crude residue was purified by 
column chromatography on silica gel (80% EtOAc/hexanes) to afford a yellow solid in 39% 
yield. The NMR data were consistent with literature values32. 
 
1H NMR (600 MHz, CDCl3) δ 7.86 (s, 1H), 7.51 – 7.46 (m, 2H), 7.42 – 7.35 (m, 3H), 7.29 
(s, 1H), 7.21 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 137.47, 135.72, 130.53, 130.02, 








1-(1-Chloronaphthalen-2-yl)-1H-imidazole (4.14). The title compound was prepared 
from S6 according to General Method A with an irradiation time of 24 hours. The crude 
residue was purified by column chromatography on silica gel (60% EtOAc/hexanes) to 
afford an orange-light brown solid in 52% yield. 
1H NMR (600 MHz, CDCl3) δ 8.38 (dd, J = 8.5, 1.0 Hz, 1H), 7.93 (d, J = 8.2 Hz, 1H), 7.88 
(d, J = 8.6 Hz, 1H), 7.80 (s, 1H), 7.71 (ddd, J = 8.4, 6.9, 1.3 Hz, 1H), 7.64 (ddd, J = 8.2, 
6.9, 1.2 Hz, 1H), 7.42 (d, J = 8.6 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H). 13C NMR (151 MHz, 
CDCl3) δ 138.06, 133.70, 132.56, 131.28, 129.58, 128.48, 128.41, 128.28, 127.80, 
127.44, 125.29, 124.63, 120.83. 
 
IR (thin film): 3101.87, 2976.95, 1702.45, 1494.72, 1246.19, 1162.84, 1064.74, 1015.76, 
808.27, 751.02, 658.45, 535.78; LRMS: Calculated for (M)+: 228.05; found: 228.00. 
 
 
2-(1H-Imidazol-1-yl)-1-naphthonitrile (4.15). The title compound was prepared from 
S7 according to a modified General Method B with 0.10 equiv of catalyst A and an 
irradiation time of 24 hours. The crude residue was purified by column chromatography on 








1H NMR (600 MHz, CDCl3) δ 8.30 (dd, J = 8.4, 1.0 Hz, 1H), 8.20 (d, J = 8.7 Hz, 1H), 8.02 -
7.96 (m, 2H), 7.80 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H), 7.70 (ddd, J = 8.1, 6.9, 1.1 Hz, 1H), 
7.52 (d, J = 8.8 Hz, 1H), 7.47 (s, 1H), 7.31 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 139.32, 
137.09, 135.05, 132.98, 131.77, 130.97, 130.20, 128.82, 128.36, 125.71, 122.55, 119.91, 
115.10, 104.24. 
 
IR (thin film): 3099.78, 3073.38, 2922.14, 2220.56, 1592.70, 1493.39, 1464.89, 1297.82, 
1271.62, 1250.98, 1107.02, 1074.37, 1050.82, 1026.70, 990.69, 823.17, 744.98, 733.31, 
656.28, 450.63; HRMS: Calculated for (M+H)+: 220.0869; found: 220.0870. 
 
 
1-(2,4-Dichlorophenyl)-1H-imidazole (4.16). The title compound was prepared from 
S8 according to General Method A with an irradiation time of 24 hours. The crude residue 
was purified by column chromatography on silica gel (50% EtOAc/hexanes) to afford a tan-
brown solid in 79% yield. The NMR data were consistent with literature values30 and the 
values for 4.8. 
 
1H NMR (600 MHz, CDCl3) δ 7.65 (s, 1H), 7.55 (d, J = 2.3 Hz, 1H), 7.35 (dd, J = 8.5, 2.3 
Hz, 1H), 7.27 (d, J = 8.5 Hz, 1H), 7.19 (s, 1H), 7.11 (s, 1H). 13C NMR (151 MHz, CDCl3) δ 










Methyl 4-(1H-imidazol-1-yl)-3-methoxybenzoate (4.17a) and methyl 3-(1H-
imidazol-1-yl)-4-methoxybenzoate (4.17b). The title compounds were prepared from 
S9 according to General Method B with an irradiation time of 24 hours. The crude residue 
was purified by column chromatography on silica gel (80% EtOAc/hexanes to EtOAc) to 
afford a tan solid in 92% yield as an inseparable mixture of 4.17a and 4.17b. The 4.17a: 
4.17b ratio of the inseparable mixture was 7:1 as determined by 1H NMR of the isolated 
product. 
 
4.17a. 1H NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 7.74 – 7.69 (m, 2H), 7.33 (d, J = 8.6 Hz, 
1H), 7.25 (s, 1H), 7.17 (s, 1H), 3.93 (s, 3H), 3.91 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 
166.15, 152.02, 137.75, 130.30, 130.29, 129.35, 124.77, 122.71, 119.93, 113.44, 56.22, 
52.60. 
 
4.17b. 1H NMR (600 MHz, CDCl3) δ 8.04 (dd, J = 8.7, 2.1 Hz, 1H), 7.96 (d, J = 2.1 Hz, 
1H), 7.79 (s, 1H), 7.20 (d, J = 1.3 Hz, 1H), 7.17 (s, 1H), 7.07 (d, J = 8.7 Hz, 1H), 3.91 (s, 
3H), 3.89 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 165.93, 156.21, 137.82, 130.89,129.19, 
126.94, 126.43, 123.18, 120.21, 111.82, 56.27, 52.36. 
 
IR (thin film): 3142.51, 3111.88, 2965.63, 2946.45, 2921.75, 1706.73, 1517.12, 1451.74, 
1438.55, 1414.64, 1327.30, 1310.66, 1291.76, 1258.11, 1233.95, 1179.36, 1113.69, 
1097.62, 1057.05, 1029.61, 977.47, 878.06, 808.47, 759.90, 752.73, 724.80, 649.19; 














4-(1H-Imidazol-1-yl)-3-methoxybenzonitrile (4.18a) and 3-(1H-imidazol-1-yl)-4-
methoxybenzonitrile (4.18b). The title compounds were prepared from 3,4-dimethoxy-
benzonitrile according to General Method B with an irradiation time of 24 hours. The crude 
residue was purified by column chromatography on silica gel (80% EtOAc/hexanes to 
EtOAc) to afford a tan solid in 99% yield as an inseparable mixture of 4.18a and 4.18b. 
The 4.18a: 4.18b ratio of the inseparable mixture was 17:1 as determined by 1H NMR of 
the isolated product. The 1H and 13C spectra for 4.18b are not reported due to its low 
partial yield, but its peaks are labeled in the 1H and 13C spectra of the mixture. 
 
4.18a. 1H NMR (600 MHz, CDCl3) δ 7.86 (s, 1H), 7.39 (d, J = 8.1 Hz, 1H), 7.36 (dd, J = 
8.1, 1.6 Hz, 1H), 7.30 (d, J = 1.6 Hz, 1H), 7.24 (s, 1H), 7.18 (s, 1H), 3.91 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 152.41, 137.61, 130.54, 129.69, 125.59, 125.52, 119.77, 
118.04, 115.79, 112.14, 56.46. 
 
IR (thin film): 3106.45, 3033.09, 2981.39, 2918.47, 2851.44, 2228.05, 1518.72, 
1511.47, 1482.78, 1461.36, 1411.26, 1307.35, 1290.88, 1278.17, 1252.83, 1168.36, 
1111.17, 1094.33, 1051.54, 1026.24, 959.95, 904.94, 827.70, 749.54, 657.88, 626.60, 













4-(1H-Imidazol-1-yl)-3-methoxyphenyl trifluoromethanesulfonate (4.19a) and 3-
(1H-imidazol-1-yl)-4-methoxyphenyl trifluoromethanesulfonate (4.19b). The title 
compounds were prepared from S10 according to General Method B with an irradiation 
time of 24 hours. The crude residue was purified by column chromatography on silica gel 
(80% EtOAc/hexanes to EtOAc) to afford a red solid in 76% yield as an inseparable mixture 
of 4.19a and 4.19b. The 4.19a: 4.19b ratio of the inseparable mixture was 2:1 as 
determined by 1H NMR of the isolated product. 
 
4.19a. 1H NMR (600 MHz, CDCl3) δ 7.79 (s, 1H), 7.35 (d, J = 8.5 Hz, 1H), 7.18 – 7.17 (m, 
2H), 6.97 (dd, J = 8.5, 2.6 Hz, 1H), 6.95 (d, J = 2.6 Hz, 1H), 3.88 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 153.76, 149.00, 137.68, 129.24, 126.54, 120.20, 118.76 (q, J = 320.8 Hz), 
113.64, 113.14, 106.40, 56.51.19F NMR (376 MHz, CDCl3) δ -72.62. 
 
4.19b. 1H NMR (600 MHz, CDCl3) δ 7.82 (s, 1H), 7.28 (dd, J = 9.1, 3.0 Hz, 1H), 7.23 (d, J 
= 3.0 Hz, 1H), 7.21 – 7.16 (m, 2H), 7.09 (d, J = 9.1 Hz, 1H), 3.88 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 152.24, 142.36, 137.69, 129.43, 127.32, 126.59, 121.54, 120.02, 118.80, 
56.49, [CF3 quartet not observable]. 19F NMR (376 MHz, CDCl3) δ -72.57. 
 
IR (thin film): 3139.88, 3110.06, 3018.82, 2947.27, 1510.06, 1415.19, 1239.30, 1199.08, 
1132.70, 1107.44, 1095.83, 1055.41, 1022.15, 944.79, 888.31, 842.55, 825.33, 812.09, 
660.53, 618.31, 596.27, 572.42, 507.25; LRMS: Calculated for (M)+: 322.02; found: 

















3-(1H-Imidazol-1-yl)-4-methoxybenzaldehyde (4.20a) and 4-(1H-imidazol-1-yl)-3-
methoxybenzaldehyde (4.20b). The title compounds were prepared from 3,4-dimethoxy-
benzaldehyde according to a modified General Method B with 0.10 equiv of catalyst A and 
an irradiation time of 24 hours. The crude residue was purified by column chromatography 
on silica gel (EtOAc to 5% MeOH/EtOAc) to afford a yellow-green solid in 44% yield as an 
inseparable mixture of 4.20a and 4.20b. The 4.20a: 4.20b ratio of the inseparable 
mixture was 8:1 as determined by 1H NMR of the isolated product. The NMR data were 
consistent with literature values33. 
 
4.20a. 1H NMR (600 MHz, CDCl3) δ 9.93 (s, 1H), 7.90 (dd, J = 8.5, 2.0 Hz, 1H), 7.83 (d, J 
= 2.0 Hz, 1H), 7.82 (s, 1H), 7.22 (s, 1H), 7.20 – 7.17 (m, 2H), 3.96 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 189.93, 157.47, 137.83, 131.79, 130.18,129.43, 127.45, 126.07, 120.18, 
112.38, 56.54. 
 
4.20b. 1H NMR (600 MHz, CDCl3) δ 10.01 (s, 1H), 7.91 (s, 1H), 7.59 (d, J = 1.6 Hz, 1H), 
7.56 (dd, J = 7.9, 1.7 Hz, 1H), 7.47 (d, J = 7.9 Hz, 1H), 7.28 (s, 1H), 7.19 (s, 1H), 3.96 (s, 
3H). 13C NMR (151 MHz, CDCl3) δ 190.92, 152.83, 136.35, 131.72, 129.60, 125.30, 
124.69, 119.93, 111.19, 56.35 [one 13C peak not observable]. 
 















Methyl 3-(benzyloxy)-4-(1H-imidazol-1-yl)benzoate (4.21). The title compound was 
prepared from S11 according to General Method B with an irradiation time of 24 hours. 
The crude residue was purified by column chromatography on silica gel (70% 
EtOAc/hexanes to EtOAc) to afford a pink-beige solid in 80% yield. 
1H NMR (600 MHz, CDCl3) δ 7.90 (s, 1H), 7.83 (d, J = 1.8 Hz, 1H), 7.74 (dd, J = 8.1, 1.7 
Hz, 1H), 7.41- 7.29 (m, 6H), 7.28 (s, 1H), 7.17 (s, 1H), 5.18 (s, 2H), 3.94 (s, 3H). 13C 
NMR (151 MHz, CDCl3) δ 166.08, 151.04, 137.71, 135.48, 130.76, 130.26, 129.40, 128.83, 
128.42, 127.33, 124.90, 123.09, 120.01, 115.09, 71.20, 52.62. 
 
IR (thin film): 3112.01, 3032.02, 2953.47, 2919.89, 1705.08, 1523.83, 1434.99, 1422.89, 
1329.00, 1294.65, 1282.94, 1232.10, 1189.53, 1114.13, 1092.37, 1050.68, 1039.65, 
1027.81, 989.08, 902.23, 877.30, 831.26, 764.86, 730.44, 693.00, 658.42, 463.92; 
HRMS: Calculated for (M+H)+: 309.1234; found: 309.1223. 
 
 
Methyl 4-(1H-imidazol-1-yl)-3-((triisopropylsilyl)oxy)benzoate (4.22). The title 
compound was prepared from S12 according to General Method B with an irradiation time 
of 24 hours. The crude residue was purified by column chromatography on silica gel (80% 
















1H NMR (600 MHz, CDCl3) δ 7.79 (s, 1H), 7.71-7.65 (m, 2H), 7.31 (d, J = 8.0 Hz, 1H), 
7.20 (s, 1H), 7.16 (s, 1H), 3.93 (s, 3H), 1.22 (hept, J = 7.5 Hz, 3H), 1.00 (d, J = 7.7 Hz, 
18H). 13C NMR (151 MHz, CDCl3) δ 166.11, 149.40, 137.54, 132.35, 130.49, 129.35, 
125.82, 122.86, 121.32, 120.07, 52.61, 17.82, 12.87. 
 
IR (thin film): 3113.72, 2947.39, 2893.17, 2866.18, 1719.24, 1518.70, 1435.88, 1422.59, 
1292.91, 1228.71, 1105.18, 1054.20, 994.87, 922.53, 881.99, 824.11, 812.01, 762.65, 
740.05, 672.90, 653.15; HRMS: Calculated for (M+H)+: 375.2099; found: 375.2081. 
 
 
3-(Benzyloxy)-4-(1H-imidazol-1-yl)phenyl trifluoromethanesulfonate (4.23). The 
title compound was prepared from S14 according to a modified General Method B with a 
9:1 DCE:TFE solvent system and an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (80% EtOAc/hexanes) to afford a tan-beige 
solid in 76% yield. 
 
1H NMR (600 MHz, CDCl3) δ 7.80 (s, 1H), 7.39 – 7.31 (m, 5H), 7.30 (s, 1H), 7.30 (d, J = 
8.1 Hz, 1H), 7.21 (s, 1H), 7.18 (s, 1H), 7.03 (d, J = 2.6 Hz, 1H), 6.99 (dd, J = 8.6, 2.6 Hz, 
1H), 5.13 (s, 2H). 13C NMR (151 MHz, CDCl3) δ 152.69, 148.81, 137.69, 134.75, 129.55, 
128.99, 128.72, 127.27, 127.18, 126.63, 120.23, 118.77 (q, J = 321.1 Hz). 114.12, 










IR (thin film): 3134.55, 3111.99, 3044.51, 3029.34, 2923.77, 2853.72, 1519.49, 1508.95, 
1417.23, 1400.37, 1236.35, 1202.29, 1128.87, 1104.50, 1096.75, 1052.55, 1036.88, 
1027.27, 963.91, 874.84, 851.40, 819.75, 726.04, 692.99, 659.86, 631.25, 609.91, 
597.11, 509.93; HRMS: Calculated for (M+H)+: 399.0626; found: 399.0618. 
 
 
3-(1H-Imidazol-1-yl)-4-methoxybenzaldehyde (4.24). The title compound was 
prepared from S15 according to a modified General Method B with 0.10 equiv of catalyst 
A and an irradiation time of 24 hours. The crude residue was purified by column 
chromatography on silica gel (80% EtOAc/hexanes to EtOAc) to afford a yellow-green solid 
in 60% yield. The NMR data were consistent with literature values33. 
1H NMR (600 MHz, CDCl3) δ 9.94 (s, 1H), 7.90 (dd, J = 8.5, 2.0 Hz, 1H), 7.84 (d, J = 2.0 
Hz, 1H), 7.83 (s, 1H), 7.23 (t, J = 1.3 Hz, 1H), 7.21 – 7.18 (m, 2H), 3.97 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 189.98, 157.45, 137.83, 131.82, 130.14, 129.45, 127.43, 126.07, 
120.18, 112.36, 56.55. 
 
 
4-(Benzyloxy)-3-(1H-imidazol-1-yl)benzaldehyde (4.25). The title compound was 
prepared from S16 according to a modified General Method B with 0.10 equiv of catalyst 














chromatography on silica gel (80% EtOAc/hexanes to EtOAc) to afford a yellow solid in 60% 
yield. 
1H NMR (600 MHz, CDCl3) δ 9.92 (s, 1H), 7.89 - 7.82 (m, 3H), 7.41 - 7.29 (m, 5H), 7.29 - 
7.22 (m, 2H), 7.19 (s, 1H), 5.24 (s, 2H). 13C NMR (151 MHz, CDCl3) δ 189.94, 156.41, 
137.78, 134.98, 131.63, 130.31, 129.49, 129.00, 128.67, 127.77, 127.14, 126.17, 120.22, 
113.81, 71.30. 
 
IR (thin film): 3114.93, 3064.89, 3032.61, 3014.62, 2916.77, 2835.06, 2735.48, 1687.53, 
1601.03, 1508.28, 1486.37, 1453.40, 1304.95, 1269.67, 1252.61, 1240.18, 1183.42, 
1141.98, 1105.36, 1091.91, 1054.10, 1033.86, 1016.53, 993.74, 814.78, 731.42, 717.68, 
694.97, 657.06, 624.02; HRMS: Calculated for (M+H)+: 279.1128; found: 279.1119. 
 
 
1-(4-(Benzyloxy)-3-(1H-imidazol-1-yl)phenyl)ethan-1-one (4.26) and 1-(4-(1H-
imidazol-1-yl)-3-methoxyphenyl)ethan-1-one (4.27). The title compounds were 
prepared from S17 according to a modified General Method B with 0.10 equiv of catalyst 
A and an irradiation time of 24 hours. The crude residue was purified by column 
chromatography on silica gel (EtOAc to 5% MeOH/EtOAc) to afford 4.26 as a pale yellow-
orange solid in 39% yield and 4.27 as a pale yellow-orange solid in 45% yield. 
 
4.26. 1H NMR (600 MHz, CDCl3) δ 7.97 – 7.91 (m, 2H), 7.84 (s, 1H), 7.40 – 7.29 (m, 5H), 
7.25 (s, 1H), 7.19 (s, 1H), 7.16 (d, J = 9.1 Hz, 1H), 5.21 (s, 2H), 2.58 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 195.91, 155.41, 137.83, 135.23, 130.86, 129.81, 129.37, 128.95, 












IR (thin film): 3132.96, 3114.58, 2946.29, 2923.59, 1670.40, 1598.61, 1516.85, 1504.83, 
1477.78, 1435.75, 1304.25, 1250.85, 1237.98, 1159.99, 1078.74, 1053.23, 984.13, 
959.87, 907.61, 823.16, 809.49, 732.49, 696.59, 657.51, 641.80, 609.26, 554.82; HRMS: 
Calculated for (M+H)+: 293.1285; found: 293.1284. 
 
4.27. 1H NMR (600 MHz, CDCl3) δ 7.89 (s, 1H), 7.68 (d, J = 1.8 Hz, 1H), 7.63 (dd, J = 8.1, 
1.8 Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.27 (s, 1H), 7.19 (s, 1H), 3.94 (s, 3H), 2.64 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 196.87, 152.39, 137.80, 137.15, 130.58, 129.50, 124.83, 
122.11, 119.97, 111.53, 56.25, 26.80. 
 
IR (thin film): 3127.82, 3099.02, 2950.80, 2924.54, 1679.34, 1596.92, 1514.08, 1484.40, 
1467.56, 1449.36, 1410.00, 1370.07, 1306.35, 1283.41, 1269.08, 1255.72, 1241.17, 
1221.00, 1177.57, 1149.04, 1108.93, 1055.97, 1023.87, 958.05, 903.69, 884.33, 820.98, 
743.19, 705.42, 656.54, 645.86, 636.55, 624.07, 567.96, 549.15; HRMS: Calculated for 
(M+H)+: 217.0972; found: 217.0973. 
 
 
1-(3-(Benzyloxy)-4-(1H-imidazol-1-yl)phenyl)ethan-1-one (4.28) and 1-(3-(1H-
imidazol-1-yl)-4-methoxyphenyl)ethan-1-one (4.29). The title compounds were 
prepared from S18 according to a modified General Method B with 0.10 equiv of catalyst 













chromatography on silica gel (EtOAc to 5% MeOH/EtOAc) to afford 4.28 as a pale yellow-
orange solid in 42% yield and 4.29 as a pale yellow-orange solid in 39% yield. 
 
4.28. 1H NMR (600 MHz, CDCl3) δ 7.92 (s, 1H), 7.77 (d, J = 1.8 Hz, 1H), 7.64 (dd, J = 8.1, 
1.8 Hz, 1H), 7.40 (d, J = 8.1 Hz, 1H), 7.39 – 7.32 (m, 5H), 7.30 (s, 1H), 7.18 (s, 1H), 5.20 
(s, 2H), 2.63 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 196.77, 151.36, 137.76, 137.06, 
135.52, 130.99, 129.52, 128.90, 128.49, 127.38, 124.98, 122.42, 120.05, 113.26, 71.22, 
26.79. 
 
IR (thin film): 3120.01, 3063.76, 3035.24, 2923.45, 2853.76, 1681.81, 1582.55, 1518.83, 
1478.87, 1413.88, 1366.32, 1299.29, 1277.31, 1250.65, 1221.02, 1137.60, 1107.33, 
1077.05, 1054.75, 1037.56, 1028.97, 955.68, 901.06, 826.72, 726.11, 693.25, 661.07, 
642.85, 606.15; HRMS: Calculated for (M+H)+: 293.1285; found: 293.1290. 
 
4.29. 1H NMR (600 MHz, CDCl3) δ 7.98 (dd, J = 8.6, 2.2 Hz, 1H), 7.91 (d, J = 2.2 Hz, 1H), 
7.80 (s, 1H), 7.22 (d, J = 1.3 Hz, 1H), 7.18 (s, 1H), 7.10 (d, J = 8.6 Hz, 1H), 3.93 (s, 3H), 
2.59 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 195.96, 156.45, 137.87, 130.61, 129.96, 
129.29, 126.71, 125.81, 120.27, 111.81, 56.37, 26.51. 
 
IR (thin film): 3110.83, 3023.04, 2954.24, 2922.53, 2848.72, 1673.38, 1604.48, 1583.88, 
1522.37, 1510.40, 1491.12, 1368.58, 1307.52, 1276.99, 1264.39, 1238.36, 1183.45, 
1140.96, 1105.28, 1058.77, 1008.14, 982.48, 963.10, 906.08, 824.41, 815.95, 717.37, 




4-Chloro-7-(1H-imidazol-1-yl)-6-methoxyquinoline (4.30). The title compound was 
prepared from S19 according to General Method B with an irradiation time of 24 hours. 
The crude residue was purified by column chromatography on silica gel (EtOAc to 10% 
MeOH/EtOAc) to afford an off-white solid in 99% yield. 
1H NMR (600 MHz, CDCl3) δ 8.73 (d, J = 4.8 Hz, 1H), 8.08 (s, 1H), 7.91 (s, 1H), 7.59 (s, 
1H), 7.41 (d, J = 4.8 Hz, 1H), 7.33 (s, 1H), 7.22 (s, 1H), 4.01 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 154.62, 151.00, 149.48, 142.27, 138.04, 129.50, 128.92, 121.36, 120.60, 
120.33, 119.99, 109.68, 56.48. 
 
IR (thin film): 3115.26, 3019.76, 2919.55, 2850.11, 1625.63, 1556.23, 1506.63, 1448.52, 
1421.44, 1337.06, 1296.41, 1258.37, 1234.97, 1188.84, 1161.55, 1107.75, 1058.41, 
1049.32, 1014.53, 968.96, 932.18, 903.61, 843.86, 829.94, 727.67, 684.34, 657.10, 
472.03; HRMS: Calculated for (M+H)+: 260.0585; found: 260.0585. 
 
 
7-(1H-Imidazol-1-yl)-6-methoxyisoquinoline (4.31). The title compound was prepared 
from S20 according to General Method B with an irradiation time of 24 hours. The crude 
residue was purified by column chromatography on silica gel (EtOAc to 10% MeOH/EtOAc) 
to afford a pale, tan solid in 97% yield. 
1H NMR (600 MHz, CDCl3) δ 9.14 (s, 1H), 8.51 (d, J = 5.7 Hz, 1H), 7.87 (s, 1H), 7.85 (s, 










NMR (151 MHz, CDCl3) δ 154.63, 151.67, 144.36, 137.99, 136.51, 129.38, 128.66, 
123.90, 123.75, 120.59, 119.42, 105.82, 56.31. 
 
IR (thin film): 3104.49, 3021.36, 1632.85, 1504.44, 1474.01, 1396.08, 1241.92, 1220.47, 
1171.10, 1057.39, 1014.98, 750.65, 715.76, 656.88, 569.54; HRMS: Calculated for 




dione (4.32) and 2-(2-(3-(1H-imidazol-1-yl)-4-methoxyphenyl)-2-
oxoethyl)isoindoline-1,3-dione (4.33). The title compounds were prepared from S22 
according to a modified General Method B with 0.10 equiv of catalyst A and an irradiation 
time of 24 hours. The crude residue was purified by column chromatography on silica gel 
(80% EtOAc/hexanes to EtOAc to 5% MeOH/EtOAc) to afford 4.32 as a green-yellow solid 
in 26% yield and 4.33 as a tan-yellow solid in 47% yield. 
 
4.32. 1H NMR (600 MHz, CDCl3) δ 7.96 (s, 1H), 7.91 (dd, J = 5.4, 3.0 Hz, 2H), 7.79 – 7.76 
(m, 3H), 7.71 (dd, J = 8.1, 1.8 Hz, 1H), 7.46 (d, J = 8.1 Hz, 1H), 7.39 – 7.30 (m, 6H), 7.20 
(s, 1H), 5.19 (s, 2H), 5.12 (s, 2H). 13C NMR (151 MHz, CDCl3) δ 189.97, 167.94, 151.54, 
137.74, 135.27, 134.41, 134.23, 132.22, 131.72, 129.60, 128.95, 128.60, 127.41, 125.12, 


















IR (thin film): 3150.45, 3066.05, 3032.91, 2920.20, 1714.41, 1703.87, 1416.51, 1390.69, 
1290.19, 1262.74, 1250.66, 1195.34, 1102.07, 1032.81, 991.25, 948.05, 812.16, 747.09, 
712.68, 697.01, 655.07, 610.23, 528.85; HRMS: Calculated for (M+H)+: 438.1448; found: 
438.1436. 
 
4.33. 1H NMR (600 MHz, CDCl3) δ 8.03 (dd, J = 8.6, 2.2 Hz, 1H), 7.94 (d, J = 2.2 Hz, 1H), 
7.88 (dd, J = 5.4, 3.0 Hz, 2H), 7.81 (s, 1H), 7.75 (dd, J = 5.4, 3.0 Hz, 2H), 7.21 (s, 1H), 
7.18 (s, 1H), 7.14 (d, J = 8.7 Hz, 1H), 5.09 (s, 2H), 3.95 (s, 3H). 13C NMR (151 MHz, 
CDCl3) δ 188.95, 167.94, 157.11, 137.81, 134.32, 132.20, 129.69, 129.37, 127.73, 
127.04, 125.68, 123.68, 120.22, 112.11, 56.47, 43.98. 
 
IR (thin film): 3116.86, 2929.22, 1710.04, 1689.06, 1602.96, 1519.18, 1416.19, 
1391.55, 1302.04, 1275.30, 1254.88, 1206.44, 1102.89, 1055.87, 1010.42, 712.80, 




yl)propanoate (4.34). The title compound was prepared from S24 according to a 
modified General Method B with 0.10 equiv of catalyst A and an irradiation time of 24 
hours. The crude residue was purified by column chromatography on silica gel (EtOAc to 5% 
MeOH/EtOAc) to afford a tan solid in 38% yield. 
1H NMR (600 MHz, CDCl3) δ 7.80 (dd, J = 5.5, 3.1 Hz, 2H), 7.76 (s, 1H), 7.71 (dd, J = 5.5, 
3.0 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 7.19 (s, 1H), 7.14 (s, 1H), 









14.5, 11.3 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 169.17, 167.58, 136.27, 136.20, 135.55, 
134.44, 131.55, 130.47, 130.45, 123.74, 121.57, 118.16, 53.19, 53.07, 34.25. 
 
IR (thin film): 3102.09, 2954.14, 2926.12, 2853.18, 1751.65, 1709.88, 1523.71, 1386.17, 
1350.47, 1303.43, 1215.53, 1165.00, 1102.85, 1077.50, 1059.31, 878.71, 813.39, 718.12, 





yl)phenyl pivalate (4.35). The title compound was prepared from S28 according to a 
modified General Method B with 0.10 equiv of catalyst A and an irradiation time of 24 
hours. The crude residue was purified by column chromatography on silica gel (EtOAc to 
2.5% MeOH/EtOAc) to afford a yellow solid in 56% yield. 
1H NMR (600 MHz, CDCl3) δ 7.82 (dd, J = 5.5, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 2H), 
7.51 (s, 1H), 7.20 (d, J = 8.1 Hz, 1H), 7.17 (dd, J = 8.1, 1.9 Hz, 1H), 7.08 (s, 1H), 6.98 (d, 
J = 1.8 Hz, 1H), 6.97 (s, 1H), 5.16 (dd, J = 11.1, 5.2 Hz, 1H), 3.78 (s, 3H), 3.66 (dd, J = 
14.6, 5.2 Hz, 1H), 3.59 (dd, J = 14.5, 11.1 Hz, 1H), 1.09 (s, 9H). 13C NMR (151 MHz, 
CDCl3) δ 176.20, 169.01, 167.63, 145.18, 138.90, 137.55, 134.42, 131.63, 129.34, 
129.25, 127.23, 126.99, 124.58, 123.78, 120.43, 53.23, 52.82, 39.04, 34.30, 26.95. 
 
IR (thin film): 3119.16, 2959.46, 2926.20, 2872.88, 2853.30, 1747.07, 1712.14, 1522.05, 
1384.84, 1261.66, 1244.00, 1097.49, 1054.91, 902.68, 718.49, 660.59; HRMS: Calculated 














methoxy-3-oxopropyl)phenyl)-L-histidinate (4.36). The title compound was prepared 
from S24 according to a modified General Method C on a 0.25 mmol scale with 4.0 equiv. 
of S35, a 1:1 DCE:TFE solvent system, 0.10 equiv of catalyst A and an irradiation time of 
24 hours. The crude residue was purified by column chromatography on silica gel (EtOAc to 
5% MeOH/EtOAc) to afford a yellow solid in 17% yield. 
1H NMR (600 MHz, CDCl3) δ 7.79 (dd, J = 5.5, 3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.0 Hz, 2H), 
7.67 (s, 1H), 7.26 (d, J = 8.5 Hz, 2H), 7.16 (d, J = 8.1 Hz, 2H), 6.96 (s, 1H), 5.84 (t, J = 
8.3 Hz, 1H), 5.15 (dd, J = 11.3, 5.3 Hz, 1H), 4.60 - 4.51 (m, 1H), 3.78 (s, 3H), 3.69 (s, 
3H), 3.63 (dd, J = 14.5, 5.4 Hz, 1H), 3.58 (dd, J = 14.4, 11.2 Hz, 1H), 3.11 (dd, J = 14.8, 
5.6 Hz, 1H), 3.04 (dd, J = 14.8, 4.8 Hz, 1H), 1.41 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 
172.64, 169.16, 167.57, 155.69, 138.68, 136.22, 135.96, 135.19, 134.51, 134.45, 131.53, 
130.45, 123.75, 121.26, 121.23, 115.66, 79.80, 53.50, 53.18, 53.04, 52.42, 34.24, 30.37, 
30.34, 29.82, 28.44. 
 
IR (thin film): 2953.82, 2925.20, 2851.76, 1743.30, 1710.90, 1521.29, 1386.21, 1365.17, 
1244.19, 1202.76, 1161.76, 1019.97, 720.35; HRMS: Calculated for (M+H)+: 577.2293; 














1-(2,4-Dichlorophenyl)-1H-pyrazole (4.37). The title compound was prepared 
according to General Method C on a 0.5 mmol scale with pyrazole, a 1:1 DCE:TFE solvent 
system and an irradiation time of 24 hours. The crude residue was purified by column 
chromatography on silica gel (20% EtOAc/hexanes) to afford a white solid in 94% yield. The 
NMR data were consistent with literature values .  
1H NMR (600 MHz, CDCl3) δ 7.86 (d, J = 2.7 Hz, 1H), 7.74 (d, J = 1.8 Hz, 1H), 7.53 (d, J = 
8.6 Hz, 1H), 7.52 (d, J = 2.3 Hz, 1H), 7.35 (dd, J = 8.6, 2.4 Hz, 1H), 6.47 (dd, J = 2.5, 1.8 
Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 141.28, 136.95, 134.13, 131.31, 130.45, 128.88, 
128.55, 128.06, 107.09. 
 
 
1-(2,4-Dichlorophenyl)-4-methyl-1H-pyrazole (4.38). The title compound was 
prepared according to General Method C on a 0.5 mmol scale with 4-methylpyrazole, a 
1:1 DCE:TFE solvent system and an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (20% EtOAc/hexanes) to afford a white 
solid in 74% yield.  
1H NMR (600 MHz, CDCl3) δ 7.65, 7.54, 7.52 - 7.49 (m, 2H), 7.33 (dd, J = 8.6, 2.3 Hz, 
1H), 2.16. 13C NMR (151 MHz, CDCl3) δ 142.13, 137.12, 133.69, 130.44, 129.77, 128.47, 














IR (thin film): 3098.46, 3038.33, 2923.70, 2864.23, 1494.89, 1421.04, 1103.43, 810.21, 
788.53, 610.75; LRMS: Calculated for (M)+: 226.01; found: 226.00. 
 
 
1-(2,4-Dichlorophenyl)-3-methyl-1H-pyrazole (4.39). The title compound was 
prepared according to General Method C on a 0.5 mmol scale with 3-methylpyrazole, a 
1:1 DCE:TFE solvent system and an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (20% EtOAc/hexanes) to afford a white 
solid in 96% yield.  
1H NMR (600 MHz, CDCl3) δ 7.76 (d, J = 2.4 Hz, 1H), 7.52 (d, J = 8.6 Hz, 1H), 7.48 (d, J = 
2.3 Hz, 1H), 7.31 (dd, J = 8.6, 2.3 Hz, 1H), 6.24 (d, J = 2.4 Hz, 1H), 2.35 (s, 3H). 13C NMR 
(151 MHz, CDCl3) δ 150.61, 136.94, 133.52, 132.00, 130.34, 128.33, 127.96, 107.07, 
13.66. 
 
IR (thin film): 3076.95, 2983.83, 2961.11, 2923.77, 1535.15, 1484.65, 1458.51, 1410.22, 
1372.66, 944.44, 805.58, 748.29; LRMS: Calculated for (M)+: 226.01; found: 226.0. 
 
 
1-(4-(tert-Butyl)-2-chlorophenyl)-3-methyl-1H-pyrazole (4.40). The title compound 














methylpyrazole, a 1:1 DCE:TFE solvent system and an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (20% EtOAc/hex-anes) 
to afford a yellow solid in 92% yield. 
1H NMR (600 MHz, CDCl3) δ 7.73 (d, J = 2.3 Hz, 1H), 7.49 – 7.46 (m, 2H), 7.35 (dd, J = 
8.3, 2.2 Hz, 1H), 6.23 (d, J = 2.3 Hz, 1H), 2.37 (s, 3H), 1.32 (s, 9H). 13C NMR (151 MHz, 
CDCl3) δ 152.42, 150.00, 135.71, 132.01, 127.64, 127.49, 127.24, 124.84, 106.43, 34.84, 
31.20, 13.70. 
 
IR (thin film): 3142.42, 3124.47, 2958.15, 2927.99, 2868.28, 1528.68, 1509.12, 1495.29, 
1463.65, 1364.67, 1033.50, 950.65, 829.61, 779.77, 618.24; LRMS: Calculated for (M)+: 
248.11; found: 248.10. 
 
 
1-(2,4-Dichlorophenyl)-3,5-dimethyl-1H-pyrazole (4.41). The title compound was 
prepared according to General Method C on a 0.5 mmol scale with 1,3-dimethyl-pyrazole, 
a 1:1 DCE:TFE solvent system and an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (20% EtOAc/hexanes) to afford a white 
solid in 33% yield.  
1H NMR (600 MHz, CDCl3) δ 7.52 (d, J = 2.1 Hz, 1H), 7.35 (d, J = 8.5 Hz, 2.0 Hz, 1H), 
7.32 (d, J = 8.4 Hz, 1H), 2.28 (s, 3H), 2.10 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 149.87, 










IR (thin film): 3078.10, 3051.34, 2952.89, 2922.96, 2855.29, 1552.61, 1495.92, 1388.17, 
1374.61, 1362.79, 1099.97, 1078.24, 859.18, 831.20, 810.58, 778.92, 536.13, 432.86; 
LRMS: Calculated for (M)+: 240.02; found: 240.00. 
 
 
1-(2,4-Dichlorophenyl)-1H-benzo[d]imidazole (4.42). The title compound was 
prepared according to a modified General Method C on a 0.5 mmol scale with 1.1 equiv. of 
benzimidazole, a 1:1 DCE:TFE solvent system and an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (50 to 60% 
EtOAc/hexanes) to afford a white solid in 54% yield.  
1H NMR (600 MHz, CDCl3) δ 8.02 (s, 1H), 7.89 (dt, J = 8.2, 0.9 Hz, 1H), 7.66 (d, J = 2.3 
Hz, 1H), 7.45 (dd, J = 8.4, 2.3 Hz, 1H), 7.41 (d, J = 8.4 Hz, 1H), 7.37 - 7.29 (m, 2H), 7.20 
(dt, J = 7.8, 1.0 Hz, 1H). 13C NMR (151 MHz, CDCl3) δ 143.26, 142.83, 135.74, 134.20, 
132.42, 132.32, 131.05, 129.62, 128.52, 124.06, 123.12, 120.71, 110.44. 
 
IR (thin film): 3079.76, 3050.98, 3021.26, 1611.92, 1497.30, 1453.30, 1311.80, 1284.72, 
1227.81, 1098.17, 1065.33, 831.22, 804.33, 766.14, 741.16, 588.09, 431.37; LRMS: 










carboxamide (4.43b). The title compounds were prepared according to a modified 
General Method C on a 0.25 mmol scale with 0.10 equiv of catalyst A, 2.0 equiv. of S42, a 
1:1 DCE:TFE solvent system, and an irradiation time of 24 hours. The crude residue was 
purified by column chromatography on silica gel (50% EtOAc/hexanes) to afford an 
inseparable mixture of 4.43a and 4.43b (1.9:1) as a yellow solid in 41% yield. 4.43a was 
identified as the major isomer using 1H NMR analysis in comparison to previously reported 
spectra for similar N-aryl benzimidazoles35. 
4.43a. 1H NMR (600 MHz, CDCl3) δ 8.30 (d, J = 1.5 Hz, 1H), 8.04 (s, 1H), 7.87 (dd, J = 
8.5, 1.6 Hz, 1H), 7.67 (d, J = 2.3 Hz, 1H), 7.52 - 7.42 (m, 2H), 7.42 - 7.35 (m, 2H), 7.25 - 
7.21 (m, 3H), 6.91 (t, J = 6.1 Hz, 1H), 4.77 (d, J = 6.0 Hz, 2H). 13C NMR (151 MHz, CDCl3) 
δ 167.54, 144.32, 142.98, 136.25, 135.79, 133.81, 132.44, 131.81, 131.16, 130.48, 
130.30, 129.75, 129.69, 129.58, 129.14, 128.69, 127.29, 123.83, 119.46, 110.73, 42.32. 
4.43b. 1H NMR (600 MHz, CDCl3) δ 8.10 (s, 1H), 7.87 (d, J = 8.5 Hz, 1H), 7.80 (d, J = 1.5 
Hz, 1H), 7.69 (dd, J = 8.5, 1.6 Hz, 1H), 7.65 (d, J = 2.2 Hz, 1H), 7.51 – 7.43 (m, 2H), 7.42 
– 7.35 (m, 2H), 7.25 – 7.20 (m, 2H), 6.82 (t, J = 6.1 Hz, 1H), 4.73 (d, J = 6.0 Hz, 2H). 13C 
NMR (151 MHz, CDCl3) δ 167.30, 145.62, 144.99, 136.38, 135.64, 134.42, 133.82, 
132.51, 131.68, 131.10, 130.60, 130.56, 129.68, 129.18, 127.28, 125.44, 121.18, 120.55, 


















IR (thin film): 3066.36, 2953.89, 2922.92, 1638.27, 1616.37, 1535.85, 1492.62, 1442.04, 
1303.83, 1228.82, 1103.72, 820.07, 803.13, 747.94, 727.26; HRMS: Calculated for 
(M+H)+: 430.0275; found: 430.0268 and 430.0251 (two peaks by LCMS). 
 
 
Methyl Nα-(tert-butoxycarbonyl)-Nτ-(2,4-dichlorophenyl)-L-histidinate (4.44). The 
title compound was prepared according to General Method C on a 0.25 mmol scale with 
4.0 equiv. of S35, a 1:1 DCE:TFE solvent system, and an irradiation time of 24 hours. The 
crude residue was purified by column chromatography on silica gel (80% EtOAc/hexanes) to 
afford an orange-red gummy solid in 41% yield. The spectra agree with the product 
synthesized (S36) via a Chan-Lam coupling. 
1H NMR (600 MHz, CDCl3) δ 7.57 (s, 1H), 7.56 (d, J = 2.2 Hz, 1H), 7.36 (dd, J = 8.5, 2.3 
Hz, 1H), 7.26 (d, J = 8.4 Hz, 1H), 6.91 (s, 1H), 5.87 (d, J = 8.5 Hz, 1H), 4.62 (dt, J = 9.1, 
5.2 Hz, 1H), 3.71 (s, 3H), 3.17 (dd, J = 14.9, 5.7 Hz, 1H), 3.09 (dd, J = 14.8, 4.8 Hz, 1H), 
1.44 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.60, 155.69, 138.11, 137.31, 135.16, 
133.71, 130.81, 130.77, 128.40, 128.29, 118.10, 79.85, 53.54, 52.43, 30.41, 28.48.  
 
IR (thin film): 2978.12, 2930.18, 1741.05, 1699.70, 1496.43, 1365.77, 1160.50, 1053.22, 










1-(2,4-Dichlorophenyl)-1H-1,2,3-triazole (4.45). The title compound was prepared 
according to a modified General Method C on a 0.25 mmol scale with 1,2,3-triazole, 0.10 
equiv of catalyst A, a TFT solvent system and an irradiation time of 24 hours. The crude 
residue was purified by column chromatography on silica gel (20 to 30% EtOAc/hexanes) to 
afford a pale off-white solid in 58% yield. 
1H NMR (600 MHz, CDCl3) δ 8.01 (d, J = 1.1 Hz, 1H), 7.88 (d, J = 1.2 Hz, 1H), 7.61 (d, J = 
2.3 Hz, 1H), 7.59 (d, J = 8.5 Hz, 1H), 7.45 (dd, J = 8.5, 2.3 Hz, 1H). 13C NMR (151 MHz, 
CDCl3) δ 136.38, 133.90, 133.64, 130.74, 129.52, 128.70, 128.45, 125.72. 
 
IR (thin film): 3162.16, 3131.47, 3100.07, 3085.67, 2922.49, 2851.59, 1502.69, 1485.23, 
1472.81, 1376.65, 1238.63, 1096.44, 1014.50, 978.21, 859.39, 826.08, 805.39, 779.75, 




triazol-4-yl)butanoate (4.46). The title compound was prepared according to a modified 
General Method C on a 0.25 mmol scale with 0.10 equiv of catalyst A, 4.0 equiv. of S43, a 














purified by column chromatography on silica gel (20 to 30% EtOAc/hexanes) to afford a 
yellow solid in 27% yield. 
 
1H NMR (600 MHz, CDCl3) δ 7.75 (s, 1H), 7.58 (d, J = 2.2 Hz, 1H), 7.55 (d, J = 8.5 Hz, 
1H), 7.42 (dd, J = 8.5, 2.2 Hz, 1H), 7.37 – 7.31 (m, 5H), 5.22 – 5.12 (m, 3H), 4.42 (td, J = 
8.5, 4.9 Hz, 1H), 2.87 (t, J = 7.8 Hz, 2H), 2.36 – 2.23 (m, 1H), 2.09 (dq, J = 15.1, 7.7 Hz, 
1H), 1.44 (s, 9H). 13C NMR (151 MHz, CDCl3) δ 172.45, 155.58, 146.52, 136.12, 135.32, 
133.76, 130.67, 129.36, 128.76, 128.62, 128.58, 128.48, 128.36, 123.43, 80.21, 67.37, 
53.03, 32.48, 28.43, 21.75. 
 
IR (thin film): 3033.36, 2974.32, 2929.38, 2856.55, 1703.89, 1495.25, 1365.54, 1247.80, 




2,4-Dichloroaniline (4.47). The title compound was prepared according to a modified 
General Method C on a 0.5 mmol scale with 8.0 equiv. of ammonium carbamate 
[(NH4)O2CNH2] , a 10:1 DCE:H2O solvent system, 0.10 equiv of catalyst A, and an 
irradiation time of 24 hours. The crude residue was purified by column chromatography on 
silica gel (20% EtOAc/hexanes) to afford pale tan-white crystals in 45% yield. The analytical 
data matches those reported previously.36  
1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 2.1 Hz, 1H), 7.03 (dd, J = 8.6, 2.2 Hz, 1H), 6.69 
(d, J = 8.6 Hz, 1H), 4.04 (s, 2H). 13C NMR (151 MHz, CDCl3) δ 141.75, 129.05, 127.82, 







2,4-Dichloro-1-(2,2,2-trifluoroethoxy)benzene (4.48). The title compound was 
prepared according to a modified General Method C on a 0.25 mmol scale with 0.10 equiv 
of catalyst A, 3.0 equiv. of 1,1,3,3-tetramethylguanidine, a TFE solvent system, and an 
irradiation time of 24 hours. The crude residue was purified by column chromatography on 
silica gel (hexanes) to afford an inseparable mixture of 4.48 and starting material as a 
colorless oil. The ratio of 4.48 to starting material was 1.6:1 and the yield of 4.48 was 
determined to be 44% via 1H NMR analysis of the isolated mixture.  
1H NMR (600 MHz, CDCl3) δ 7.41 (dd, J = 2.5, 0.8 Hz, 1H), 7.21 (ddd, J = 8.8, 2.6, 0.7 Hz, 
1H), 6.91 (dd, J = 8.8, 0.8 Hz, 1H), 4.38 (q, J = 8.0 Hz, 2H). 13C NMR (151 MHz, CDCl3) δ 
152.19, 130.67, 128.62, 125.27, 123.09 (q, J = 278.4 Hz), 116.65, 67.61 (q, J = 36.0 Hz). 
19F NMR (376 MHz, CDCl3) δ -73.94. 
 
IR (thin film): 2924.52, 2852.53, 1477.74, 1456.87, 1289.72, 1248.01, 1164.31, 1104.72, 




Methyl (S)-2-(5-cyano-6-(1H-imidazol-1-yl)naphthalen-2-yl)propanoate (4.49). 
The title compound was prepared from S30 according to a modified General Method B 













purified by column chromatography on silica gel (80% EtOAc/hexanes to EtOAc) to afford a 
pale yellow-white crystalline solid in 94% yield. 
1H NMR (600 MHz, CDCl3) δ 8.26 (d, J = 8.6 Hz, 1H), 8.16 (d, J = 8.8 Hz, 1H), 7.97 (s, 
1H), 7.89 (d, J = 1.8 Hz, 1H), 7.75 (dd, J = 8.7, 1.8 Hz, 1H), 7.51 (d, J = 8.7 Hz, 1H), 7.46 
(s, 1H), 7.29 (s, 1H), 3.96 (q, J = 7.2 Hz, 1H), 3.69 (s, 3H), 1.62 (d, J = 7.2 Hz, 3H). 13C 
NMR (151 MHz, CDCl3) δ 174.29, 140.88, 139.15, 137.04, 134.87, 132.15, 131.89, 
130.94, 130.29, 126.99, 126.16, 122.82, 119.87, 115.03, 104.01, 52.45, 45.38, 18.54. 
 
IR (thin film): 3147.09, 3117.53, 3049.00, 3022.30, 2982.18, 2950.21, 2222.34, 1727.08, 
1593.36, 1515.24, 1493.47, 1451.53, 1300.37, 1246.00, 1195.55, 1166.53, 1063.42, 
1045.72, 802.17, 744.47, 651.15, 452.62; HRMS: Calculated for (M+Na)+: 328.1056; 
found: 328.1057. [a]D: + 37.1 (c = 0.005, CHCl3). 
 
 
1-(4-(1H-Imidazol-1-yl)-3-methoxyphenyl)ethan-1-one (4.50). The title compound 
was prepared from S32 according to a modified General Method B with 0.10 equiv of 
catalyst A and an irradiation time of 24 hours. The crude residue was purified by column 
chromatography on silica gel (EtOAc to 5% MeOH/EtOAc) to afford a pale yellow solid in 








1-(4-(1H-Imidazol-1-yl)-3-methoxyphenyl)ethan-1-one-2,2,2-d3 (4.51). The title 
compound was prepared from S41 according to a modified General Method B with 0.10 
equiv of catalyst A and an irradiation time of 24 hours. The crude residue was purified by 
column chromatography on silica gel (EtOAc to 5% MeOH/EtOAc) to afford a pale yellow 
solid in 48% yield.  
 
1H NMR (600 MHz, CDCl3) δ 7.89 (s, 1H), 7.68 (d, J = 1.7 Hz, 1H), 7.62 (dd, J = 8.1, 1.7 
Hz, 1H), 7.38 (d, J = 8.0 Hz, 1H), 7.27 (s, 1H), 7.19 (s, 1H), 3.94 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 197.03, 152.38, 137.79, 137.14, 130.56, 129.46, 124.83, 122.11, 119.98, 
111.49, 56.25. 
 
IR (thin film): 3127.62, 3099.10, 2951.04, 2922.86, 2850.73, 2254.71, 1675.52, 
1595.84, 1515.48, 1410.28, 1306.50, 1283.20, 1269.59, 1255.65, 1241.43, 1224.17, 
1177.02, 1058.47, 1022.46, 959.11, 817.60, 742.73, 656.23, 533.51; HRMS: Calculated 







B.5 Computational Data 
All computations were carried out in the Gaussian 09 program suite37 at the 
B3LYP/6-31G+(d,p) level of theory. Natural population analyses (NPA atomic charges and 
molecular orbital populations) were performed using the NBO formalism and the NPA values 
were calculated in 1,2-dicholorethane according to a prior procedure from our laboratory38. 
The NPA values for 2-chloroanisole were obtained from our prior study38. 
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Figure B.3. Natural population analyses for the ground state and radical cation of selected 
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Figure B.4. Natural population analyses for the ground state and radical cation of selected 
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Figure B.5. Natural population analyses for the ground state and radical cation of N-
phthaloyl-4-methoxy-3-pivaloyl L-DOPA methyl ester (top), N-phthaloyl-3-benzyloxy-4-
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B.6 NMR Spectra Data  
See Supplementary Materials for Tay and Nicewicz39 which is available online.  










Figure B.6. X-ray structure of 4.40 (left) and its 2-D molecular representation (right) 
B.7.1 Experimental  
X-Ray quality single crystals (light tan-brown) of C14H17ClN2 (4.40) were grown by slow 
evaporation (MeOH). A suitable crystal was selected and mounted on a 'Bruker APEX-II CCD' 
diffractometer. The crystal was kept at 100 K during data collection. Using Olex240, the 
structure was solved with the olex2.solve structure solution program41 using Charge Flipping 
and refined with the XL refinement package42 using Least Squares minimization. 
B.7.2 Crystal structure determination of 4.40 
Crystal Data for C14H17ClN2 (M =248.74 g/mol): monoclinic, space group P21/c (no. 14), 
a = 8.1835(6) Å, b = 14.6901(10) Å, c = 11.1371(8) Å, β = 90.394(4)°, V = 1338.83(16) Å3, 
Z = 4, T = 100 K, µ(CuKα) = 2.347 mm-1, Dcalc = 1.234 g/cm3, 13641 reflections measured 
(9.966° ≤ 2Θ ≤ 145.894°), 2631 unique (Rint = 0.0362, Rsigma = 0.0241) which were used in 









Table B.2. Crystal data and structure refinement for compound 4.40.  
Identification code  x1605003  
Empirical formula  C14H17ClN2  
Formula weight  248.74  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  8.1835(6)  
b/Å  14.6901(10)  
c/Å  11.1371(8)  
α/°  90  
β/°  90.394(4)  
γ/°  90  
Volume/Å3  1338.83(16)  
Z  4  
ρcalcg/cm3  1.234  
µ/mm-1  2.347  
F(000)  528.0  
Crystal size/mm3  0.179 × 0.136 × 0.07  
Radiation  CuKα (λ = 1.54178)  
2Θ range for data collection/°  9.966 to 145.894  
Index ranges  -10 ≤ h ≤ 9, -18 ≤ k ≤ 18, -13 ≤ l ≤ 13  
Reflections collected  13641  
Independent reflections  2631 [Rint = 0.0362, Rsigma = 0.0241]  
Data/restraints/parameters  2631/0/158  
 259 
Goodness-of-fit on F2  1.039  
Final R indexes [I>=2σ (I)]  R1 = 0.0332, wR2 = 0.0873  
Final R indexes [all data]  R1 = 0.0368, wR2 = 0.0903  
Largest diff. peak/hole / e Å-3  0.37/-0.19  
 
Table B.3. Bond Lengths for 4.40. 
Atom Atom Length/Å   Atom Atom Length/Å 
Cl1 C2 1.7413(13)   C8 C9 1.5321(19) 
C2 C3 1.3921(19)   C8 C10 1.5370(19) 
C2 C7 1.3918(19)   C8 C11 1.537(2) 
C3 C4 1.3894(19)   N12 N13 1.3700(15) 
C4 C5 1.4008(19)   N12 C16 1.3587(18) 
C4 C8 1.5321(18)   N13 C14 1.3312(18) 
C5 C6 1.383(2)   C14 C15 1.410(2) 
C6 C7 1.3958(19)   C14 C17 1.4938(19) 
C7 N12 1.4216(17)   C15 C16 1.369(2) 
 
Table B.4. Bond Angles for 4.40. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C3 C2 Cl1 117.11(10)   C9 C8 C4 112.26(11) 
C7 C2 Cl1 121.86(11)   C9 C8 C10 108.11(12) 
C7 C2 C3 121.03(12)   C9 C8 C11 108.45(12) 
C4 C3 C2 121.50(12)   C11 C8 C10 109.91(12) 
C3 C4 C5 117.06(12)   N13 N12 C7 118.07(10) 
C3 C4 C8 122.50(12)   C16 N12 C7 130.09(11) 
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C5 C4 C8 120.45(12)   C16 N12 N13 111.68(11) 
C6 C5 C4 121.68(12)   C14 N13 N12 104.75(11) 
C5 C6 C7 120.93(12)   N13 C14 C15 111.23(12) 
C2 C7 C6 117.74(12)   N13 C14 C17 120.12(12) 
C2 C7 N12 123.65(12)   C15 C14 C17 128.65(13) 
C6 C7 N12 118.60(12)   C16 C15 C14 105.45(12) 
C4 C8 C10 108.75(11)   N12 C16 C15 106.87(12) 
C4 C8 C11 109.34(11)           
 
Table B.5. Torsion Angles for 4.40. 
A B C D Angle/˚   A B C D Angle/˚ 
Cl1 C2 C3 C4 178.44(10)   C5 C4 C8 C11 -67.39(16) 
Cl1 C2 C7 C6 -177.48(10)   C5 C6 C7 C2 -0.99(19) 
Cl1 C2 C7 N12 1.09(18)   C5 C6 C7 N12 -179.64(12) 
C2 C3 C4 C5 -0.96(19)   C6 C7 N12 N13 35.74(17) 
C2 C3 C4 C8 178.82(12)   C6 C7 N12 C16 -139.20(14) 
C2 C7 N12 N13 -142.81(13)   C7 C2 C3 C4 -1.4(2) 
C2 C7 N12 C16 42.2(2)   C7 N12 N13 C14 -176.85(11) 
C3 C2 C7 C6 2.38(19)   C7 N12 C16 C15 176.17(13) 
C3 C2 C7 N12 -179.06(12)   C8 C4 C5 C6 -177.43(12) 
C3 C4 C5 C6 2.35(19)   N12 N13 C14 C15 0.66(15) 
C3 C4 C8 C9 -7.57(18)   N12 N13 C14 C17 -179.19(12) 
C3 C4 C8 C10 -127.15(13)   N13 N12 C16 C15 0.98(16) 
C3 C4 C8 C11 112.83(14)   N13 C14 C15 C16 -0.10(16) 
C4 C5 C6 C7 -1.4(2)   C14 C15 C16 N12 -0.52(15) 
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C5 C4 C8 C9 172.21(13)   C16 N12 N13 C14 -1.02(14) 
C5 C4 C8 C10 52.62(16)   C17 C14 C15 C16 179.74(14) 
 
B.8 Mechanism Data  
 
Table B.6. Control experiments for observed substitutive defluorination under photoredox-
catalyzed cation radical accelerated SNAr conditions. 
 












1:1 DCE:TFE, 24 h
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NH





























Figure B.8. Summary of electrochemical data. The half-wave potentials (vs. SCE) of 4.8 
and imidazole (left), the excited state reduction potential of 9-mesityl-3,6-di-tert-butyl-10-
phenylacridinium tetrafluoroborate (center) and the excited state reduction potential of the 
Ir (III) photocatalyst [Ir(dF(CF3)ppy) 2(5,5′-d(CF3)bpy)]PF6 (right). 
 
Figure B.9. Transformation of S8 and imidazole under photoredox-catalyzed cation radical 






































0.05 equiv catalyst A
4.0 equiv imidazole
DCE:TFE (1:1; 0.1 M)





















   
Figure B.11. GC-MS trace of imidazole (top, first left), benzyl alcohol (top, second left), 














Figure B.12. The effect of 2,2,2-trifluoroethanol on the product ratio of 4.23 to 4.19b. 
 
3-(Benzyloxy)-4-(1H-imidazol-1-yl)phenyl trifluoromethanesulfonate (4.23) and 
3-(1H-imidazol-1-yl)-4-methoxyphenyl trifluoromethanesulfonate (4.19b). The title 
compounds were prepared from S14 using General Method B with a 1:1 DCE:TFE solvent 
mixture and an irradiation time of 24 hours. The reaction was run through a plug of silica, 
concentrated and the reaction was purified by column chromatography on silica gel (80% 
EtOAc/Hexanes) to afford an inseparable solid mixture of 4.23 and 4.19b in an overall 80% 
product formation. The 4.23: 4.19b ratio of the inseparable mixture was 2.5:1 as 
determined by 1H NMR of the isolated product. The spectral data were in agreement with 
aforementioned values for 4.23 and 4.19b. 
23. 1H NMR (600 MHz, CDCl3) δ 7.80 (s, 1H), 7.39 – 7.31 (m, 4H), 7.29 (d, J = 6.8 Hz, 
2H), 7.21 (s, 1H), 7.18 (s, 1H), 7.03 (d, J = 2.6 Hz, 1H), 6.99 (dd, J = 8.7, 2.6 Hz, 1H), 
5.13 (s, 2H). 
19b. 1H NMR (600 MHz, CDCl3) δ 7.81 (s, 1H), 7.31 – 7.27 (m, 1H), 7.24 (d, J = 3.0 Hz, 




















0.05 equiv catalyst A
4.0 equiv imidazole
DCE:TFE (x:y; 0.1 M)
455 nm LEDs, N2
Solvent conditions
A. 9:1 DCE:TFE; only 4.23 observed
















































Figure B.13. NMR spectrum (in CDCl3) of veratraldehyde under reaction conditions. 
Broadening of the aldehyde proton (A) observed as well as the suggested formation of a 








Figure B.14. Comparison of hypothesized benzylic C–H shift of the hemiacetal 4.54 (left) 

















B.9 Examples of Incompatible Substrates 
 
Figure B.15. Selected examples of molecules currently unreactive under photoredox-
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APPENDIX C: SUPPORTING INFORMATION FOR “DIRECT ARENE C–H 
FLUORINATION WITH 18F– VIA ORGANIC PHOTOREDOX CATALYSIS” 
 
C.1 General Information: Materials and Methods 
C.1.1 General Reagent Information 
Commercially available reagents were purchased from Sigma-Aldrich, Acros, Alfa 
Aesar, or TCI, Matrix Scientific, Combi-Blocks, Oakwood Chemical, Chem Impex 
International, and Fisher Scientific and were used as received unless otherwise noted. 
Diethyl ether (Et2O), dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and 
dimethylformamide (DMF) were dried by passing through activated alumina under nitrogen 
prior to use. Other common solvents and chemical reagents were purified by standard 
published methods as noted or used as received. All catalyst and substrate syntheses were 
run under a nitrogen atmosphere unless specified otherwise.  
The following compounds employed as reagents in the photoredox-catalyzed C–H 
(radio)fluorination were obtained from commercial vendors and used as received: diphenyl 
ether, biphenyl, naphthalene, 2-bromoansiole, 2-chloroanisole, 2-methoxyacetophenone, 2-
methoxybenzonitrile, o-anisaldehyde, p-anisaldehyde, 4-methoxyacetophenone, 4-
methoxybenzophenone, 3-methoxyacetophenone, mesitylene, 3,5-dimethoxypyridine, 2-
chloro-5-fluoro-6-methoxyquinoline, 2-methylbenzo[d]oxazole, clofibrate, and fenofibrate.  
C.1.2 General Analytical Information 
 
Proton, carbon, and fluorine nuclear magnetic resonance spectra (1H NMR, 13C NMR, 
19F NMR) were recorded on a Bruker Avance 400 (1H NMR at 400 MHz, 13C NMR at 100 MHz, 
and 19F NMR at 376 MHz), a Bruker Avance III 600 (1H NMR at 600 MHz, 13C NMR at 151 
MHz, and 19F NMR at 565 MHz) spectrometer, an Inova 700 MHz (1H NMR at 700 MHz, 13C 
NMR at 176 MHz), and a Bruker Avance III HD 850 (1H NMR at 850 MHz, 13C NMR at 214 
MHz). Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to residual protium in the solvent (1H NMR: CHCl3 at 
7.26 ppm, MeOD at 3.31 ppm, acetone-d6 at 2.05 ppm and DMSO- d6 at 2.50 ppm). 
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Chemical shifts for carbon signals are reported in parts per million downfield from 
tetramethylsilane and are referenced to the carbon resonances of the solvent peak (13C 
NMR: CDCl3 at 77.16 ppm, MeOD at 49.00 ppm, acetone-d6 at 29.84 ppm (CD3) and at 
206.46 (C=O), and DMSO-d6 at 39.52 ppm). Chemical shifts for fluorine signals are reported 
in parts per million downfield from tetramethylsilane and are referenced to 
hexafluorobenzene, which was added as an internal standard. Solvent-dependent 19F values 
of hexafluorobenzene are obtained from Togni et al.1 [19F NMR: C6F6(CDCl3) at -161.64 ppm, 
C6F6(MeOD) at -165.37 ppm, C6F6(acetone-d6) at -164.67 ppm, C6F6(DMSO-d6) at -162.45 
ppm]. 1H, 13C and 19F NMR data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, hept = heptet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, m = multiplet, bs = broad singlet, app = apparent), coupling 
constants (Hz), and integration. Attenuated total reflectance FTIR spectra were recorded on 
a Bruker Alpha FTIR Spectrometer with the Plantinum ATR attachment. Spectra were 
averaged over 24 scans with a spectral resolution of 4 cm-1. Data processing was performed 
using Bruker's OPUS spectroscopy software. High Resolution Mass Spectra (HRMS) were 
obtained via direct infusion using a Thermo LTQ FT mass spectrometer with positive mode 
electrospray ionization, via gas chromatography using an Exactive GC gas chromatographic 
system in positive mode chemical ionization, equipped with a Trace 1300 SSL injector and 
TriPlus RSH autosampler, or via liquid chromatography using Waters Acquity H-class liquid 
chromatograph system coupled to a Thermo LTQ FT mass spectrometer with positive mode 
electrospray ionization. The instrumental control, data acquisition and data processing for 
HRMS were performed with Thermo's Xcalibur and TraceFinder software packages. Thin 
layer chromatography (TLC) was performed on SiliaPlate 250 µm thick silica gel plates 
provided by Silicycle or on Alumina N 200 µm thick aluminium oxide plates (polyester 
backed) provided by Sorbtech. Visualization was accomplished with short wave UV light 
(254 nm), or development with iodine, ninhydrin solution, cerium ammonium molybdate or 
potassium permanganate solution followed by heating. Column chromatography was 
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performed using SiliaFlash P60 silica gel (40–63 µm) purchased from Silicycle or using Acros 
Organics aluminium oxide (basic, Brockmann I, 50–200 µm, 60 Å). Reverse-phase flash 
liquid chromatography was performed using a Biotage® Isolera One instrument with a 
Biotage® SNAP Ultra C18 cartridge (30 g). Unless noted all reactions were run under an 
atmosphere of nitrogen in flame-dried glassware with magnetic stirring. Irradiation of 
photochemical reactions was carried out using a PAR38 Royal Blue aquarium LED lamp 
(Model #6851) fabricated with high-power Cree XR-E LEDs as purchased from Ecoxotic 
(www.ecoxotic.com) with standard borosilicate glass vials purchased from Fischer Scientific. 
For all photolyses, reactions were stirred using a PTFE coated magnetic stir bar on a 
magnetic stir plate. GC quantitation experiments were performed on an Agilent 6850 series 
instrument equipped with a split- mode capillary injection system and Agilent 5973 network 
mass spec detector (MSD). Yield refers to isolated yield of analytically pure material unless 
otherwise noted. GC yields were determined using 3-bromotoluene as an internal standard. 
All other reagents were obtained from commercial sources and used without further 
purification unless otherwise noted. 
C.1.3 Photoreactor Configuration (LEDs) 
Reactions were irradiated using a simple photoreactor consisting of two Par38 Royal 
Blue Aquarium LED lamps (Model #6851) is shown in which one reaction (2 dram vial) is 
irradiated with a foil barrier preventing irradiation by two lamps. In order to ensure that the 
reactions are run near room temperature, a simple cooling fan was installed perpendicular 
to the reactor to aid in heat dissipation (generated from both nonradiative decay pathways 
of the excited state catalysts and the heat generated from high power LEDs). The vial was 
positioned on a stir plate approximately 3–4 cm from a Par38 LED lamp supplying blue light 
(λ = 440–460 nm). An equilibrium temperature of 33 °C was measured with a standard 
alcohol thermometer. While a number of other blue LED sources are effective, we have 
found that LED emitters with high luminous flux and narrow viewing angle give the best 
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results. Reaction optimizations were performed on a 16-well proprietary photoreactor with 
the following parameters. 
 
Basic Parameters:  
 
Input: AC 100–240 V 50/60 Hz  
Output: 12 W  
Light-emitting angle: 45º  
Pulse current: 700 mA 
Lumens (LM): 130–140 LM 
Wavelength: 465–470 nm; Max wavelength: 467.5 nm  
Working temperature: –10 – +60 ºC 
LED lifetime100000 hours 
Size: 20cm*20cm*20cm 
 
   
Figure C.1. Side-on (top left) and top-down (top right) views of the simple photoreactor. 
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C.1.4. Radiochemistry  
All chemicals are analytical grade and used without further purification. Ultrapure 
water was obtained from a Millipore MilliQ Gradient A10 system. Pre-conditioned Sep-PAK® 
light QMA cartridge were purchased form ABX Corporation, and were flushed with 10 ml of 
water before use. The 450 nm OEM blue diode laser used (OEM-SD-450, 450nm, the power 
rating is 3.5W after fiber coupling).  for the photochemical experiments was purchased from 
Changchun New Industries Optoelectronics Tech. Co., Ltd. A schematic of the reaction set-
up is shown in section C.5.3 (Figure C.3). Glass backed thin layer chromatography (TLC) 
plates coated with silica gel 60F254 were used for radio-TLC analysis and were purchased 
from EMD-Millipore.  
[18F]Fluoride was produced via the 18O(p,n)18F reaction by proton irradiation (40µA, 
2–5min) of  an [18O]H2O containing target in a GE PETTrace cyclotron. The [18F]fluoride (ca. 
1.2–2.2Ci) was delivered to the synthesis module in a bolus of [18O]H2O by stream of argon. 
The aqueous solution of [18F]fluoride was passed through a QMA cartridge (water 
preconditioning) to trap [18F]fluoride before elution into the reactor vessel with a aqueous 
solution of 20% w/w tetrabutylammonium bicarbonate (TBAB). This solution was 
azeotropically dried by heating the reaction vessel to 100 °C and drawing vacuum (ca. 1 
kPa) for 5 min, followed by simultaneous vacuum draw and nitrogen stream for a further 6 
minutes. The dried [18F]TBAF was cooled to 50 °C before addition of anhydrous MeCN. The 
mixture was transferred out of the reactor under N2 pressure into a sterile vial to yield a 
solution of [18F]TBAF (1.1–1.8 Ci, average = 1.5 Ci) in MeCN. 10–100 µL aliquots of this 
solution were then used for manual methodology experiments. 
Radio-TLC analysis was performed using a Bioscan AR 2000 Radio-TLC scanner (Ekert and 
Ziegler) 18F activity was counted using a CRC-25 PET detector from Capintec. Analytical 
reversed-phase high-performance liquid chromatography (HPLC) was accomplished on a 
SHIMADZU chromatography system (Model CBM-20A) and analyzed using LabSolutions 
software. The λ absorbance detector and the model 2200 scaler ratemeter radiation 
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detector were added to the HPLC system. HPLC conditions are listed accordingly for each 
experiment (Section C.5). 
All radiochemical yields (RCY) quoted are decay corrected and are reported as 
isolated RCY other than Section C.5.4. An aliquot of the reaction mixture (typically 400-
800µCi) was taken for radio-HPLC analysis. The activity injected into HPLC was measured 
(this activity was denoted by α) and the time of injection was recorded. The fraction 
corresponding to radiolabeled product was collected and the activity was measured (this 
activity was denoted by β). The decay-corrected RCY was calculated by dividing the decay-
corrected β by α. All RCY were calculated with respect to the starting 18F activity of the 
eluted fluoride. The identities of the 18F-labeled compounds were confirmed by comparison 
to authentic 19F standards. The following fluorination standards were obtained from 
commercial vendors and used as received: 4-fluorophenoxybenzene (5.2), 4-fluorobiphenyl 
(5.3) , 1-fluoronaphthalene (5.4), 2-bromo-4-fluoroanisole (5.5), 2-chloro-4-fluoroanisole 
(5.6), methyl 5-fluoro-2-methoxybenzoate (5.8), 1-(5-fluoro-2-methoxyphenyl)ethenone 
(5.9), 5-fluoro-2-methoxybenzonitrile (5.10), 5-fluoro-2-methoxybenzaldehyde (5.11), 3-
fluoro-4-methoxybenzaldehyde (5.15), 1-(3-fluoro-4-methoxyphenyl)ethenone (5.16), 
methyl 3-fluoro-4-methoxybenzoate (5.18), 1-(4-fluoro-3-methoxyphenyl)ethenone (5.20, 
[4-F]) and 2-fluoromesitylene (5.25). The preparation of aromatic fluorinated standards 




C.2. Optimization Studies for Arene C–H 19F-fluorination  
 










entry TEMPO equiv solvent [M]† total yield*,‡
0.20 DCE [0.10] 4%2
0.50 DCE [0.10] 12%9
0.20 DCE [0.10] 3%3
0.20 DCE [0.10] 0%4






Reactions were performed using diphenyl ether (0.50 mmol), catalyst S1 (0.05 equiv) under O2
*Yields determined by gas chromatography analysis using 3-bromotoluene as the internal standard
† DCE: 1,2 Dichloroethane; TFT: α, α, α Trifluorotoluene; MeCN: Acetonitrile
‡ Greater than 10:1 ratio of 4-fluoro product typically detected; 13:1 ratio detected for entry 10
0.20 DCE [0.10] <1%5 none
0.20 DCE[0.10] 6%1 NBu4HSO4
0.20 MeCN [0.10] 2%6 NBu4HSO4
0.20 TFT [0.10] 0%7 NBu4HSO4

























Table C.1. Selected optimization table for photoredox-catalyzed C–H fluorination
Mes-Acr+ (S1)
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C.3. Experimental Procedures: Catalyst and Substrate Synthesis 
C.3.1 Preparation of Acridinium Photocatalysts 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium tetrafluoroborate (S1) The title 
compound was prepared according to a published procedure; spectra data are in agreement 
with literature values.2 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium perchlorate (5.1) To a dry, clean 
round-bottomed flask was added 9-mesityl-3,6-di-tert-butyl-10-phenylacridinium 
tetrafluoroborate (150 mg, 0.262 mmol, 1.0 equiv), which was dissolved in 10 mL of dry 
acetone. Then an excess of sodium perchlorate (approximately 10-15 equiv) was added to 
the solution and the reaction was stirred for 2 h. After 2 h. the reaction was diluted with 
DCM (40 mL) and a formation of a precipitate was observed. This precipitate was dissolved 
in deionized H2O (40 mL) and the two layers were separated. The aqueous layer was 
extracted with 20 mL DCM and the organic layers were combined and washed with brine. 
The organic layer was then dried over Na2SO4 and concentrated. The resulting product 
(yellow-orange amorphous solid) was then resuspended in dry diethyl ether and sonicated 
to yield a bright yellow solid which was collected by vacuum filtration (150 mg, 98% yield).  
1H NMR (600 MHz, CDCl3) δ 7.95 (t, J = 7.6 Hz, 2H), 7.88 (t, J = 7.5 Hz, 1H), 7.83 – 


















13C NMR (176 MHz, CDCl3) δ 163.55, 162.33, 142.35, 140.22, 137.13, 136.42, 131.84, 
131.63, 129.54, 129.04, 128.41, 128.33, 127.53, 124.25, 115.30, 36.79, 30.37, 21.43, 
20.43. 
 
IR (thin film): 2956.5784, 2912.2719, 2871.2659, 1611.6495, 1575.68, 1455.0618, 
1440.7732, 1098.8189, 1079.2542, 1059.5842, 1030.7769, 849.4037, 620.8047 
HRMS (ESI): Calculated for C36H40N (M+)+: 486.31553; found: 486.31408. 
 
C.3.2 Preparation of Arene Substrates (S2-S27) 
 
2-Methoxyphenyl trifluoromethanesulfonate (S2) The title compound was prepared 
according to a published procedure; spectra data are in agreement with literature values.3 
 
Methyl 2-methoxybenzoate (S3) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.4 
 
N,N-Diethyl-2-methoxybenzamide (S4) The title compound was prepared according to a 











2'-Methoxy-[1,1'-biphenyl]-4-carbonitrile (S5) The title compound was prepared 
according to a published procedure6; spectra data are in agreement with literature values.7 
 
2-Chloro-2'-methoxy-1,1'-biphenyl (S6) The title compound was prepared according to 
a published procedure; spectra data are in agreement with literature values.6 
 
Methyl 4-methoxybenzoate (S7) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.8 
 
N,N-Diethyl-4-methoxybenzamide (S8) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.9 
 
4-Ethyl-2-methoxyphenyl trifluoromethanesulfonate (S9) To a dry, clean round 
bottomed flask equipped with a stir bar was added 4-ethyl-2-methoxyphenol (457 mg, 3.00 
mmol, 1.0 equiv) and the solid was dissolved in 30 mL of DCM under N2. The solution was 
cooled to 0 ºC before pyridine (0.48 mL, 6.00 mmol, 2.0 equiv) was added to the solution. 














reaction dropwise and the solution was stirred for 15 minutes before being warmed to room 
temperature. The reaction was then run for 2 h. before being quenched with DI water. The 
reaction was then diluted with DCM before the layers were separated. The aqueous layer 
was extracted once with DCM (10 mL) and the organic layers were combined, washed 
sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over Na2SO4 and 
concentrated. The crude product was purified via flash chromatography (10% EtOAc) to 
yield 4-ethyl-2-methoxyphenyl trifluoromethanesulfonate as a yellow oil (810 mg, 95%). 
 
1H NMR (600 MHz, CDCl3) δ 7.12 (d, J = 8.3 Hz, 1H), 6.86 (d, J = 2.1 Hz, 1H), 6.79 (dt, J 
= 8.3, 1.3 Hz, 1H), 3.90 (s, 3H), 2.66 (q, J = 7.6 Hz, 2H), 1.26 (t, J = 7.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 151.21, 146.11, 136.92, 122.16, 120.15, 118.91 (q, J = 
320.5 Hz), 112.84, 56.16, 28.98, 15.46. 
19F NMR (376 MHz, CDCl3) δ -73.75.  
 
HRMS (ESI): Calculated for C10H11F3O4S (M+H)+: 285.03989; found: 285.04028. 
 
tert-Butyl (4-hydroxy-3-methoxybenzyl)carbamate (S10) was prepared according to 
a published procedure; spectra data are in agreement with literature values.10  
 
4-(((tert-Butoxycarbonyl)amino)methyl)-2-methoxyphenyl 
trifluoromethanesulfonate (S11) tert-Butyl (4-hydroxy-3-methoxybenzyl)carbamate 
(0.834 g, 3.29 mmol, 1.0 equiv) was added to a dry, clean round bottomed flask equipped 








before pyridine (0.53 mL, 6.59 mmol, 2.0 equiv) was added to the solution. 
Trifluoromethanesulfonic anhydride (0.67 mL, 4.00 mmol, 1.2 equiv) was then added to the 
reaction dropwise and the solution was stirred for 15 minutes before being warmed to room 
temperature. The reaction was then run for 2 h. before being quenched with DI water. The 
reaction was then diluted with DCM before the layers were separated. The aqueous layer 
was extracted once with DCM (10 mL) and the organic layers were combined, washed 
sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over Na2SO4 and 
concentrated. The crude product was purified via flash chromatography (10 to 20% EtOAc) 
to yield 4-(((tert-Butoxycarbonyl)amino)-methyl)-2-methoxyphenyl 
trifluoromethanesulfonate as a white solid (1.15 g, 91%). 
 
1H NMR (600 MHz, CDCl3) δ 7.15 (d, J = 8.3 Hz, 1H), 6.97 (s, 1H), 6.86 (dd, J = 8.3, 2.0 
Hz, 1H), 4.97 (s, 1H), 4.30 (d, J = 6.3 Hz, 2H), 3.89 (s, 3H), 1.46 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 156.06, 151.56, 141.03, 137.92, 122.53, 119.56, 118.85 
(q, J = 320.5 Hz), 112.28, 80.03, 56.27, 44.34, 28.48. 
19F NMR (376 MHz, CDCl3) δ -73.78. 
 
HRMS (ESI): Calculated for C14H18F3NO6S (M+Na)+: 408.06993; found: 408.06909. 
 
2-Methoxy-4-(nonanamidomethyl)phenyl trifluoromethanesulfonate (S12) To a 
dry, clean round bottomed flask equipped with a stir bar was added nonivamide (354.0 mg, 
1.21 mmol, 1.0 equiv) and the solid was dissolved in 12 mL of DCM under N2. The solution 
was cooled to 0 ºC before triethylamine (0.18 mL, 1.33 mmol, 1.1 equiv) and 1,1,1-








1.02 equiv) were sequentially added. The reaction was stirred at 0 ºC for 15 minutes before 
being warmed to room temperature. The reaction was then run for 4 h. before being 
quenched with DI water. The reaction was then diluted with DCM before the layers were 
separated. The aqueous layer was extracted once with DCM (10 mL) and the organic layers 
were combined, washed sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (40% 
EtOAc) to yield 2-methoxy-4-(nonanamidomethyl)phenyl trifluoromethanesulfonate as an 
off-white solid (439 mg, 86%). 
 
1H NMR (600 MHz, CDCl3) δ 7.15 (d, J = 8.3 Hz, 1H), 6.96 (d, J = 2.0 Hz, 1H), 6.86 (dd, 
J = 8.3, 2.0 Hz, 1H), 5.81 (s, 1H), 4.43 (d, J = 6.0 Hz, 2H), 3.89 (s, 3H), 2.26 – 2.16 (m, 
2H), 1.66 (p, J = 7.6 Hz, 2H), 1.36 – 1.18 (m, 10H), 0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 173.40, 151.61, 140.46, 138.01, 122.59, 119.93, 118.84 
(q, J = 320.4 Hz), 112.72, 56.30, 43.18, 36.86, 31.93, 29.44, 29.43, 29.28, 25.88, 22.75, 
14.19. 
19F NMR (376 MHz, CDCl3) δ -73.77. 
 
HRMS (ESI): Calculated for C18H26F3NO5S (M+Na)+: 448.13762; found: 448.13638. 
 
2-Methoxy-4-(3-oxobutyl)phenyl trifluoromethanesulfonate (S13) (NT-06-180) To 
a dry, clean round bottomed flask equipped with a stir bar was added zingerone (971.0 mg, 
5.00 mmol, 1.0 equiv) and the solid was dissolved in 50 mL of DCM under N2. The solution 
was cooled to 0 ºC before triethylamine (0.76 mL, 5.50 mmol, 1.1 equiv) and 1,1,1-






1.02 equiv) were sequentially added. The reaction was stirred at 0 ºC for 15 minutes before 
being warmed to room temperature. The reaction was then run for 4 h. before being 
quenched with DI water. The reaction was then diluted with DCM before the layers were 
separated. The aqueous layer was extracted once with DCM (10 mL) and the organic layers 
were combined, washed sequentially with 20 mL of dilute HCl (2.0 M) and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (40% to 
50% EtOAc) to yield 2-methoxy-4-(3-oxobutyl)phenyl trifluoromethanesulfonate as an 
cream-colored liquid (1.39 g, 85%). 
 
1H NMR (600 MHz, CDCl3) δ 7.06 (d, J = 8.3 Hz, 1H), 6.85 (d, J = 2.1 Hz, 1H), 6.74 (dd, 
J = 8.3, 2.0 Hz, 1H), 3.83 (s, 3H), 2.85 (t, J = 7.5 Hz, 2H), 2.74 (t, J = 7.5 Hz, 2H), 2.10 
(s, 3H). 
13C NMR (151 MHz, CDCl3) δ 207.25, 151.14, 143.08, 137.04, 122.18, 120.52, 118.75 
(q, J = 320.3 Hz), 113.40, 56.04, 44.63, 29.93, 29.42. 
19F NMR (565 MHz, CDCl3) δ -73.67. 
 
HRMS (ESI): Calculated for C12H13F3O5S (M+H)+: 327.05203; found: 327.05085 
 
1,3-Dihexylquinazoline-2,4(1H,3H)-dione (S14) The title compound was prepared 









1-Methyl-1H-indazole (S15) The title compound was prepared according to a published 
procedure; spectra data are in agreement with literature values. 2 
 
2-Chloro-1-methyl-1H-benzo[d]imidazole (S16) The title compound was prepared 
according to a published procedure; spectra data are in agreement with literature values.11 
 
Methyl 2-(3-phenoxyphenyl)propanoate (S17) The title compound was prepared 
according to a published procedure; spectral data are in agreement with literature values.12 
 
Methyl 2-(2-fluoro-[1,1'-biphenyl]-4-yl)propanoate (S18) The title compound was 




















3-Methoxy-4-((triisopropylsilyl)oxy)benzaldehyde (S19) The title compound was 





((triisopropylsilyl)oxy)phenyl)acrylate (S20) Methyl 2-((tert-butoxycarbonyl)amino)-
2-(dimethoxyphosphoryl)acetate (2.58 g, 8.67 mmol, 1.2 equiv) was added to a flame dried 
round bottomed flask equipped with a stir bar and dissolved in 10 mL of dry DCM under N2. 
Then 1,8-diazabicyclo[5.4.0]undec-7-ene (1.09 mL, 7.23 mmol, 1.0 equiv) was added via 
syringe and the mixture was stirred at room temperature for 15 minutes. While the 
phosphonate ester solution was stirring, a solution of 3-methoxy-4-
((triisopropylsilyl)oxy)benzaldehyde (2.23 g, 7.23 mmol, 1.0 equiv) in 10 mL DCM was 
prepared. This benzaldehyde solution was added to the phosphonate ester solution dropwise 
at room temperature. Reaction conversion was monitored via TLC (reaction takes 
approximately 4 h.) and at the end of the reaction, the solution was concentrated and 
loaded onto Celite. The crude reaction mixture was then purified via flash chromatography 
(10 to 20 % EtOAc) to yield methyl 2-((tert-butoxycarbonyl)-amino)-3-(3-methoxy-4-











1H NMR (600 MHz, CDCl3) δ 7.20 (bs, 1H), 7.14 (s, 1H), 7.02 (d, J = 7.9 Hz, 1H), 6.80 
(d, J = 8.2 Hz, 1H), 6.25 (bs, 1H), 3.77 (s, 3H), 3.75 (s, 3H), 1.36 (bs, 9H), 1.25 – 1.16 
(m, 3H), 1.05 (d, J = 7.6 Hz, 18H). 
13C NMR (151 MHz, CDCl3) δ 166.31, 153.28, 150.58, 146.97, 132.02, 127.36, 123.85, 
122.58, 120.21, 113.29, 80.56, 55.21, 52.30, 28.09, 17.83, 12.86. 
 




((triisopropylsilyl)oxy)phenyl)acrylate (S21) To a dry, clean round bottomed flask 
equipped with a stir bar was added methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(3-
methoxy-4-((triisopropylsilyl)oxy)phenyl)acrylate (2.30 g, 4.79 mmol, 1.0 equiv), which 
was then dissolved in 60 mL of a THF:EtOH (2:1) solution. 10% Palladium on carbon (153.0 
mg, 1.44 mmol, 0.30 equiv) was added to the solution and the reaction was placed under 
N2. The solution was purged and backfilled with H2 before being placed under a H2 
atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). Once the 
reaction was complete, the solution was run through a Celite plug and concentrated. The 
crude mixture was then purified by flash chromatography (10% EtOAc:Hex) to yield methyl 
2-((tert-butoxycarbonyl)amino)-3-(3-methoxy-4-((triisopropylsilyl)oxy)phenyl)propanoate 
as a white solid (2.26 g, 98%).  
 
1H NMR (600 MHz, CDCl3) δ 6.78 (d, J = 8.0 Hz, 1H), 6.59 (d, J = 2.1 Hz, 1H), 6.54 (dd, 






1H) + rotamer at 4.34 (bs), 3.77 (s, 3H), 3.67 (s, 3H), 3.03 – 2.96 (m, 2H), 1.42 (s, 9H), 
1.27 – 1.15 (m, 3H), 1.08 (d, J = 7.4 Hz, 18H). 
13C NMR (151 MHz, CDCl3) δ 172.66, 155.22, 150.94, 144.70, 129.11, 121.50, 120.53, 
113.20, 80.00, 55.55, 54.69, 52.26, 38.21, 28.46, 18.03, 12.98. 
 




methoxyphenyl)propanoate (S22) Methyl 2-((tert-butoxycarbonyl)amino)-3-(3-
methoxy-4-((triisopropylsilyl)oxy)phenyl)propanoate (2.00g, 4.15 mmol, 1.0 equiv) was 
added to a clean, dry round bottomed flask equipped with a stir bar and the solid was 
dissolved in 35 mL of THF under N2. The solution was then cooled to 0 ºC before a solution 
of tetrabutylammonium fluoride (1.0 M in THF, 4.6 mL, 4.57 mmol, 1.1 equiv) was added 
dropwise to the reaction mixture. The reaction was then warmed to room temperature and 
allowed to stir for 2 h. At the end of the reaction, the reaction was quenched with 15 mL 
NH4Cl solution before being diluted with EtOAc. The layers were separated and the aqueous 
layer was extracted twice with 10 mL EtOAc. The organic layers were combined, dried over 
Na2SO4, concentrated and purified by flash chromatography (40-50% EtOAc:Hex) to yield 
methyl 2-((tert-butoxycarbonyl)amino)-3-(4-hydroxy-3-methoxyphenyl)propanoate as a 
white solid (1.25 g, 93%). 
 
1H NMR (600 MHz, CDCl3) δ 6.82 (d, J = 8.0 Hz, 1H), 6.65 – 6.56 (m, 2H), 5.57 (s, 1H), 






(bs), 3.86 (s, 3H), 3.71 (s, 3H), 3.01 (qd, J = 14.0, 6.0 Hz, 2H) + rotamer at 2.88 (bs), 
1.42 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.59, 155.23, 146.61, 144.83, 127.86, 122.22, 114.51, 
111.77, 80.06, 55.97, 54.69, 52.33, 38.13, 28.45. 
 
HRMS (ESI): Calculated for C16H23NO6 (M+Na)+: 348.14179; found: 348.14087. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(3-methoxy-4 
(((trifluoromethyl)sulfonyl)oxy)phenyl)-propanoate (S23) To a dry, clean round 
bottomed flask equipped with a stir bar was added methyl 2-((tert-butoxycarbonyl)amino)-
3-(4-hydroxy-3-methoxyphenyl)propanoate (1.25 g, 3.84 mmol, 1.0 equiv) and the solid 
was dissolved in 30 mL of DCM under N2. The solution was cooled to 0 ºC before pyridine 
(0.62 mL, 7.68 mmol, 2.0 equiv) was added to the solution. Trifluoromethanesulfonic 
anhydride (0.78 mL, 4.61 mmol, 1.2 equiv) was then added to the reaction dropwise and 
the solution was stirred for 15 minutes before being warmed to room temperature. The 
reaction was then run for 2 h. before being quenched with DI water. The reaction was then 
diluted with DCM before the layers were separated. The aqueous layer was extracted once 
with DCM (10 mL) and the organic layers were combined, washed sequentially with 10 mL 
of dilute HCl (2.0 M) and brine, dried over Na2SO4 and concentrated. The crude product was 
purified via flash chromatography (10% EtOAc) to yield methyl 2-((tert-
butoxycarbonyl)amino)-3-(3-methoxy-4 (((trifluoromethyl)sulfonyl)oxy)phenyl)-propanoate 
as a white solid (1.67 g, 95%). 
 
1H NMR (600 MHz, CDCl3) 1H NMR (600 MHz, CDCl3) δ 7.12 (d, J = 8.2 Hz, 1H), 6.81 (d, J 






4.60 (d, J = 7.1 Hz, 1H) + rotamer at 4.38 (bs), 3.88 (s, 3H), 3.70 (s, 3H), 3.13 (dd, J = 
14.0, 5.9 Hz, 1H), 3.02 (dd, J = 14.0, 6.8 Hz, 1H) + rotamer at 2.91 (bs), 1.40 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.10, 155.09, 151.31, 138.11, 137.84, 122.40, 121.71, 
118.83 (q, J = 320.3 Hz), 114.18, 80.29, 56.24, 54.28, 52.47, 38.46, 28.36. 
19F NMR (376 MHz, CDCl3) δ -73.76. 
 
HRMS (ESI): Calculated for C17H22F3NO8S (M+Na)+: 480.09106; found: 480.08988. 
 
Methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(3-methoxyphenyl)acrylate (S24) 
Methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate (2.500 g, 8.40 
mmol, 1.2 equiv) was added to a flame dried round bottomed flask equipped with a stir bar 
and dissolved in 15 mL of dry DCM under N2. Then 1,8-diazabicyclo[5.4.0]undec-7-ene 
(1.06 mL, 7.00 mmol, 1.0 equiv) was added via syringe and the mixture was stirred at 
room temperature for 15 minutes. While the phosphonate ester solution was stirring, a 
solution of 2-methoxybenzaldehyde (0.9530 g, 7.00 mmol, 1.0 equiv) in 15 mL DCM was 
prepared. This benzaldehyde solution was added to the phosphonate ester solution dropwise 
at room temperature. Reaction conversion was monitored via TLC (reaction takes 
approximately 4 h.) and at the end of the reaction, the solution was concentrated and 
loaded onto Celite. The crude reaction mixture was then purified via flash chromatography 
(20 to 30% EtOAc) to yield methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(3-
methoxyphenyl)acrylate as a white solid (1.84 g, 86%) 
 
1H NMR (600 MHz, CDCl3) δ 7.52 (d, J = 7.7 Hz, 1H), 7.34 (bs, 1H), 7.30 (t, J = 7.8 Hz, 
1H), 6.95 (t, J = 7.7 Hz, 1H), 6.92 (d, J = 8.3 Hz, 1H), 6.40 (bs, 1H), 3.87 (s, 2H), 3.84 (s, 





13C NMR (151 MHz, CDCl3) δ 166.25, 157.13, 152.87, 130.42, 129.80, 125.70, 123.76, 
123.17, 120.65, 111.15, 80.77, 55.77, 52.58, 28.16. 
 
HRMS (ESI): Calculated for C16H21NO5 (M+Na)+: 330.13122; found: 330.13130. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(3-methoxyphenyl)propanoate (S25) 
To a dry, clean round bottomed flask equipped with a stir bar was added methyl (Z)-2-
((tert-butoxycarbonyl)amino)-3-(3-methoxyphenyl)acrylate (1.84 g, 5.99 mmol, 1.0 equiv), 
which was then dissolved in 60 mL of a THF:EtOH (2:1) solution. 10% Palladium on carbon 
(191 mg, 0.30 mmol, 0.10 equiv) was added to the solution and the reaction was placed 
under N2. The solution was purged and backfilled with H2 before being placed under a H2 
atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). Once the 
reaction was complete, the solution was run through a Celite plug and concentrated. The 
crude mixture was then purified by flash chromatography (10 to 20% EtOAc:Hex) to yield 
methyl 2-((tert-butoxycarbonyl)amino)-3-(3-methoxyphenyl)propanoate as a white solid 
(1.75 g, 95%). The spectra data are in agreement with literature values.15 
 
Methyl (Z)-3-([1,1'-biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)acrylate (S26) 
Methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate (1.783 g, 6.00 
mmol, 1.2 equiv) was added to a flame dried round bottomed flask equipped with a stir bar 
and dissolved in 15 mL of dry DCM under N2. Then 1,8-diazabicyclo[5.4.0]undec-7-ene 
(0.75 mL, 5.00 mmol, 1.0 equiv) was added via syringe and the mixture was stirred at 







solution of biphenyl-4-carboxaldehyde (0.9111 g, 5.00 mmol, 1.0 equiv) in 15 mL DCM was 
prepared. This benzaldehyde solution was added to the phosphonate ester solution dropwise 
at room temperature. Reaction conversion was monitored via TLC (reaction takes 
approximately 4 h.) and at the end of the reaction, the solution was concentrated and 
loaded onto Celite. The crude reaction mixture was then purified via flash chromatography 
(20 to 30% EtOAc) to yield methyl (Z)-3-([1,1'-biphenyl]-4-yl)-2-((tert-
butoxycarbonyl)amino)acrylate as a white solid (1.56 g, 88%). The spectra data are in 
agreement with literature values.16  
 
Methyl 3-([1,1'-biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)propanoate (S27) 
To a dry, clean round bottomed flask equipped with a stir bar was added methyl (Z)-3-
([1,1'-biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)acrylate (1.55 g, 4.39 mmol, 1.0 
equiv), which was then dissolved in 20 mL of a THF:EtOH (3:1) solution. 10% Palladium on 
carbon (93.3 mg, 0.20 mmol, 0.10 equiv) was added to the solution and the reaction was 
placed under N2. The solution was purged and backfilled with H2 before being placed under a 
H2 atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). Once the 
reaction was complete, the solution was run through a Celite plug and concentrated. The 
crude mixture was then purified by flash chromatography (10 to 20% EtOAc:Hex) to yield 
methyl 3-([1,1'-biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)propanoate as a white solid 
(1.34 g, 97%). The spectra data are in agreement with literature values.17 





C.3.3 Preparation of aromatic fluorinated standards (5.7, 5.12, 5.13, 5.14, 5.17, 
5.19, 5.20 [2-F], 5.21-5.24, 5.26-5.42) and corresponding synthetic intermediates 
(i-1 – i-39) 
 
The following fluorination standards were obtained from commercial vendors and used as 
received: 4-fluorophenoxybenzene (5.2), 4-fluorobiphenyl (5.3) , 1-fluoronaphthalene 
(5.4), 2-bromo-4-fluoroanisole (5.5), 2-chloro-4-fluoroanisole (5.6), methyl 5-fluoro-2-
methoxybenzoate (5.8), 1-(5-fluoro-2-methoxyphenyl)ethenone (5.9), 5-fluoro-2-
methoxybenzonitrile (5.10), 5-fluoro-2-methoxybenzaldehyde (5.11), 3-fluoro-4-
methoxybenzaldehyde (5.15), 1-(3-fluoro-4-methoxyphenyl)ethenone (5.16), methyl 3-
fluoro-4-methoxybenzoate (5.18), 1-(4-fluoro-3-methoxyphenyl)ethenone (5.20, [4-F]) 
and 2-fluoromesitylene (5.25). 
 
General Method A (Synthesis of 5.26 and 5.27) 
To a clean, dry 2 dram vial containing a Teflon-coated magnetic stir bar was added 380.0 
mg of cesium fluoride (2.50 mmol, 10 equiv) under an inert atmosphere. The vial was then 
removed from the inert atmosphere and a series of reagents were added: 0.0125 mmol of 
S1 (0.05 equiv), tetrabutylammonium hydrogensulfate (2.50 mmol, 1.0 equiv), 2,2,6,6-
tetramethyl-1-piperidinyloxy (0.125 mmol, 0.50 equiv), and arene (0.25 mmol, 1.0 equiv). 
The reagent mixture was then dissolved in solvent (2.5 mL, 0.1 M) and DI water (0.25 mL, 
1.0 M) was subsequently added. The vial was then sealed with a Teflon-lined septum screw 
cap. The septum was pierced with a disposable steel needle connected to a balloon 
containing positive oxygen pressure. A vent needle was inserted and the reaction medium 
was sparged for 10 minutes by bubbling oxygen through the mixture. The vent needle was 
removed and the positive oxygen pressure was maintained. The vial was positioned on a stir 
plate approximately 3-4 cm from a Par38 LED lamp supplying blue light (λ = 440-460 nm) 
and irradiated for a designated time. The crude reaction mixture was then concentrated in 
 296 
vacuo and purified by reverse-phase flash liquid chromatography (conditions noted in each 
entry). 
 
5-Fluoro-2-methoxyphenyl trifluoromethanesulfonate (5.7) 5-fluoro-2-
methoxyphenol (0.426 g, 3.00 mmol, 1.0 equiv) was added to a dry, clean round bottomed 
flask equipped with a stir bar and dissolved in 20 mL of DCM under N2. The solution was 
cooled to 0 ºC before pyridine (0.48 mL, 6.00 mmol, 2.0 equiv) was added to the solution. 
Trifluoromethanesulfonic anhydride (0.60 mL, 3.60 mmol, 1.2 equiv) was then added to the 
reaction dropwise and the solution was stirred for 15 minutes before being warmed to room 
temperature. The reaction was then run for 2 h. before being quenched with DI water. The 
reaction was then diluted with DCM before the layers were separated. The aqueous layer 
was extracted once with DCM (10 mL) and the organic layers were combined, washed 
sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over Na2SO4 and 
concentrated. The crude product was purified via flash chromatography (10 to 20% EtOAc) 
to yield 5-fluoro-2-methoxyphenyl trifluoromethanesulfonate as a yellow oil (757 mg, 92%). 
 
1H NMR (600 MHz, CDCl3) δ 7.05 (ddd, J = 9.1, 7.7, 3.0 Hz, 1H), 7.02 – 6.97 (m, 2H), 
3.88 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.90 (d, J = 243.1 Hz), 148.30 (d, J = 3.2 Hz), 138.30 (d, 
J = 11.0 Hz), 118.87 (q, J = 320.3 Hz), 115.68 (d, J = 22.4 Hz), 113.69 (d, J = 8.8 Hz), 
110.81 (d, J = 26.9 Hz), 56.68. 
19F NMR (376 MHz, CDCl3) δ -73.68, -120.14 (td, J = 7.8, 5.1 Hz). 
 






N,N-Diethyl-5-fluoro-2-methoxybenzamide (5.12) To a clean, dry round bottomed 
flask equipped with a stir bar was added 5-fluoro-2-methoxybenzoic acid (851 mg, 5.00 
mmol, 1.0 equiv). The solid was dissolved in PhMe (10 mL) before a catalytic amount of 
DMF (19.4 µL, 0.25 mmol, 0.05 equiv) and thionyl chloride (0.73 mL, 10.0 mmol, 2.0 equiv) 
was added. The reaction was allowed to stir for 2 h. before being concentrated under 
reduced pressure to yield the acid chloride as a pale yellow solid. The crude product was 
then dissolved in 10 mL of DCM under N2 and cooled to 0 ºC. Triethylamine (1.74 mL, 12.5 
mmol, 2.5 equiv) and diethylamine (0.67 mL, 6.5 mmol, 1.3 equiv) were sequentially added 
and the reaction mixture was stirred at 0 ºC for 30 min. before warming up to room 
temperature, where it was stirred further for an additional hour. At the end of the reaction, 
the mixture was quenched with 10 mL dilute acid (3 N HCl solution) and the layers were 
separated. The aqueous layer was extracted with 2 x 10 mL of DCM and the organic layers 
were combined. The organic layers were washed sequentially with saturated NaHCO3 
solution and brine, dried over Na2SO4 and concentrated to yield a yellow liquid. The crude 
product was then purified by flash chromatography (50% EtOAc:Hex) to yield N,N-diethyl-
5-fluoro-2-methoxybenzamide as a pale yellow liquid (1.01 g, 89%). 
 
1H NMR (600 MHz, CDCl3) δ 6.96 (ddd, J = 9.1, 8.0, 3.1 Hz, 1H), 6.87 (dd, J = 8.0, 3.1 
Hz, 1H), 6.80 (dd, J = 9.1, 4.1 Hz, 1H), 3.74 (s, 3H), 3.57 – 3.43 (m, 2H), 3.10 (q, J = 7.2 
Hz, 2H), 1.19 (t, J = 7.2 Hz, 3H), 1.00 (t, J = 7.2 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 167.24 (d, J = 1.8 Hz), 156.81 (d, J = 240.3 Hz), 151.35 (d, 
J = 2.1 Hz), 128.03 (d, J = 6.9 Hz), 115.91 (d, J = 22.8 Hz), 114.45 (d, J = 24.4 Hz), 








9F NMR (376 MHz, CDCl3) δ -123.19 (td, J = 8.0, 4.1 Hz). 
 
HRMS (ESI): Calculated for C12H16FNO2 (M+H)+: 226.1243; found: 226.1232. 
 
5'-Fluoro-2'-methoxy-[1,1'-biphenyl]-4-carbonitrile (5.13) To a dry, clean 3-neck 
round bottomed flask equipped with a stir bar and a condenser was added (5-fluoro-2-
methoxyphenyl)boronic acid (357 mg, 2.10 mmol, 1.05 equiv), potassium carbonate (829 
mg, 6.00 mmol, 3.0 equiv) and 4-bromobenzonitrile (364 mg, 2.00 mmol, 1.0 equiv). The 
flask was then transferred to a glovebox (N2), where tetrakis(triphenylphosphine)-
palladium(0) (231.1 mg, 0.200 mmol, 0.10 equiv) was added to the mixture. The flask was 
then sealed with rubber septa, brought out of the glovebox and placed under positive N2 
pressure. 1,2-Dimethoxyethane (13 mL) and degassed H2O (4 mL) were then added to the 
reaction mixture and stirred. The suspension was then purged and backfilled three times 
with N2 before being heated to 80 ºC for 22 h. At the end of the reaction, the mixture was 
cooled to room temperature and subsequently diluted with ether. The suspension was then 
neutralized with 2 N HCl solution (10 mL) and the layers were separated. The aqueous layer 
was then extracted twice with ether (2 x 10 mL) and the organic layers were combined. The 
organic layers were then washed sequentially with NaHCO3 solution and brine, dried over 
Na2SO4 and concentrated to yield an off-white solid. The crude product was then purified by 
flash chromatography (10 to 15% EtOAc:Hex) to yield a white solid (426 mg, 94%). 
  
1H NMR (600 MHz, CDCl3) δ 7.69 (d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 1H), 7.07 (ddd, 
J = 9.0, 7.8, 3.2 Hz, 1H), 7.03 (dd, J = 8.8, 3.1 Hz, 1H), 6.94 (dd, J = 9.0, 4.4 Hz, 1H), 





13C NMR (151 MHz, CDCl3) δ 156.98 (d, J = 239.8 Hz), 152.44 (d, J = 2.4 Hz), 142.09, 
129.65 (d, J = 7.3 Hz), 117.08 (d, J = 23.8 Hz), 115.62 (d, J = 22.6 Hz), 112.41 (d, J = 
8.2 Hz), 56.06. 
19F NMR (376 MHz, CDCl3) δ -123.36 (td, J = 8.3, 4.6 Hz). 
 
HRMS (ESI): Calculated for C14H9ClFNO (M+H)+: 228.0825; found: 228.0814. 
 
 
2'-Chloro-5-fluoro-2-methoxy-1,1'-biphenyl (5.14) To a dry, clean 3-neck round 
bottomed flask equipped with a stir bar and a condenser was added (2-chlorophenyl)boronic 
acid (1.06 g, 6.80 mmol, 1.7 equiv) and potassium carbonate (1.38 g, 10.0 mmol, 2.5 
equiv). The flask was transferred into a glovebox (N2), where tetrakis(triphenylphosphine)-
palladium(0) (231.1 mg, 0.200 mmol, 0.10 equiv) was added to the mixture. The flask was 
then sealed with rubber septa, brought out of the glovebox and placed under positive N2 
pressure. 1,2-Dimethoxyethane (27 mL) and degassed H2O (5 mL) were then added to the 
reaction mixture and stirred. 2-Bromo-4-fluoroanisole (0.52 mL, 4.00 mmol, 1.0 equiv) was 
added to the reaction before the suspension was purged and backfilled three times with N2. 
The reaction was then heated to 80 ºC for 22 h. At the end of the reaction, the mixture was 
cooled to room temperature and subsequently diluted with ether. The suspension was then 
neutralized with 2 N HCl solution (10 mL) and the layers were separated. The aqueous layer 
was then extracted twice with ether (2 x 10 mL) and the organic layers were combined. The 
organic layers were then washed sequentially with NaHCO3 solution and brine, dried over 
Na2SO4 and concentrated. The crude product was then purified by flash chromatography (10 






1H NMR (600 MHz, CDCl3) δ 7.50 (dt, J = 7.6, 3.0 Hz, 1H), 7.33 (dd, J = 5.9, 3.7 Hz, 
3H), 7.10 (ddd, J = 9.0, 8.0, 3.2 Hz, 1H), 6.98 (dd, J = 8.6, 3.2 Hz, 1H), 6.94 (dd, J = 9.0, 
4.4 Hz, 1H), 3.78 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.74 (d, J = 238.9 Hz), 153.13 (d, J = 2.2 Hz), 136.74 (d, 
J = 1.8 Hz), 133.84, 131.60, 129.86 (d, J = 8.0 Hz), 129.53, 129.02, 126.62, 117.89 (d, J 
= 23.3 Hz), 115.21, 112.09 (d, J = 8.3 Hz), 56.30. 
19F NMR (376 MHz, CDCl3) δ -124.24 (td, J = 8.2, 4.4 Hz). 
 
HRMS (ESI): Calculated for C13H10ClFO (M)+: 236.0404; found: 236.0256. 
 
N-Methoxy-N-methylbenzamide (i-1) was prepared according to a published procedure; 
spectra data are in agreement with literature values.18 
 
(3-Fluoro-4-methoxyphenyl)(phenyl)methanone (5.17) To a clean, dry round-
bottomed flask equipped with a stir bar was added 4-bromo-2-fluoroanisole (0.38 mL, 2.94 
mmol, 0.91 equiv) under N2. Then THF (20 mL) was added and the reaction was cooled to -
78 ºC. A solution of nBuLi (2.5 M in hexanes, 1.3 mL, 3.23 mmol, 1.0 equiv) was added 
dropwise under positive N2 pressure and the reaction was allowed to stir for 20 minutes. A 
solution of N-methoxy-N-methylbenzamide (0.535 g, 3.24 mmol, 1.0 equiv) in THF (5 mL) 
was prepared and added dropwise to the aryllithium species under positive N2 pressure. The 
solution was allowed to stir at -78 ºC for 1.5 h and subsequently quenched at -78ºC with i-
PrOH (5 mL) and DI H2O (5 mL), and allowed to warm to room temperature. Ether (10 mL) 









separated. The aqeuous layer was extracted with ether (10 mL x 2) and the organic layers 
were combined. The combined organic fractions were washed with brine, dried over Na2SO4 
and concentrated. The crude mixture was purified via flash chromatography (10 to 20% 
EtOAc:Hex) to yield (3-fluoro-4-methoxyphenyl)(phenyl)methanone as a white solid (0.447 
g, 60%). The spectral data for the product are in agreement with literature values.19 
 
N,N-Diethyl-3-fluoro-4-methoxybenzamide (5.19) To a clean, dry round bottomed 
flask equipped with a stir bar was added 3-fluoro-4-methoxybenzoic acid (0.680 mg, 4.00 
mmol, 1.0 equiv). The solid was dissolved in PhMe (10 mL) before a catalytic amount of 
DMF (16.0 µL, 0.20 mmol, 0.05 equiv) and thionyl chloride (0.58 mL, 8.00 mmol, 2.0 equiv) 
was added. The reaction was allowed to stir for 2 h. before being concentrated under 
reduced pressure to yield the acid chloride as a pale yellow solid. The crude product was 
then dissolved in 10 mL of DCM under N2 and cooled to 0 ºC. Triethylamine (1.40 mL, 10.0 
mmol, 2.5 equiv) and diethylamine (0.54 mL, 5.2 mmol, 1.3 equiv) were sequentially added 
and the reaction mixture was stirred at 0 ºC for 30 min. before warming up to room 
temperature, where it was stirred further for an additional hour. At the end of the reaction, 
the mixture was quenched with 10 mL dilute acid (3 N HCl solution) and the layers were 
separated. The aqueous layer was extracted with 2 x 10 mL of DCM and the organic layers 
were combined. The organic layers were washed sequentially with saturated NaHCO3 
solution and brine, dried over Na2SO4 and concentrated to yield a yellow liquid. The crude 
product was then purified by flash chromatography (50% EtOAc:Hex) to yield N,N-diethyl-









1H NMR (600 MHz, CDCl3) δ 7.04 – 6.93 (m, 2H), 6.86 (t, J = 8.5 Hz, 1H), 3.77 (s, 3H), 
3.43 – 3.02 (m, 4H, 2 rotamers), 1.05 (bs, 6H, 2 rotamers). 
13C NMR (151 MHz, CDCl3) δ 151.61 (d, J = 247.4 Hz), 148.30 (d, J = 10.4 Hz), 129.59 
(d, J = 5.6 Hz), 122.70 (d, J = 3.7 Hz), 114.64 (d, J = 19.5 Hz), 112.83 (d, J = 2.1 Hz), 
56.00, 43.20, 39.32, 13.92, 12.66. 
19F NMR (376 MHz, CDCl3) δ -129.35 – -145.34 (m). 
 




1-(2-Fluoro-5-methoxyphenyl)ethan-1-ol (i-2) To a clean, dry 2-neck round bottomed 
flask equipped with a stir bar was added 2-fluoro-5-methoxybenzaldehyde (0.50 mL, 4.00 
mmol, 1.0 equiv), which was then dissolved in THF (10 mL) under N2. The reaction was 
cooled to 0 ºC before a solution of methylmagnesium bromide (3.0 M in THF, 1.6 mL, 4.80 
mmol, 1.2 equiv) was added dropwise. The reaction was then warmed up to room 
temperature and allowed to stir for 5 h. After the reaction was complete, the solution was 
quenched with HCl solution (3 N, 10 mL) and diluted with EtOAc (15 mL). The layers were 
separated and the aqueous layer was extracted once with 10 mL of EtOAc. The organic 























product was purified via flash chromatography (10 to 30% EtOAc:Hex) to yield 1-(2-fluoro-
5-methoxyphenyl)ethan-1-ol (0.64 g, 94%). 
 
1H NMR (600 MHz, CDCl3) δ 7.00 (dd, J = 6.0, 3.2 Hz, 1H), 6.92 (t, J = 9.4 Hz, 1H), 6.72 
(dt, J = 8.9, 3.6 Hz, 1H), 5.14 (qd, J = 6.5, 2.6 Hz, 1H), 3.77 (s, 3H), 2.33 (s, 1H),1.47 (d, 
J = 6.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.89 (d, J = 2.0 Hz), 153.95 (d, J = 237.5 Hz), 133.55 (d, 
J = 15.3 Hz), 115.90 (d, J = 23.8 Hz), 113.55 (d, J = 8.2 Hz), 111.36 (d, J = 4.5 Hz), 
64.54 (d, J = 2.5 Hz), 55.82, 24.11. 
19F NMR (376 MHz, CDCl3) δ -130.65 (dt, J = 10.1, 4.6 Hz). 
 
HRMS (ESI): Calculated for C9H11FO2 (M+)+: 170.07430; found: 170.0731 
 
1-(2-Fluoro-5-methoxyphenyl)ethan-1-one (5.20, 2-F) To a clean, dry round 
bottomed flask equipped with a stir bar was added 1-(2-fluoro-5-methoxyphenyl)ethan-1-ol 
(0.53 g, 3.12 mmol, 1.0 equiv), which was then dissolved in 10 mL of DCM. Pyridinium 
dichromate (3.52 g, 9.36 mmol, 3.0 equiv) was then added to the reaction mixture and 
allowed to stir overnight. At the end of the reaction, the solution was diluted with 20 mL of 
DCM and filtered through Celite. The filtrate was then concentrated and purified via flash 
chromatography (5-10% EtOAc:Hex) to yield 1-(2-fluoro-5-methoxyphenyl)ethan-1-one as 
a colorless liquid (0.45 g, 87%). 
 
1H NMR (600 MHz, CDCl3) δ 7.32 – 7.28 (m, 1H), 7.04 – 7.02 (m, 1H), 7.02 (d, J = 1.9 






13C NMR (151 MHz, CDCl3) δ 195.83 (d, J = 3.8 Hz), 156.99 (d, J = 247.9 Hz), 155.68 (d, 
J = 1.9 Hz), 125.58 (d, J = 14.4 Hz), 121.79 (d, J = 8.8 Hz), 117.72 (d, J = 26.4 Hz), 
112.60 (d, J = 2.7 Hz), 55.91, 31.57 (d, J = 8.1 Hz). 
19F NMR (376 MHz, CDCl3) δ -119.33 (dt, J = 8.1, 4.8 Hz). 
 




2-Fluoro-4-hydroxy-5-methoxybenzaldehyde (i-3, major) and 2-fluoro-5-hydroxy-
4-methoxybenzaldehyde (i-4, minor) To a clean, dry round bottomed flask equipped 
with a stir bar was added 2-fluoro-4,5-dimethoxybenzaldehyde (1.84 g, 10.0 mmol, 1.0 
equiv), which was then dissolved in 100 mL of DCM. Aluminum trichloride (8.00 g, 60.0 
mmol, 6.0 equiv) was then added in three portions to the reaction mixture and the reaction 















































exothermic!) and stirred until all the ice was melted. The organic layer was then separated, 
dried over MgSO4 and concentrated to yield an off-white solid. The crude product (1.68 g, 
98.8%) was clean by 1H-NMR analysis and showed an approximate 9:1 ratio of the major 
isomer 2-fluoro-4-hydroxy-5-methoxybenzaldehyde to the minor isomer 2-fluoro-5-
hydroxy-4-methoxybenzaldehyde. The assigned peaks for the products are in agreement 




1H NMR (600 MHz, CDCl3) δ 10.21 (s, 1H), 7.29 (d, J = 6.1 Hz, 1H), 6.71 (d, J = 10.9 Hz, 
1H), 6.38 (d, J = 1.6 Hz, 1H), 3.93 (s, 3H).  
13C NMR (151 MHz, CDCl3) δ 185.97 (d, J = 6.9 Hz), 161.63 (d, J = 253.0 Hz), 153.15 (d, 
J = 13.4 Hz), 143.81 (d, J = 2.0 Hz), 116.58 (d, J = 9.0 Hz), 107.64 (d, J = 3.4 Hz), 
102.90 (d, J = 26.3 Hz), 56.61. 
19F NMR (376 MHz, CDCl3) δ -128.32. (ddd, J = 11.0, 6.1, 1.5 Hz) 
Minor:  
1H NMR (600 MHz, CDCl3) δ 10.21 (s, 1H), 7.35 (d, J = 6.7 Hz, 1H), 6.65 (d, J = 11.2 Hz, 
1H), 5.52 (s, 1H), 3.97 (s, 3H). 
13C assignments for the minor isomer were not provided due to low abundance. 
19F NMR (376 MHz, CDCl3) δ -128.58 (multiplet not assigned due to low abundance) 
 










5-Fluoro-2-methoxy-4-vinylphenol (i-5, major) and 4-fluoro-2-methoxy-5-
vinylphenol (i-6, minor) To a clean, dry two-neck round bottomed flask equipped with an 
addition funnel and a stir bar was added methyltriphenylphosphonium bromide (5.29 g, 
14.8 mmol, 1.5 equiv), which was dissolved in dry THF (20 mL). The reaction was then 
placed under N2 and potassium tert-butoxide (2.77 g, 24.7 mmol, 2.5 equiv) was added to 
the mixture, which turned bright yellow, and the suspension was stirred for 10 minutes. A 
solution of 2-fluoro-4-hydroxy-5-methoxybenzaldehyde and 2-fluoro-5-hydroxy-4-
methoxybenzaldehyde (9:1) in THF (10 mL) was prepared and transferred to the addition 
funnel, where it was then added to the ylide suspension. The reaction was then stirred 
overnight at room temperature and when the reaction was complete, it was quenched with 
saturated ammonium chloride solution (15 mL) and diluted with DCM (20 mL). The layers 
were separated and the aqueous layer was extracted twice with DCM (2 x 10 mL). The 
organic layers were collected and washed with brine, dried over Na2SO4 and concentrated. 
The crude product was then purified via flash chromatography (15 to 30% EtOAc:Hex) to 
yield a pale, off-white solid (1.57 g, 95%) containing a 9:1 ratio of 5-fluoro-2-methoxy-4-
vinylphenol to 4-fluoro-2-methoxy-5-vinylphenol. 
 
Major:  
1H NMR (600 MHz, CDCl3) δ 6.92 (d, J = 6.8 Hz, 1H), 6.81 (dd, J = 17.7, 11.2 Hz, 1H), 
6.65 (d, J = 10.9 Hz, 1H), 5.75 (s, 1H), 5.64 (dd, J = 17.7, 1.1 Hz, 1H), 5.24 (dd, J = 11.2, 
1.1 Hz, 1H), 3.90 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.14 (d, J = 243.1 Hz), 146.40 (d, J = 13.1 Hz), 143.20 
(d, J = 2.6 Hz), 129.21 (d, J = 3.8 Hz), 116.52 (d, J = 13.8 Hz), 113.60 (d, J = 4.6 Hz), 
107.76 (d, J = 5.3 Hz), 102.86 (d, J = 27.8 Hz), 56.50. 




1H NMR (600 MHz, CDCl3) δ 7.03 (d, J = 7.3 Hz, 1H), 6.79 (dd, J = 17.7, 11.2 Hz, 1H), 
6.58 (d, J = 11.2 Hz, 1H), 5.65 (dd, J = 17.7, 1.1 Hz, 1H), 5.33 (s, 1H), 5.24 (dd, J = 11.2, 
1.0 Hz, 1H), 3.87 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 154.20 (d, J = 242.3 Hz), 146.75 (d, J = 10.1 Hz), 141.81 
(d, J = 2.6 Hz), 128.74 (d, J = 3.8 Hz), 117.59 (d, J = 13.7 Hz), 114.30 (d, J = 4.4 Hz), 
111.14 (d, J = 4.9 Hz), 99.36 (d, J = 28.6 Hz), 56.32. 
19F NMR (376 MHz, CDCl3) δ -126.55. 
 
HRMS (ESI): Calculated for C9H9FO2 (M+H)+: 169.0656; found: 169.0665. 
 
4-Ethyl-5-fluoro-2-methoxyphenol (i-7, major) and 5-ethyl-4-fluoro-2-
methoxyphenol (i-8, minor) To a dry, clean round bottomed flask equipped with a stir 
bar was added a solid containing a 9:1 mixture of 5-fluoro-2-methoxy-4-vinylphenol and 4-
fluoro-2-methoxy-5-vinylphenol (1.54 g, 9.16 mmol, 1.0 equiv), which was then dissolved 
in 20 mL of a THF. 10% Palladium on carbon (97.5 mg, 0.92 mmol, 0.10 equiv) was added 
to the solution and the reaction was placed under N2. The solution was purged and 
backfilled with H2 before being placed under a H2 atmosphere (1 atm) overnight (reaction is 
typically done in about 2-3 hours). Once the reaction was complete, the solution was run 
through a Celite plug and concentrated. The crude mixture was then purified by flash 
chromatography (10% EtOAc:Hex) to yield a colorless liquid (1.50 g, 96%) containing a 













1H NMR (600 MHz, CDCl3) δ  6.65 (d, J = 7.1 Hz, 2H), 6.64 (d, J = 10.4 Hz, 2H), 5.63 (s, 
1H), 5.63 (s, 1H), 3.86 (s, 3H), 2.59 (qd, J = 7.6, 1.3 Hz, 2H), 1.20 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.18 (d, J = 237.1 Hz), 144.30 (d, J = 12.6 Hz), 142.80 
(d, J = 2.5 Hz), 121.43 (d, J = 17.8 Hz), 111.59 (d, J = 6.7 Hz), 102.66 (d, J = 28.2 Hz), 
56.55, 22.03 (d, J = 2.4 Hz), 14.97. 
19F NMR (376 MHz, CDCl3) δ -126.85 (dd, J = 10.3, 7.4 Hz) 
Minor:  
1H NMR (600 MHz, CDCl3)  δ 6.75 (d, J = 7.4 Hz, 1H), 6.58 (d, J = 10.7 Hz, 1H), 5.36 (s, 
1H), 3.84 (s, 3H). 2.60-2.55 (m, 2H), 1.20-1.17 (m, 3H). 
13C NMR (151 MHz, CDCl3) δ 154.29 (d, J = 236.5 Hz), 144.79 (d, J = 10.0 Hz), 141.48 
(d, J = 2.8 Hz), 122.71 (d, J = 17.6 Hz), 114.77 (d, J = 6.3 Hz), 99.38 (d, J = 28.6 Hz), 
56.30, 21.61 (d, J = 2.6 Hz), 14.70. 
19F NMR (376 MHz, CDCl3) δ -127.56 (dd, J = 10.7, 7.5 Hz). 
 
HRMS (ESI): Calculated for C9H11FO2 (M)+: 170.0734; found: 170.0749. 
 
4-Ethyl-5-fluoro-2-methoxyphenyl trifluoromethanesulfonate (5.21, major) and 5-
ethyl-4-fluoro-2-methoxyphenyl trifluoromethanesulfonate (i-9, minor) To a dry, 
clean round bottomed flask equipped with a stir bar was added a 9:1 mixture of 4-ethyl-5-
fluoro-2-methoxyphenol to 5-ethyl-4-fluoro-2-methoxyphenol (1.10 g, 6.46 mmol, 1.0 
equiv), which was then dissolved in 20 mL of DCM under N2. The solution was cooled to 0 











Trifluoromethanesulfonic anhydride (1.31 mL, 7.76 mmol, 1.2 equiv) was then added to the 
reaction dropwise and the solution was stirred for 15 minutes before being warmed to room 
temperature. The reaction was then run for 2 h. before being quenched with DI water. The 
reaction was then diluted with DCM before the layers were separated. The aqueous layer 
was extracted once with DCM (10 mL) and the organic layers were combined, washed 
sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over Na2SO4 and 
concentrated. The crude product was purified via flash chromatography (10% EtOAc) to 
yield a yellow liquid (1.77 g, 91%) consisting of a 9:1 mixture of 4-ethyl-5-fluoro-2-




1H NMR (600 MHz, CDCl3) δ 6.94 (d, J = 8.9 Hz, 1H), 6.86 (d, J = 6.8 Hz, 1H), 3.88 (s, 
3H), 2.67 (qd, J = 7.6, 1.4 Hz, 2H), 1.24 (t, J = 7.7 Hz, 3H).  
13C NMR (151 MHz, CDCl3) δ 153.78 (d, J = 241.6 Hz), 147.92 (d, J = 3.0 Hz), 136.05 (d, 
J = 11.1 Hz), 132.12 (d, J = 17.5 Hz), 118.87 (q, J = 320.3 Hz), 113.82 (d, J = 5.7 Hz), 
110.27 (d, J = 28.1 Hz), 56.66, 22.50 (d, J = 2.2 Hz), 14.24 (d, J = 1.2 Hz). 
19F NMR (376 MHz, CDCl3) δ -73.71, -125.35. 
Minor:  
1H NMR (600 MHz, CDCl3) δ 7.06 (d, J = 7.1 Hz, 1H), 6.72 (d, J = 10.8 Hz, 1H), 3.87 (s, 
3H), 2.61 (qd, J = 7.5, 1.2 Hz, 2H), 1.20 (t, J = 7.6 Hz, 3H).  
13C NMR (151 MHz, Chloroform-d) δ 160.09 (d, J = 247.4 Hz), 150.48 (d, J = 10.6 Hz), 
134.58 (d, J = 3.4 Hz), 123.37 (d, J = 19.1 Hz), 123.12 (d, J = 7.8 Hz), 118.90 (q, J = 
320.3 Hz), 101.40 (d, J = 28.7 Hz), 56.53, 21.43 (d, J = 2.2 Hz), 14.19. 
19F NMR (376 MHz, CDCl3) δ -73.68, -114.61. 
 





2-Fluoro-4-hydroxy-5-methoxybenzaldehyde oxime (i-10) To a clean, dry two-neck 
round bottomed flask equipped with a condenser and a stir bar was added 2-fluoro-4-
hydroxy-5-methoxybenzaldehyde (681 mg, 4.00 mmol, 1.0 equiv), which was then 
dissolved in EtOH (8 mL) and placed under N2. Hydroxylamine sulfate (629 mg, 4.80 mmol, 
1.2 equiv) and sodium acetate (328 mg, 4.00 mmol, 1.0 equiv) were then added 
successively to the reaction mixture and the suspension was refluxed for 4 h. Once the 
reaction was complete, it was cooled to room temperature and concentrated under reduced 
pressure. The crude mixture was then resuspended in CH2Cl2 (10 mL), filtered and washed 
with CH2Cl2. The filtrate was then concentrated and purified via flash chromatography (30% 
EtOAc:Hex) to yield 2-fluoro-4-hydroxy-5-methoxybenzaldehyde oxime as a white solid 
(740 mg, 99%). 
 
1H NMR (600 MHz, DMSO-d6) δ 11.20 (s, 1H), 10.00 (s, 1H), 8.08 (s, 1H), 7.14 (d, J = 









































13C NMR (151 MHz, DMSO-d6) δ 154.74 (d, J = 242.8 Hz), 149.38 (d, J = 11.8 Hz), 
144.84 (d, J = 1.7 Hz), 141.55 (d, J = 2.3 Hz), 110.12 (d, J = 12.1 Hz), 108.02 (d, J = 4.8 
Hz), 103.23 (d, J = 25.4 Hz), 56.01.  
19F NMR (376 MHz, DMSO) δ -127.84 (dt, J = 11.6, 5.6 Hz). 
 
HRMS (ESI): Calculated for C8H8FNO3 (M+H)+: 186.05609; found: 186.05579. 
 
4-(Aminomethyl)-5-fluoro-2-methoxyphenol hydrochloride (i-11) To a dry, clean 
round bottomed flask equipped with a stir bar was added 2-fluoro-4-hydroxy-5-
methoxybenzaldehyde oxime (0.699 g, 3.78 mmol, 1.0 equiv), which was then dissolved in 
50 mL of EtOH.10% Palladium on carbon (40.2 mg, 0.38 mmol, 0.10 equiv) and HCl (14 N, 
2.73 mL, 90 mmol, 24 equiv) were added to the solution and the reaction was placed under 
N2. The solution was purged and backfilled with H2 before being placed under a H2 
atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). Once the 
reaction was complete, the solution was run through a Celite plug and concentrated. The 
crude product was then reconstituted in EtOH and concentrated again to remove excess 
HCl. This process yields 4-(aminomethyl)-5-fluoro-2-methoxyphenol hydrochloride as a tan-
grey solid (0.760 g, 97%).  
 
1H NMR (600 MHz, DMSO-d6) δ 9.87 (s, 1H), 8.39 (s, 3H), 7.21 (d, J = 7.3 Hz, 1H), 6.70 
(d, J = 11.0 Hz, 1H), 3.91 (d, J = 5.1 Hz, 2H), 3.75 (s, 3H).  
13C NMR (151 MHz, DMSO-d6) δ 154.50 (d, J = 238.8 Hz), 148.35 (d, J = 11.6 Hz), 
144.30 (d, J = 2.0 Hz), 114.45 (d, J = 4.8 Hz), 109.69 (d, J = 16.1 Hz), 103.02 (d, J = 







19F NMR (376 MHz, DMSO-d6) δ -125.73 (dd, J = 10.8, 7.3 Hz). 
 
HRMS (ESI): Calculated for C8H10FNO2 (M+H)+: 172.07683; found: 172.07653 (only free 
amine mass detected). 
 
tert-Butyl (2-fluoro-4-hydroxy-5-methoxybenzyl)carbamate (i-12) To a dry, clean 
round bottomed flask equipped with a stir bar was added 4-(aminomethyl)-5-fluoro-2-
methoxyphenol hydrochloride (300 mg, 1.45 mmol, 1.0 equiv), which was dissolved in 10 
mL of DCM. The suspension is then placed under N2 and cooled to 0 ºC before successive 
additions of triethylamine (0.66 mL, 4.77 mmol, 3.3 equiv) and di-tert-butyl dicarbonate 
(0.34 mL, 1.46 mmol, 1.01 equiv). The reaction is allowed to stir for 30 min. before it is 
warmed to room temperature and stirred overnight. At the end of the reaction, the reaction 
was quenched with DI H2O and the layers separated. The aqueous layer was extracted with 
DCM (2 x 5 mL) and the organic layers were combined, dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified via flash chromatography (30 to 
40% EtOAc:Hex) to yield tert-butyl (2-fluoro-4-hydroxy-5-methoxybenzyl)carbamate as a 
white solid (333.0 mg, 85%) 
 
1H NMR (600 MHz, CDCl3) δ 6.76 (d, J = 6.5 Hz, 1H), 6.59 (dd, J = 11.2, 4.7 Hz, 1H), 
6.36 (bs, 1H), 5.06 (d, J = 17.1 Hz, 1H), 4.22 (t, J = 5.3 Hz, 2H), 3.77 (s, 3H), 1.42 (s, 
9H).  
13C NMR (151 MHz, CDCl3) δ 156.14, 155.21 (d, J = 238.1 Hz), 145.97 (d, J = 12.4 Hz), 
143.10 (d, J = 2.1 Hz), 116.14 (d, J = 16.6 Hz), 111.87 (d, J = 5.6 Hz), 102.78 (d, J = 






19F NMR (376 MHz, CDCl3) δ -127.03 (d, J = 8.5 Hz). 
 
HRMS (ESI): Calculated for C13H18FNO4 (M+Na)+: 294.11123; found: 294.11040. 
 
4-(((tert-Butoxycarbonyl)amino)methyl)-5-fluoro-2-methoxyphenyl 
trifluoromethanesulfonate (5.22) To a dry, clean round bottomed flask equipped with a 
stir bar was added tert-butyl (2-fluoro-4-hydroxy-5-methoxybenzyl)carbamate (0.197 g, 
0.777 mmol, 1.0 equiv) and the solid was dissolved in 20 mL of DCM under N2. The solution 
was cooled to 0 ºC before pyridine (0.13 mL, 1.56 mmol, 2.0 equiv) was added to the 
solution. Trifluoromethanesulfonic anhydride (0.16 mL, 0.932 mmol, 1.2 equiv) was then 
added to the reaction dropwise and the solution was stirred for 15 minutes before being 
warmed to room temperature. The reaction was then run for 2 h. before being quenched 
with DI water. The reaction was then diluted with DCM before the layers were separated. 
The aqueous layer was extracted once with DCM (10 mL) and the organic layers were 
combined, washed sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (10% 
EtOAc) to yield 4-(((tert-butoxycarbonyl)amino)methyl)-5-fluoro-2-methoxyphenyl 
trifluoromethanesulfonate as a white solid (269 mg, 90%). 
 
1H NMR (600 MHz, CDCl3) δ 7.04 (d, J = 6.6 Hz, 1H), 6.97 (d, J = 8.8 Hz, 1H), 4.98 (t, J 
= 6.3 Hz, 1H), 4.34 (d, J = 6.4 Hz, 2H), 3.88 (s, 3H), 1.45 (s, 9H).  
13C NMR (151 MHz, CDCl3) δ 156.02, 153.55 (d, J = 242.3 Hz), 148.16 (d, J = 3.2 Hz), 
137.20 (d, J = 10.8 Hz), 127.22 (d, J = 14.7 Hz), 118.81 (q, J = 320.6 Hz), 113.80, 110.65 






19F NMR (376 MHz, CDCl3) δ -73.77, -125.87 (t, J = 7.8 Hz). 
 




N-(2-Fluoro-4-hydroxy-5-methoxybenzyl)nonanamide (i-13) To a dry, clean round 
bottomed flask equipped with a stir bar was added 4-(aminomethyl)-5-fluoro-2-
methoxyphenol hydrochloride (190 mg, 0.915 mmol, 1.0 equiv) which was then dissolved in 
DMF (2 mL) under N2. N,N-Diisopropylethylamine (0.32 mL, 1.83 mmol, 2.0 equiv) was 
then added to the solution, which was stirred for an hour at room temperature. Nonanoyl 
chloride (162 mg, 0.915 mmol, 1.0 equiv) was then added dropwise to the reaction and the 
reaction was allowed to stir for 5 h. At the end of the reaction, the mixture was diluted with 
EtOAc (15 mL) and DI H2O (25 mL). The layers were separated and the aqueous layer 
extracted twice with EtOAc (2 x 10 mL). The organic layers were then combined, washed 
sequentially with 20% LiCl solution (twice) and brine, dried over MgSO4 and concentrated. 
The crude mixture was purified via flash chromatography (40 to 50% EtOAc:Hex) to yield 
N-(2-fluoro-4-hydroxy-5-methoxybenzyl)nonanamide as an off-white solid (261.3 mg, 
95%). The isolated product contains minor impurity N,N-dimethylnonanamide (i-14, vide 
infra), which is inseparable from the desired product. Its spectral data are in agreement 






































N,N-Dimethylnonanamide (i-14)  
1H NMR (600 MHz, CDCl3) δ 6.82 (d, J = 6.8 Hz, 1H), 6.65 (d, J = 10.5 Hz, 1H), 5.94 (s, 
1H), 5.82 (t, J = 6.1 Hz, 1H), 4.37 (dd, J = 5.9, 1.2 Hz, 2H), 3.84 (s, 3H), 2.22 – 2.06 (m, 
2H), 1.62 (dq, J = 14.7, 7.1 Hz, 2H), 1.26 (dqt, J = 19.8, 13.0, 5.3 Hz, 10H), 0.86 (t, J = 
7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 173.25, 155.54 (d, J = 238.2 Hz), 146.14 (d, J = 12.6 Hz), 
143.07 (d, J = 2.5 Hz), 115.90 (d, J = 16.9 Hz), 112.28 (d, J = 5.6 Hz), 102.73 (d, J = 
27.3 Hz), 56.56, 37.43 (d, J = 3.2 Hz), 36.91, 31.92, 29.42, 29.39, 29.27, 25.84, 22.76, 
14.21. 
19F NMR (376 MHz, CDCl3) δ -126.99 (td, J = 11.4, 10.9, 6.3 Hz). 
 
HRMS (ESI): Calculated for C17H26FNO3 (M+H)+: 312.19695; found: 312.19606. 
 
5-Fluoro-2-methoxy-4-(nonanamidomethyl)phenyl trifluoromethanesulfonate 
(5.23) To a dry, clean round bottomed flask equipped with a stir bar was added N-(2-
fluoro-4-hydroxy-5-methoxybenzyl)nonanamide (248 mg, 0.795 mmol, 1.0 equiv), which 
was then dissolved in 10 mL of DCM under N2. The solution was then cooled to 0 ºC before 
triethylamine (0.12 mL, 0.874 mmol, 1.1 equiv) and 1,1,1-trifluoro-N-phenyl-N-
((trifluoromethyl)sulfonyl)methanesulfonamide (290 mg, 0.811 mmol, 1.02 equiv) were 
added consecutively to the reaction and the mixture was stirred for an additional 15 min. 
The reaction was then warmed to room temperature and stirred overnight before being 












separated. The aqueous layer was extracted once with DCM (10 mL) and the organic layers 
were combined, washed sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (30 to 
40% EtOAc) to yield 5-fluoro-2-methoxy-4-(nonanamidomethyl)phenyl 
trifluoromethanesulfonate as an off-white solid (295.2 mg, 84%). The isolated product 
contains a minor amount of impurity N,N-dimethylnonanamide (i-14, vide supra). 
 
1H NMR (600 MHz, CDCl3) δ 7.02 (d, J = 6.6 Hz, 1H), 6.93 (d, J = 8.8 Hz, 1H), 6.39 (t, J 
= 5.9 Hz, 1H), 4.40 (d, J = 6.1 Hz, 2H), 3.83 (s, 3H), 2.18 (t, J = 7.6 Hz, 2H), 1.59 (t, J = 
7.3 Hz, 2H), 1.27 – 1.16 (m, 10H), 0.84 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 173.67, 153.55 (d, J = 242.8 Hz), 148.05 (d, J = 3.1 Hz), 
137.14 (d, J = 10.9 Hz), 126.71 (d, J = 16.1 Hz), 118.73 (q, J = 320.5 Hz), 114.19 (d, J = 
4.8 Hz), 110.52 (d, J = 27.1 Hz), 56.67, 37.07 (d, J = 3.2 Hz), 36.60, 31.85, 29.37, 29.35, 
29.21, 25.78, 22.67, 14.08. 
19F NMR (376 MHz, CDCl3) δ -73.61 (d, J = 2.7 Hz), -125.49 (t, J = 7.8 Hz). 
 






(E)-4-(2-Fluoro-4-hydroxy-5-methoxyphenyl)but-3-en-2-one (i-15) To a dry, clean 
two-neck round bottomed flask equipped with an addition funnel and a stir bar was added 
2-fluoro-4-hydroxy-5-methoxybenzaldehyde (341.3 mg, 2.01 mmol, 1.0 equiv), which was 
then dissolved in acetone (11 mL, 2.0 M) and placed under N2. An aqueous solution (1 N) of 
NaOH was transferred to the addition funnel, which was then added dropwise to the reaction 
mixture. The mixture was stirred at room temperature for 12 h. The reaction turned a bright 
yellow color upon addition of NaOH solution. At the end of the reaction, the reaction was 
neutralized with 2 N HCl, and the acetone was evaporated off under reduced pressure. The 
crude mixture was then diluted with EtOAc and the layers were separated. The aqueous 
layer was washed with EtOAc (2 x 15 mL) and the organic layers were combined, washed 
with brine, and dried with Na2SO4. The crude mixture was then concentrated and purified 
via column chromatography (50-60% EtOAc:Hex) to yield (E)-4-(2-fluoro-4-hydroxy-5-







































1H NMR (600 MHz, CDCl3) δ 7.64 (d, J = 16.4 Hz, 1H), 6.97 (d, J = 6.5 Hz, 1H), 6.70 (d, 
J = 10.9 Hz, 1H), 6.61 (d, J = 16.4 Hz, 1H), 6.11 (bs, 1H), 3.91 (s, 3H), 2.38 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 198.76, 156.96 (d, J = 248.1 Hz), 149.32 (d, J = 12.9 Hz), 
143.59 (d, J = 2.2 Hz), 136.09 (d, J = 3.6 Hz), 126.68 (d, J = 4.9 Hz), 113.58 (d, J = 12.9 
Hz), 108.44 (d, J = 4.2 Hz), 103.27 (d, J = 27.6 Hz), 56.52, 27.25. 
19F NMR (565 MHz, CDCl3) δ -121.06 (ddd, J = 10.6, 6.7, 3.9 Hz). 
 
HRMS (ESI): Calculated for C11H11FO3 (M+H)+: 211.07650; found: 211.07588 
 
4-(2-Fluoro-4-hydroxy-5-methoxyphenyl)butan-2-one (i-16) To a dry, clean round 
bottomed flask equipped with a stir bar was added (E)-4-(2-fluoro-4-hydroxy-5-
methoxyphenyl)but-3-en-2-one (0.421.4 g, 2.01 mmol, 1.0 equiv), which was then 
dissolved in 10 mL of MeOH. 10% Palladium on carbon (21.3 mg, 0.201 mmol, 0.10 equiv) 
was added to the solution and the reaction was placed under N2. The solution was purged 
and backfilled with H2 before being placed under a H2 atmosphere (1 atm) overnight. The 
reaction was checked by TLC and no further conversion was observed after 12 h. The 
solution was then run through a Celite plug and concentrated. The crude product was then 
purified via column chromatography (30-50% EtOAc:Hex) to yield 4-(2-fluoro-4-hydroxy-5-
methoxyphenyl)butan-2-one as a pale-yellow liquid (0.283 g, 67%) with (E)-4-(2-fluoro-4-
hydroxy-5-methoxyphenyl)but-3-en-2-one recovered (134.8 mg, 32%) [99% brsm]. 
 
1H NMR (600 MHz, CDCl3) δ 6.66 (d, J = 6.9 Hz, 1H), 6.62 (d, J = 10.5 Hz, 1H), 5.63 (s, 







13C NMR (151 MHz, CDCl3) δ 208.17, 155.35 (d, J = 237.2 Hz), 144.85 (d, J = 12.3 Hz), 
142.79 (d, J = 2.7 Hz), 118.14 (d, J = 17.6 Hz), 112.48 (d, J = 6.3 Hz), 102.75 (d, J = 
27.7 Hz), 56.56, 44.17, 30.18, 23.38 (d, J = 2.1 Hz). 
19F NMR (565 MHz, CDCl3) δ -126.09 (td, J = 11.1, 6.8 Hz). 
 
HRMS (ESI): Calculated for C11H13FO3 (M+H)+: 213.09215; found: 213.09174 
 
5-Fluoro-2-methoxy-4-(3-oxobutyl)phenyl trifluoromethanesulfonate (5.24) To a 
dry, clean round bottomed flask equipped with a stir bar was added 4-(2-fluoro-4-hydroxy-
5-methoxyphenyl)butan-2-one (272.7 mg, 1.40 mmol, 1.0 equiv), which was then dissolved 
in 20 mL of DCM under N2. The solution was then cooled to 0 ºC before triethylamine (0.21 
mL, 1.54 mmol, 1.1 equiv) and 1,1,1-trifluoro-N-phenyl-N-
((trifluoromethyl)sulfonyl)methanesulfonamide (512 mg, 1.43 mmol, 1.02 equiv) were 
added consecutively to the reaction and the mixture was stirred for an additional 15 min. 
The reaction was then warmed to room temperature and stirred overnight before being 
quenched with DI water. The reaction was then diluted with DCM before the layers were 
separated. The aqueous layer was extracted once with DCM (20 mL) and the organic layers 
were combined, washed sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (20 to 
30% EtOAc) to yield 5-fluoro-2-methoxy-4-(3-oxobutyl)phenyl trifluoromethanesulfonate as 
a pale-yellow liquid (300.8 mg, 66%) with 4-(2-fluoro-4-hydroxy-5-methoxyphenyl)butan-
2-one recovered (90.1 mg, 33%) [99% brsm]. 
1H NMR (600 MHz, CDCl3) δ 6.92 (d, J = 8.9 Hz, 1H), 6.89 (d, J = 6.7 Hz, 1H), 3.85 (s, 







13C NMR (151 MHz, CDCl3) δ 207.06, 153.79 (d, J = 242.1 Hz), 147.81 (d, J = 3.1 Hz), 
136.35 (d, J = 11.1 Hz), 129.06 (d, J = 16.8 Hz), 118.76 (q, J = 320.4 Hz), 114.92 (d, J = 
5.5 Hz), 110.41 (d, J = 27.7 Hz), 56.68, 43.21, 29.95, 23.44 (d, J = 1.9 Hz). 
19F NMR (565 MHz, CDCl3) δ -73.62, -124.62 (t, J = 7.7 Hz). 
 
HRMS (ESI): Calculated for C12H12F4O5S (M+H)+: 345.04142; found: 345.04071 
 
2-Fluoro-3,5-dimethoxypyridine (5.26) The title compound was prepared from 3,5-
dimethoxypyridine according to General Method A with an irradiation time of 24 h. The 
crude mixture was purified via flash LC with (20% acetonitrile:water to 30% 
acetonitrile:water with 0.1% TFA) to afford a yellow oil (2.5 mg, 6.5%). 
 
1H NMR (600 MHz, CDCl3) δ 7.32 (t, J = 2.7 Hz, 1H), 6.87 (dd, J = 8.4, 2.6 Hz, 1H), 3.87 
(s, 3H), 3.85 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 154.75 (d, J = 3.3 Hz), 148.20 (d, J = 232.0 Hz), 143.16 (d, 
J = 29.2 Hz), 119.85 (d, J = 14.2 Hz), 110.54 (d, J = 4.3 Hz). 
19F NMR (376 MHz, CDCl3) δ -92.72 (d, J = 8.4 Hz). 
 
HRMS (ESI): Calculated for C7H8FNO2 (M+H)+: 158.06118; found: 158.06084. 
 
2-Chloro-5-fluoro-6-methoxyquinoline (5.27) The title compound was prepared from 
2-chloro-6-methoxyquinoline according to General Method A with an irradiation time of 24 
h. The crude mixture was purified via flash LC with (20% acetonitrile:water to 30% 









1H NMR (700 MHz, CDCl3) δ 8.32 (dd, J = 8.8, 0.8 Hz, 1H), 7.83 – 7.76 (m, 1H), 7.54 (t, 
J = 9.0 Hz, 1H), 7.40 (d, J = 8.8 Hz, 1H), 4.05 (s, 3H). 
13C NMR (176 MHz, CDCl3) δ 149.57, 145.56 (d, J = 252.7 Hz), 143.92 (d, J = 9.3 Hz), 
142.75 (d, J = 1.4 Hz), 131.45 (d, J = 4.5 Hz), 124.75 (d, J = 4.4 Hz), 122.88 (d, J = 2.7 
Hz), 119.66 (d, J = 2.5 Hz), 118.47 (d, J = 13.9 Hz). 
19F NMR (376 MHz, CDCl3) δ -144.92 (d, J = 8.4 Hz). 
 




2-Amino-5-fluoro-N-hexylbenzamide (i-17) To a dry, clean round bottomed flask 
equipped with a stir bar was added 2-amino-5-fluorobenzoic acid (1.86 g, 12.0 mmol, 1.0 
equiv), which was then dissolved in THF (24 mL) under N2. Carbonyldiimidazole (2.05 g, 
12.6 mmol, 1.05 equiv) was then added to the reaction mixture and the suspension was 
allowed to stir for 30 min. N,N-Diisopropylethylamine (2.5 mL, 14.4 mmol, 1.2 equiv) and 








































n-hexylamine (1.7 mL, 13.2 mmol, 1.1 equiv) were then sequentially added to the reaction 
mixture and the reaction was allowed to stir overnight (done in about 5-6 h.). At the end of 
the reaction, the mixture was quenched with 1 N HCl (15 mL) and diluted with EtOAc (20 
mL) before the pH was adjusted to 7 with 2 M NaOH. The layers were separated and the 
aqueous layer was extracted once with 10 mL of ETOAc. The organic layers were then 
combined, washed consecutively with saturated NaHCO3 solution and brine, dried over 
Na2SO4 and concentrated. The crude product was purified via flash chromatography (30 to 
50% EtOAc:Hex) to yield 2-amino-5-fluoro-N-hexylbenzamide as a pale yellow solid (2.38 
g, 83%). 
 
1H NMR (600 MHz, CDCl3) δ 7.01 (dd, J = 9.2, 2.9 Hz, 1H), 6.95 (ddd, J = 8.9, 7.9, 2.9 
Hz, 1H), 6.63 (dd, J = 8.9, 4.7 Hz, 1H), 5.98 (s, 1H), 5.25 (s, 2H), 3.39 (td, J = 7.2, 5.7 
Hz, 2H), 1.66 – 1.53 (m, 3H), 1.45 – 1.23 (m, 6H), 0.97 – 0.80 (m, 3H). 
13C NMR (151 MHz, CDCl3) δ 168.38 (d, J = 2.3 Hz), 154.64 (d, J = 236.0 Hz), 144.85, 
119.50 (d, J = 22.5 Hz), 118.56 (d, J = 7.1 Hz), 117.09 (d, J = 5.4 Hz), 113.10 (d, J = 
22.7 Hz), 39.99, 31.64, 29.72, 26.83, 22.71, 14.16. 
19F NMR (376 MHz, CDCl3) δ -127.59 (dt, J = 8.3, 4.3 Hz).  
 
HRMS (ESI): Calculated for C13H19FN2O (M+H)+: 239.15541; found: 239.15467. 
 
6-Fluoro-3-hexylquinazoline-2,4(1H,3H)-dione (i-18) To a dry, clean round bottomed 
flask equipped with a stir bar was added 2-amino-5-fluoro-N-hexylbenzamide (2.38 g, 10.0 
mmol, 1.0 equiv), which was then dissolved in DMF (20 mL) under N2. Carbonyldiimidazole 
(2.11 g, 13.0 mmol, 1.30 equiv) was then added to the reaction mixture and the suspension 









(30 mL) and DI H2O (40 mL). The layers were separated and the aqueous layer extracted 
twice with EtOAc (2 x 15 mL). The organic layers were then combined, washed sequentially 
with 20% LiCl solution (twice) and brine, dried over MgSO4 and concentrated to yield 6-
fluoro-3-hexylquinazoline-2,4(1H,3H)-dione as a pale, off-white solid (2.44 g, 92%) that 
was analytically pure by 1H and 13C NMR. The crude product was carried onto the next 
synthetic step without further purification.   
 
1H NMR (600 MHz, CDCl3) δ 10.93 (s, 1H), 7.79 (dd, J = 8.3, 2.9 Hz, 1H), 7.35 (td, J = 
8.4, 2.9 Hz, 1H), 7.15 (dd, J = 8.8, 4.0 Hz, 1H), 4.11 – 4.03 (m, 2H), 1.77 – 1.60 (m, 2H), 
1.45 – 1.37 (m, 2H), 1.37 – 1.26 (m, 4H), 0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 161.70 (d, J = 2.9 Hz), 158.67 (d, J = 244.1 Hz), 152.32, 
135.23, 123.16 (d, J = 24.4 Hz), 117.07 (d, J = 7.6 Hz), 115.89 (d, J = 7.8 Hz), 113.82 (d, 
J = 24.2 Hz), 41.41, 31.62, 27.93, 26.74, 22.68, 14.19. 
19F NMR (376 MHz, CDCl3) δ -117.93 (td, J = 8.1, 4.1 Hz). 
 
HRMS (ESI): Calculated for C14H17FN2O2 (M+H)+: 265.13468; found: 265.13404. 
 
6-Fluoro-1,3-dihexylquinazoline-2,4(1H,3H)-dione (5.28) To a dry, clean round 
bottomed flask equipped with a stir bar was added 6-fluoro-3-hexylquinazoline-2,4(1H,3H)-
dione (2.44 g, 9.20 mmol, 1.0 equiv) and potassium carbonate (6.36 g, 46 mmol, 5.0 
equiv). The solids were dissolved in DMF (28 mL) under N2 before 1-bromohexane (3.9 mL, 
27.6 mmol, 3.0 equiv) was added dropwise. The reaction was then heated to 60 ºC and 
stirred overnight. At the end of the reaction, the mixture was diluted with ether (30 mL) and 









ether (2 x 15 mL). The organic layers were then combined, washed sequentially with 20% 
LiCl solution and brine, dried over MgSO4 and concentrated. The crude product was purified 
via flash chromatography (5 to 10% EtOAc:Hex) to yield 6-fluoro-1,3-dihexylquinazoline-
2,4(1H,3H)-dione as an off-white solid (2.08 g, 65%).  
 
1H NMR (600 MHz, CDCl3) δ 7.86 (dd, J = 8.2, 3.1 Hz, 1H), 7.35 (ddd, J = 9.3, 7.6, 3.1 
Hz, 1H), 7.13 (dd, J = 9.2, 3.9 Hz, 1H), 4.10 – 3.99 (m, 4H), 1.74 – 1.59 (m, 4H), 1.47 – 
1.15 (m, 12H), 0.86 (dt, J = 11.6, 6.9 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 160.90 (d, J = 2.7 Hz), 158.16 (d, J = 244.1 Hz), 136.34 (d, 
J = 1.7 Hz), 122.63 (d, J = 24.0 Hz), 117.15 (d, J = 7.6 Hz), 115.50 (d, J = 7.3 Hz), 
114.61 (d, J = 23.8 Hz), 44.15, 42.24, 31.58, 31.54, 27.81, 27.35, 26.73, 26.54, 22.65, 
22.64, 14.11, 14.06. 
19F NMR (376 MHz, CDCl3) δ -119.59 (td, J = 7.9, 4.0 Hz). 
 
HRMS (ESI): Calculated for C20H29FN2O2 (M+H)+: 349.2291; found: 349.2280. 
 
3-Fluoro-1-methyl-1H-indazole (5.29) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.22 
 
6-Fluoro-2-methylbenzo[d]oxazole (5.30) The title compound was prepared according 














6-Fluoro-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one (i-19) The title 
compound was prepared by adapting a procedure from Buchwald et al.25. An oven-dried test 
tube equipped with a magnetic stir bar and a Teflon screw-cap was charged with BrettPhos-
G3 (22.7 mg, 25.0 µmmol, 0.05 equiv), 1-methylurea (92.60 mg, 1.25 mmol, 2.5 equiv) 
and K3PO4 (254.7 mg, 1.2 mmol, 2.4 equiv). The tube was evacuated and backfilled with 
nitrogen (repeated two additional times). t-BuOH (2 mL) and 1-bromo-2-chloro-4-
fluorobenzene (59.8 µL, 0.500 mmol, 1.0 equiv) were sequentially added via syringe and 
the punctured cap was replaced with a new one under a stream of nitrogen. The test tube 
was placed in a preheated oil bath at 110 ºC and stirred for 14 h. After cooling to room 
temperature, the mixture was diluted with EtOAc (5 mL), filtered through a short silica plug 
(EtOAc rinse) and concentrated using a rotary evaporator. The residue was purified using 
silica gel chromatography (50 to 80% EtOAc:Hex) to afford 6-fluoro-1-methyl-1,3-dihydro-
2H-benzo[d]imidazol-2-one as a white solid (58.5 mg, 70%). 
 
1H NMR (600 MHz, MeOD) δ 7.00 (dd, J = 8.6, 4.4 Hz, 1H), 6.94 (s, 1H), 6.83 – 6.76 (m, 
1H), 3.37 (s, 3H), 2.12 (t, J = 2.3 Hz, 1H). 
13C NMR (151 MHz, MeOD) δ 160.13 (d, J = 236.1 Hz), 157.40, 133.05 (d, J = 12.5 Hz), 
125.62, 110.66 (d, J = 9.4 Hz), 108.79 (d, J = 24.3 Hz), 97.17 (d, J = 29.1 Hz), 27.18. 





































HRMS (ESI): Calculated for C8H7FN2O (M+H)+: 167.06151; found: 167.06227 
 
2-Chloro-6-fluoro-1-methyl-1H-benzo[d]imidazole (5.31) The title compound was 
synthesized according to a published procedure26; the compound was purified via flash 
chromatography (20 to 30% EtOAc:Hex) with basic aluminum oxide as the stationary phase 
(substrate: 91.5 mg, 0.55 mmol; product: 38.3 mg, 38%) 
 
1H NMR (850 MHz, CDCl3) δ 7.65 (dd, J = 8.8, 4.6 Hz, 1H), 7.14 – 6.94 (m, 2H), 3.78 (s, 
3H). 
13C NMR (214 MHz, CDCl3) δ 160.12 (d, J = 241.7 Hz), 141.01s, 137.34, 135.61 (d, J = 
13.1 Hz), 120.31 (d, J = 9.9 Hz), 111.60 (d, J = 25.0 Hz), 96.63 (d, J = 27.9 Hz), 31.05. 
19F NMR (376 MHz, CDCl3) δ -117.17. 
 
























i-20, 73% 5.32, 84%, two steps
Pd(OAc)2 (0.03 eq.) 
DavePhos (0.06 eq.)







tert-Butyl 2-(3-(4-fluorophenoxy)phenyl)propanoate (i-20) To a clean, dry 3-neck 
round bottomed flask equipped with a stir bar and a condenser were added palladium (II) 
acetate (33.7 mg, 0.15 mmol, 0.03 equiv) and 2-dicyclohexylphosphino-2′-(N,N-
dimethylamino)biphenyl (DavePhos, 118.1 mg, 0.30 mmol, 0.06 equiv) under an inert 
atmosphere. The flask was sealed with rubber septa and placed under a positive N2 
pressure. The solids were then dissolved in PhMe (15 mL) and stirred for 15 min. before a 
solution of lithium bis(trimethylsilyl)amide (1.0 M in hexanes, 12.5 mL, 12.5 mmol, 2.5 
equiv) was added dropwise. The reaction was stirred for an additional 15 minutes before it 
was cooled to -10 ºC. tert-Butyl propionate (1.7 mL, 11.5 mmol, 2.3 equiv) was then added 
dropwise to the reaction mixture and stirred for an additional 10 minutes. 1-Bromo-3-(4-
fluorophenoxy)benzene (0.90 mL, 5.00 mmol, 1.0 equiv) was then added dropwise and the 
reaction was allowed to warm to room temperature before being heated to 80 ºC and stirred 
overnight. At the end of the reaction, the reaction mixture was filtered through a silica plug 
and concentrated to yield a liquid. The crude product was then purified via flash 
chromatography (2 to 5% EtOAc:Hex) to yield tert-butyl 2-(3-(4-
fluorophenoxy)phenyl)propanoate as a yellow liquid (1.15 g, 73%).  
 
1H NMR (600 MHz, CDCl3) δ 7.28 (t, J = 7.9 Hz, 1H), 7.07 – 7.01 (m, 3H), 7.02 – 6.96 
(m, 2H), 6.95 (t, J = 2.2 Hz, 1H), 6.86 (dd, J = 8.2, 2.7 Hz, 1H), 3.60 (q, J = 7.2 Hz, 1H), 
1.45 (d, J = 7.2 Hz, 3H), 1.41 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 173.48, 158.91 (d, J = 241.6 Hz), 157.84, 153.01 (d, J = 
2.5 Hz), 143.35, 129.84, 122.38, 120.59 (d, J = 8.2 Hz), 117.57, 116.80, 116.37 (d, J = 
23.2 Hz), 80.70, 46.46, 28.01, 18.48. 








HRMS (ESI): Calculated for C19H21FO3 (M+H)+: 317.1553; found: 317.1557. 
 
Methyl 2-(3-(4-fluorophenoxy)phenyl)propanoate (5.32) To a clean, dry round 
bottomed flask equipped with a stir bar was added tert-butyl 2-(3-(4-
fluorophenoxy)phenyl)propanoate (1.15 g, 3.63 mmol, 1.0 equiv), which was then dissolved 
in 8.6 mL of DCM. Trifluoroacetic acid (8.6 mL) was then added to the solution and the 
reaction was stirred for 2 h. At the end of the reaction, the mixture was concentrated under 
reduced pressure and reconstituted in 10 mL of DCM. TLC analysis suggested full conversion 
to the desired product, thus the crude was then re-concentrated to remove excess 
trifluoroacetic acid and was carried forward to the esterification without further purification. 
The dry crude was then dissolved in 10 mL of dry MeOH under N2 and a catalytic amount of 
sulfuric acid was added to the solution. The reaction was then refluxed for 3 h. At the end of 
the reaction, the solution was concentrated, diluted with ether and neutralized with 
saturated NaHCO3 solution. The layers were then separated and the aqueous layer was 
extracted once with 10 mL of ether. The organic layers were combined, washed with brine, 
dried over Na2SO4 and concentrated. The crude product was purified via column 
chromatography (5 to 15% EtOAc:Hex) to yield methyl 2-(3-(4-
fluorophenoxy)phenyl)propanoate as a colorless liquid (0.851 g, 84%) 
 
1H NMR (600 MHz, CDCl3) δ 7.26 (t, J = 7.9 Hz, 1H), 7.05 – 7.00 (m, 3H), 7.00 – 6.96 
(m, 2H), 6.96 – 6.94 (m, 1H), 6.83 (ddd, J = 8.2, 2.5, 1.0 Hz, 1H), 3.70 (q, J = 7.2 Hz, 







13C NMR (151 MHz, CDCl3) δ 174.68, 158.96 (d, J = 241.7 Hz), 157.98, 152.75 (d, J = 
2.6 Hz), 142.68, 129.97, 122.28, 120.70 (d, J = 8.3 Hz), 117.61, 116.74, 116.39 (d, J = 
23.2 Hz), 52.14, 45.34, 18.58. 
19F NMR (376 MHz, CDCl3) δ -119.87 (ddd, J = 12.3, 8.0, 4.6 Hz). 
 




tert-Butyl 2-(4-chloro-3-fluorophenyl)propanoate (i-21) To a clean, dry 3-neck round 
bottomed flask equipped with a stir bar and a condenser were added palladium (II) acetate 
(33.7 mg, 0.15 mmol, 0.03 equiv), 2-dicyclohexylphosphino-2′-(N,N-
dimethylamino)biphenyl (DavePhos, 118.1 mg, 0.30 mmol, 0.06 equiv), and lithium 
bis(trimethylsilyl)amide (2.09 g, 12.5 mmol, 2.5 equiv) under an inert atmosphere. The 
flask was sealed with rubber septa and placed under a positive N2 pressure. The solids were 
then dissolved in PhMe (15 mL) and stirred for 15 min. at room temperature before the 













i-21, 58% i-22, 86%, two steps
Pd(OAc)2 (0.03 eq.) 
DavePhos (0.06 eq.)












Pd(OAc)2 (0.03 eq.) 
SPhos (0.06 eq.)










then added dropwise to the reaction mixture and stirred for an additional 10 minutes. 4-
Bromo-1-chloro-2-fluorobenzene (0.61 mL, 5.00 mmol, 1.0 equiv) was then added dropwise 
and the reaction was allowed to warm to room temperature before being heated to 80 ºC 
and stirred overnight. At the end of the reaction, the reaction mixture was filtered through a 
silica plug and concentrated to yield a liquid. The crude product was then purified via flash 
chromatography (5 to 10% DCM:Hex) to yield tert-butyl 2-(4-chloro-3-
fluorophenyl)propanoate as a pale yellow liquid (0.760 g, 58%). 
 
1H NMR (600 MHz, CDCl3) δ 7.31 (t, J = 8.0 Hz, 1H), 7.10 (dd, J = 10.2, 2.1 Hz, 1H), 
7.01 (dd, J = 8.4, 2.1 Hz, 1H), 3.57 (q, J = 7.2 Hz, 1H), 1.42 (d, J = 7.2 Hz, 3H), 1.39 (s, 
9H).  
13C NMR (151 MHz, CDCl3) δ 172.96, 158.10 (d, J = 248.6 Hz), 142.07 (d, J = 6.6 Hz), 
130.55, 124.09 (d, J = 3.7 Hz), 119.43 (d, J = 17.6 Hz), 115.85 (d, J = 21.5 Hz), 81.16, 
45.97 (d, J = 1.6 Hz), 27.99, 18.42. 
19F NMR (376 MHz, CDCl3) δ -118.27 (dd, J = 10.1, 7.7 Hz). 
 
HRMS (ESI): Calculated for C13H16ClFO2 (M+H)+: 259.08956; found: 259.15081. 
 
Methyl 2-(4-chloro-3-fluorophenyl)propanoate (i-22) To a clean, dry round bottomed 
flask equipped with a stir bar was added tert-butyl 2-(4-chloro-3-fluorophenyl)propanoate 
(0.648 g, 2.50 mmol, 1.0 equiv), which was then dissolved in 5.9 mL of DCM. Trifluoroacetic 
acid (5.9 mL) was then added to the solution and the reaction was stirred for 2 h. At the 
end of the reaction, the mixture was concentrated under reduced pressure and 
reconstituted in 10 mL of DCM. TLC analysis suggested full conversion to the desired 







was carried forward to the esterification without further purification. The dry crude was then 
dissolved in 10 mL of dry MeOH under N2 and a catalytic amount of sulfuric acid was added 
to the solution. The reaction was then refluxed for 3 h. At the end of the reaction, the 
solution was concentrated, diluted with ether and neutralized with saturated NaHCO3 
solution. The layers were then separated and the aqueous layer was extracted once with 10 
mL of ether. The organic layers were combined, washed with brine, dried over Na2SO4 and 
concentrated. The crude product was purified via column chromatography (5 to 10% 
DCM:Hex) to yield methyl 2-(4-chloro-3-fluorophenyl)propanoate as a colorless liquid 
(0.468 g, 86%). 
 
1H NMR (600 MHz, CDCl3) δ 7.31 (td, J = 7.8, 1.7 Hz, 1H), 7.10 (dt, J = 10.0, 1.7 Hz, 
1H), 7.02 (dd, J = 8.3, 2.1 Hz, 1H), 3.69 (q, J = 7.3 Hz, 1H), 3.66 (t, J = 1.2 Hz, 3H), 1.47 
(dd, J = 7.2, 1.5 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 174.14, 158.12 (d, J = 248.8 Hz), 141.32 (d, J = 6.5 Hz), 
130.69, 124.14 (d, J = 3.7 Hz), 119.75 (d, J = 17.6 Hz), 115.93 (d, J = 21.5 Hz), 52.31, 
44.82, 18.44. 
19F NMR (376 MHz, CDCl3) δ -114.86 (ddd, J = 11.0, 7.7, 3.4 Hz). 
 
HRMS (ESI): Calculated for C10H10ClFO2 (M+H)+: 217.04261; found: 217.04216. 
 
Methyl 2-(2,4'-difluoro-[1,1'-biphenyl]-4-yl)propanoate (5.33) To a clean, dry 2 
dram vial equipped with a stir bar was added potassium phosphate tribasic (212.3 mg, 1.00 
mmol, 2.0 equiv) and (4-fluorophenyl)boronic acid (70.0 mg, 0.500 mmol, 1.0 equiv). The 







µmol, 0.02 equiv) and dicyclohexyl(2',6'-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine (SPhos, 
8.2 mg, 20.0 µmol, 0.04 equiv) were added consecutively to the solids. Dry toluene (1 mL) 
was added, the vial was then sealed with a septum cap and the reaction was stirred for 
approximately 2 min. before the addition of methyl 2-(4-chloro-3-fluorophenyl)propanoate 
(108.3 mg, 88.9 µL, 0.500 mmol, 1.0 equiv). The vial was resealed with the septum cap, 
brought out of the glovebox and heated at 90 ºC for 19 h. At the end of the reaction, the 
the vial was cooled to room temperature before being diluted with ether (10 mL), filtered 
through a silica plug and concentrated to yield a liquid. The crude product was then purified 
via flash chromatography (20 to 30% DCM:Hex) to yield methyl 2-(2,4'-difluoro-[1,1'-
biphenyl]-4-yl)propanoate as a colorless liquid (136 mg, 99%).  
 
1H NMR (600 MHz, CDCl3) δ 7.50 (ddt, J = 6.9, 5.4, 1.6 Hz, 2H), 7.35 (t, J = 8.0 Hz, 1H), 
7.16 – 7.10 (m, 4H), 3.76 (q, J = 7.2 Hz, 1H), 3.70 (s, 3H), 1.54 (d, J = 7.2 Hz, 3H).  
13C NMR (151 MHz, CDCl3) δ 174.53, 162.55 (d, J = 247.2 Hz), 159.71 (d, J = 248.1 Hz), 
142.07 (d, J = 7.5 Hz), 131.56 (d, J = 3.3 Hz), 130.78 (d, J = 3.9 Hz), 130.71 (dd, J = 8.1, 
3.1 Hz), 126.97 (d, J = 13.4 Hz), 123.72 (d, J = 3.6 Hz), 115.54 (d, J = 21.5 Hz), 115.42 
(d, J = 23.4 Hz), 52.36, 45.02, 18.54.  
19F NMR (376 MHz, CDCl3) δ -114.44 (ddd, J = 14.2, 8.8, 5.2 Hz), -117.61 (dd, J = 11.5, 
8.1 Hz). 
 
HRMS (ESI): Calculated for C16H14F2O2 (M+H)+: 277.07899; found: 277.08288. 
 
Ethyl 2-(4-chloro-2-fluorophenoxy)-2-methylpropanoate (5.34) To a dry, clean 3-
neck round bottomed flask equipped with a condenser and a stir bar was added potassium 








mmol, 1.0 equiv). The flask was then sealed with rubber septa and the solids were then 
dissolved in DMF (10 mL) under N2. Ethyl 2-bromo-2-methylpropanoate (1.47 mL, 10.0 
mmol, 2.0 equiv) was added dropwise via syringe and the reaction was heated to 70 ºC 
overnight. At the end of the reaction, the reaction was cooled to room temperature before 
being diluted with ether (15 mL) and water (30 mL). The layers were separated and the 
aqueous layer was extracted twice with 10 mL of ether. The organic layers were combined, 
washed sequentially with 20% LiCl solution (15 mL) and brine (15 mL), dried over MgSO4 
and concentrated to yield a yellow oil. The crude product was then purified via flash 
chromatography (5-20% EtOAc:Hex) to yield ethyl 2-(4-chloro-2-fluorophenoxy)-2-
methylpropanoate as an oil (0.885 g, 68%). 
 
1H NMR (600 MHz, CDCl3) δ 7.07 (dd, J = 10.5, 2.5 Hz, 1H), 6.99 – 6.95 (m, 1H), 6.92 
(t, J = 8.6 Hz, 1H), 4.22 (q, J = 7.2 Hz, 2H), 1.55 (d, J = 2.4 Hz, 6H), 1.26 (t, J = 7.3 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) δ 173.46, 155.12 (d, J = 250.4 Hz), 141.92 (d, J = 11.1 Hz), 
128.26 (d, J = 9.2 Hz), 124.23 (d, J = 3.8 Hz), 123.50 (d, J = 2.0 Hz), 117.29 (d, J = 22.8 
Hz), 81.41, 61.64, 24.97, 14.15. 
19F NMR (376 MHz, CDCl3) δ -119.87 – -135.56 (m). 
 






4-Chloro-N-methoxy-N-methylbenzamide (i-23) was prepared according to a published 
procedure; spectra data are in agreement with literature values.27 
 
(4-Chlorophenyl)(3-fluoro-4-methoxyphenyl)methanone (i-24) To a clean, dry 
round-bottomed flask equipped with a stir bar was added 4-bromo-2-fluoroanisole (0.88 
mL, 6.79 mmol, 0.91 equiv) under N2. Then THF (45 mL) was added and the reaction was 
cooled to -78 ºC. A solution of nBuLi (2.5 M in hexanes, 3.0 mL, 7.48 mmol, 1.0 equiv) was 
added dropwise under positive N2 pressure and the reaction was allowed to stir for 20 
minutes. A solution of 4-chloro-N-methoxy-N-methylbenzamide (1.49 g, 7.49 mmol, 1.0 
equiv) in THF (10 mL) was prepared and added dropwise to the aryllithium species under 
positive N2 pressure. The solution was allowed to stir at -78 ºC for 1.5 h and subsequently 


















































temperature. Ether (20 mL) and DI H2O (20 mL) were then added to the reaction mixture 
and the layers were separated. The aqeuous layer was extracted with ether (10 mL x 2) and 
the organic layers were combined. The combined organic fractions were washed with brine, 
dried over Na2SO4 and concentrated. The crude mixture was purified via flash 
chromatography (10 to 20% EtOAc:Hex) to yield (4-chlorophenyl)(3-fluoro-4-
methoxyphenyl)methanone as a white solid (1.25 g, 63%). 
 
1H NMR (600 MHz, CDCl3) δ 7.72 – 7.68 (m, 2H), 7.62 – 7.54 (m, 2H), 7.48 – 7.45 (m, 
2H), 7.02 (t, J = 8.4 Hz, 1H), 3.98 (s, 3H).  
13C NMR (151 MHz, CDCl3) δ 151.98 (d, J = 248.6 Hz), 151.91 (d, J = 10.7 Hz), 138.83, 
136.07, 131.27, 130.13 (d, J = 5.0 Hz), 128.82, 127.73 (d, J = 3.3 Hz), 117.86 (d, J = 
19.1 Hz), 112.41 (d, J = 2.1 Hz), 56.50.  
19F NMR (376 MHz, CDCl3) δ -133.81 – -133.89 (m). 
 
HRMS (ESI): Calculated for C14H10ClFO2 (M+H)+: 265.04261; found: 265.04216. 
 
(4-Chlorophenyl)(3-fluoro-4-hydroxyphenyl)methanone (i-25) To a clean, dry 2-
neck round bottomed flask equipped with a stir bar was added (4-chlorophenyl)(3-fluoro-4-
methoxyphenyl)methanone (1.23 g, 4.63 mmol, 1.0 equiv), which was then dissolved in 
benzene (50 mL) under N2. Aluminum chloride (3.70 g, 27.8 mmol, 6.0 equiv) was then 
added in three portions to the solution and the reaction mixture was refluxed overnight. At 
the end of the reaction, the reaction was quenched with ice (approx. 10 g), and the layers 
were separated. The aqueous layer was extracted twice with DCM (10 mL) and the organic 
layers were combined. The organic fractions were then washed with saturated ammonium 





flash chromatography (30 to 40% EtOAc:Hex) to yield (4-chlorophenyl)(3-fluoro-4-
hydroxyphenyl)methanone as a pink solid (1.10 g, 95%). 
 
1H NMR (600 MHz, Acetone-d6) δ 9.64 (s, 1H), 7.80 – 7.71 (m, 2H), 7.61 – 7.56 (m, 
3H), 7.53 (ddd, J = 8.3, 2.1, 0.9 Hz, 1H), 7.14 (t, J = 8.5 Hz, 1H).  
13C NMR (151 MHz, Acetone-d6) δ 193.24 (d, J = 1.5 Hz), 151.91 (d, J = 243.0 Hz), 
150.48 (d, J = 12.9 Hz), 138.60, 137.50, 132.10, 130.26 (d, J = 4.7 Hz), 129.49, 128.74 
(d, J = 2.9 Hz), 118.49 (d, J = 19.3 Hz), 118.29 (d, J = 2.8 Hz). 
19F NMR (376 MHz, Acetone-d6) δ -137.61 (dd, J = 11.7, 8.5 Hz). 
 
HRMS (ESI): Calculated for C13H8ClFO2 (M+H)+: 251.02696; found: 251.02653. 
 
Isopropyl 2-(4-(4-chlorobenzoyl)-2-fluorophenoxy)-2-methylpropanoate (5.35) To 
a dry, clean 3-neck round bottomed flask equipped with a condenser and a stir bar was 
added potassium carbonate (1.49 g, 10.8 mmol, 2.5 equiv) and (4-chlorophenyl)(3-fluoro-
4-hydroxyphenyl)methanone (1.08 mg, 4.31 mmol, 1.0 equiv). The flask was then sealed 
with rubber septa and the solids were then dissolved in DMF (10 mL) under N2. Isopropyl 2-
bromo-2-methylpropanoate (1.45 mL, 8.62 mmol, 2.0 equiv) was added dropwise via 
syringe and the reaction was heated to 70 ºC overnight. At the end of the reaction, the 
reaction was cooled to room temperature before being diluted with ether (15 mL) and water 
(30 mL). The layers were separated and the aqueous layer was extracted twice with 10 mL 
of ether. The organic layers were combined, washed sequentially with 20% LiCl solution (15 









crude product was then purified via flash chromatography (5-20% EtOAc:Hex) to yield 
isopropyl 2-(4-(4-chlorobenzoyl)-2-fluorophenoxy)-2-methylpropanoate as a pink-red solid 
(983 mg, 60%). 
 
1H NMR (600 MHz, CDCl3) δ 7.72 – 7.65 (m, 2H), 7.57 (dd, J = 11.3, 2.1 Hz, 1H), 7.48 – 
7.42 (m, 3H), 6.92 (t, J = 8.2 Hz, 1H), 5.09 (hept, J = 6.3 Hz, 1H), 1.65 (s, 6H), 1.22 (d, J 
= 6.3 Hz, 6H).  
13C NMR (151 MHz, CDCl3) δ 193.31 (d, J = 1.4 Hz), 172.73, 153.63 (d, J = 248.9 Hz), 
147.88 (d, J = 10.9 Hz), 138.89, 135.86, 131.44 (d, J = 5.4 Hz), 131.25, 128.80, 126.63 
(d, J = 3.5 Hz), 119.16, 118.29 (d, J = 20.4 Hz), 81.12, 69.54, 25.28, 21.65.  
19F NMR (376 MHz, CDCl3) δ -129.29 (dd, J = 11.4, 8.0 Hz). 
 

























































2-Fluoro-4-hydroxy-5-methoxybenzaldehyde (i-26) To a clean, dry round bottomed 
flask equipped with a stir bar was added 2-fluoro-4,5-dimethoxybenzaldehyde (1.04 g, 5.64 
mmol, 1.0 equiv), which was then dissolved in 80 mL of DCM. Aluminum trichloride (4.51 g, 
33.8 mmol, 6.0 equiv) was then added in three portions to the reaction mixture and the 
reaction was kept under N2 for 20 h. The reaction was then carefully poured into ice 
(caution: exothermic!) and stirred until all the ice was melted. The organic layer was then 
separated, dried over MgSO4, concentrated and purified via flash chromatography (DCM to 
10% EtOAc:DCM) to provide 2-fluoro-4-hydroxy-5-methoxybenzaldehyde (0.785 g, 82%) 
as a white solid and the isomeric 2-fluoro-5-hydroxy-4-methoxybenzaldehyde (97.0 mg, 
10%) as a pale yellow solid. 
 
1H NMR (600 MHz, CDCl3) δ 10.21 (s, 1H), 7.29 (d, J = 6.1 Hz, 1H), 6.72 (d, J = 10.9 Hz, 
1H), 6.35 (d, J = 1.4 Hz, 1H), 3.94 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 185.96 (d, J = 6.7 Hz), 161.63 (d, J = 253.0 Hz), 153.13 (d, 
J = 13.5 Hz), 143.79 (d, J = 2.1 Hz), 116.60 (d, J = 9.1 Hz), 107.63 (d, J = 3.4 Hz), 
102.90 (d, J = 26.3 Hz), 56.61.  
19F NMR (376 MHz, CDCl3) δ -128.30 (dt, J = 10.2, 4.7 Hz). 
 








2-Fluoro-5-methoxy-4-((triisopropylsilyl)oxy)benzaldehyde (i-27) To a clean, dry 
round bottomed flask equipped with a stir bar was added 2-fluoro-4-hydroxy-5-
methoxybenzaldehyde (681 mg, 4.00 mmol, 1.0 equiv) and imidazole (545 mg, 8.00 mmol, 
2.0 equiv). The solids were dissolved in 20 mL of DCM under N2 and the solution was cooled 
to 0 ºC. Triisopropylsilyl chloride (1.0 mL, 4.80 mmol, 1.2 equiv) was then added to the 
reaction mixture dropwise and the reaction was then warmed to room temperature and 
stirred for 6 h. At the end of the reaction, the mixture was concentrated under reduced 
pressure, loaded onto Celite and purified via column chromatography (2 to 10% EtOAc:Hex) 
to yield a colorless oil (1.09 g, 84%). 
 
1H NMR (600 MHz, CDCl3) δ 10.17 (d, J = 2.6 Hz, 1H), 7.24 (dd, J = 6.7, 1.9 Hz, 1H), 
6.61 (dd, J = 11.3, 2.2 Hz, 1H), 3.80 (s, 3H), 1.25 (dt, J = 15.0, 7.5 Hz, 3H), 1.06 (dd, J = 
7.6, 2.7 Hz, 18H).  
13C NMR (151 MHz, CDCl3) δ 185.95 (d, J = 6.0 Hz), 160.76 (d, J = 253.4 Hz), 153.23 (d, 
J = 12.2 Hz), 148.31 (d, J = 2.1 Hz), 117.24 (d, J = 8.8 Hz), 108.42 (d, J = 3.7 Hz), 
108.12 (d, J = 23.4 Hz), 55.81, 17.82, 12.96. 
19F NMR (376 MHz, CDCl3) δ -129.93 (ddd, J = 10.7, 7.2, 3.4 Hz). 
 










Methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate (1.08 g, 3.62 
mmol, 1.2 equiv) was added to a flame dried round bottomed flask equipped with a stir bar 
and dissolved in 6 mL of dry DCM under N2. Then 1,8-diazabicyclo[5.4.0]undec-7-ene (0.46 
mL, 3.02 mmol, 1.0 equiv) was added via syringe and the mixture was stirred at room 
temperature for 15 minutes. While the phosphonate ester solution was stirring, a solution of 
2-fluoro-5-methoxy-4-((triisopropylsilyl)oxy)benzaldehyde (2.23 g, 7.23 mmol, 1.0 equiv) 
in 6 mL DCM was prepared. This benzaldehyde solution was added to the phosphonate ester 
solution dropwise at room temperature. Reaction conversion was monitored via TLC 
(reaction takes approximately 4 h.) and at the end of the reaction, the solution was 
concentrated and loaded onto Celite. The crude reaction mixture was then purified via flash 
chromatography (10 to 20% EtOAc) to yield methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-
(2-fluoro-5-methoxy-4-((triisopropylsilyl)oxy)phenyl)acrylate as a white solid (1.01 g, 67%) 
 
1H NMR (600 MHz, CDCl3) δ 7.38 (s, 1H), 7.17 (d, J = 6.9 Hz, 1H), 6.61 (d, J = 11.2 Hz, 
1H), 3.85 (s, 3H), 3.76 (s, 3H), 1.39 (s, 9H), 1.26 (dt, J = 14.9, 7.5 Hz, 3H), 1.09 (d, J = 
7.5 Hz, 18H).  
13C NMR (151 MHz, CDCl3) δ 166.14, 155.63 (d, J = 246.5 Hz), 148.10 (d, J = 11.8 Hz), 
147.41, 122.76 (d, J = 4.3 Hz), 114.28 (d, J = 13.9 Hz), 111.77, 108.08 (d, J = 25.3 Hz), 
81.02, 56.00, 52.74, 28.26, 17.96, 13.00. 








HRMS (ESI): Calculated for C25H40FNO6Si (M+H)+: 498.26817; found: 498.26692. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-methoxy-4-
((triisopropylsilyl)oxy)phenyl)propanoate (i-29) To a dry, clean round bottomed flask 
equipped with a stir bar was added methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-
5-methoxy-4-((triisopropylsilyl)oxy)phenyl)acrylate (0.977 g, 1.96 mmol, 1.0 equiv), which 
was then dissolved in 12 mL of a THF:EtOH (2:1) solution. 10% Palladium on carbon (20.9 
mg, 0.20 mmol, 0.10 equiv) was added to the solution and the reaction was placed under 
N2. The solution was purged and backfilled with H2 before being placed under a H2 
atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). Once the 
reaction was complete, the solution was run through a Celite plug and concentrated. The 
crude mixture was then purified by flash chromatography (10% EtOAc:Hex) to yield methyl 
2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-methoxy-4-
((triisopropylsilyl)oxy)phenyl)propanoate as a white solid (0.950 g, 97%).  
 
1H NMR (600 MHz, CDCl3) δ 6.58 (d, J = 10.7 Hz, 1H), 6.56 (d, J = 7.7 Hz, 1H), 5.05 (d, 
J = 8.3 Hz, 1H) + rotamer at 4.80 (s), 4.52 (q, J = 6.8 Hz, 1H) + rotamer at 4.36 (s), 3.75 
(s, 3H), 3.69 (s, 3H), 3.03 (qd, J = 14.0, 6.3 Hz, 2H), 1.41 (s, 9H), 1.27 – 1.20 (m, 3H), 
1.07 (d, J = 7.5 Hz, 18H). 
13C NMR (151 MHz, CDCl3) δ 172.49, 155.22 (d, J = 238.6 Hz), 155.15, 147.43 (d, J = 
2.6 Hz), 145.46 (d, J = 11.4 Hz), 114.58 (d, J = 17.4 Hz), 114.26 (d, J = 6.2 Hz), 108.20 
(d, J = 25.3 Hz), 79.97, 56.20, 53.93, 52.41, 31.73, 28.43, 17.96, 12.91.  








HRMS (ESI): Calculated for C25H42FNO6Si (M+Na)+: 522.26579; found: 522.26462. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-4-hydroxy-5-
methoxyphenyl)propanoate (i-30) Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-
5-methoxy-4-((triisopropylsilyl)oxy)phenyl)propanoate (0.925 g, 1.85 mmol, 1.0 equiv) was 
added to a clean, dry round bottomed flask equipped with a stir bar and the solid was 
dissolved in 20 mL of THF under N2. The solution was then cooled to 0 ºC before a solution 
of tetrabutylammonium fluoride (1.0 M in THF, 2.0 mL, 2.04 mmol, 1.1 equiv) was added 
dropwise to the reaction mixture. The reaction was then warmed to room temperature and 
allowed to stir for 2 h. At the end of the reaction, the reaction was quenched with 15 mL 
NH4Cl solution before being diluted with EtOAc. The layers were separated and the aqueous 
layer was extracted twice with 10 mL EtOAc. The organic layers were combined, dried over 
Na2SO4, concentrated and purified by flash chromatography (40-50% EtOAc:Hex) to yield 
methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-4-hydroxy-5-
methoxyphenyl)propanoate as a white solid (0.620 g, 98%). 
 
1H NMR (600 MHz, CDCl3) δ 6.64 (d, J = 10.2 Hz, 1H), 6.58 (d, J = 6.7 Hz, 1H), 5.68 (s, 
1H), 5.07 (d, J = 8.3 Hz, 1H) + rotamer at 4.79 (s), 4.52 (q, J = 6.8 Hz, 1H) + rotamer at 
4.36 (s), 3.84 (s, 3H), 3.73 (s, 3H), 3.11 – 2.96 (m, 2H) + rotamer at 2.87 (s), 1.41 (s, 
9H).  
13C NMR (151 MHz, CDCl3) δ 172.43, 155.82 (d, J = 238.0 Hz), 155.20, 145.66 (d, J = 
12.3 Hz), 142.96 (d, J = 2.6 Hz), 113.33 (d, J = 18.0 Hz), 112.82 (d, J = 4.1 Hz), 102.74 
(d, J = 28.2 Hz), 80.05, 56.54, 54.02, 52.49, 31.61, 28.44. 








HRMS (ESI): Calculated for C16H22FNO6 (M+Na)+: 366.13236; found: 366.13142. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-methoxy-4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate (5.36) To a dry, clean round 
bottomed flask equipped with a stir bar was added methyl 2-((tert-butoxycarbonyl)amino)-
3-(2-fluoro-4-hydroxy-5-methoxyphenyl)propanoate (0.570 g, 1.75 mmol, 1.0 equiv) and 
the solid was dissolved in 20 mL of DCM under N2. The solution was cooled to 0 ºC before 
pyridine (0.28 mL, 3.50 mmol, 2.0 equiv) was added to the solution. 
Trifluoromethanesulfonic anhydride (0.36 mL, 2.10 mmol, 1.2 equiv) was then added to the 
reaction dropwise and the solution was stirred for 15 minutes before being warmed to room 
temperature. The reaction was then run for 2 h. before being quenched with DI water. The 
reaction was then diluted with DCM before the layers were separated. The aqueous layer 
was extracted once with DCM (10 mL) and the organic layers were combined, washed 
sequentially with 10 mL of dilute HCl (2.0 M) and brine, dried over Na2SO4 and 
concentrated. The crude product was purified via flash chromatography (10% EtOAc) to 
yield methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-methoxy-4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)-propanoate as a white solid (720 mg, 90%). 
 
1H NMR (600 MHz, CDCl3) δ 6.96 (d, J = 8.6 Hz, 1H), 6.83 (d, J = 6.4 Hz, 1H), 5.15 (d, J 
= 8.3 Hz, 1H) + rotamer at 4.98 (s), 4.58 (q, J = 7.2 Hz, 1H) + rotamer at 4.41 (s), 3.86 
(s, 3H), 3.72 (s, 3H), 3.18 (dd, J = 14.1, 5.9 Hz, 1H), 3.03 (dd, J = 14.1, 7.3 Hz, 1H) + 







13C NMR (151 MHz, CDCl3) δ 171.94, 155.06, 154.20 (d, J = 242.4 Hz), 147.87 (d, J = 
2.9 Hz), 137.02 (d, J = 11.0 Hz), 124.49 (d, J = 17.2 Hz), 118.76 (q, J = 320.4 Hz), 
115.26 (d, J = 4.9 Hz), 110.50 (d, J = 28.1 Hz), 80.26, 56.73, 53.37, 52.61, 32.09, 28.30. 
19F NMR (376 MHz, CDCl3) δ -73.59 (d, J = 2.9 Hz), -123.68 (d, J = 7.7 Hz). 
 
HRMS (ESI): Calculated for C17H21F4NO8S (M+Na)+: 498.08164; found: 498.08065. 
 
Methyl 2-amino-3-(2-fluoro-4-hydroxy-5-methoxyphenyl)propanoate (i-31) To a 
dry, clean round bottomed flask equipped with a stir bar was added methyl 2-((tert-
butoxycarbonyl)amino)-3-(2-fluoro-5-methoxy-4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate (0.300 g, 0.874 mmol, 1.0 equiv). The 
fluoroarene was then dissolved in 4 mL of DCM under N2 and the stirring solution was cooled 
to 0 ºC. Trifluoroacetic acid (1 mL) was added dropwise to the reaction and substrate 
conversion was observed by TLC. Once the reaction was complete, the solution was 
concentrated under reduced pressure (to remove excess TFA) and reconstituted in 10 mL 
DCM. This new solution was then cooled to 0 ºC before dropwise addition of triethylamine 
(0.13 mL, 0.917 mmol, 1.05 equiv). The reaction mixture was allowed to stir for 2 h. Once 
the reaction was complete, it was diluted with H2O (10 mL) and DCM (10 mL). The organic 
layers were combined, washed with an additional portion of water (10 mL), dried over 
MgSO4, and concentrated under reduced pressure. The crude product was used without 








1H NMR (600 MHz, CDCl3) δ 6.60 (d, J = 6.8 Hz, 1H), 6.55 (d, J = 10.5 Hz, 1H), 3.75 (s, 
3H), 3.74 – 3.71 (m, 2H), 3.70 (s, 3H), 3.61 (bs, 2H), 3.00 (dd, J = 13.9, 5.3 Hz, 1H), 2.84 
(dd, J = 13.9, 7.6 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 175.23, 155.62 (d, J = 237.7 Hz), 145.87 (d, J = 12.4 Hz), 
143.36 (d, J = 2.4 Hz), 113.54 (d, J = 17.6 Hz), 113.13 (d, J = 6.2 Hz), 103.16 (d, J = 
27.6 Hz), 56.37, 54.67, 52.22, 34.06. 
19F NMR (376 MHz, CDCl3) δ -125.24 (dd, J = 10.6, 6.5 Hz). 
 
HRMS (ESI): Calculated for C11H14FNO4 (M+H)+: 244.09796; found: 244.09880 
 
2-Amino-3-(2-fluoro-4-hydroxy-5-methoxyphenyl)propanoic acid (i-32) The title 
compound was prepared from methyl 2-amino-3-(2-fluoro-4-hydroxy-5-
methoxyphenyl)propanoate according to a published procedure28 for the non-fluorinated 
congener (methyl 2-amino-3-(4-hydroxy-5-methoxyphenyl)propanoate); spectra data are in 
agreement with literature values.29 
 
6-Fluoro-L-3,4-dihydroxyphenylalanine (5.37) The title compound was prepared 

















Methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate (1.783 g, 6.00 
mmol, 1.2 equiv) was added to a flame dried round bottomed flask equipped with a stir bar 
and dissolved in 15 mL of dry DCM under N2. Then 1,8-diazabicyclo[5.4.0]undec-7-ene 
(0.75 mL, 5.00 mmol, 1.0 equiv) was added via syringe and the mixture was stirred at 
room temperature for 15 minutes. While the phosphonate ester solution was stirring, a 
solution of 2-fluoro-5-methoxybenzaldehyde (0.7707 g, 5.00 mmol, 1.0 equiv) in 15 mL 
DCM was prepared. This benzaldehyde solution was added to the phosphonate ester 
solution dropwise at room temperature. Reaction conversion was monitored via TLC 
(reaction takes approximately 4 h.) and at the end of the reaction, the solution was 








































chromatography (20 to 30% EtOAc) to yield methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-
(2-fluoro-5-methoxyphenyl)-acrylate as a white solid (1.37 g, 84%) 
 
1H NMR (600 MHz, CDCl3) δ 7.34 (bs, 1H), 7.25 (dd, J = 9.7, 2.9 Hz, 1H), 6.97 (td, J = 
9.1, 3.1 Hz, 1H), 6.83 (dd, J = 9.1, 4.5 Hz, 1H), 6.46 (s, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 
1.38 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 166.01, 156.69 (d, J = 238.2 Hz), 153.51 (d, J = 2.1 Hz), 
152.43, 125.76, 124.50 (d, J = 8.2 Hz), 122.44, 116.48 (d, J = 23.2 Hz), 115.80 (d, J = 
24.3 Hz), 111.99 (d, J = 8.3 Hz), 81.05, 56.32, 52.72, 28.13. 
19F NMR (376 MHz, CDCl3) δ -123.87. 
 




To a dry, clean round bottomed flask equipped with a stir bar was added methyl (Z)-2-
((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-methoxyphenyl)acrylate (1.37 g, 4.21 mmol, 
1.0 equiv), which was then dissolved in 20 mL of a THF:EtOH (2:1) solution. 10% Palladium 
on carbon (89.6 mg, 0.20 mmol, 0.10 equiv) was added to the solution and the reaction 
was placed under N2. The solution was purged and backfilled with H2 before being placed 
under a H2 atmosphere (1 atm) overnight (reaction is typically done in about 2-3 hours). 
Once the reaction was complete, the solution was run through a Celite plug and 






EtOAc:Hex) to yield methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-5-
methoxyphenyl)propanoate (1.34 g, 97%) as a white solid.  
 
1H NMR (600 MHz, CDCl3) δ 6.90 (td, J = 8.5, 3.1 Hz, 1H), 6.81 (dd, J = 8.8, 3.1 Hz, 
1H), 6.76 (dd, J = 9.1, 4.4 Hz, 1H), 5.18 (d, J = 8.1 Hz, 1H) + rotamer at 5.03 (d, J = 7.4 
Hz), 4.51 (q, J = 7.2 Hz, 1H) + rotamer at 4.33 (bs), 3.79 (s, 3H), 3.70 (s, 3H), 3.08 (dd, J 
= 13.6, 5.5 Hz, 1H), 2.98 (dd, J = 13.7, 7.8 Hz, 1H), 1.38 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.70, 156.83 (d, J = 238.3 Hz), 155.26, 153.88 (d, J = 
2.1 Hz), 126.46 (d, J = 7.3 Hz), 117.98 (d, J = 23.0 Hz), 114.22 (d, J = 22.6 Hz), 111.18 
(d, J = 8.3 Hz), 79.83, 55.96, 53.77, 52.29, 32.99, 28.36. 
19F NMR (376 MHz, CDCl3) δ -124.13 (td, J = 8.2, 4.2 Hz). 
 




To a dry, clean round bottomed flask equipped with a stir bar was added methyl 2-((tert-
butoxycarbonyl)amino)-3-(2-fluoro-5-methoxyphenyl)propanoate (327.0 mg, 1.00 mmol, 
1.0 equiv). The solid was dissolved in MeOH (5 mL) and a 2 N solution of sodium hydroxide 
(2.0 mL, 4.00 mmol, 4.0 equiv) was slowly added to the methanol solution. The reaction 
was then stirred at room temperature until all of the starting material was consumed 
(monitored via TLC). Upon completion of hydrolysis, the reaction mixture was diluted with 
EtOAc (15 mL) and dilute HCl solution was added until solution pH < 2.0. The layers were 






10 mL). The organic layers were combined, washed with brine, dried over MgSO4, and 
concentrated under reduced pressure to reveal 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-
5-methoxyphenyl)propanoic acid as a white solid. The isolated product was sufficiently pure 
to be used without further purification (310 mg, 99%). 
 
1H NMR (600 MHz, Acetone-d6) δ 11.11 (bs, 1H), 7.02 (dd, J = 9.3, 2.6 Hz, 1H), 6.99 – 
6.92 (m, 2H), 6.09 (d, J = 8.7 Hz, 1H) + rotamer at 5.69 (d, J = 8.4 Hz), 4.47 (td, J = 9.2, 
4.8 Hz, 1H) + rotamer at 4.39 (bs), 3.85 (s, 3H), 3.27 (dd, J = 13.7, 4.9 Hz, 1H), 2.89 (dd, 
J = 13.6, 9.8 Hz, 1H), 1.33 (s, 9H). 
13C NMR (151 MHz, Acetone-d6) δ 173.69, 157.46 (d, J = 235.7 Hz), 156.24, 155.07 (d, 
J = 2.1 Hz), 128.57 (d, J = 7.6 Hz), 118.51 (d, J = 23.5 Hz), 114.39 (d, J = 22.6 Hz), 
112.25 (d, J = 8.5 Hz), 79.13, 56.33, 53.99, 33.19, 28.47. 
19F NMR (376 MHz, Acetone-d6) δ -126.24 – -126.44 (m). 
 
HRMS (ESI): Calculated for C15H20FNO5 (M+Na)+: 336.12180; found: 336.12168. 
 
2-Fluoro-5-methoxy-DL-phenylalanine trifluoroacetate salt (39) To a dry, clean 
round bottomed flask equipped with a stir bar was added 2-((tert-butoxycarbonyl)amino)-3-
(2-fluoro-5-methoxyphenyl)propanoic acid (235.0 mg, 0.750 mmol, 1.0 equiv). The solid 
was dissolved in acetone (10 mL) and the solution was cooled to 0 ºC. Trifluoroacetic acid 
(2 mL) was added dropwise to the reaction solution and after 10 minutes of stirring, was 
allowed to warm to room temperature. The reaction was allowed to stir for 3 hours and 
upon the completion of the reaction, the solvents were removed under reduced pressure. 








diethyl ether. A brown crystalline solid (2-fluoro-5-methoxy-DL-phenylalanine 
trifluoroacetate salt) was isolated and was analyzed without further purification (240.0 mg, 
98%). 
 
1H NMR (600 MHz, DMSO) δ 13.91 (bs, 1H), 8.28 (bs, 2H), 7.10 (td, J = 8.7, 3.2 Hz, 1H), 
7.03 (dd, J = 9.0, 3.2 Hz, 1H), 6.99 (dd, J = 9.0, 4.5 Hz, 1H), 4.38 (bs, 1H), 4.09 (t, J = 
7.0 Hz, 1H), 3.77 (s, 3H), 3.14 (dd, J = 13.9, 6.6 Hz, 1H), 2.97 (dd, J = 13.9, 7.3 Hz, 1H). 
13C NMR (151 MHz, DMSO) δ 170.46, 158.01 (q, J = 30.9 Hz), 155.96 (d, J = 235.6 Hz), 
154.00 (d, J = 1.5 Hz), 124.55 (d, J = 7.7 Hz), 117.81 (d, J = 23.3 Hz), 117.28 (q, J = 
300.1 Hz), 114.63 (d, J = 22.5 Hz), 111.97 (d, J = 8.4 Hz), 55.90, 51.78, 30.98. 
19F NMR (376 MHz, DMSO) δ -73.51, -124.19 (td, J = 8.7, 4.6 Hz). 
 
HRMS (ESI): Calculated for C10H12FNO3 (M+H)+: 214.08739; found: 214.08765 (only free 
amine mass detected). 
 
  





































N-Boc-4-(trifluoromethanesulfonyl)-L-phenylalanine methyl ester (i-35) The title 
compound was prepared according to a published procedure; spectra data are in agreement 
with literature values.31 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4'-fluoro-[1,1'-biphenyl]-4-
yl)propanoate (5.40, a-F) To a clean, dry round bottomed flask equipped with a stir bar 
was added (4-fluorophenyl)boronic acid (276.4 mg, 1.98 mmol, 1.3 equiv) and potassium 
carbonate (546.1 mg, 3.95 mmol, 2.6 equiv). The flask containing the solids was then 
transferred into an N2 glovebox, where tetrakis(triphenylphos-phine)palladium(0) (175.6 
mg, 0.152 mmol, 0.10 equiv) was added. The flask was then sealed with a rubber septum 
and subsequently removed from the glovebox. The flask was then placed under a positive 
N2 pressure and the solids in the flask were dissolved in a 10:1 PhMe:DMF mixture (15.4 
mL, 0.1 M). A prepared solution of N-Boc-4-(trifluoromethanesulfonyl)-L-phenylalanine 
methyl ester (649.5 mg, 1.52 mmol, 1.0 equiv) in PhMe (~0.4 M) was then added, and the 
reaction was stirred at 100 ºC overnight. Upon completion (confirmed by consumption of 
substrate by TLC), the reaction was filtered through Celite into a separatory funnel, and 
diluted with EtOAc (10 mL) and water (20 mL). The layers were separated and the aq. layer 
was extracted with one portion of EtOAc (10 mL). The organic layers were combined and 
washed with two portions of LiCl solution and one portion of brine before being dried over 








(10 to 30% EtOAc:Hex) to yield methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4'-fluoro-
[1,1'-biphenyl]-4-yl)propanoate as a white solid (0.5430 g, 96%). 
 
1H NMR (600 MHz, CDCl3) δ 7.55 – 7.49 (m, 2H), 7.48 (d, J = 7.6 Hz, 2H), 7.22 (d, J = 
7.9 Hz, 2H), 7.12 (td, J = 8.6, 1.9 Hz, 2H), 5.18 (d, J = 8.6 Hz, 1H) + rotamer at 5.03 (bs), 
4.66 (q, J = 6.7 Hz, 1H) + rotamer at 4.46 (bs), 3.20 (dd, J = 13.9, 5.8 Hz, 1H), 3.10 (dd, 
J = 13.9, 6.4 Hz, 1H), 1.45 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.34, 162.38 (d, J = 246.2 Hz), 155.16, 138.82, 136.82 
(d, J = 3.2 Hz), 135.16, 129.78, 128.50 (d, J = 7.8 Hz), 127.05, 115.59 (d, J = 21.3 Hz), 
79.92, 54.41, 52.23, 37.86, 28.27. 
19F NMR (376 MHz, CDCl3) δ -115.54 (td, J = 8.7, 8.2, 4.6 Hz). 
 




To a dry, clean round bottomed flask equipped with a stir bar was added methyl (S)-2-
((tert-butoxycarbonyl)amino)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)propanoate (444.0 mg, 1.19 
mmol, 1.0 equiv). The solid was dissolved in MeOH (5 mL) and a 2 N solution of sodium 
hydroxide (2.4 mL, 4.76 mmol, 4.0 equiv) was slowly added to the methanol solution. The 
reaction was then stirred at room temperature until all of the starting material was 
consumed (monitored via TLC). Upon completion of hydrolysis, the reaction mixture was 
diluted with EtOAc (15 mL) and dilute HCl solution was added until solution pH < 2.0. The 
layers were then separated and the aq. layer was extracted with two additional portions of 





MgSO4, and concentrated under reduced pressure to reveal (S)-2-((tert-
butoxycarbonyl)amino)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)propanoic acid as a white solid. The 
isolated product was sufficiently pure to be used without further purification (374.0 mg, 
87%).  
 
1H NMR (600 MHz, Acetone-d6) δ 11.25 (s, 1H), 7.68 (dd, J = 8.6, 5.5 Hz, 2H), 7.58 (d, 
J = 7.9 Hz, 2H), 7.39 (d, J = 7.9 Hz, 2H), 7.22 (t, J = 8.8 Hz, 2H), 6.11 (d, J = 8.5 Hz, 1H) 
+ rotamer at 5.71 (d, J = 7.0 Hz), 4.46 (td, J = 8.7, 4.9 Hz, 1H) + rotamer at 4.37 (bs), 
3.25 (dd, J = 13.9, 5.0 Hz, 1H), 3.05 (dd, J = 13.9, 9.0 Hz, 1H), 1.36 (s, 9H). 
13C NMR (151 MHz, Acetone-d6) δ 173.57, 163.29 (d, J = 244.3 Hz), 156.32, 139.11, 
138.06 (d, J = 3.2 Hz), 137.85, 130.84, 129.53 (d, J = 8.2 Hz), 127.61, 116.41 (d, J = 
21.5 Hz), 79.32, 55.72, 37.81, 28.55. 
19F NMR (376 MHz, Acetone-d6) δ -117.66 (tt, J = 8.3, 5.1 Hz). 
 
HRMS (ESI): Calculated for C20H22FNO4 (M+Na)+: 382.14253; found: 382.14239. 
 
(S)-2-Amino-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)propanoic acid trifluoroacetate salt 
(5.41) 
To a dry, clean round bottomed flask equipped with a stir bar was added (S)-2-((tert-
butoxycarbonyl)amino)-3-(4'-fluoro-[1,1'-biphenyl]-4-yl)propanoic acid (334.6 mg, 0.931 
mmol, 1.0 equiv). The solid was dissolved in acetone (10 mL) and the solution was cooled 
to 0 ºC. Trifluoroacetic acid (2 mL) was added dropwise to the reaction solution and after 10 
minutes of stirring, was allowed to warm to room temperature. The reaction was allowed to 







reduced pressure. Excess trifluoroacetic acid was azeotropically removed with small 
amounts of toluene and diethyl ether. An off-white solid [(S)-2-amino-3-(4'-fluoro-[1,1'-
biphenyl]-4-yl)propanoic acid trifluoroacetate salt] was isolated and was analyzed without 
further purification (345.7 mg, 99%). 
 
1H NMR (600 MHz, CD3CN) δ 7.69 – 7.65 (m, 2H), 7.64 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 
8.2 Hz, 2H), 7.25 – 7.18 (m, 2H), 4.30 (dd, J = 8.1, 5.5 Hz, 1H), 3.36 (dd, J = 14.7, 5.5 
Hz, 1H), 3.19 (dd, J = 14.8, 8.1 Hz, 1H). (NH3 and COOH peaks not observed) 
1H NMR (600 MHz, MeOD) δ 7.65 – 7.60 (m, 4H), 7.38 (d, J = 8.2 Hz, 2H), 7.18 (t, J = 
8.8 Hz, 2H), 4.27 (dd, J = 7.9, 5.3 Hz, 1H), 3.36 (dd, J = 14.6, 5.4 Hz, 1H), 3.19 (dd, J = 
14.5, 7.9 Hz, 1H). (NH3 and COOH peaks not observed) 
13C NMR (151 MHz, CD3CN) δ 169.73, 163.52 (d, J = 244.7 Hz), 159.11 (q, J = 39.5 Hz), 
140.34, 137.40 (d, J = 3.3 Hz), 133.97, 131.18, 129.69 (d, J = 8.3 Hz), 128.39, 116.64 (d, 
J = 21.6 Hz), 116.24 (q, J = 286.8 Hz), 55.28, 35.74. 
13C NMR (151 MHz, MeOD) δ 171.35, 164.00 (d, J = 245.1 Hz), 141.01, 138.14 (d, J = 
3.2 Hz), 134.74, 131.05, 129.75 (d, J = 8.1 Hz), 128.60, 116.62 (d, J = 21.5 Hz), 55.17, 
37.01. (TFA peaks not observed) 
19F NMR (376 MHz, CD3CN) δ -76.76, -116.95 – -117.08 (m). 
19F NMR (376 MHz, MeOD) δ -77.09, -117.79 (ddd, J = 14.1, 9.5, 5.4 Hz). 
 
HRMS (ESI): Calculated for C15H14FNO2 (M+H)+: 260.10813; found: 260.10836 (only free 





2-Fluoro-4-formylphenyl trifluoromethanesulfonate (i-37) The title compound was 
prepared according to a published procedure32; spectra data are provided herein. 
 
1H NMR (600 MHz, CDCl3) δ 9.98 (d, J = 1.9 Hz, 1H), 7.81 – 7.69 (m, 2H), 7.54 (dd, J = 
8.6, 6.8 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 189.28 (d, J = 2.0 Hz), 154.28 (d, J = 257.4 Hz), 140.95 (d, 
J = 13.8 Hz), 137.30 (d, J = 5.0 Hz), 126.92 (d, J = 3.8 Hz), 124.62, 118.73 (q, J = 320.7 
Hz), 117.67 (d, J = 18.8 Hz). 
19F NMR (376 MHz, CDCl3) δ -72.79 (d, J = 4.9 Hz), -124.44 (dpd, J = 10.0, 4.9, 2.3 Hz). 
 






































2-Fluoro-[1,1'-biphenyl]-4-carbaldehyde (i-38) To a clean, dry round bottomed flask 
equipped with a stir bar was added phenylboronic acid (949.0 mg, 7.79 mmol, 1.3 equiv) 
and potassium carbonate (2.15 g, 15.6 mmol, 2.6 equiv). The flask containing the solids 
was then transferred into an N2 glovebox, where tetrakis(triphenylphosphine)palladium(0) 
(692 mg, 0.599 mmol, 0.10 equiv) was added. The flask was then sealed with a rubber 
septum and subsequently removed from the glovebox. The flask was then placed under a 
positive N2 pressure and the solids in the flask were dissolved in a 10:1 PhMe:DMF mixture 
(55 mL, 0.1 M). A prepared solution of 2-fluoro-4-formylphenyl trifluoromethane-sulfonate 
(1.63 g, 5.99 mmol, 1.0 equiv) in PhMe (~0.4 M) was then added, and the reaction was 
stirred at 100 ºC overnight. Upon completion (confirmed by consumption of substrate by 
TLC), the reaction was filtered through Celite into a separatory funnel, and diluted with 
EtOAc (10 mL) and water (20 mL). The layers were separated and the aq. layer was 
extracted with one portion of EtOAc (10 mL). The organic layers were combined and washed 
with two portions of LiCl solution and one portion of brine before being dried over MgSO4 
and concentrated. The crude mixture was then purified by column chromatography (10 to 
30% EtOAc:Hex) to yield 2-fluoro-[1,1'-biphenyl]-4-carbaldehyde as a white solid (1.05 g, 
88%). 
1H NMR (600 MHz, CDCl3) δ 10.01 (d, J = 1.8 Hz, 1H), 7.74 (dd, J = 7.8, 1.6 Hz, 1H), 
7.67 (dd, J = 10.3, 1.6 Hz, 1H), 7.63 (t, J = 7.6 Hz, 1H), 7.59 (dt, J = 8.1, 1.5 Hz, 2H), 
7.51 – 7.46 (m, 2H), 7.46 – 7.42 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 190.75 (d, J = 2.1 Hz), 160.08 (d, J = 251.1 Hz), 137.14 (d, 
J = 6.6 Hz), 135.37 (d, J = 13.8 Hz), 134.57 (d, J = 1.5 Hz), 131.57 (d, J = 3.4 Hz), 
129.15 (d, J = 3.1 Hz), 128.84, 128.78, 126.18 (d, J = 3.4 Hz), 116.46 (d, J = 23.7 Hz). 





HRMS (ESI): Calculated for C13H9FO (M+H)+: 201.07102; found: 201.07122. 
 
Methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-[1,1'-biphenyl]-4-
yl)acrylate (i-39) Methyl 2-((tert-butoxycarbonyl)amino)-2-(dimethoxyphosphoryl)acetate 
(0.884 g, 5.30 mmol, 1.2 equiv) was added to a flame dried round bottomed flask equipped 
with a stir bar and dissolved in 15 mL of dry DCM under N2. Then 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.67 mL, 4.42 mmol, 1.0 equiv) was added via syringe and 
the mixture was stirred at room temperature for 15 minutes. While the phosphonate ester 
solution was stirring, a solution of 2-fluoro-[1,1'-biphenyl]-4-carbaldehyde (0.8840 g, 4.42 
mmol, 1.0 equiv) in 12 mL DCM was prepared. This benzaldehyde solution was added to the 
phosphonate ester solution dropwise at room temperature. Reaction conversion was 
monitored via TLC (reaction takes approximately 4 h.) and at the end of the reaction, the 
solution was concentrated and loaded onto Celite. The crude reaction mixture was then 
purified via flash chromatography (20 to 30% EtOAc) to yield methyl (Z)-2-((tert-
butoxycarbonyl)amino)-3-(2-fluoro-[1,1'-biphenyl]-4-yl)acry-late as a white solid (1.51 g, 
92%) 
 
1H NMR (600 MHz, CDCl3) δ 7.56 (dt, J = 8.1, 1.5 Hz, 2H), 7.48 – 7.41 (m, 3H), 7.40 – 
7.34 (m, 3H), 7.26 (bs, 1H), 6.41 (bs, 1H), 3.88 (s, 3H), 1.43 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 165.97, 159.60 (d, J = 247.7 Hz), 152.40, 135.42, 135.36, 
130.61 (d, J = 3.9 Hz), 129.76 (d, J = 13.7 Hz), 129.08 (d, J = 3.2 Hz), 128.65, 128.17 (d, 
J = 2.4 Hz), 128.13, 126.22 (d, J = 3.2 Hz), 124.88, 116.91 (d, J = 24.4 Hz), 81.47, 52.95, 
28.24. 






HRMS (ESI): Calculated for C21H22FNO4 (M+Na)+: 394.14253; found: 394.14247. 
 
Methyl 2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-[1,1'-biphenyl]-4-
yl)propanoate (5.40, b-F) To a dry, clean round bottomed flask equipped with a stir bar 
was added methyl (Z)-2-((tert-butoxycarbonyl)amino)-3-(2-fluoro-[1,1'-biphenyl]-4-
yl)acry-late (1.51 g, 4.07 mmol, 1.0 equiv), which was then dissolved in 27 mL of a 
THF:EtOH (2:1) solution. 10% Palladium on carbon (86.5 mg, 0.20 mmol, 0.10 equiv) was 
added to the solution and the reaction was placed under N2. The solution was purged and 
backfilled with H2 before being placed under a H2 atmosphere (1 atm) overnight (reaction is 
typically done in about 2-3 hours). Once the reaction was complete, the solution was run 
through a Celite plug and concentrated. The crude mixture was then purified by flash 
chromatography (10 to 30% EtOAc:Hex) to yield methyl 2-((tert-butoxycarbonyl)amino)-3-
(2-fluoro-5-methoxyphenyl)propanoate (1.43 g, 94%) as a white solid.  
 
1H NMR (600 MHz, CDCl3) δ 7.56 (dt, J = 8.1, 1.5 Hz, 2H), 7.47 (t, J = 7.7 Hz, 2H), 7.42 
– 7.35 (m, 2H), 7.04 – 6.99 (m, 1H), 6.97 (d, J = 11.3 Hz, 1H), 5.10 (d, J = 8.3 Hz, 1H) + 
rotamer at 4.85 (bs), 4.66 (dt, J = 8.2, 5.9 Hz, 1H) + rotamer at 4.47 (bs), 3.79 (s, 3H), 
3.21 (dd, J = 13.9, 5.6 Hz, 1H), 3.10 (dd, J = 13.9, 6.2 Hz, 1H), 1.46 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.19, 159.65 (d, J = 248.2 Hz), 155.16, 137.67 (d, J = 
7.7 Hz), 135.59, 130.85 (d, J = 3.9 Hz), 129.04 (d, J = 3.0 Hz), 128.75 (d, J = 12.1 Hz), 
128.56, 127.76, 125.44 (d, J = 3.4 Hz), 117.10 (d, J = 23.0 Hz), 80.23, 54.33, 52.53, 
37.91, 28.40. 






HRMS (ESI): Calculated for C21H24FNO4 (M+Na)+: 396.15818; found: 396.15814. 
 
2-(3-(4-Fluorophenoxy)phenyl)propanoic acid (5.42) To a dry, clean round bottomed 
flask equipped with a stir bar was added methyl 2-(3-(4-fluorophenoxy)phenyl)propanoate 
(256.0 mg, 0.933 mmol, 1.0 equiv). The solid was dissolved in MeOH (5 mL) and a 2 N 
solution of sodium hydroxide (2.4 mL, 4.76 mmol, 4.0 equiv) was slowly added to the 
methanol solution. The reaction was then stirred at room temperature until all of the 
starting material was consumed (monitored via TLC). Upon completion of hydrolysis, the 
reaction mixture was diluted with EtOAc (15 mL) and dilute HCl solution was added until 
solution pH < 2.0. The layers were then separated and the aq. layer was extracted with two 
additional portions of EtOAc (2 x 10 mL). The organic layers were combined, washed with 
brine, dried over MgSO4, and concentrated under reduced pressure to reveal 2-(3-(4-
fluorophenoxy)phenyl)propanoic acid as a white solid. The isolated product was sufficiently 
pure to be used without further purification (220.0 mg, 91%).  
 
1H NMR (600 MHz, CDCl3) δ 11.15 (s, 1H), 7.28 (t, J = 7.8 Hz, 1H), 7.08 – 7.01 (m, 3H), 
7.00 – 6.96 (m, 3H), 6.84 (dd, J = 8.3, 2.4 Hz, 1H), 3.71 (q, J = 7.1 Hz, 1H), 1.50 (d, J = 
7.2 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 180.71, 159.02 (d, J = 241.9 Hz), 158.06, 152.64 (d, J = 
2.7 Hz), 141.82, 130.07, 122.40, 120.81 (d, J = 8.2 Hz), 117.74, 116.96, 116.48 (d, J = 
23.2 Hz), 45.33, 18.15. 
19F NMR (376 MHz, CDCl3) δ -119.75 (dt, J = 8.8, 4.8 Hz). 
 








C.4 Synthesis and Analysis of Fluorinated HPLC Standards for Arene C–H 
Fluorination 
C.4.1 General C–H fluorination procedure for CsF as the fluorine source 
 
Photocatalyst S1 (1.4 mg, 0.0025 mmol, 0.05 equiv), diphenyl ether (8.5 mg, 0.05 
mmol, 1.0 equiv), TBAHSO4 (8.5 mg, 0.025 mmol, 0.5 equiv), TEMPO (3.9 mg, 0.025 
mmol, 0.5 equiv) and CsF (76.0 mg, 0.5 mmol, 10 eq) were weighed and added 
sequentially to a dried glass vial equipped with a stir bar. 225 µL DCE and 75 µL H2O was 
added. The vial was then sealed with a Teflon-lined septum screw cap. The septum was 
then pierced with a disposable steel needle connected to an oxygen-filled balloon. A vent 
needle was inserted and the reaction medium was sparged for 1 minutes by bubbling 
oxygen through the mixture. Then the vent needle was removed, and the oxygen balloon 
was maintained, providing approximately 1 atm of oxygen to the vial headspace for the 
course of the reaction. The reaction flask was then placed on a stir plate and illuminated 
with blue LED lamps (455 nm). Analysis the reaction by HPLC at 2.5 h and 24 h.  
C.4.2 General C–H fluorination procedure for TBAF as the fluorine source 
 
Photocatalyst S1 (1.4 mg, 0.0025 mmol, 0.05 equiv), diphenyl ether (8.5 mg, 0.05 
mmol, 1.0 equiv), TEMPO (3.9 mg, 0.025 mmol, 0.5 equiv) were weighed and added 
sequentially to a dried glass vial equipped with a stir bar. 500 µL anhydrous TBAF (1M in 
THF) was added. The vial was then sealed with a Teflon-lined septum screw cap. The 




















































balloon. A vent needle was inserted and the reaction medium was sparged for 1 minutes by 
bubbling oxygen through the mixture. Then the vent needle was removed, and the oxygen 
balloon was maintained, providing approximately 1 atm of oxygen to the vial headspace for 
the course of the reaction. The reaction flask was then placed on a stir plate and illuminated 
with blue LED lamps (455 nm). Analysis the reaction by HPLC at 2.5 h and 24 h.  
C.4.3 General HPLC conditions 
Column: Phenomenex, Kinetex® Aeris PEPTIDE 3.6u XB-C18, 250 x 4.6 mm LC Column. 
Solvent A: 0.1% TFA water; Solvent B: 0.1% TFA acetonitrile; Grad/isocrat: 0 to 2 min: 5% 
to 45% solvent B, 2 to 22 min: 45% to 50% solvent B, 22 to 28 min: 50% to 95% solvent 
B, 28 to 28.1 min: 95% to 5% solvent B, 28.1 to 30 min: isocratic elution at 5% solvent B. 
Flow rate: 1 mL/min, column temperature: 19 to 21 °C.  
       
  
Figure C.2. Overlaid (A and B) or enlarged (C and D) UV-HPLC chromatograms (at 212 
nm) for the crude reaction mixture of CsF or TBAF system at 2.5 h and 24 h 
 





























































Fluorine source Reaction time Area ratio 
(5.2:a) 
CsF 
2.5 h 1:15.12 
24 h 1:5.765 
TBAF 
2.5 h 1:262.48 
24 h 1:218.8 
 
Table C.2. Time and 19F-source dependent C–H fluorination of diphenyl ether 
 
C.5 Experimental Procedures for Radiochemistry 
C5.1 Synthesis of [18F]TBAF, [18F]CsF, [18F]KF, K[18F]F-kryptofix 
C5.1.1 General procedure for the preparation of [18F]TBAF 
[18F]TBAF was prepared on a TRACERLab FXFN (General Electric, GE) automated 
radiochemistry synthesis module. Before [18F]fluoride delivery, ports in the module were 
charged under ambient atmosphere as follows:  
• Port 1: A combination of 70 µl tetrabutylammonium bicarbonate (TBAB) solution 
(20%, w/w), 53 µL H2O, and 477 µL MeCN (Total volume: 600 µL)    
• Port 3: anhydrous MeCN (1 mL) 
• Port 4: anhydrous MeCN (1 mL) 
[18F]Fluoride was produced via the 18O(p,n)18F reaction by proton irradiation (40 µA, 
2-5 min) of  an [18O]H2O containing target in a GE PETTrace cyclotron. The [18F]fluoride (ca. 
1.2-2.2Ci) was delivered to the synthesis module in a bolus of [18O]H2O by stream of argon. 
The aqueous solution of [18F]fluoride was passed through a QMA cartridge (water 
preconditioning) to trap [18F]fluoride before elution into the reactor vessel with a solution of 
TBAB (contents of Port 1). This solution was azeotropically dried by heating the reaction 
vessel to 100 °C and drawing vacuum (ca. 1 kPa) for 5 min, followed by simultaneous 
vacuum draw and nitrogen stream for a further 6 minutes. The dried [18F]TBAF was cooled 
to 50 °C before addition of anhydrous MeCN (contents of Port 3). The mixture was 
transferred out of the reactor under N2 pressure into a sterile vial to yield a solution of 
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[18F]TBAF (1.1-1.8 Ci, average = 1.5 Ci) in MeCN. 10-100 µL aliquots of this solution were 
then used for manual methodology experiments.  
C.5.1.2 General procedure for the preparation of [18F]CsF solution 
First Method: 0.9% cesium chloride as the eluent.  
QMA-light Sep-Paks were preconditioned with 10 mL of 0.9% cesium chloride 
solution, followed by 10 mL of water before use. Target rinse (200 mCi) was then passed 
through the QMA-light Sep-Pak to trap the fluoride-18. The QMA cartridge was washed with 
additional 10mL ultrapure water to remove any residual [18O]H2O and then eluted with 1mL 
of 0.9% cesium chloride solution to yield an aqueous solution of [18F]CsF (~150 mCi) into a 
5mL glass tube for use.  
Second Method: 0.9% cesium carbonate as the eluent.  
QMA cartridge were preconditioned with 10mL of 0.9% cesium carbonate solution, 
followed by 10 mL of water before use. Target rinse (200 mCi) was then passed through the 
QMA-light Sep-Pak to trap the fluoride-18. The QMA cartridge was washed with additional 
10 mL ultrapure water to remove any residual [18O]H2O and then eluted with 1mL of 0.9% 
cesium carbonate solution to yield an aqueous solution of [18F]CsF (~150 mCi) into a 5 mL 
glass tube for use.  
Third Method: 0.9% cesium fluoride as the eluent.  
QMA-light Sep-Paks were preconditioned with 10mL of 0.9% cesium fluoride 
solution, followed by 10 mL of water before use. Target rinse (200 mCi) was then passed 
through the QMA cartridge to trap the fluoride-18. The QMA cartridge was washed with 
additional 10mL ultrapure water to remove any residual [18O]H2O and then eluted with 1mL 
of 0.9% cesium fluoride solution to yield an aqueous solution of [18F]CsF (~150 mCi) into a 
5mL glass tube for use.  
Fourth Method: A mixture of 4.2mg CsCl (0.025 mmol) and [18F]TBAF (10~20 mCi) 
S1 (1.4 mg, 0.0025 mmol, 0.05 equiv), diphenyl ether (8.5 mg, 0.05 mmol, 1.0 
equiv), CsCl (4.2 mg, 0.025 mmol, 0.5 equiv), TBAHSO4 (8.5 mg, 0.025 mmol, 0.5 equiv), 
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TEMPO (3.9 mg, 0.025 mmol, 0.5 equiv) were weighed into a 2.5mL dried glass vial 
equipped with a stir bar and dissolved in 175 µL DCE and 75 µL H2O. Then a 50 µL aliquot of 
[18F]TBAF in DCE (typically 10-20 mCi, preparation method: MeCN in [18F]TBAF was dried by 
heating to 100 oC and argon stream for 5 min, then cooled to RT before addition of 200 µL 
anhydrous DCE) was added to the reaction vial via syringe.  
Fifth Method: A mixture of 7.6 mg CsF (0.05 mmol) and [18F]TBAF (10~20 mCi) 
S1 (1.4 mg, 0.0025 mmol, 0.05 equiv), diphenyl ether (8.5 mg, 0.05 mmol, 1.0 
equiv), CsF (7.6 mg, 0.05 mmol, 1.0 equiv), TBAHSO4 (8.5 mg, 0.025 mmol, 0.5 equiv), 
TEMPO (3.9 mg, 0.025 mmol, 0.5 equiv) were weighed into a 2.5 mL dried glass vial 
equipped with a stir bar and dissolved in 175 µL DCE and 75 µL H2O. Then a 50 µL aliquot of 
[18F]TBAF in DCE (typically 10-20 mCi) was added to the reaction vial via syringe.  
C.5.1.3 General procedure for the preparation of [18F]KF solution 
QMA-light Sep-Paks were preconditioned with 10mL of 0.9% potassium perchlorate 
solution, followed by 10 mL of water before use. Target rinse (200 mCi) was then passed 
through the QMA-light Sep-Pak to trap the fluoride-18. The QMA cartridge was washed with 
additional 10mL ultrapure water to remove any residual [18O]H2O and then eluted with 1 mL 
of 0.9% potassium perchlorate solution to yield an aqueous solution of [18F]KF (~150 mCi) 
into a 5 mL glass tube for use.  
C.5.1.4 General procedure for the preparation of K[18F]F-kryptofix solution 
K[18F]F-kryptofix preparation was conducted on a TRACERLab FXFN (General Electric, 
GE) automated radiochemistry synthesis module which is same as [18F]TBAF preparation 
procedure. The 18F was released from the QMA cartridge by passing K2CO3 solution through 
the cartridge and allowed to enter into the reactor. Kryptofix K2.2.2 solution was added into 
the reactor and the whole mixture was dried at 95 °C in combination of nitrogen flow and 
vacuum. Then 1 mL anhydrous MeCN was added to yield K[18F]F-kryptofix (~1.3 Ci) for use.  
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C.5.2 General HPLC Conditions 
Four general sets of HPLC conditions were used. Conditions A, B, C were normally 
used for HPLC yield calculation of different substrates. Condition D were used for 
[18F]labeled product purification.  
HPLC Condition A: 
Column: Phenomenex, Kinetex® 5µm EVO C18 100 Å, 250 x 4.6 mm LC Column.  
Solvent A: 0.1% TFA:water; Solvent B: 0.1% TFA:acetonitrile; 
Grad/isocrat: 0 to 2 min: 5% to 45% solvent B, 2 to 22 min: 45% to 50% solvent B, 22 to 
28 min: 50% to 95% solvent B, 28 to 28.1 min: 95% to 5% solvent B, 28.1 to 30 min: 
isocratic elution at 5% solvent B.  
Flow rate: 1 mL/min, column temperature: 19 to 21 °C. 
HPLC Condition B: 
Column: Phenomenex, Kinetex® 5µm EVO C18 100 Å, 250 x 4.6 mm LC Column.  
Solvent A: 0.1% TFA:water; Solvent B: 0.1%TFA acetonitrile; 
Grad/isocrat: 0 to 2 min: 30% to 50% solvent B, 2 to 22 min: 50% to 50% solvent B, 22 to 
28 min: 50% to 95% solvent B, 28 to 28.1 min: 95% to 30% solvent B, 28.1 to 30 min: 
isocratic elution at 30% solvent B.  
Flow rate: 1 mL/min, column temperature: 19 to 21 °C. 
HPLC Condition C: 
Column: Phenomenex, Kinetex® 5µm EVO C18 100 Å, 250 x 4.6 mm LC Column.  
Solvent A: 0.1% TFA:water; Solvent B: 0.1% TFA:acetonitrile; 
Grad/isocrat: 0 to 2 min: isocratic elution at 5% solvent B, 2 to 22 min: 5% to 95% solvent 
B, 22 to 28 min: isocratic elution at 95% solvent B, 28 to 28.1 min: 95% to 5% solvent B, 
28.1 to 30 min: isocratic elution at 5% solvent B.  
Flow rate: 1 mL/min, column temperature: 19 to 21 °C. 
HPLC Condition D: 
Column: Phenomenex, Kinetex® 5µm F5 100 Å, 250 x 4.6 mm LC Column  
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Solvent A: 0.1% TFA:water; Solvent B: 0.1% TFA:acetonitrile; 
Grad/isocrat: 0 to 2 min: 20% to 45% solvent B, 2 to 22 min: 45% to 60% solvent B, 22 to 
28 min: 60% to 95% solvent B, 28 to 28.1 min: 95% to 20% solvent B, 28.1 to 30 min: 
isocratic elution at 20% solvent B.  
Flow rate: 1 mL/min, column temperature: 19 to 21 °C.  
 
C.5.3 General procedure for the synthesis of18F-fluoroarenes  
General procedure A: Photocatalyst 1 (1.5mg, 0.0025mmol, 0.05 to 0.01 equiv), 
substrate (0.05 to 0.25mmol, 1.0 equiv), TEMPO (3.9mg, 0.025mmol, 0.5 to 0.1 equiv) 
were weighed into a 1.5mL microcentrifuge tube and dissolved in 50–70µL anhydrous MeCN 
and 400µL t-BuOH. The resulting solution was transferred to a 5 mL v-vial via a pipette, and 
then a 30–50 µL aliquot of [18F]TBAF in MeCN (typically 10–30 mCi) [total volume of MeCN 
is 100 µL] was immediately added to the reaction vial via pipette. Decay in [18F]TBAF 
activity was monitored upon addition of [18F]TBAF to the substrate solution. The reaction v-
vial was then fixed on an iron support and cooled to using an ice-acetone bath. A needle 
connected to an oxygen-filled balloon was inserted to the bottom of the v-vial and the 
reaction medium was continuously sparged with oxygen throughout the entire reaction time 
(30 min. to 1 h.). The reaction was then irradiated top-down with the optic fiber of an OEM 
blue diode laser (OEM-SD-450, 450 nm, 3.5W after fiber coupling) for 30 min to 1 h. 18F 
activity was recorded at the end of the reaction. The resulting solution was diluted 
with MeCN (0.3-0.5 mL). An aliquot of the reaction mixture (typically 400-800µCi) was 
taken for radio-HPLC analysis. The activity injected into HPLC was measured (this activity 
was denoted by α) and the time was recorded. The fraction corresponding to radiolabeled 
product was collected and the activity was measured (this activity was denoted by β). The 
radiochemical yields of all [18F]-labeled molecules were isolated via HPLC. The decay-
corrected RCY was calculated by dividing the decay-corrected β by α. All RCY were 
calculated with respect to the starting 18F activity of the eluted fluoride. [18F]-Radiolabeled 
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products were confirmed by the co-injection of commercial or synthesized 19F standards via 
HPLC. General Method A (Section C.3.3) was used for the positive identification of desired 
fluorinated congener; mass detection of the desired 19F-fluorination products indicates the 
compatibility of the arene for radiofluorination. Quality control (QC) was run separately to 




Figure C.3. Reaction set-up for photoredox-catalyzed arene radiofluorination.  
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C.5.4 Comparision of isolation, radio-TLC and radio-HPLC yields for the 




Yield Analysis Method Yield of 5.2 and a 
HPLC isolation 28.7% 
Radio-HPLC > 80% 
Radio-TLC 40.23% 
 
Figure C.4. Comparison of isolation, radio-HPLC (A) and radio-TLC (B) yields for the radio-
fluorination of diphenyl ether with corresponding yields (C). 
  
 









































Region 1 1.8 4.3 0.032 878 0.37 0.35
FreeF 4.3 20.8 0.141 118960 50.16 46.87
Region 2 22.1 29.6 0.243 14111 5.95 5.56
Region 3 33.7 35.8 0.342 1503 0.63 0.59
Region 4 40.3 44.5 0.440 3668 1.55 1.44
Region 5 45.5 49.6 0.458 2620 1.10 1.03
F18 optical 57.5 80.5 0.687 95407 40.23 37.59















C.5.5 Summary of Reaction Optimization for Arene Radiofluorination 
C.5.5.1 to C.5.5.8 
See Supplementary Materials for Chen et al.33 which is available online. 
C.5.5.9 Molar activity calculations 
Molar activity (the measured radioactivity per mole of compound) was calculated using a 
standard curve of the corresponding fluorinated arene. An example for calculating molar 
activity is shown below. A 19F standard curve [Y axis = UV area, X axis =mass(µg)] was 
created from the HPLC trace for a standard solution of 1-fluoro-4-phenoxybenzene . The 
radiolabeled product was collected and purified via HPLC; the UV area overlapping with 
radio peak was then recorded. The standard curve was used to calculate the mass and mole 
number. Dividing the product activity by the mole number gives the molar activity in 
Ci/µmol. In this example, [18F]-1-fluoro-4-phenoxybenzene isolated has a molar activity of 













A 115 µCi 817897 1.28 Ci/µmol 
B 85 µCi 627625 1.48 Ci/µmol 
C 63 µCi 593897 1.36 Ci/µmol 
 
Figure C.5. Radio-HPLC and UV traces for [18F]-1-fluoro-4-phenoxybenzene (A, B, C); 
standard curve generated from the UV traces (D); calculation of molar activity using the 
standard curve (E) 
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C.5.6 Radio-HPLC analysis and characterization for 18F-radiolabeled arenes 
C.5.6.1 General information: All the labelling reactions are carried out using general 
procedure A from the section 5.3 unless specified otherwise. The amounts of photocatalyst 
5.1 (1.5 mg) and TEMPO (3.9 mg) were kept consistent for all radiolabeling experiments. 
The respective molar equivalents of 5.1 and TEMPO (with respect to the arenes) are as 
follows: 1) Arene (0.05 mmol/0.10 mmol/0.125 mmol/0.25 mmol); 2) Photocatalyst 5.1 
(0.05 equiv/0.025 equiv/0.02 equiv/0.01 equiv); 3) TEMPO (0.5 equiv/0.25 equiv/0.2 
equiv/0.1 equiv) Three replicate experiments were used to calculate RCYs (five replicates 
were run for 5.2). The co-injection of the hot product and standard are offset by  0.04–0.06 
min due to the distance of the UV and radio detector. The red HPLC traces in the following 
spectra were obtained with a UV signal at 212nm. The black HPLC traces are the radio 
signal for the crude and isolated radiolabeled products. HPLC conditions for analysis and 
purification are listed for each radiolabeled product.  
The following fluorination standards were obtained from commercial vendors and used as 
received: 4-fluorophenoxybenzene (5.2), 4-fluorobiphenyl (5.3) , 1-fluoronaphthalene 
(5.4), 2-bromo-4-fluoroanisole (5.5), 2-chloro-4-fluoroanisole (5.6), methyl 5-fluoro-2-
methoxybenzoate (5.8), 1-(5-fluoro-2-methoxyphenyl)ethenone (5.9), 5-fluoro-2-
methoxybenzonitrile (5.10), 5-fluoro-2-methoxybenzaldehyde (5.11), 3-fluoro-4-
methoxybenzaldehyde (5.15), 1-(3-fluoro-4-methoxyphenyl)ethenone (5.16), methyl 3-
fluoro-4-methoxybenzoate (5.18), 1-(4-fluoro-3-methoxyphenyl)ethenone (5.20, [4-F]) 
and 2-fluoromesitylene (5.25). The preparation of aromatic fluorinated standards (5.7, 





C.5.6.2. Radio-HPLC traces for 18F-radiolabeled arenes, decay corrected isolated 
radiochemical yields (RCY), Radio-HPLC traces for quality control (QC) and co-
injection, and HPLC conditions for isolating the corresponding 18F-radiolabeled 
arenes.  
See Supplementary Materials for Chen et al.33 which is available online. 
C.5.6.3. Synthesis of [18F]DOPA (5.37) 
See Supplementary Materials for Chen et al.33 which is available online. 
C.5.6.4 Synthesis of [18F]2-methoxy-5-fluoro-phenylalanine (39) 
See Supplementary Materials for Chen et al.33 which is available online. 
C.5.6.5 Synthesis of [18F]4-(4'-fluorophenyl)phenylalanine (5.41) 
See Supplementary Materials for Chen et al.33 which is available online. 
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C.6. Positron Emission Tomography (PET) and Computed Tomography (CT) 
Imaging Studies 
C.6.1 Ex vivo PET/CT Imaging of Mouse Ear Inflammation Models 
C.6.1.1 Materials and Methods 
All animal studies conformed to protocol approved by the University of North 
Carolina Institutional Animal Care and Use Committee. Female 10-12-week-old nude mice 
(Division of Comparative Medicine, University of North Carolina at Chapel Hill) were housed 
at constant temperature (23 °C) and relative humidity (60%) with a fixed 12 h light: 12 h 
dark cycle and had free access to food and water. Acute inflammation was induced by 
topical application of 10 µL 12-o-tetradecanoylphorbol-13-acetate (TPA) acetone solution 
(125 µg/ml) to the inner and outer surface of the right ear of each mouse as previously 
described34,35. Six hours after TPA exposure, mice received an intravenous bolus injection of 
[18F]Fenoprofen (-5.8 MBq). At 1 h post-injection (p.i.), the animals were euthanized and 
the ears were harvested and subjected to a 10-min static PET scan (SuperArgus 
4R, SEDECAL, Madrid, Spain). After PET scans, the ears were wet-weighed and counted in a 
gamma counter. The percentage-injected dose per gram (% ID/g) was determined and the 
results were reported as mean ± SD. To investigate the pharmacokinetics of 
[18F]Fenoprofen, dynamic PET acquisitions was started and [18F]Fenoprofen was 
administered in a rapid bolus through the tail vein catheter. Thirty minutes of dynamic PET 
data were acquired following [18F]Fenoprofen administration. Dynamic PET data were binned 
into 14 frames (3×20s, 4×60s, 4×120s, 3×300s) and frames were reconstructed using non-
scatter-corrected 3D ordered-subset expectation maximization (OSEM3D). Static PET data 




C.6.1.1 Results of Inflammation Experiments   
 Rapid [18F]Fenoprofen accumulation in the heart and liver were observed in nude 
mouse (N=1) following a rapid intravenous bolus injection. PET time-activity curve (TAC) is 
shown in Figure C.6G, and tabulated data is listed in table. Following initial distribution (<1 
min), uptake was observed to be stable over 30 minutes of PET imaging. Six hours after 
TPA application, the treated ears exhibited edema. Accumulation of [18F]Fenoprofen in TPA-
treated ear and normal ear was measured using PET imaging. Quantitative analysis showed 
significant higher uptake of [18F]Fenoprofen in TPA-treated inflamed ear (1.48 ± 0.57, N=3) 
as compared with normal ear (0.64 ± 0.10, N=4) (P < 0.05). Ex vivo gamma counting 
validated PET quantification result, with (4.82 ± 0.58) % ID/g (N=4) in TPA treated ear and 
(3.08 ± 1.03) % ID/g (N=12) in normal ear, respectively (p<0.05). The relatively higher 
value obtained from gamma counting is probably due to the thin thickness of ear, which 
make positron annihilation less efficient. The coronal slices, maximum intensity projection 
(MIP) static PET image, and CT image of a representative TPA-treated ear (C.6-A, C.6-C 




Figure C.6.: Ex vivo [18F]Fenoprofen PET imaging. Coronal slice, maximum intensity 
projection (MIP) static PET image, and CT image of representative TPA-treated ear (A, C and 
E) or normal ear (B, D and F) harvested from the mice injected intravenously with 
[18F]Fenoprofen. (G) Dynamic PET time-activity curve (tac) of organ ROIs in nude mice 
injected with a rapid intravenous bolus of [18F]Fenoprofen, imaged for 30 minutes post-
injection. (H) Uptake of [18F]Fenoprofen in TPA-treated or normal ear measured by ROIs 
hand-drawn on static ex vivo PET images. (I) Uptake of [18F]Fenoprofen  in TPA-treated or 
normal ear measured by gamma counting.  
 
Sample N %ID/g(mean±SD) 
TPA treated ear 4 4.82±0.58 
Normal ear 12 3.08±1.3 
Table C.3. [18F]Fenoprofen uptake in TPA-treated ear and normal ear, quantified by ex vivo 
gamma counting.  
 
C.6.2 In vivo PET/CT Imaging of Mouse Tumor Models 
 
C.6.2.1 Materials and Methods 
 
 All animal studies conformed to protocol approved by the University of North 
Carolina Institutional Animal Care and Use Committee. Human breast cancer cell line MCF-7 
and human glioblastoma cell line U87MG were obtained from American Type Culture 
(Manassas, VA, USA) and cultured in Eagle's Minimum Essential Medium (EMEM) (Gibco, 
TPA-treated Control
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Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (Omega 
Scientific, Tarzana, CA, USA) at 37˚C in an atmosphere containing 5% CO2. Tumor model 
was established in 4- to 6- week old female nude mice (Division of Comparative Medicine, 
the University of North Carolina at Chapel Hill). For U87MG tumor model, the tumor cells 
were suspended in PBS (2× 107/ml) and mixed with 1:1 Matrigel (v:v). Then a 100 µL cell 
suspension was inoculated subcutaneously at the flank. For MCF-7 tumor model, a slow-
release 17-β-estradiol (7.5 mg/pellet, 60-day slow release; 125 µg/day) was implanted. In 
brief, the mouse was anesthetized under 2% isoflurane. The skin on the lateral side of the 
neck of the mouse was lifted, then a 3–5 mm incision was made. With a pair of forceps, a 
small pocket beyond the incision site was created, and the pellet was introduced. The 
incision site was closed with a 5-0 silk suture. Four days later, MCF-7 cells were harvested, 
resuspended in PBS (2× 107/ml) and mixed 1:1 Matrigel (v:v). Then a 100 µL cell 
suspension was inoculated subcutaneously at the flank. 
 
C.6.2.2 Results of in vivo PET/CT Imaging (MCF7 and U87MG Tumors) 
 The MCF7 or U87MG tumor bearing mice received an intravenous injection of 18F-
PET agents (-5.5 MBq). At 1 h, 3 h and 4.5 h post-injection (p.i.), the animals were 
anesthetized under 2% isoflurane and subjected to 10-min static PET scan (SuperArgus 
4R, SEDECAL, Madrid, Spain). The percentage-injected dose per gram (% ID/g) of major 
organs were calculated and reported as mean ± SD. PET data were reconstruction into a 
single frame by OSEM 3D.  
 [18F]4-(4'-fluoro-phenyl)phenylalanine (5.41) showed relatively high background 
level in MCF7 tumor models at all time points (Figure C.7). The tumor uptake of 5.41 was 
4.11 ± 0.36 % ID/g, 3.69 ± 0.66 % ID/g and 3.19 ± 0.64 % ID/g at 1 h, 3 h and 4.5 h 
respectively post-injection (p.i.). [18F]2-Methoxy-5-fluoro-phenylalanine (5.39) had tumor 
uptake of 8.24 ± 0.90 % ID/g, 5.94 ± 1.34 % ID/g and 4.13 ± 1.88 % ID/g at 1 h, 3 h and 
4.5 h respectively post-injection (p.i.). High liver uptake was observed for 5.41 with tumor 
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to liver uptake ratio of 0.36 ± 0.01, 0.45 ± 0.02 and 0.55 ± 0.01 at 1 h, 3 h and 4.5 h. 
5.39 displayed significantly lower tumor to liver uptake ratio [3.63 ± 0.29, 4.88 ± 0.45 and 
4.06 ± 0.65 at the respective time points]. 5.39 also demonstrated prominent uptake in the 
U87MG xenografts. The tumor uptake was 5.64 ± 0.60 % ID/g, 4.64 ± 0.47 % ID/g and 
2.93 ± 1.07 % ID/g at 1 h, 3 h and 4.5 h respectively p.i. The coronal slices of static PET 
images are shown in Figure C.7. 
 
 
Figure C.7. Representative PET/CT images of MCF7 model at 1, 3 and 4.5h post injection of 
5.41 and the quantitative uptake of major organs derived from PET images (first panel), 











































































































C.7 Mechanism Proposal and Computational Data 
 
All computations were carried out in the Gaussian 09 program suite36 at the B3LYP/6-
31G+(d,p) level of theory. Natural population analyses (NPA atomic charges and molecular 
orbital populations) were performed using the NBO formalism and the NPA values were 
calculated in 1,2-dicholorethane according to a prior procedure from our laboratory37.  
 
 
Figure C.8. Mechanistic Proposal for Oxidative C–H 18F-Fluorination of Aromatics (A). LUMO 
charge density maps calculated at the B3LYP/6-31G+(d,p) level correspond to the cation 
radicals of the starting arenes for 5.21, 5.30 and 5.33 (B). The darkest blue carbon atoms 

































































Figure C.9. Natural population analyses for the ground state and radical cation of selected 


























































































Figure C.10. Natural population analyses for the ground state and radical cation of selected 






























































































































Figure C.12. Natural population analyses for the ground state and radical cation of 
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Figure C.13. A comparison of electrostatic potentials (left) and LUMO charge density (right) 
maps for the methoxyarenes listed in Figure C.8. Red arrows indicate the reactive arene C–
H site (5.21, 5.30, 5.33) 
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APPENDIX D: SUPPORTING INFORMATION FOR “CATION RADICAL ACCELERATED 
NUCLEOPHILIC AROMATIC DEOXYFLUORINATION WITH 19F– AND 18F– VIA 
ORGANIC PHOTOREDOX CATALYSIS” 
 
D.1 General Information: Materials and Methods 
D.1.1 General Reagent Information 
Commercially available reagents were purchased from Sigma-Aldrich, Acros, Alfa 
Aesar, or TCI, Matrix Scientific, Combi-Blocks, Oakwood Chemical, Chem Impex 
International, and Fisher Scientific and were used as received unless otherwise noted. 
Diethyl ether (Et2O), dichloromethane (DCM), tetrahydrofuran (THF), toluene (PhMe), and 
dimethylformamide (DMF) were dried by passing through activated alumina under nitrogen 
prior to use. Other common solvents and chemical reagents were purified by standard 
published methods as noted or used as received. All catalyst and substrate syntheses were 
run under a nitrogen atmosphere unless specified otherwise.  
D.1.2 General Analytical Information 
Proton, carbon, and fluorine nuclear magnetic resonance spectra (1H NMR, 13C NMR, 
19F NMR) were recorded on a Bruker Avance 400 (1H NMR at 400 MHz, 13C NMR at 100 MHz, 
and 19F NMR at 376 MHz), a Bruker Avance III 600 (1H NMR at 600 MHz, 13C NMR at 151 
MHz, and 19F NMR at 565 MHz) spectrometer. Chemical shifts for protons are reported in 
parts per million downfield from tetramethylsilane and are referenced to residual protium in 
the solvent (1H NMR: CHCl3 at 7.26 ppm, MeOD at 3.31 ppm, acetone-d6 at 2.05 ppm and 
DMSO- d6 at 2.50 ppm). Chemical shifts for carbon signals are reported in parts per million 
downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent peak (13C NMR: CDCl3 at 77.16 ppm, MeOD at 49.00 ppm, acetone-d6 at 29.84 ppm 
(CD3) and at 206.46 (C=O), and DMSO- d6 at 39.52 ppm). Chemical shifts for fluorine 
signals are reported in parts per million downfield from tetramethylsilane and are referenced 
to hexafluorobenzene or to fluorobenzene, which was added as an internal standard. 
Solvent-dependent 19F values of hexafluorobenzene are obtained from Togni et al. 1 [19F 
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NMR: C6F6(CDCl3) at -161.64 ppm, C6F6(MeOD) at -165.37 ppm, C6F6(acetone-d6) at -
164.67 ppm, C6F6(DMSO-d6) at -162.45 ppm]. Solvent-dependent 19F values of 
fluorobenzene are obtained from Togni et al. 1 [19F NMR: PhF(CDCl3) at -112.96 ppm, PhF 
(MeOD) at -115.42 ppm, PhF (acetone-d6) at -114.72 ppm, PhF (DMSO-d6) at -112.83 
ppm].1H, 13C and 19F NMR data are reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, p =pentent, h = sextet, hept = heptet, dd = 
doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, td = 
triplet of doublets, ddt = doublet of doublet of triplets, tt = triplet of triplets, m = multiplet, 
bs = broad singlet, app = apparent), coupling constants (Hz), and integration. Attenuated 
total reflectance FTIR spectra were recorded on a Bruker Alpha FTIR Spectrometer with the 
Plantinum ATR attachment. Spectra were averaged over 24 scans with a spectral resolution 
of 4 cm-1. Data processing was performed using Bruker's OPUS spectroscopy software. High 
Resolution Mass Spectra (HRMS) were obtained via direct infusion using a Thermo LTQ FT 
mass spectrometer with positive mode electrospray ionization, via gas chromatography 
using an Exactive GC gas chromatographic system in positive mode chemical ionization, 
equipped with a Trace 1300 SSL injector and TriPlus RSH autosampler, or via liquid 
chromatography using Waters Acquity H-class liquid chromatograph system coupled to a 
Thermo LTQ FT mass spectrometer with positive mode electrospray ionization. The 
instrumental control, data acquisition and data processing for HRMS were performed with 
Thermo's Xcalibur and TraceFinder software packages. Thin layer chromatography (TLC) 
was performed on SiliaPlate 250 µm thick silica gel plates provided by Silicycle or on 
Alumina N 200 µm thick aluminium oxide plates (polyester backed) provided by Sorbtech. 
Visualization was accomplished with short wave UV light (254 nm), or development with 
iodine, ninhydrin solution, cerium ammonium molybdate or potassium permanganate 
solution followed by heating. Column chromatography was performed using SiliaFlash P60 
silica gel (40-63 µm) purchased from Silicycle or using Acros Organics aluminium oxide 
(basic, Brockmann I, 50-200 µm, 60 Å). Reverse-phase flash liquid chromatography was 
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performed using a Biotage® Isolera One instrument with a Biotage® SNAP Ultra C18 
cartridge using HP-Sphere™ C18 25 µm spherical silica (18 or 30 g). Unless noted all 
reactions were run under an atmosphere of nitrogen in flame-dried glassware with magnetic 
stirring. Irradiation of photochemical reactions was carried out using a PAR38 Royal Blue 
aquarium LED lamp (Model #6851) fabricated with high-power Cree XR-E LEDs as 
purchased from Ecoxotic (www.ecoxotic.com) with standard borosilicate glass vials 
purchased from Fischer Scientific. For all photolyses, reactions were stirred using a PTFE 
coated magnetic stir bar on a magnetic stir plate. GC quantitation experiments were 
performed on an Agilent 6850 series instrument equipped with a split- mode capillary 
injection system and Agilent 5973 network mass spec detector (MSD). Yield refers to 
isolated yield of analytically pure material unless otherwise noted. GC yields were 
determined using 3-bromotoluene as an internal standard. All other reagents were obtained 
from commercial sources and used without further purification unless otherwise noted. 
D.1.3 Photoreactor Configuration (LEDs) 
Reactions were irradiated using a simple photoreactor consisting of two Par38 Royal 
Blue Aquarium LED lamps (455 nm) (Model #6851) or two Kessil PR160-427 LED 
Photoredox Lights (427 nm), in which one reaction (2 dram vial) is irradiated with a foil 
barrier preventing irradiation by two lamps. In order to ensure that the reactions are run 
near room temperature, a simple cooling fan was installed perpendicular to the reactor to 
aid in heat dissipation (generated from both nonradiative decay pathways of the excited 
state catalysts and the heat generated from high power LEDs). The vial was positioned on a 
stir plate approximately 3-4 cm from a Par38 LED lamp supplying blue light (λ = 440-460 
nm). An equilibrium temperature of 33 °C (Par38) and an equilbrium temperature range (35 
to 45 ºC , average was 40 ºC) were measured with a standard alcohol thermometer. While 
a number of other blue LED sources are effective, we have found that LED emitters with 
high luminous flux and narrow viewing angle give the best results.  
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Figure D.1. Top-down (top left) and side-on (top right) views of the simple photoreactor 




D.2. Optimization Studies for Arene Cation Radical Accelerated SNAr 19F-
fluorination 
 
Table D.1. Reaction optimization and control experiments. 
 
  




24 h, 33 ºC
Atmosphere


































(0.1 M, 25:1) 455 nm LEDs air 79%







































(0.1 M, 10:1) 455 nm LEDs 40%
10 TBAF•3H2O
DCM:H2O













(0.1 M, 10:1) no catalyst air 9%
0.50












(0.1 M, 10:1) no light air N/A
0.50
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D.3. Experimental Procedures: Catalyst and Substrate Synthesis 
D.3.1 Preparation of Acridinium Photocatalysts 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium tetrafluoroborate (S1) The title 
compound was prepared according to a published procedure; spectra data are in agreement 
with literature values.2 
 
9-Mesityl-3,6-di-tert-butyl-10-phenylacridinium perchlorate (6.1) The title 
compound was prepared according to a published procedure; spectra data are in agreement 




















D.3.2 Preparation of Arene Substrates 
General synthetic strategy A for asymmetrical diaryl ethers  
 
 
The method for the synthesis of the title compounds was adapted from Maiti and 
Buchwald.4 A generic procedure is as follows: To a dry, clean round-bottomed flask 
equipped with a stir bar was added copper(I) iodide (5 mol %), picolinic acid (10 mol %), 1-
chloro-4-iodobenezene, substituted phenol (1.0-1.2 mmol), and K3PO4 (2.0 mmol). The 
vessel was then sealed with a rubber septum and placed under N2. Dimethyl sulfoxide (0.5 
M) was then added and the reagents were mixed. The reaction vessel was then evacuated 
and backfilled with nitrogen three times. The reaction was stirred vigorously for 24 hours at 
elevated temperature (90-110 ºC, specified for each example). Upon the conclusion of the 
reaction, the mixture was cooled to room temperature before the addition of ethyl acetate 
and water. After mixing the two organic and aqueous fractions for a minute, the layers were 
separated. The aqueous fraction was extracted twice using ethyl acetate, and the organic 
layers were combined and washed with ammonium chloride before being dried over 
magnesium sulfate and concentrated under reduced pressure. The crude product was 

















DMSO (0.5 M), 80-110 ºC
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General procedure B for synthesis of carbonates. 
 
 
To a mixture of [1,1'-biphenyl]-4-ol (1 equiv) and the chloroformate (1.2 equiv) in 
DCM or THF (1 M) at 0 °C was added pyridine (1.4 equiv) slowly. The mixture was stirred at 
room temperature overnight then water was added. The aqueous layer was extracted with 
DCM or ethyl acetate (x1) then the combined organic layer was washed with water (x1), 
saturated aqueous NaHCO3 solution (x1), brine (x1), dried (MgSO4) and concentrated. The 
crude product was purified via column chromatography (conditions specified for each 
example).   
 
General procedure C for synthesis of diaryl ethers 
 
 
The title compounds were prepared according to the following literature procedure 
from Čermák and Církva.5 A dry round-bottomed flask equipped with a stir bar was charged 
with 4-chlorophenylboronic acid (2 equiv), copper acetate (1 equiv), substituted phenol (1 
equiv), TEA, 4Å molecular sieves and DCM (0.2 M). The mixture was cooled to 0 °C and was 







pyridine (1.4 equiv) 

















Excess hexane was added, the mixture was filtered through a pad of Celite and the filtrate 
was concentrated under reduced pressure. The crude product was purified via column 
chromatography (conditions specified for each example).  
 
General procedure D for synthesis of diaryl ethers 
 
 
The title compounds were prepared according to the following literature procedure by 
Chan et al.6 A dry round-bottomed flask was charged with substituted phenol (1 equiv), 1-
chloro-4-iodobenezene (1 equiv), CuI (10 mol%), tetrabutylammonium bromide (10 mol%), 
K3PO4 (2 equiv) and DMF (1.5 M). The flask was fitted with a reflux condenser and the 
mixture placed in a preheated 150 °C oil bath. After 20 hours, the mixture was cooled to 
room temperature then saturated aqueous NH4Cl was added. The mixture was extracted 
with ethyl acetate (x3) and the combined organic layer was washed with saturated aqueous 
NH4Cl (x1), 2M NaOH (x2), water (x1), brine (x1), dried (MgSO4) and concentrated under 
reduced pressure. The crude product was purified via column chromatography (conditions 
















4-(4-Chlorophenoxy)-1,1'-biphenyl (S2) The title compound was prepared according to 
general procedure A at 80 °C. The title compound was purified by column chromatography 
on silica gel (10% DCM/hexanes) to give a white solid in 72% yield (6.08 g). 
1H NMR (600 MHz, CDCl3) δ 7.57 – 7.56 (m, 4H), 7.45 – 7.43 (m, 2H), 7.36 – 7.33 (m, 
1H), 7.31 (AA’BB’, J = 9.0 Hz, 2H), 7.07 (AA’BB’, J = 8.4 Hz, 2H), 6.99 (AA’BB’, J = 9.0 Hz, 
2H).  
13C NMR (151 MHz, CDCl3) δ 156.58, 156.01, 140.54, 136.88, 129.92, 128.96, 128.70, 
128.51, 127.30, 127.07, 120.30, 119.26. 
 
 
2-(4-Chlorophenoxy)-1,1'-biphenyl (S3) The title compound was prepared according to 
general procedure A at 110 °C. The title compound was purified by column chromatography 
on silica gel (100% hexanes to 10% ethyl acetate/hexanes) to give a white solid in 87% 
yield (1.219 g). 
1H NMR (600 MHz, CDCl3) δ 7.54 – 7.49 (m, 2H), 7.47 (dd, J = 7.6, 1.8 Hz, 1H), 7.36 (t, 
J = 7.5 Hz, 2H), 7.34 – 7.28 (m, 2H), 7.24 (dd, J = 7.5, 1.3 Hz, 1H), 7.20 (d, J = 8.9 Hz, 
2H), 7.02 (dd, J = 8.1, 1.2 Hz, 1H), 6.84 (d, J = 8.9 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 156.64, 153.19, 137.58, 134.06, 131.56, 129.65, 129.25, 







3-Chloro-4-(4-chlorophenoxy)-1,1'-biphenyl (S4) The title compound was prepared 
according to general procedure D. The title compound was purified by column 
chromatography on silica gel (0% to 2% ethyl acetate/hexanes) to give a clear colorless oil 
in 31% yield (0.35 g). 
1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 2.4 Hz, 1H), 7.57 – 7.54 (m, 2H), 7.47 – 7.44 
(m, 3H), 7.40 – 7.35 (m, 1H), 7.31 (AA’BB’, J = 8.8 Hz, 2H), 7.06 (d, J = 8.4 Hz, 1H), 6.94 
(AA’BB’, J = 8.8 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 155.83, 151.44, 139.26, 138.75, 129.93, 129.56, 129.11, 
128.53, 127.93, 127.08, 126.82, 126.42, 121.32, 119.18. 
 
 
2-Chloro-4-(4-chlorophenoxy)-1,1'-biphenyl (S5) A dry round-bottomed flask was 
charged with 4-bromo-3-chlorophenol (2.50 g, 12.1 mmol), phenylboronic acid (2.06 g, 
16.9 mmol) and Na2CO3 (3.83 g, 36.2 mmol). In a glove box, Pd(PPh3)4 (0.70 g, 0.60 
mmol) was added and the flask was removed from the glove box. Degassed water (20 mL) 
and dimethoxyethane (55 mL) were then added and the mixture was heated at 95 °C for 24 
hours. The reaction mixture was cooled to room temperature, poured into dilute aqueous 
NH4Cl solution and extracted with ethyl acetate (x2). The combined organic phase was 
washed with dilute aqueous NH4Cl solution (x1), brine (x1), dried (Na2SO4) and 


























acetate/hexanes) gave 2-chloro-[1,1'-biphenyl]-4-ol (I-1) as a pale yellow liquid in 
quantitative yield (2.47 g). 
1H NMR (600 MHz, CDCl3) δ 7.43 – 7.40 (m, 4H), 7.38 – 7.34 (m, 1H), 7.22 (d, J = 8.4 
Hz, 1H), 6.99 (d, J = 2.4 Hz, 1H), 6.80 (dd, J = 8.4, 2.4 Hz, 1H). 
 
The title compound was prepared using 2-chloro-[1,1'-biphenyl]-4-ol according to general 
procedure A at 80 °C. The title compound was purified by column chromatography on silica 
gel (0% to 2.5% ethyl acetate/hexanes) to give a clear colorless oil in 35% yield (0.77 g). 
1H NMR (600 MHz, CDCl3) δ 7.45 – 7.42 (m, 4H), 7.40 – 7.37 (m, 1H), 7.35 (AA’BB’, J = 
9.0 Hz, 2H), 7.31 (d, J = 8.4 Hz, 1H), 7.11 (d, J = 2.4 Hz, 1H), 7.02 (AA’BB’, J = 9.0 Hz, 
2H), 6.95 (dd, J = 8.4, 2.4 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 157.01, 155.17, 138.89, 135.89, 133.45, 132.37, 130.13, 
129.65, 129.29, 128.24, 127.74, 120.80, 119.87, 117.13. 
HRMS (APCI) calculated for C18H12Cl2O [M]+⦁ = 314.0265; found 314.0254. 
 
 
4-(4-Chlorophenoxy)phenyl pivalate (S6) 4-(4-chlorophenoxy)phenol (I-2) was 
prepared according to the following procedure by Marcune et al.7 A mixture of 1-chloro-4-
fluorobenzene (1.96 g, 15 mmol), hydroquinone (6.61 g, 60 mmol), KOt-Bu (6.73 g, 60 
mmol) and 18-Crown-6 (1.98 g, 7.5 mmol) in DMSO (50 mL) was heated at 140 °C for 2.5 
days. The mixture was cooled to room temperature and partitioned between water and 
hexane. The aqueous phase was extracted with diethyl ether (x2), the combined organic 










DMSO, 140 °C O
Cl OPiv
PivCl (1.1 equiv)
TEA (1.1 equiv), DCM
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concentrated. Column chromatography on silica gel (DCM) gave 4-(4-chlorophenoxy)phenol 
(I-2) as an orange solid in 59% yield (1.95 g). 
1H NMR (400 MHz, CDCl3) δ 7.24 (AA’BB’, J = 8.8 Hz, 2H), 6.92 (AA’BB’, J = 8.8 Hz, 2H), 
6.87 (AA’BB’, J = 8.8 Hz, 2H), 6.82 (AA’BB’, J = 8.8 Hz, 2H). 
 
To a solution of 4-(4-chlorophenoxy)phenol (0.44 g, 2.0 mmol) in DCM (6 mL) at 0 °C was 
added TEA (0.30 mL, 2.2 mmol) and pivaloyl chloride (0.27 mL, 2.2 mmol) dropwise. The 
mixture was stirred at room temperature overnight then saturated aqueous NH4Cl solution 
was added, the mixture was extracted with DCM (x3) and the combined organic phase dried 
(MgSO4) and concentrated. The title compound was purified by column chromatography on 
silica gel (5% ethyl acetate/hexanes) to give a white solid in 90% yield (0.55 g). 
1H NMR (600 MHz, CDCl3) δ 7.28 (AA’BB’, J = 9.0 Hz, 2H), 7.03 (AA’BB’, J = 9.0 Hz, 2H), 
6.99 (AA’BB’, J = 9.0 Hz, 2H), 6.93 (AA’BB’, J = 9.0 Hz, 2H), 1.36 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 177.36, 156.22, 154.24, 147.02, 129.89, 128.41, 122.94, 
119.94, 119.92, 39.21, 27.27. 
 
 
4,4'-Oxybis(chlorobenzene) (S7) The title compound was prepared according to general 
procedure D. The title compound was purified by column chromatography on silica gel 
(hexanes) to give a clear colorless liquid in 74% yield (0.88 g). 
1H NMR (500 MHz, CDCl3) δ 7.31 (AA’BB’, J = 9.0 Hz, 4H), 6.95 (AA’BB’, J = 9.0 Hz, 4H). 
13C NMR (151 MHz, CDCl3) δ 155.71, 130.00, 128.82, 120.24. 




1-(4-Chlorophenoxy)-4-ethyl-2-methoxybenzene (S8) The title compound was 
prepared according to general procedure A at 110 °C. The title compound was purified by 
column chromatography on silica gel (5% ethyl acetate/hexanes to 10% ethyl 
acetate/hexanes) to give a clear colorless oil in 57% yield (0.300 g). 
 
1H NMR (500 MHz, CDCl3) δ 7.25 – 7.20 (m, 2H), 6.91 (d, J = 8.0 Hz, 1H), 6.85 (dd, J = 
8.6, 2.0 Hz, 3H), 6.77 (dd, J = 8.1, 2.0 Hz, 1H), 3.81 (s, 3H), 2.66 (q, J = 7.6 Hz, 2H), 
1.27 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 157.17, 151.32, 142.21, 141.95, 129.47, 127.06, 121.42, 
120.34, 118.01, 112.64, 56.01, 28.88, 15.80. 
 
 
2-(4-Chlorophenoxy)-4-ethyl-1-methoxybenzene (S9) The title compound was 
prepared according to general procedure A at 80°C. The title compound was purified by 
column chromatography on silica gel (hexanes to 10% ethyl acetate/hexanes) to give a pale 
yellow oil in 49% yield (0.630 g). 
 
1H NMR (600 MHz, CDCl3) δ 7.23 (d, J = 8.9 Hz, 2H), 6.98 (dd, J = 8.3, 2.1 Hz, 1H), 6.92 
(d, J = 8.3 Hz, 1H), 6.89 – 6.85 (m, 2H), 6.83 (d, J = 2.1 Hz, 1H), 3.80 (s, 3H), 2.57 (q, J 
= 7.6 Hz, 2H), 1.19 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.93, 149.45, 144.25, 137.64, 129.52, 127.22, 124.43, 
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The title compound was prepared according to general procedure C. The title compound was 
purified by column chromatography on silica gel (2.5% ethyl acetate/hexanes) to give a 
pale yellow oil in 52% yield (0.81 g). 
 
1H NMR (600 MHz, CDCl3) δ 7.24 (AA’BB’, J = 9.0 Hz, 2H), 7.12 (d, J = 1.8 Hz, 1H), 7.06 
(dd, J = 8.4, 1.8 Hz, 1H), 6.86 – 6.84 (m, 3H), 3.82 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.38, 152.21, 144.01, 129.69, 127.86, 124.16, 122.47, 




The title compound was prepared according to general procedure D. The title compound was 
purified by column chromatography on silica gel (2% ethyl acetate/hexanes) to give a white 
solid in 46% yield (0.74 g). 
 
1H NMR (400 MHz, CDCl3) δ 7.24 (AA’BB’, J = 8.8 Hz, 2H), 6.99 – 6.98 (m, 1H), 6.91 (m, 
2H), 6.84 (AA’BB’, J =8.8 Hz, 2H), 3.81 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.51, 152.07, 143.41, 130.32, 129.68, 127.79, 122.11, 




The title compound was then prepared according to general procedure D using 2-chloro-4-
methoxyphenol. The title compound was purified by column chromatography on silica gel 
(3% ethyl acetate/hexanes) to give a clear colorless liquid in 50% yield (0.81 g). 
 
1H NMR (600 MHz, CDCl3) δ 7.25 – 7.22 (m, 2H), 7.01 (d, J = 0.7 Hz, 1H), 7.00 (d, J = 
5.2 Hz, 1H), 6.81 (dd, J = 9.0, 3.1 Hz, 3H), 3.81 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 157.01, 156.84, 145.06, 129.70, 127.60, 127.40, 123.07, 
117.82, 115.92, 114.08, 55.99. 
 
 
1-Chloro-4-(4-chlorophenoxy)-2-methoxybenzene (S13) To a solution of 3-
methoxyphenol (3.3 mL, 30 mmol) in acetonitrile (60 mL) at 0 °C was added NCS (4.8 g, 
36 mmol). The mixture was heated at reflux overnight then concentrated to give an oily red 
solid. Purification by column chromatography on silica gel (10% to 20% ethyl 
acetate/hexanes) gave 2-chloro-5-methoxyphenol (higher Rf) as a pale yellow liquid in 47% 
yield (2.24 g) and 4-chloro-3-methoxyphenol (lower Rf, desired regioisomer) as a yellow 
liquid in 42% yield (2.48 g). The yield of 4-chloro-3-methoxyphenol (I-3) was corrected 
















DMF (1.5 M), 150 °C
(1 equiv)
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1H NMR (600 MHz, CDCl3) δ 7.18 (d, J = 8.4 Hz, 1H), 6.47 (d, J = 3.0 Hz, 1H), 6.36 (dd, 
J = 8.4, 3.0 Hz, 1H), 3.89 (s, 3H). 
 
The title compound was then prepared according to general procedure D using 4-chloro-3-
methoxyphenol. The title compound was purified by column chromatography on silica gel 
(2% ethyl acetate/hexanes) to give a clear colorless liquid in 26% yield (0.41 g).  
1H NMR (600 MHz, CDCl3) δ 7.30 (m, 3H), 6.95 (AA’BB’, J = 9.0 Hz, 2H), 6.63 (d, J = 2.4 
Hz, 1H), 6.50 (dd, J = 9.0, 2.4 Hz, 1H), 3.85 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.72, 156.14, 155.64, 130.71, 129.98, 128.82, 120.22, 




methoxybenzyl alcohol was prepared according to general procedure A, using 10 mol% CuI 
and 20 mol% picolinic acid at 90 °C. Column chromatography on silica gel (30% ethyl 
acetate/hexanes) gave 4-(4-chlorophenoxy)-3-methoxybenzyl alcohol (I-4) as a pale yellow 
solid in 58% yield (2.31 g). 
1H NMR (600 MHz, CDCl3) δ 7.23 (AA’BB’, J = 9.0 Hz, 2H), 7.05 (d, J = 1.8 Hz, 1H), 6.96 
(d, J = 7.8 Hz, 1H), 6.90 (dd, J = 7.8, 1.8 Hz, 1H), 6.85 (AA’BB’, J = 9.0 Hz, 2H), 4.69 (s, 
2H), 3.83 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.80, 151.63, 144.03, 138.31, 129.56, 127.47, 121.30, 



















A mixture of 4-(4-chlorophenoxy)-3-methoxybenzyl alcohol (0.48 g, 1.8 mmol), PCC (0.58 
g, 2.7 mmol) and Celite (1.1 g) in DCM (5 mL) was stirred at room temperature overnight. 
The mixture was then filtered through a pad of Celite and the filtrate was concentrated. The 
title compound was purified by column chromatography on silica gel (20% ethyl 
acetate/hexanes) to give a white solid in 91% yield (0.43 g). 
1H NMR (600 MHz, CDCl3) δ 9.91 (s, 1H), 7.53 (d, J = 1.8 Hz, 1H), 7.41 (dd, J = 7.8, 1.8 
Hz, 1H), 7.33 (AA’BB’, J = 9.0 Hz, 2H), 6.99 – 6.95 (m, 3H), 3.94 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 190.95, 154.78, 151.52, 151.28, 132.89, 130.06, 129.43, 
125.77, 120.43, 118.49, 110.91, 56.27. 
 
 
1-(4-(4-Chlorophenoxy)-3-methoxyphenyl)ethenone (S15) HOBt hydrate (0.45 g, 
3.0 mmol), EDC (0.52 mL, 3.0 mmol) and N,O-dimethylhydroxylamine hydrochloride (0.22 
g, 2.2 mmol) were added to a mixture of 4-(4-chlorophenoxy)-3-methoxybenzoic acid (0.41 
g, 1.5 mmol) in DMF (5 mL) at room temperature. DIPEA (0.77 mL, 4.4 mmol) was added 
and the mixture was stirred overnight. Water was added, the mixture was extracted with 
ethyl acetate (x2) and the combined organic phase washed with water (x1), brine (x2), 
dried (MgSO4) and concentrated. Column chromatography on silica gel (50% ethyl 
acetate/hexanes) gave 4-(4-chlorophenoxy)-N,3-dimethoxy-N-methylbenzamide (I-5) as a 
pale yellow oil in 77% yield (0.36 g). 
1H NMR (600 MHz, CDCl3) δ 7.39 (d, J = 1.8 Hz, 1H), 7.31 (dd, J = 8.4, 1.8 Hz, 1H), 7.27 
(AA’BB’, J = 9.0 Hz, 2H), 6.92 – 6.90 (m, 3H), 3.87 (s, 3H), 3.60 (s, 3H), 3.38 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 169.10, 155.84, 150.64, 147.29, 130.42, 129.79, 128.38, 

























To a solution of 4-(4-chlorophenoxy)-N,3-dimethoxy-N-methylbenzamide (0.36 g, 1.1 
mmol) in THF (10 mL) at 0 °C was added MeMgBr (0.75 mL of a 3.0 M solution in diethyl 
ether, 2.3 mmol). The mixture was stirred at 0 °C for 1.5 hours then was quenched with 1M 
HCl. The mixture was extracted with DCM (x2) and the combined organic phase was washed 
with brine (x1), dried (MgSO4) and concentrated. The title compound was purified by 
column chromatography on silica gel (20% to 30% ethyl acetate/hexanes) to give a white 
solid in 90% yield (0.28 g). 
1H NMR (600 MHz, CDCl3) δ 7.64 (d, J = 1.8 Hz, 1H), 7.51 (dd, J = 8.4, 1.8 Hz, 1H), 7.30 
(AA’BB’, J = 9.0 Hz, 2H), 6.94 (AA’BB’, J = 9.0 Hz, 2H), 6.91 (d, J = 8.4 Hz, 1H), 3.92 (s, 
3H), 2.59 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 196.92, 155.26, 150.95, 150.04, 133.75, 129.95, 128.99, 
122.75, 119.97, 118.69, 111.81, 56.25, 26.57. 
 
 
Methyl 4-(4-chlorophenoxy)-3-methoxybenzoate (S16) Concentrated sulfuric acid 
(1.9 mL) was added to CrO3 (1.88 g, 18.8 mmol) in an Erlenmeyer flask. The mixture was 
cooled to 0 °C and water (5.7 mL) was slowly added with stirring. 
This solution (Jones reagent) was then added via pipette to a solution of 4-(4-
chlorophenoxy)-3-methoxybenzyl alcohol (1.25 g, 4.7 mmol) in acetone (8 mL) at 0 °C. The 
reaction mixture was stirred at room temperature overnight. i-PrOH (1 mL) was added and 
the mixture was stirred for 1 hr, then was diluted with excess diethyl ether and washed with 
2% aqueous NaHSO3 solution (x5). The combined aqueous phase was back-extracted with 















NaHSO3 solution (x1), water (x1) and brine (x1). The organic layer was concentrated to 
give 4-(4-chlorophenoxy)-3-methoxybenzoic acid (I-6) as a pale yellow solid in 71% yield 
(0.93 g). 
1H NMR (600 MHz, CDCl3) δ 7.73 (d, J = 2.4 Hz, 1H), 7.71 (dd, J = 8.4, 2.4 Hz, 1H), 7.31 
(AA’BB’, J = 9.0 Hz, 2H), 6.96 (AA’BB’, J = 9.0 Hz, 2H), 6.92 (d, J = 8.4 Hz, 1H), 3.94 (s, 
3H).  
13C NMR (151 MHz, CDCl3) δ 170.68, 155.10, 150.66, 150.61, 130.00, 129.14, 125.14, 
124.17, 120.13, 118.73, 114.11, 56.29. 
 
A mixture of 4-(4-chlorophenoxy)-3-methoxybenzoic acid (0.42 g, 1.5 mmol) and 
concentrated sulfuric acid (5 drops) in methanol (15 mL) was heated at reflux overnight. 
Then mixture was then cooled to room temperature, basified with saturated aqueous 
NaHCO3 solution and extracted with ethyl acetate (x3). The combined organic phase was 
washed with brine (x1), dried (MgSO4) and concentrated to give a light brown solid. The 
title compound was purified by column chromatography on silica gel (20% ethyl 
acetate/hexanes) to give a white solid in 89% yield (0.39 g). 
1H NMR (600 MHz, CDCl3) δ 7.67 (d, J = 1.8 Hz, 1H), 7.62 (dd, J = 8.4, 1.8 Hz, 1H), 7.29 
(AA’BB’, J = 9.0 Hz, 2H), 6.93 (AA’BB’, J = 9.0 Hz, 2H), 6.90 (d, J = 8.4 Hz, 1H), 3.92 (s, 
3H), 3.91 (s, 3H).  
13C NMR (151 MHz, CDCl3) δ 166.52, 155.35, 150.59, 149.52, 129.82, 128.70, 126.41, 















4-(4-Chlorophenoxy)-3-methoxybenzonitrile (S17) The title compound was prepared 
according to the following literature procedure from Huang et al.9 A Schlenk flask was 
charged with CuI (17 mg, 90 µmol), 2,2′-bipyridine (14 mg, 90 µmol), TEMPO (14 mg, 
µmol) and 4-(4-chlorophenoxy)-3-methoxybenzyl alcohol (0.48 g, 1.8 mmol). The flask was 
evacuated and backfilled with oxygen three times. Ethanol (3.6 mL) and ammonium 
hydroxide (28%, 0.28 mL) were added and the mixture was stirred under an atmosphere of 
oxygen for 21 hours. The mixture was concentrated then taken up in ethyl acetate and 
passed through a plug of silica, and the filtrate concentrated to give a red liquid. The title 
compound was purified by column chromatography on silica gel (5% to 10% ethyl 
acetate/hexanes) to give a white solid in 25% yield (0.12 g). 
1H NMR (600 MHz, CDCl3) δ 7.32 – 7.28 (m, 2H), 7.21 (dq, J = 4.0, 1.8 Hz, 2H), 6.95 – 
6.90 (m, 2H), 6.88 (d, J = 8.7 Hz, 1H), 3.88 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 154.48, 150.84, 149.90, 130.03, 129.42, 126.01, 120.19, 
119.18, 118.69, 115.67, 107.48, 56.31. 
 
 
Ethyl (E)-3-(4-(4-chlorophenoxy)-3-methoxyphenyl)acrylate (S18) To a dry, clean 
round-bottomed flask equipped with a stir bar was added triethyl phosphonoacetate (1.16 
mL, 5.8 mmol, 1.25 equiv) and 16 mL of THF. The reaction mixture was cooled to –78 ºC 
before a 2.5M solution of n-Buli in hexanes (2.8 mL, 7.0 mmol, 1.5 equiv). This solution was 
stirred for about 30 mins. A solution of S14 (1.22 g, 4.6 mmol, 1.0 equiv) in THF (12 mL) 
was prepared and added dropwise to the n-BuLi solution. The reaction was stirred at -78 ºC 
for 10 minutes before being warmed up to room temperature, where it was allowed to stir 







diluted with 40 mL of EtOAc. The layers were separated and the aqueous layer was 
extracted (x2) with two 10 mL portions of EtOAc. The organic layers were combined, 
washed with brine, dried over MgSO4 and concentrated under reduced pressure. The title 
compound was purified by column chromatography on silica gel (5% to 30% ethyl 
acetate/hexanes) to give a clear oil in 80% yield (1.19 g).  
1H NMR (600 MHz, CDCl3) δ 7.64 (d, J = 15.9 Hz, 1H), 7.27 (d, J = 7.8 Hz, 2H), 7.14 (s, 
1H), 7.08 (d, J = 8.3 Hz, 1H), 6.90 (d, J = 8.2 Hz, 3H), 6.37 (d, J = 16.6 Hz, 1H), 4.27 (q, 
J = 7.5, 6.9 Hz, 2H), 3.87 (s, 3H), 1.34 (t, J = 7.2 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 167.07, 155.84, 151.28, 147.08, 144.01, 131.37, 129.78, 
128.32, 121.94, 120.34, 119.25, 117.86, 111.50, 60.70, 56.09, 14.46. 
 
 
4-(4-Chlorophenoxy)-3-methoxybenzyl acetate (S19) To a dry, clean round-bottomed 
flask equipped with a stir bar was added I-4 (534.5 mg, 2.0 mmol, 1.0 equiv) and DCM 10 
mL. The reaction was then cooled to 0 ºC before sequential addition of pyridine (0.24 mL, 
3.0 mmol, 3.0 equiv) and acetyl chloride (0.16 mL, 2.2 mmol, 1.1 equiv). The reaction was 
stirred for 1 hr. at 0 ºC before it was warmed up to room temperature and stirred overnight. 
Upon completion of the reaction, the mixture was quenched with DI water and diluted with 
20 mL of DCM. The layers were separated and the aqueous layer was extracted (x2) with 
two 10 mL portions of DCM. The organic layers were combined, washed with saturated 
bicarbonate solution and brine, dried over MgSO4 and concentrated under reduced pressure. 
The title compound was purified by column chromatography on silica gel (5% to 20% ethyl 
acetate/hexanes) to give a clear oil in 71% yield (438.4 mg).  
1H NMR (600 MHz, CDCl3) δ 7.29 – 7.18 (m, 2H), 7.00 (s, 1H), 6.96 – 6.90 (m, 2H), 6.89 






13C NMR (151 MHz, CDCl3) δ 171.03, 156.49, 151.38, 144.73, 133.09, 129.61, 127.68, 
121.33, 121.02, 118.56, 113.04, 66.19, 56.10, 21.22. 
 
 
Methyl 3-(4-(4-chlorophenoxy)-3-methoxyphenyl)propanoate (S20)  
The title compound was prepared on a 5.0 mmol scale according to general procedure A at 
90 °C. The title compound was purified by column chromatography on silica gel (100% 
hexanes to 30% ethyl acetate/hexanes) to give a light yellow solid in 71% yield (0.97 g). 
1H NMR (600 MHz, CDCl3) δ 7.21 (d, J = 8.6 Hz, 2H), 6.88 (d, J = 8.1 Hz, 1H), 6.85 – 
6.81 (m, 3H), 6.73 (dd, J = 8.1, 2.0 Hz, 1H), 3.80 (s, 3H), 2.89 (t, J = 7.5 Hz, 2H), 2.79 (t, 
J = 7.5 Hz, 2H), 2.17 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 207.85, 156.97, 151.38, 142.70, 138.64, 129.46, 127.18, 
121.46, 120.77, 118.08, 113.23, 56.01, 45.24, 30.23, 29.60. 
 
 
4-(4-Chlorophenoxy)benzyl acetate (S21) To a dry, clean round-bottomed flask 
equipped with a stir bar was added (4-(4-chlorophenoxy)phenyl)methanol (234mg, 1 mmol, 
1 equiv), DMAP (24 mg, 0.2 mmol), and DCM (10 ml). The solution was cooled to 0 ºC 
before sequential dropwise addition of triethylamine (202 mg, 2 mmol) and acetic anhydride 
(122 mg,1.2 mmol). The reaction solution was stirred under room temperature for 2h. Upon 
completion of the reaction, the mixture was quenched with DI water and DCM (20 mL) was 
added. The solution was washed with aq.HCl( 1N, 3x20ml) and the layers were separated. 










fractions were combined and washed with brine, dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give the 4-(4-chlorophenoxy)benzyl acetate 
(254mg, 92%) which was used without further purification. 
1H NMR (600 MHz, CDCl3) δ 7.34 (d, J = 8.6 Hz, 2H), 7.29 (d, J = 8.9 Hz, 2H), 6.98 (d, J 
= 8.6 Hz, 2H), 6.94 (d, J = 8.9 Hz, 2H), 5.08 (s, 2H), 2.10 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 171.03, 157.09, 155.68, 131.21, 130.32, 129.90, 128.61, 
120.36, 118.88, 65.91, 21.17. 
 
 
((1R,5S)-8-((4-Bromophenyl)sulfonyl)-8-azabicyclo[3.2.1]octan-3-one) (I-7) The 
title compound was prepared according to a procedure adapted from a literature protocol 
(93%, 3.20 g).10 
1H NMR (600 MHz, CDCl3) δ 7.79 – 7.72 (m, 2H), 7.69 – 7.63 (m, 2H), 4.49 (dp, J = 5.1, 
1.8 Hz, 2H), 2.79 (dd, J = 16.6, 4.5 Hz, 2H), 2.38 (dt, J = 15.5, 1.7 Hz, 2H), 1.87 – 1.68 
(m, 2H), 1.68 – 1.49 (m, 2H). 





The title compound was prepared according to a published procedure11; spectra data are in 













azabicyclo[3.2.1]octan-3-one (S22) To a clean, dry round-bottomed flask equipped with 
a stir bar was added 8-((4-bromophenyl)sulfonyl)-8-azabicyclo[3.2.1]octan-3-one (1.03 g, 
3.0 mmol, 1.0 equiv), (4-(4-chlorophenoxy)phenyl)boronic acid (745 mg, 3.0 mmol, 1.0 
equiv) and potassium carbonate (871 mg, 6.30 mmol, 2.1 equiv). The reaction vessel was 
then moved into a glovebox (N2 atmosphere), where tetrakis(triphenylphosphine)-
palladium(0) (173 mg, 0.15 mmol, 0.05 equiv) was added. The vessel was sealed, removed 
from the glovebox, and placed under a positive pressure of N2. The solids were then 
dissolved in a 2:1 mixture of 1,2 dimethoxyethane:DI water (45 mL), and the reaction was 
heated at reflux for 16 h. Upon completion of the reaction, crude mixture was cooled, 
filtered through Celite®, quenched with ammonium chloride (20 mL), and diluted with 
EtOAc (30 mL). The layers were separated and the aqueous layer was extracted 3x with 
ethyl acetate (3 x 10 mL). The organic fractions were combined, washed with brine, dried 
over magnesium sulfate and concentrated under reduced pressure. The title compound was 
purified by column chromatography on silica gel (100% DCM to 5% EtOAc:Hex) to give an 
off-white solid in 46% yield (0.65 g). 
1H NMR (600 MHz, CDCl3) δ 7.95 (d, J = 8.5 Hz, 2H), 7.69 (d, J = 8.5 Hz, 2H), 7.58 (d, J 
= 8.0 Hz, 2H), 7.32 (d, J = 8.8 Hz, 2H), 7.08 (d, J = 8.6 Hz, 2H), 6.99 (d, J = 8.9 Hz, 1H), 
4.54 (dt, J = 4.9, 2.4 Hz, 2H), 2.81 (dd, J = 16.5, 4.5 Hz, 2H), 2.38 (d, J = 15.6 Hz, 2H), 
1.76 (dd, J = 9.2, 4.5 Hz, 2H), 1.60 (d, J = 7.9 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 206.93, 157.82, 155.31, 145.22, 138.11, 134.17, 129.98, 









3-(4-(Benzyloxy)phenyl)pyridine (I-9) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.13 
 
 
4-(Pyridin-3-yl)phenol (I-10) The title compound was prepared according to a published 




3-(4-(4-Chlorophenoxy)phenyl)pyridine (S23) 6-193 The title compound was 
prepared with 1.3 mmol of I-10 according to general procedure A at 90 °C. The title 
compound was purified by column chromatography on silica gel (100% hexanes to 50% 
ethyl acetate/hexanes) to give a light yellow solid in 93% yield (274.3 mg). 
 
1H NMR (600 MHz, CDCl3) δ 8.83 (d, J = 2.4 Hz, 1H), 8.58 (dd, J = 4.8, 1.6 Hz, 1H), 7.84 
(dt, J = 7.9, 2.0 Hz, 1H), 7.55 (d, J = 8.6 Hz, 2H), 7.36 (dd, J = 7.9, 4.8 Hz, 1H), 7.32 (d, J 
= 8.8 Hz, 2H), 7.09 (d, J = 8.6 Hz, 2H), 6.99 (d, J = 8.8 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 157.35, 155.57, 148.47, 148.22, 135.98, 134.21, 133.23, 













The title compound was prepared according to a published procedure; spectra data are in 
agreement with literature values.14 
 
 
5-(4-(Benzyloxy)phenyl)pyrimidine (I-12) To a clean, dry round-bottomed flask 
equipped with a stir bar was added I-11 (1.05 g, 4.0 mmol, 1.0 equiv), pyrimidin-5-
ylboronic acid (644 mg, 5.2 mmol, 1.3 equiv) and sodium carbonate (3.18 g, 30.0 mmol, 
7.5 equiv). The reaction vessel was then moved into a glovebox (N2 atmosphere), where 
tetrakis(triphenylphosphine)palladium(0) (139 mg, 0.12 mmol, 0.03 equiv) was added. The 
vessel was sealed, removed from the glovebox, and placed under a positive pressure of N2. 
The solids were then dissolved in a 2:2:1 mixture of toluene:DI water:ethanol (35 mL), and 
the reaction was heated at reflux for 16 h. Upon completion of the reaction, crude mixture 
was cooled, filtered through Celite®, quenched with ammonium chloride (20 mL), and 
diluted with EtOAc (40 mL). The layers were separated and the aqueous layer was extracted 
3x with ethyl acetate (3 x 10 mL). The organic fractions were combined, washed with brine, 
dried over magnesium sulfate and concentrated under reduced pressure. The title 
compound was purified by column chromatography on silica gel (10 to 50% EtOAc:Hex) to 
give an off-white solid in 96% yield (718 mg). 
1H NMR (600 MHz, CDCl3) δ 9.16 (s, 1H), 8.91 (s, 2H), 7.54 – 7.50 (m, 2H), 7.48 – 7.32 







13C NMR (151 MHz, CDCl3) δ 159.71, 157.02, 154.59, 136.60, 134.06, 128.84, 128.32, 
128.30, 127.61, 126.87, 115.97, 70.26. 
 
 
4-(Pyrimidin-5-yl)phenol (I-13) To a clean, dry round-bottomed flask equipped with a 
stir bar was added I-12 (718 mg, 2.74 mmol, 1.0 equiv) and a solvent mixture of 
THF:MeOH (1:1, 14 mL). Palladium hydroxide on carbon (115 mg, 0.82 mmol, 0.3 equiv) 
was added to the reaction mixture and the reaction flask was sealed. The reaction was then 
evacuated and refilled with H2 (3x) before being placed under an H2 atmosphere (1 atm) 
overnight (approx. 6-8 h.). Upon reaction completion as determined by TLC, the mixture 
was filtered through sequential Celite® and silica layers before being concentrated under 
reduced pressure. The title compound was purified by column chromatography on silica gel 
(50 EtOAc:Hex to 5% MeOH:EtOAc) to give an tan solid in 81% yield (397 mg). 
1H NMR (600 MHz, DMSO-d6) δ 9.87 (s, 1H), 9.07 (d, J = 22.3 Hz, 3H), 7.68 – 7.56 (m, 
2H), 6.97 – 6.86 (m, 2H). 




5-(4-(4-Chlorophenoxy)phenyl)pyrimidine (S24) The title compound was prepared 
with 1.87 mmol of I-13 according to general procedure A at 90 °C. The title compound was 
purified by column chromatography on silica gel (100% hexanes to 50% ethyl 









1H NMR (600 MHz, CDCl3) δ 9.19 (s, 1H), 8.93 (s, 2H), 7.55 (d, J = 8.6 Hz, 2H), 7.34 (d, 
J = 8.8 Hz, 2H), 7.13 (d, J = 8.6 Hz, 2H), 7.01 (d, J = 8.8 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 158.27, 157.46, 155.17, 154.79, 133.78, 130.11, 129.43, 
129.21, 128.68, 120.80, 119.46. 
 
 
1-Chloro-4-(4-cyclohexylphenoxy)benzene (S25) The title compound was prepared on 
a 5.0 mmol scale according to general procedure A at 110 °C. The title compound was 
purified by column chromatography on silica gel (100% hexanes to 10% ethyl 
acetate/hexanes) to give a light yellow solid in 94% yield (1.35 g). 
1H NMR (600 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.22 – 7.17 (m, 2H), 6.99 – 6.90 (m, 
4H), 2.52 (tq, J = 11.6, 3.5 Hz, 1H), 1.95 – 1.80 (m, 4H), 1.81 – 1.66 (m, 1H), 1.42 (td, J 
= 9.2, 3.0 Hz, 4H), 1.33 – 1.20 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 156.49, 154.69, 143.72, 129.71, 128.19, 127.89, 119.80, 




1(2H)-carboxylate (I-14) The title compound was prepared according to a published 













15) To a clean, dry round-bottomed flask equipped with a stir bar was added I-8 (0.996 g, 
3.0 mmol, 1.0 equiv), I-14 (0.985 g, 2.9 mmol, 1.0 equiv), potassium carbonate (1.19 g, 
8.61 mmol, 3.0 equiv), and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) 
(126 mg, 0.17 mmol, 0.06 equiv). The vessel was sealed before being evacuated and 
refilled with N2 (3x). The reaction was placed under a positive pressure of N2 and the solids 
were dissolved in a DMF (20 mL), and the reaction was heated at reflux for 24 h. Upon 
completion of the reaction, crude mixture was cooled, filtered through Celite®, 
quenched with ammonium chloride (20 mL), and diluted with EtOAc (40 mL). The layers 
were separated and the aqueous layer was extracted 3x with ethyl acetate (3 x 10 mL). The 
organic fractions were combined, washed with brine, dried over magnesium sulfate and 
concentrated under reduced pressure. The title compound was purified by column 
chromatography on silica gel (100% hexanes to 10% EtOAc:Hex) to give an off-white solid 
in 68% yield (821 mg). 
1H NMR (600 MHz, CDCl3) δ 7.44 – 7.33 (m, 9H), 7.29 (dd, J = 8.9, 6.8 Hz, 2H), 7.05 – 
6.90 (m, 2H), 6.03 (dd, J = 40.9, 22.8 Hz, 1H), 5.21 (s, 2H), 4.18 (s, 2H), 3.84 – 3.57 (m, 
2H), 2.56 (t, J = 15.5 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 156.21, 155.84, 155.43 (d, J = 35.5 Hz), 140.53, 136.75 (d, 
J = 3.9 Hz), 136.05, 129.78, 128.56, 128.48, 128.09 (d, J = 2.8 Hz), 128.00 (d, J = 1.6 
Hz), 126.41, 124.96, 120.08, 118.81, 67.20 (d, J = 3.2 Hz), 43.81 (d, J = 29.5 Hz), 40.68 







4-(4-(4-Chlorophenoxy)phenyl)piperidine (I-16) To a clean, dry round-bottomed flask 
equipped with a stir bar was added I-12 (1.08 g, 2.57 mmol, 1.0 equiv) and a solvent 
mixture of THF:MeOH (1:1, 20 mL). Palladium on carbon (81 mg, 0.26 mmol, 0.3 equiv) 
was added to the reaction mixture and the reaction flask was sealed. The reaction was then 
evacuated and refilled with H2 (3x) before being placed under an H2 atmosphere (1 atm) 
overnight (approx. 6-8 h.) at 50 ºC. Note: avoid temperatures > 60 ºC as minor reduction 
of the aryl chloride is observed. Upon reaction completion as determined by TLC, the 
mixture was filtered through sequential Celite® and silica layers before being concentrated 
under reduced pressure. The title compound was purified by column chromatography on 
silica gel (20 EtOAc:Hex to 80% EtOAc:Hex) to give an yellow solid in quantitative yield 
(739 mg). 
1H NMR (600 MHz, MeOD) δ 7.34 (td, J = 8.2, 7.3, 1.9 Hz, 2H), 7.26 (dd, J = 8.5, 1.9 
Hz, 2H), 7.13 – 7.03 (m, 1H), 6.95 (dd, J = 8.7, 2.1 Hz, 4H), 3.52 – 3.38 (m, 2H), 3.08 (tt, 
J = 13.0, 2.4 Hz, 2H), 2.92 – 2.80 (m, 1H), 2.10 – 1.93 (m, 3H), 1.92 – 1.81 (m, 2H). 
13C NMR (151 MHz, MeOD) δ 158.81, 157.47, 140.78, 130.87, 129.08, 124.33, 120.08, 
119.70, 45.88, 40.80, 31.80. 
 
 
Benzyl 4-(4-(4-chlorophenoxy)phenyl)piperidine-1-carboxylate (S26) To a clean, 
dry round-bottomed flask equipped with a stir bar was added I-16 (687.6 mg, 2.39 mmol, 
1.0 equiv) and DCM (15 mL). Hünig’s base (1.3 mL, 7.17 mmol, 3.0 equiv) was added to 








3.58 mmol, 1.5 equiv) was then added dropwise and the reaction was stirred at 0 ºC for 10 
minutes before being warmed to room temperature and stirred overnight. Upon reaction 
completion, the mixture was quenched with water (20 mL) and diluted with 20 mL of DCM. 
The layers were separated and the aqueous layer was extracted with DCM (2 x 10 mL). The 
organic fractions were combined, washed with saturated bicarbonate solution and brine, 
dried over MgSO4, concentrated under reduced pressure. The title compound was purified 
by column chromatography on silica gel (100% hexanes to 40% EtOAc:Hex) to give an 
yellow gummy solid in 73% yield (739 mg). 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.35 (m, 4H), 7.35 – 7.31 (m, 3H), 7.17 – 7.13 (m, 
2H), 7.04 – 6.97 (m, 2H), 6.96 – 6.92 (m, 2H), 5.16 (s, 2H), 4.34 (d, J = 33.2 Hz, 2H), 
2.89 (s, 2H), 2.66 (tt, J = 12.2, 3.6 Hz, 1H), 1.85 (d, J = 10.5 Hz, 2H), 1.63 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 157.37, 155.63, 155.32, 140.49, 136.89, 129.74, 128.53, 




5-Chloro-1-(4-(4-chlorophenoxy)phenyl)pentan-1-one (I-17) To a clean, dry 50 mL 
round bottomed flask equipped with a stir bar was added aluminum chloride (1.33 g, 10.0 
mmol, 1 equiv) and DCM (7 mL). The solution was cooled to 0°C for 10 minutes. After this 
time, 5-chloropentanoyl chloride (1.55 g, 1.3 mL, 10.0 mmol, 1 equiv) was added dropwise. 
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The mixture was allowed to stir for 30 minutes. Separately, a solution of 1-chloro-4-
phenoxybenzene (2.25 g, 1.89 mL, 11.0 mmol, 1.1 equiv) in DCM (4 mL) was prepared and 
added to the round bottom flask dropwise after the aforementioned time. The reaction was 
stirred under N2 overnight. The reaction was quenched with excess 1 M HCl solution and the 
aqueous layer was separated from the organic. The aqueous layer was extracted with DCM 
(3 x 50 mL). The combined organic layers were washed with brine (1 x 50 mL), dried over 
sodium sulfate, and concentrated in vacuo. The crude product was purified via column 
chromatography on silica gel (5-20% EtOAc in Hex) to afford 5-chloro-1-(4-(4-
chlorophenoxy)phenyl)pentan-1-one as a white solid in 86% yield (2.781 g) 
1H NMR (600 MHz, CDCl3) δ 7.95 (d, J = 8.8 Hz, 2H), 7.35 (d, J = 8.8 Hz, 2H), 7.00 (dd, 
J = 8.9, 6.8 Hz, 4H), 3.58 (t, J = 6.2 Hz, 2H), 2.98 (t, J = 6.9 Hz, 2H), 1.92 – 1.84 (m, 
4H). 
13C NMR (151 MHz, CDCl3) δ 198.31, 161.60, 154.23, 131.97, 130.49, 130.21, 129.86, 
121.51, 117.54, 44.87, 37.49, 32.15, 21.70. 
 
 
5-Chloro-1-(4-(4-chlorophenoxy)phenyl)pentan-1-ol (I-18) To a clean, dry 100 mL 
round bottomed flask equipped with a stir bar was added 5-chloro-1-(4-(4-chlorophenoxy)-
phenyl)pentan-1-one (2.250 g, 6.96 mmol, 1 equiv) and 4:1 EtOH:THF solution (50 mL). 
This solution was cooled to 0°C on an ice bath for 10 minutes, after which time sodium 
borohydride (263.4 mg, 6.96 mmol, 1 equiv) was added portion-wise. The ice bath was 
removed after 10 minutes and the mixture was stirred at room temperature under N2 
overnight. The reaction was quenched with excess saturated ammonium chloride solution. 
Upon separation of the layers, the aqueous layer was extracted with EtOAc (3 x 50 mL). The 
combined organic layers were washed with brine, dried over sodium sulfate, and 
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concentrated in vacuo. The crude product was purified via column chromatography on silica 
gel (20% EtOAc in Hex) to afford 5-chloro-1-(4-(4-chlorophenoxy)phenyl)pentan-1-ol as a 
clear yellow oil in 86% yield (1.957 g). 
1H NMR (600 MHz, CDCl3) δ 7.31 (d, J = 8.6 Hz, 2H), 7.28 (d, J = 8.9 Hz, 2H), 6.97 (d, J 
= 8.6 Hz, 2H), 6.93 (d, J = 8.9 Hz, 2H), 4.67 (dd, J = 7.6, 5.7 Hz, 1H), 3.53 (t, J = 6.7 Hz, 
2H), 1.92 (s, 1H), 1.86 – 1.77 (m, 3H), 1.72 (ddt, J = 13.4, 10.9, 5.6 Hz, 1H), 1.62 – 1.54 
(m, 1H), 1.43 (ddtd, J = 13.2, 10.5, 7.6, 5.4 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 156.43, 155.95, 139.95, 129.86, 128.40, 127.54, 118.99, 
74.03, 45.01, 38.36, 32.52, 23.35. 
 
 
2-(4-(4-Chlorophenoxy)phenyl)tetrahydro-2H-pyran (S27) To a clean, dry 250 mL 
round bottomed flask equipped with a stir bar was charged with 5-chloro-1-(4-(4-
chlorophenoxy)phenyl)pentan-1-ol (1.957 g, 6.02 mmol, 1 equiv) and THF (50 mL). To this 
solution, potassium tert-butoxide (2.026 g, 18.05 mmol, 3 equiv) was added. The flask was 
sealed with a septum under N2 and stirred at room temperature overnight. After this time, 
the solvent was removed in vacuo, reconstituted in Et2O, and diluted with water. The 
aqueous and organic layers were separated, and the aqueous layer was extracted with Et2O 
(3 x 50 mL). The combined organic layers were washed with water (1 x 50 mL), brine (1 x 
50 mL), and dried over sodium sulfate. Upon concentration, 2-(4-(4-
chlorophenoxy)phenyl)tetrahydro-2H-pyran was isolated as a white solid in 96% yield (1.67 
g). 
1H NMR (600 MHz, CDCl3) δ 7.34 (d, J = 8.6 Hz, 2H), 7.26 (d, J = 8.9 Hz, 2H), 6.97 (d, J 
= 8.6 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 4.31 (dd, J = 10.9, 2.2 Hz, 1H), 4.16 – 4.11 (m, 





Hz, 1H), 1.72 – 1.57 (m, 4H). 
13C NMR (151 MHz, CDCl3) δ 156.33, 155.97, 138.96, 129.76, 128.08, 127.65, 119.87, 
119.10, 79.75, 69.20, 34.01, 25.97, 24.09. 
 
 
4-(4-Chlorophenoxy)-3-methoxyphenyl pivalate (S28) mCPBA (1.31 g, 5.8 mmol) 
was added to a solution of 4-(4-chlorophenoxy)-3-methoxybenzaldehyde (1.17 g, 4.47 
mmol) in DCM (10 mL) at 0 °C. The mixture was stirred at room temperature overnight 
then saturated aqueous NaHCO3 solution was added, the mixture was diluted with water 
and the layers were separated. The aqueous phase was extracted with DCM (x1), then the 
combined organic phase was washed with saturated aqueous NaHCO3 (x1), water (x1), 
brine (x1), dried (Na2SO4) and concentrated to give a yellow liquid. This material was 
dissolved in methanol (18 mL) then K2CO3 (3.11 g, 22.5 mmol) was added at room 
temperature. After 3 hours, the mixture was concentrated, water was added and the 
mixture was extracted with diethyl ether (x2). The combined organic phase was washed 
with water (x1), brine (x1), dried (Na2SO4) and concentrated to give 4-(4-chlorophenoxy)-
3-methoxyphenol (I-18) as a yellow oil in 98% yield (1.10 g). 
1H NMR (600 MHz, CDCl3) δ 7.21 (AA’BB’, J = 9.0 Hz, 2H), 6.89 (d, J = 8.4 Hz, 1H), 6.81 
(AA’BB’, J = 9.0 Hz, 2H), 6.54 (d, J = 3.0 Hz, 1H), 6.38 (dd, J = 8.4, 3.0 Hz, 1H), 4.66 (s, 
1H), 3.77 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 157.62, 153.54, 152.74, 137.86, 129.46, 126.85, 122.80, 


















The title compound was then prepared according to the procedure used for S6. The title 
compound was purified by column chromatography on silica gel (10% ethyl 
acetate/hexanes) to give a clear colorless oil in 70% yield (0.52 g). 
1H NMR (500 MHz, CDCl3) δ 7.23 (AA’BB’, J = 9.0 Hz, 2H), 6.98 (d, J = 8.5 Hz, 1H), 6.85 
(AA’BB’, J = 9.0 Hz, 2H), 6.72 (d, J = 2.5 Hz, 1H), 6.64 (dd, J = 8.5, 2.5 Hz, 1H), 3.80 (s, 
3H), 1.37 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 177.27, 156.84, 151.99, 148.31, 141.88, 129.57, 127.44, 
121.66, 118.08, 113.73, 107.00, 56.20, 39.25, 27.27. 
 
 
2-(4-Chlorophenoxy)-4,5-dimethoxybenzaldehyde (S29) To a clean, dry 250 mL 
round bottomed flask equipped with a stir bar was added 4-chlorophenol (3.86 g, 3.0 mmol, 
3.0 equiv), K2CO3 (4.1 g, 3.0 mmol, 3.0 equiv), and DMF (40ml). 2-Fluoro-4,5-
dimethoxybenzaldehyde (1.84 g, 10 mmol 1.0 equiv) was then added and the mixture was 
stirred under N2 at 110 oC overnight. Upon completion of the reaction, the mixture was 
cooled to room temperature. H2O (50ml) and ethyl acetate (50ml) were then added. The 
layers were separated and the aqueous layer was extracted with EtOAc (2 x 15 mL). The 
organic fractions were combined, washed with H2O (3 x 50ml), lithium chloride solution,and 
brine. The organic layer was then dried over Na2SO4 and concentrated under reduced 
pressure. The title compound was purified by column chromatography on silica gel (100% 
hexanes to 10% EtOAc:Hex) to give an white solid in 48% yield (1.40 g). The spectra data 








5-Fluoro-2-nitro-1,1'-biphenyl (I-19) To a clean, dry round-bottomed flask equipped 
with a stir bar was added -bromo-4-fluoro-1-nitrobenzene (2.20 g, 10.0 mmol, 1.0 equiv), 
phenylboronic acid (1.83 g, 15.0 mmol, 1.5 equiv) and potassium carbonate (4.14 g, 30.0 
mmol, 2.0 equiv). The reaction vessel was then moved into a glovebox (N2 atmosphere), 
where tetrakis(triphenylphosphine)-palladium(0) (578 mg, 0.5 mmol, 0.05 equiv) was 
added. The vessel was sealed, removed from the glovebox, and placed under a positive 
pressure of N2. The solids were then dissolved in a 3:1 mixture of 1,4-dioxane:DI water (60 
mL), and the reaction was heated at reflux for 6 h. Upon completion of the reaction, crude 
mixture was cooled, filtered through Celite®, quenched with ammonium chloride (50 mL), 
and diluted with EtOAc (80 mL). The layers were separated and the aqueous layer was 
extracted 3x with ethyl acetate (3 x 15 mL). The organic fractions were combined, washed 
with brine, dried over magnesium sulfate and concentrated under reduced pressure. The 
title compound was purified by column chromatography on silica gel (100% hexanes to 10% 
EtOAc:Hex) to give an off-white solid in 97% yield (2.10 g). 
1H NMR (600 MHz, CDCl3) δ 7.94 (dd, J = 9.0, 5.0 Hz, 1H), 7.44 (dt, J = 5.6, 2.8 Hz, 
3H), 7.35 – 7.28 (m, 2H), 7.20 – 7.11 (m, 2H). 
13C NMR (151 MHz, CDCl3) δ 164.02 (d, J = 256.1 Hz), 145.37 (d, J = 3.2 Hz), 139.76 (d, 
J = 9.0 Hz), 136.64, 128.93, 128.83, 127.79, 127.06 (d, J = 9.9 Hz), 119.01 (d, J = 23.6 






5-(4-Chlorophenoxy)-2-nitro-1,1'-biphenyl (I-20) To a clean, dry round-bottomed 
flask equipped with a stir bar was added 4-chlorophenol(1.03 g, 8.0 mmol, 2.0 equiv), 
K2CO3 (1.66 g, 12.0 mmol, 3.0 equiv), and DMF (50mL). 5-fluoro-2-nitro-1,1'-biphenyl (880 
mg, 4.0 mmol, 1.0 equiv) was added to the reaction mixture, which was then heated under 
100oC for 2h. Upon the completion of the reaction, it was cooled to room temperature, 
quenched with H2O (50mL) and diluted with EtOAc (100mL) were added. The layers were 
separated and the aqueous layer was extracted with EtOAc (2 x 15 mL). The organic 
fractions were combined, washed with DI water (3 x 50mL) and saturated brine, dried over 
Na2SO4 concentrated under reduced pressure. The title compound was purified by column 
chromatography on silica gel (100% hexanes to 10% EtOAc:Hex) to give a pale yellow solid 
in 81% yield (1.05 g). 
1H NMR (600 MHz, CDCl3) δ 7.93 (dd, J = 9.0, 1.8 Hz, 1H), 7.46 – 7.34 (m, 5H), 7.31 – 
7.21 (m, 2H), 7.09 – 7.02 (m, 2H), 6.98 (dt, J = 9.0, 2.2 Hz, 1H), 6.93 (d, J = 2.4 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 160.74, 153.74, 143.96, 139.69, 137.52, 130.69, 130.60, 
128.91, 128.63, 127.93, 127.15, 121.88, 120.38, 116.50. 
 
 
3-(4-Chlorophenoxy)-9H-carbazole (I-21) To a clean, dry round-bottomed flask 
equipped with a stir bar was added 5-(4-chlorophenoxy)-2-nitro-1,1'-biphenyl (500 mg, 
1.54mmol, 1.0 equiv) and triethyl phosphite (20mL). The reaction was stirred under N2 at 








temperature, loaded directly onto the silica gel column and eluted with hexane to remove 
excess triethyl phosphite. The title compound was purified by column chromatography on 
silica gel (100% hexanes to 20% EtOAc:Hex) to give a white solid in 36% yield (165.0 mg). 
1H NMR (600 MHz, DMSO-d6) δ 11.33 (s, 1H), 8.10 (d, J = 7.8 Hz, 1H), 7.89 (d, J = 2.3 
Hz, 1H), 7.52 (d, J = 8.6 Hz, 1H), 7.49 (d, J = 8.1 Hz, 1H), 7.42 – 7.35 (m, 3H), 7.19 – 
7.06 (m, 2H), 6.96 (d, J = 8.9 Hz, 2H). 
13C NMR (151 MHz, DMSO-d6) δ 158.12, 147.88, 140.57, 136.79, 129.67, 126.02, 
125.74, 123.29, 122.22, 120.69, 118.72, 118.50, 118.43, 112.12, 111.67, 111.16. 
 
 
tert-Butyl 3-(4-chlorophenoxy)-9H-carbazole-9-carboxylate (S30) To a clean, dry 
round-bottomed flask equipped with a stir bar was added 3-(4-chlorophenoxy)-9H-carbazole 
(150 mg, 0.51 mmol, 1.0 equiv) and 10mL DCM. DMAP (73 mg, 0.6 mmol, 1.1 equiv) and 
Boc2O (175 mg, 0.8 mmol, 1.6 equiv) were sequentially added and the solution was stirred 
at room temperature for 0.5 h. Upon completion of the reaction, DCM (50mL) was added 
and the mixture was washed with aqueous HCl (1N). The layers were separated and the 
aqueous layer was extracted with DCM (2 x 10 mL). The organic fractions were combined, 
washed with brine, dried over Na2SO4 and concentrated in vacuo. The title compound was 
purified by column chromatography on silica gel (100% hexanes to 5% EtOAc:Hex) to give 
a pale yellow solid in 95% yield (190 mg). 
1H NMR (600 MHz, CDCl3) δ 8.30 (d, J = 8.7 Hz, 2H), 7.91 – 7.86 (m, 1H), 7.60 (d, J = 
2.5 Hz, 1H), 7.49 (ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.34 (td, J = 7.5, 1.0 Hz, 1H), 7.31 – 






13C NMR (151 MHz, CDCl3) δ 157.16, 152.46, 151.09, 139.19, 135.09, 129.81, 127.85, 




5-(4-Chlorophenoxy)-2-methoxypyridine (S31) The title compound was prepared on a 
10.0 mmol scale according to general procedure A at 110 °C. The title compound was 
purified by column chromatography on silica gel (100% hexanes to 10% ethyl 
acetate/hexanes) to give a light yellow solid in 83% yield (1.96 g). 
1H NMR (600 MHz, CDCl3) δ 7.93 (d, J = 3.0 Hz, 1H), 7.27 (dd, J = 8.9, 2.9 Hz, 1H), 7.23 
(d, J = 8.6 Hz, 2H), 6.85 (d, J = 8.7 Hz, 2H), 6.72 (d, J = 8.9 Hz, 1H), 3.90 (d, J = 1.2 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) δ 160.74, 156.85, 147.35, 138.24, 131.28, 129.78, 127.96, 
118.58, 111.70, 53.76. 
 
 
3-Hydroxy-2-methoxypyridine (I-22) The title compound was prepared from the 
pyridylboronic acid according to a procedure adapted from a literature protocol (94%, 1.17 
g).17 
1H NMR (600 MHz, CDCl3) δ 7.69 (dd, J = 5.1, 1.6 Hz, 1H), 7.12 (dd, J = 7.6, 1.6 Hz, 







13C NMR (151 MHz, CDCl3) δ 152.94, 140.68, 140.67, 137.23, 137.22, 120.89, 120.88, 
120.86, 117.84, 53.76. 
 
 
3-(4-Chlorophenoxy)-2-methoxypyridine (S32) The title compound was prepared on a 
2.24 mmol scale according to general procedure A at 110 °C. The title compound was 
purified by column chromatography on silica gel (100% hexanes to 20% ethyl 
acetate/hexanes) to give a light yellow solid in 77% yield (406.0 mg). 
1H NMR (600 MHz, CDCl3) δ 7.93 (dd, J = 4.9, 1.9 Hz, 1H), 7.22 (d, J = 7.7 Hz, 2H), 7.15 
(dd, J = 7.7, 1.9 Hz, 1H), 6.87 – 6.79 (m, 2H), 3.93 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 156.35, 155.60, 141.71, 140.08, 129.68, 128.23, 127.47, 
118.83, 117.07, 53.69. 
 
 
2-(4-Chlorophenoxy)-3-methoxypyridine (S33) To a dry, clean round-bottomed flask 
equipped with a stir bar was added 4-chlorophenol (1.03 g, 8.0 mmol, 1.6 equiv) and DME 
(7 mL). Potassium tert-butoxide (898 mg, 8.0 mmol, 1.6 equiv) was then added to the 
reaction solution and the mixture was stirred at room temperature for 20 min. A separate 
solution of 2-bromo-3-methoxypyridine (940 mg, 5.0 mmol, 1.0 equiv) and 








DME (7 mL) was prepared. This solution was transferred to the stirring phenoxide solution 
via cannula and a dark red-ish solution appeared. This solution was then heated at 100 ºC 
overnight. Upon completion of the reaction, EtOAc (30mL) was added and the mixture was 
washed with aqueous HCl (1N). The layers were separated and the aqueous layer was 
extracted with EtOAc (2 x 10 mL). The organic fractions were combined, washed with brine, 
dried over Na2SO4 and concentrated in vacuo. The title compound was purified by column 
chromatography on silica gel (100% hexanes to 20% EtOAc:Hex) to give a pale yellow solid 
in quantitative (1.18 g). 
1H NMR (600 MHz, CDCl3) δ 7.71 (dd, J = 5.2, 1.5 Hz, 1H), 7.34 (d, J = 8.8 Hz, 2H), 7.22 
(dd, J = 8.0, 1.7 Hz, 1H), 7.09 (d, J = 8.8 Hz, 2H), 6.99 (dd, J = 7.9, 4.9 Hz, 2H), 3.94 (s, 
3H). 
13C NMR (151 MHz, CDCl3) δ 153.42, 152.68, 144.83, 137.71, 129.91, 129.68, 122.81, 
119.40, 119.21, 56.03. 
 
 
3-(4-Chlorophenoxy)pyridine (I-23) The title compound was prepared on a 12.0 mmol 
scale according to general procedure A at 110 °C. The title compound was purified by 
column chromatography on silica gel (100% hexanes to 10% ethyl acetate/hexanes) to give 









trifluoromethanesulfonate (I-24) The title compound (off-white solid) was prepared 
from I-3 according to a procedure adapted from a literature protocol (87%, 5.49 g).19  
1H NMR (600 MHz, CDCl3) δ 8.66 (t, J = 4.4 Hz, 1H), 8.39 (d, J = 6.6 Hz, 1H), 7.85 (td, J 
= 6.3, 2.8 Hz, 3H), 7.78 – 7.72 (m, 12H), 7.29 (dd, J = 14.5, 5.0 Hz, 1H), 7.21 (d, J = 8.8 
Hz, 2H), 6.58 (d, J = 8.8 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 154.49, 151.44, 145.98 (d, J = 10.6 Hz), 140.21 (d, J = 4.5 
Hz), 135.90 (d, J = 3.2 Hz), 134.33 (d, J = 10.7 Hz), 131.69, 130.96 (d, J = 13.3 Hz), 
130.60, 128.65 (d, J = 6.7 Hz), 120.50, 116.27 (d, J = 91.3 Hz). OTf peaks not detected. 
19F NMR (376 MHz, CDCl3) δ -78.06. 
31P NMR (202 MHz, CDCl3) δ 20.98. 
 
 
4-(Benzyloxy)-3-(4-chlorophenoxy)pyridine (S34) The title compound (tan solid) was 
prepared from I-24 according to a procedure adapted from a literature protocol (62%, 
0.869 g).19 
1H NMR (600 MHz, CDCl3) δ 8.37 – 8.22 (m, 2H), 7.31 – 7.25 (m, 3H), 7.23 (d, J = 8.9 
Hz, 2H), 7.11 (dd, J = 7.4, 2.2 Hz, 2H), 6.92 (d, J = 5.5 Hz, 1H), 6.84 (d, J = 8.9 Hz, 2H), 













13C NMR (151 MHz, CDCl3) δ 156.55, 156.43, 147.74, 143.76, 141.41, 135.06, 129.45, 
128.57, 128.26, 127.62, 126.91, 117.72, 109.10, 70.11. 
 
 
2,4-Di-tert-butoxypyrimidin-5-ol (I-25) The title compound was prepared from the 
pyridylboronic acid according to a procedure adapted from a literature protocol (92%, 820.3 
g).17 
1H NMR (600 MHz, CDCl3) δ 7.87 (s, 1H), 5.38 (bs, 1H), 1.64 (s, 9H), 1.55 (s, 9H). 




2,4-Di-tert-butoxy-5-(4-chlorophenoxy)pyrimidine (S35) The title compound was 
prepared according to general procedure A at 90 °C. The title compound was purified by 
column chromatography on silica gel (100% hexanes to 30% ethyl acetate/hexanes) to give 
a light yellow solid in 71% yield (0.97 g). 
1H NMR (600 MHz, CDCl3) δ 8.02 (s, 1H), 7.19 (d, J = 7.2 Hz, 2H), 6.77 (d, J = 7.2 Hz, 
2H), 1.59 (s, 9H), 1.43 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 162.29, 160.44, 156.85, 150.20, 133.16, 129.23, 127.18, 


















The title compound was prepared according to general procedure A at 110 °C. The title 
compound was purified by column chromatography on silica gel (10% ethyl acetate/hexanes 
to 20% ethyl acetate/hexanes) to give a white solid in 26% yield (1.054 g). 
 
1H NMR (600 MHz, CDCl3) δ 7.28 (d, J = 8.9 Hz, 2H), 7.09 (d, J = 8.1 Hz, 2H), 6.92 (dd, 
J = 8.6, 3.8 Hz, 4H), 5.01 (d, J = 8.3 Hz, 1H), 4.58 (dt, J = 8.3, 6.0 Hz, 1H), 3.73 (s, 3H), 
3.11 (dd, J = 13.9, 5.6 Hz, 1H), 3.01 (dd, J = 13.9, 6.3 Hz, 1H), 1.42 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.42, 156.04, 155.93, 155.16, 131.38, 130.86, 129.85, 




Methyl (R)-2-amino-3-(4-(4-chlorophenoxy)phenyl)propanoate (I-27) To a clean, 
dry 25 mL round bottom flask equipped with a stir bar was added methyl (R)-2-((tert-
butoxycarbonyl)amino)-3-(4-(4-chlorophenoxy)phenyl)propanoate (1.049 g, 2.58 mmol, 1 
equiv) dissolved in 5 mL DCM. The solution was cooled to 0°C for 5 minutes. After this time, 
trifluoroacetic acid (1.474 g, 1.00 mL, 12.92 mmol, 5 equiv) was added dropwise and the 
mixture stirred overnight. Solvent and excess trifluoroacetic acid was removed in vacuo. 
The resulting residue was redissolved in 5 mL DCM and cooled to 0°C. Triethylamine (313.9 
mg, 0.43 mL, 3.10 mmol, 1.2 equiv) was added dropwise and allowed to stir for 3 hours. 
The mixture was diluted with water and extracted with DCM (2 x 25 mL). The combined 
organic layers were washed with saturated sodium bicarbonate (3 x 15 mL), dried over 
sodium sulfate, and concentrated in vacuo. Methyl (R)-2-amino-3-(4-(4-
chlorophenoxy)phenyl)propanoate was isolated as a yellow-orange oil (0.717 g, 90.8%) and 
was carried forward without further purification. 
1H NMR (600 MHz, CDCl3) δ 7.28 (d, J = 8.9 Hz, 2H), 7.16 (d, J = 8.4 Hz, 2H), 6.93 (dd, 
J = 8.7, 3.6 Hz, 4H), 3.74 – 3.70 (m, 4H), 3.06 (dd, J = 13.7, 5.1 Hz, 1H), 2.85 (dd, J = 
13.6, 7.8 Hz, 1H), 1.55 (s, 2H). 
13C NMR (151 MHz, CDCl3) δ 175.55, 155.99, 155.91, 132.56, 130.81, 129.84, 128.34, 





carboxamido)propanoate (S36) Methyl (R)-2-amino-3-(4-(4-
chlorophenoxy)phenyl)propanoate (325 mg, 1.06 mmol, 1 equiv), (1R,4R)-4-
isopropylcyclohexane-1-carboxylic acid (181 mg, 1.06 mmol, 1 equiv), and benzotriazol-1-
yloxytris(dimethylamino)phosphonium hexafluorophosphate (470 mg, 1.06 mmol, 1 equiv) 
were added to a clean, dry 50 mL round bottomed flask equipped with a stir bar. The solid 
reagents were then dissolved in MeCN (12 mL) and sealed under N2. Triethylamine (215 
mg, 0.30 mL, 2.12 mmol, 2 equiv) was added to the solution dropwise via syringe. The 
mixture was stirred at room temperature for 2 hours. Upon reaction completion, the mixture 
was diluted with water and DCM, and transferred to a separatory funnel. The aqueous layer 
was separated from the organic layer, and extracted with DCM (3 x 25 mL). The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated in vacuo. The 
crude product was purified by flash column chromatography (20-30% EtOAc:Hex) to yield 
methyl (R)-3-(4-(4-chlorophenoxy)phenyl)-2-((1R,4R)-4-isopropylcyclohexane-1-
carboxamido)propanoate (371 mg, 76%) as a white solid. 
1H NMR (600 MHz, CDCl3) δ 7.28 (d, J = 8.9 Hz, 2H), 7.04 (d, J = 8.6 Hz, 2H), 6.91 (t, J 
= 8.6 Hz, 4H), 5.90 (d, J = 7.7 Hz, 1H), 4.88 (dt, J = 7.7, 5.6 Hz, 1H), 3.74 (s, 3H), 3.16 
(dd, J = 13.9, 5.7 Hz, 1H), 3.06 (dd, J = 13.9, 5.6 Hz, 1H), 2.08 – 1.98 (m, 1H), 1.94 – 
1.82 (m, 2H), 1.82 – 1.74 (m, 2H), 1.50 – 1.32 (m, 3H), 1.08 – 0.92 (m, 3H), 0.85 (d, J = 
6.8 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 175.72, 172.33, 156.03 (d, J = 35.2 Hz), 131.28, 130.89, 
129.87, 128.45, 120.23, 118.97, 52.87, 52.54, 45.64, 43.33, 37.30, 32.89, 29.98, 29.62, 






chlorophenoxy)phenyl)propanoate (S37) The title compound was prepared on a 10.0 
mmol scale according to general procedure A at 90 °C. The title compound was purified by 
column chromatography on silica gel (100% hexanes to 30% ethyl acetate/hexanes) to give 
a light yellow solid in 71% yield (2.88 g). 
1H NMR (600 MHz, CDCl3) δ 7.28 (dd, J = 9.0, 3.3 Hz, 2H), 7.09 (dd, J = 8.3, 3.3 Hz, 
2H), 6.99 – 6.75 (m, 4H), 5.02 (d, J = 7.7 Hz, 1H) + rotamer at 4.75 (bs), 4.58 (d, J = 5.5 
Hz, 1H) + rotamer at 4.38 (bs), 3.73 (s, 3H), 3.11 (dd, J = 13.8, 5.0 Hz, 1H), 3.01 (dt, J = 
10.0, 4.5 Hz, 1H), 1.42 (9H). 
13C NMR (151 MHz, CDCl3) δ 172.41, 156.05, 155.95, 155.16, 131.41, 130.85, 129.83, 
128.36, 120.18, 119.02, 80.12, 54.56, 52.43, 37.83, 28.43. 
 
 
Methyl (S)-2-amino-3-(4-(4-chlorophenoxy)phenyl)propanoate (I-28) To a clean, 
dry 25 mL round bottom flask equipped with a stir bar was added methyl (S)-2-((tert-
butoxycarbonyl)amino)-3-(4-(4-chlorophenoxy)phenyl)propanoate (2.88 g, 7.10 mmol, 1 
equiv) dissolved in 25 mL DCM. The solution was cooled to 0°C for 5 minutes. After this 
time, trifluoroacetic acid (10 mL) was added dropwise and the mixture stirred for 2 h. 
Solvent and excess trifluoroacetic acid was removed in vacuo. The resulting residue was 
redissolved in 20 mL DCM and cooled to 0°C. Saturated bicarbonate solution was added 











mixture was diluted with water and extracted with DCM (2 x 25 mL). The combined organic 
layers were washed with brine, dried over sodium sulfate, and concentrated in vacuo. 
Methyl (S)-2-amino-3-(4-(4-chlorophenoxy)phenyl)propanoate was isolated as a 
synthetically pure yellow-orange oil that solidified upon standing (1.78 g, 82%). 
1H NMR (600 MHz, CDCl3) δ 7.27 (d, J = 8.9 Hz, 2H), 7.16 (d, J = 8.5 Hz, 2H), 6.92 (dd, 
J = 8.7, 3.7 Hz, 4H), 3.77 (dd, J = 7.7, 5.3 Hz, 1H), 3.72 (s, 3H), 3.08 (dd, J = 13.7, 5.3 
Hz, 1H), 2.89 (dd, J = 13.7, 7.7 Hz, 1H), 2.60 (s, 2H). 
13C NMR (151 MHz, CDCl3) δ 174.90, 156.00, 155.93, 132.13, 130.83, 129.83, 128.36, 




carboxamido)-propanoate (S38) The title compound was prepared from I-28 according 
to a procedure adapted from a literature protocol.20 
1H NMR (600 MHz, CDCl3) δ 7.35 – 7.19 (m, 2H), 7.12 – 6.99 (m, 2H), 6.95 – 6.79 (m, 
4H), 6.02 (d, J = 7.7 Hz, 1H) + rotamer at 6.11 (d, J = 7.6 Hz), 4.84 (ddt, J = 17.4, 7.6, 
5.8 Hz, 1H), 3.71 (s, 3H), 3.14 (dd, J = 13.8, 5.9 Hz, 1H), 3.03 (dd, J = 13.9, 5.8 Hz, 1H), 
2.01 (tt, J = 12.2, 3.5 Hz, 1H), 1.92 – 1.78 (m, 2H), 1.77 – 1.67 (m, 2H), 1.45 – 1.32 (m, 
3H), 1.07 – 0.88 (m, 2H), 0.83 (d, J = 6.8 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 175.69, 172.24, 156.00, 155.84, 131.26, 130.79, 129.76, 













chlorophenoxy)phenyl)propanoate (S39) The title compound was prepared from I-28 
according to a procedure adapted from a literature protocol.21 
 
1H NMR (600 MHz, CDCl3) δ 7.27 (dd, J = 8.9, 1.4 Hz, 2H), 7.08 (d, J = 8.5 Hz, 2H), 6.96 
– 6.80 (m, 4H), 6.44 (d, J = 74.4 Hz, 1H), 5.08 – 4.93 (m, 1H), 4.90 – 4.79 (m, 1H), 4.02 
– 3.84 (m, 1H), 3.72 (d, J = 1.3 Hz, 3H), 3.12 (dt, J = 14.0, 6.0 Hz, 1H), 3.05 (dt, J = 
14.1, 7.1 Hz, 1H), 1.42 (d, J = 5.0 Hz, 9H), 0.96 – 0.78 (m, 6H). 
13C NMR (151 MHz, CDCl3) δ 171.81 (d, J = 15.2 Hz), 171.40, 156.20, 155.93, 155.83, 
131.03 (d, J = 12.2 Hz), 130.78 (d, J = 9.4 Hz), 129.85, 128.43 (d, J = 2.8 Hz), 120.25 (d, 
J = 2.8 Hz), 119.02 (d, J = 5.5 Hz), 80.09 (d, J = 9.7 Hz), 59.92 (d, J = 47.5 Hz), 53.20 (d, 
J = 24.9 Hz), 52.53 (d, J = 3.2 Hz), 37.38 (d, J = 11.4 Hz), 30.83 (d, J = 44.0 Hz), 28.40, 




yl)propanoate (S40) The title compound was prepared from I-28 according to a 
procedure adapted from a literature protocol (80%, 1.34 g).22 
1H NMR (600 MHz, CDCl3) δ 7.80 (dd, J = 5.4, 3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.0 Hz, 

















(dd, J = 11.3, 5.2 Hz, 1H), 3.78 (s, 3H), 3.57 (dd, J = 14.4, 5.3 Hz, 1H), 3.51 (dd, J = 
14.4, 11.3 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.38, 167.57, 156.08, 155.66, 134.34, 132.21, 131.65, 






methoxyphenyl)acrylate (I-29) To a flame dried 100 mL round bottomed flask equipped 
with a stir bar was added methyl 2-((tert-butoxycarbonyl)amino)-2-
(dimethoxyphosphoryl)acetate (1.25 g, 4.20 mmol, 1.2 equiv) dissolved in 3.5 mL DCM. 
The flask was sealed with a rubber septum and N2 inlet. 1,8-Diazabicyclo[5.4.0]undec-7-
ene (533 mg, 0.53 mL, 3.50 mmol, 1 equiv) was added via syringe. This mixture was 







methoxybenzaldehyde (920 mg, 3.50 mmol, 1 equiv) was dissolved in 3.5 mL DCM. This 
was added via syringe and allowed to stir overnight. After this time, the reaction was diluted 
with water and DCM. After transfer to a separatory funnel, the aqueous and organic layers 
were separated. The aqueous layer was extracted with DCM (3 x 50 mL). The combined 
organic layers were washed with saturated ammonium chloride, dried over sodium sulfate, 
and concentrated in vacuo. The crude product was purified by flash column chromatography 
(20-30% EtOAc:Hex) to yield methyl (E)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-
chlorophenoxy)-2-methoxyphenyl)acrylate (1.263 g, 83.1%) as a white solid. 
1H NMR (600 MHz, CDCl3) δ 7.31 – 7.24 (m, 4H), 7.11 (dd, J = 8.4, 1.9 Hz, 1H), 6.90 
(dd, J = 8.6, 5.3 Hz, 3H), 6.26 (s, 1H), 3.86 (s, 3H), 3.84 (s, 3H), 1.42 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 166.16, 155.96, 150.84, 145.93, 131.11, 130.14, 129.72, 




methoxyphenyl)propanoate (I-30) To a clean, dry 100 mL round bottomed flask 
equipped with a stir bar was added methyl (E)-2-((tert-butoxycarbonyl)amino)-3-(4-(4-
chlorophenoxy)-2-methoxyphenyl)acrylate (1.254 g, 2.89 mmol, 1 equiv), which was 
dissolved in 33 mL of a THF:EtOH solution (2:1). 10% palladium on carbon (0.092 g, 0.86 
mmol, 0.3 equiv) was added to the solution and the reaction was placed under N2. The 
solution was evacuated and backfilled with H2 three times before being placed under a H2 
atmosphere (1 atm) overnight. Upon reaction completion, the solution was run through a 
plug of Celite, eluted with EtOAc, and concentrated in vacuo to afford methyl 2-((tert-
butoxycarbonyl)amino)-3-(4-(4-chlorophenoxy)-2-methoxyphenyl)propanoate (1.150 g, 
91.3%) as a light yellow oil. 
 439 
1H NMR (600 MHz, CDCl3) δ 7.23 (d, J = 8.9 Hz, 2H), 6.88 (d, J = 8.1 Hz, 1H), 6.84 (d, J 
= 8.9 Hz, 2H), 6.76 (d, J = 2.0 Hz, 1H), 6.70 – 6.66 (m, 1H), 5.03 (d, J = 8.4 Hz, 1H), 4.60 
(dt, J = 8.4, 6.1 Hz, 1H), 3.80 (s, 3H), 3.73 (s, 3H), 3.12 (dd, J = 13.8, 5.7 Hz, 1H), 3.02 
(dd, J = 13.9, 6.5 Hz, 1H), 1.42 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.42, 156.69, 155.15, 151.29, 143.65, 133.45, 129.57, 
127.48, 121.97, 121.16, 118.39, 113.85, 80.19, 56.02, 54.53, 52.47, 38.42, 31.12, 28.45. 
 
 
Methyl 2-amino-3-(4-(4-chlorophenoxy)-3-methoxyphenyl)propanoate (I-31) To a 
clean, dry 25 mL round bottom flask equipped with a stir bar was added methyl 2-((tert-
butoxycarbonyl)amino)-3-(4-(4-chlorophenoxy)-2-methoxyphenyl)propanoate (1.094 g, 
2.51 mmol, 1 equiv) dissolved in 5 mL DCM. The solution was cooled to 0°C for 5 minutes. 
After this time, trifluoroacetic acid (1.431 g, 0.97 mL, 12.55 mmol, 5 equiv) was added 
dropwise and the mixture stirred overnight. Solvent and excess trifluoroacetic acid was 
removed in vacuo. The resulting residue was reconstituted in 5 mL DCM and cooled to 0°C. 
Triethylamine (304.8 mg, 0.42 mL, 3.01 mmol, 1.2 equiv) was added dropwise and allowed 
to stir for 3 hours. The mixture was diluted with water and extracted with DCM (2 x 25 mL). 
The combined organic layers were washed with saturated sodium bicarbonate (3 x 15 mL), 
dried over sodium sulfate, and concentrated in vacuo. Methyl 2-amino-3-(4-(4-
chlorophenoxy)-2-methoxyphenyl)propanoate (0.818 g, 97.1%) was isolated as a yellow-
orange oil and was carried forward without further purification. 
1H NMR (600 MHz, CDCl3) δ 7.23 (d, J = 8.9 Hz, 2H), 6.90 (d, J = 8.1 Hz, 1H), 6.87 – 
6.83 (m, 3H), 6.75 (dd, J = 8.1, 2.0 Hz, 1H), 3.80 (s, 3H), 3.75 (dd, J = 8.0, 5.3 Hz, 1H), 







13C NMR (151 MHz, CDCl3) δ 175.51, 156.71, 151.35, 143.50, 134.63, 129.55, 127.44, 




yl)propanoate (S41) To a clean, dry 50 mL round bottomed flask equipped with a stir bar 
was added methyl 2-amino-3-(4-(4-chlorophenoxy)-2-methoxyphenyl)propanoate (0.808 g, 
2.41 mmol, 1 equiv) dissolved in toluene (10 mL). Isobenzofuran-1,3-dione (363.6 mg, 
2.45 mmol, 1.02 equiv) was added to the flask, which was fitted with a cold-water reflux 
condenser and refluxed overnight. The solvent was removed in vacuo. The crude product 
was purified by flash column chromatography (100% EtOAc) to yield methyl 3-(4-(4-
chlorophenoxy)-2-methoxyphenyl)-2-(1,3-dioxoisoindolin-2-yl)propanoate (0.556 g, 
49.6%) as a yellow solid. 
1H NMR (600 MHz, CDCl3)) δ 7.80 (dd, J = 5.5, 3.0 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 
2H), 7.16 (d, J = 8.9 Hz, 2H), 6.79 – 6.75 (m, 2H), 6.72 – 6.67 (m, 3H), 5.16 (dd, J = 
11.5, 5.2 Hz, 1H), 3.80 (s, 3H), 3.63 (s, 3H), 3.58 (dd, J = 14.4, 5.2 Hz, 1H), 3.52 (dd, J = 
14.4, 11.5 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.24, 167.43, 156.61, 151.18, 143.04, 134.33, 134.05, 






3-(4-Chlorophenoxy)-4-methoxybenzyl alcohol (I-32) The title compound was 
prepared according to general procedure A at 110 °C. The title compound was purified by 
column chromatography on silica gel (30% ethyl acetate/hexanes) to give a white solid in 
64% yield (2.525 g). Spectra data is in agreement with literature values.23 
 
 
3-(4-Chlorophenoxy)-4-methoxybenzaldehyde (I-33) The title compound was 
prepared from I-32 according to a procedure adapted from a literature protocol (99%, 
2.36g).24 
 442 
1H NMR (500 MHz, CDCl3) δ 9.83 (s, 1H), 7.68 (dd, J = 8.4, 2.0 Hz, 1H), 7.45 (d, J = 2.0 
Hz, 1H), 7.28 (d, J = 8.7 Hz, 2H), 7.11 (d, J = 8.4 Hz, 1H), 6.90 (d, J = 8.9 Hz, 2H), 3.93 
(s, 3H). 
13C NMR (151 MHz, CDCl3) δ 190.35, 156.36, 155.62, 145.91, 130.32, 129.89, 128.67, 




methoxyphenyl)acrylate (I-34) To a flame dried 100 mL round bottomed flask equipped 
with a stir bar was added methyl 2-((tert-butoxycarbonyl)amino)-2-
(dimethoxyphosphoryl)acetate (3.046 g, 10.25 mmol, 1.2 equiv) dissolved in 8 mL DCM. 
The flask was sealed with a rubber septum and N2 inlet. 1,8-Diazabicyclo[5.4.0]undec-7-
ene (1.300 g, 1.29 mL, 8.54 mmol, 1 equiv) was added via syringe. This mixture was 
allowed to stir for 15 minutes. Separately, a solution of 3-(4-chlorophenoxy)-4-
methoxybenzaldehyde (2.243 g, 8.54 mmol, 1 equiv) was prepared in 9 mL DCM. This was 
added via syringe and allowed to stir overnight. After this time, the reaction was diluted 
with water and DCM. After transfer to a separatory funnel, the aqueous and organic layers 
were separated. The aqueous layer was extracted with DCM (3 x 50 mL). The combined 
organic layers were washed with saturated ammonium chloride, dried over sodium sulfate, 
and concentrated in vacuo. The crude product was purified by flash column chromatography 
(20-30% EtOAc:Hex) to yield methyl (E)-2-((tert-butoxycarbonyl)amino)-3-(3-(4-
chlorophenoxy)-4-methoxyphenyl)acrylate (2.981 g, 80.5%) as a white solid. 
1H NMR (600 MHz, CDCl3) δ 7.38 – 7.34 (m, 1H), 7.27 – 7.26 (m, 2H), 7.23 (d, J = 8.9 
 443 
Hz, 2H), 6.98 (d, J = 8.5 Hz, 1H), 6.85 (d, J = 8.9 Hz, 2H), 6.19 (s, 1H), 3.84 (s, 3H), 3.82 
(s, 3H), 1.37 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 166.25, 156.44, 152.79, 152.36, 144.25, 130.13, 129.63, 




methoxyphenyl)propanoate (I-35) To a clean, dry 250 mL round bottomed flask 
equipped with a stir bar was added methyl (E)-2-((tert-butoxycarbonyl)amino)-3-(3-(4-
chlorophenoxy)-4-methoxyphenyl)acrylate (2.950 g, 6.80 mmol, 1 equiv), which was 
dissolved in 69 mL of a THF:EtOH solution (2:1). 10% palladium on carbon (0.217 g, 2.04 
mmol, 0.3 equiv) was added to the solution and the reaction was placed under N2. The 
solution was evacuated and backfilled with H2 three times before being placed under a H2 
atmosphere (1 atm) overnight. Upon reaction completion, the solution was run through a 
plug of celite, eluted with EtOAc, and concentrated in vacuo to afford methyl 2-((tert-
butoxycarbonyl)amino)-3-(3-(4-chlorophenoxy)-4-methoxyphenyl)propanoate (2.662 g, 
89.8%) as a light yellow oil. 
1H NMR (600 MHz, CDCl3) δ 7.24 (d, J = 8.9 Hz, 2H), 6.95 – 6.88 (m, 2H), 6.85 (d, J = 
9.0 Hz, 2H), 6.71 (d, J = 2.0 Hz, 1H), 4.97 (d, J = 8.1 Hz, 1H), 4.52 (q, J = 6.2 Hz, 1H), 
3.80 (s, 3H), 3.65 (s, 3H), 3.04 (dd, J = 13.9, 5.6 Hz, 1H), 2.95 (dd, J = 14.0, 5.8 Hz, 1H), 
1.40 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.28, 156.66, 155.11, 150.48, 144.52, 129.62, 129.06, 




Methyl 2-amino-3-(3-(4-chlorophenoxy)-4-methoxyphenyl)propanoate (I-36) To a 
clean, dry 25 mL round bottom flask equipped with a stir bar was added methyl 2-((tert-
butoxycarbonyl)amino)-3-(3-(4-chlorophenoxy)-4-methoxyphenyl)propanoate (2.662 g, 
6.108 mmol, 1 equiv) dissolved in 12 mL DCM. The solution was cooled to 0°C for 5 
minutes. After this time, trifluoroacetic acid (3.482 g, 2.35 mL, 30.539 mmol, 5 equiv) was 
added dropwise and the mixture stirred overnight. Solvent and excess trifluoroacetic acid 
was removed in vacuo. The resulting residue was reconstituted in 5 mL DCM and cooled to 
0°C. Triethylamine (741.7 mg, 1.0 mL, 7.33 mmol, 1.2 equiv) was added dropwise and 
allowed to stir for 3 hours. The mixture was diluted with water and extracted with DCM (2 x 
25 mL). The combined organic layers were washed with saturated sodium bicarbonate (3 x 
15 mL), dried over sodium sulfate, and concentrated in vacuo. Methyl 2-amino-3-(3-(4-
chlorophenoxy)-4-methoxyphenyl)propanoate (1.634 g, 79.7%) was isolated as a yellow-
orange oil and carried forward without further purification. 
1H NMR (600 MHz, CDCl3) δ 7.24 (d, J = 8.9 Hz, 2H), 6.97 (dd, J = 8.3, 2.1 Hz, 1H), 6.93 
(d, J = 8.3 Hz, 1H), 6.85 (d, J = 8.9 Hz, 2H), 6.79 (d, J = 2.1 Hz, 1H), 3.80 (s, 3H), 3.69 – 
3.63 (m, 4H), 2.97 (dd, J = 13.7, 5.3 Hz, 1H), 2.80 (dd, J = 13.7, 7.5 Hz, 1H), 1.50 (s, 
2H). 
13C NMR (151 MHz, CDCl3) δ 175.51, 156.64, 150.34, 144.59, 130.23, 129.61, 127.55, 





yl)propanoate (S42) To a clean, dry 100 mL round bottomed flask equipped with a stir 
bar was added methyl 2-amino-3-(3-(4-chlorophenoxy)-4-methoxyphenyl)propanoate 
(1.634 g, 4.87 mmol, 1 equiv) dissolved in toluene (20 mL). Isobenzofuran-1,3-dione 
(735.4 mg, 4.97 mmol, 1.02 equiv) was added to the flask, which was fitted with a cold-
water reflux condenser and refluxed overnight. The solvent was removed in vacuo. The 
crude product was purified by flash column chromatography (20-30% EtOAc:Hex) to yield 
methyl 3-(3-(4-chlorophenoxy)-4-methoxyphenyl)-2-(1,3-dioxoisoindolin-2-yl)propanoate 
(1.208 g, 53.3%) as a peach colored solid. 
1H NMR (600 MHz, CDCl3) δ 7.77 (dd, J = 5.5, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.0 Hz, 
2H), 7.05 (d, J = 8.9 Hz, 2H), 6.95 (dd, J = 8.4, 2.2 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 6.72 
(d, J = 2.2 Hz, 1H), 6.67 – 6.60 (m, 2H), 5.04 (dd, J = 11.6, 4.9 Hz, 1H), 3.76 (s, 3H), 
3.73 (s, 3H), 3.49 (dd, J = 14.4, 4.9 Hz, 1H), 3.43 (dd, J = 14.4, 11.6 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.24, 167.49, 156.52, 150.27, 144.48, 134.35, 131.59, 




4-([1,1'-Biphenyl]-4-yloxy)benzonitrile (S43) The title compound was prepared 





1H NMR (600 MHz, CDCl3) δ 7.68 – 7.60 (m, 4H), 7.59 (d, J = 7.7 Hz, 2H), 7.46 (t, J = 
7.6 Hz, 2H), 7.37 (t, J = 7.4 Hz, 1H), 7.14 (d, J = 8.4 Hz, 2H), 7.07 (d, J = 8.4 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 161.74, 154.36, 140.23, 138.40, 134.32, 129.03, 127.59, 
127.13, 120.80, 119.01, 118.12, 106.03 (one 13C peak not observed, probably overlapping 
with another peak). 
 
 
4-([1,1'-Biphenyl]-4-yloxy)phthalonitrile (S44) The title compound was prepared 
according to an SNAr procedure adapted from a literature protocol.25 
1H NMR (600 MHz, CDCl3) δ 7.75 (dd, J = 8.8, 1.5 Hz, 1H), 7.70 – 7.64 (m, 2H), 7.61 – 
7.53 (m, 2H), 7.51 – 7.45 (m, 2H), 7.43 – 7.37 (m, 1H), 7.34 (d, J = 2.1 Hz, 1H), 7.30 
(ddt, J = 8.7, 2.5, 1.0 Hz, 1H), 7.18 – 7.13 (m, 2H). 
13C NMR (151 MHz, CDCl3) δ 161.91, 153.02, 139.89, 139.66, 135.58, 129.48, 129.10, 
127.86, 127.21, 121.67, 121.59, 121.06, 117.82, 115.53, 115.10, 109.01. 
 
 
4-(3,4-Dichlorophenoxy)-1,1'-biphenyl (S45) The title compound was prepared 
according to an SNAr procedure adapted from a literature protocol.25 
1H NMR (600 MHz, CDCl3) δ 7.59 (t, J = 8.3 Hz, 4H), 7.45 (t, J = 7.6 Hz, 2H), 7.40 (d, J 
= 8.8 Hz, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.14 (d, J = 2.8 Hz, 1H), 7.12 – 7.06 (m, 2H), 6.91 
(dd, J = 8.8, 2.9 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 156.70, 155.68, 140.36, 137.53, 133.35, 131.17, 128.99, 












4-(4-Nitrophenoxy)-1,1'-biphenyl (S46) The title compound was prepared according to 
an SNAr procedure adapted from a literature protocol.25 
1H NMR (600 MHz, CDCl3) δ 8.23 (d, J = 9.3 Hz, 2H), 7.65 (d, J = 8.7 Hz, 2H), 7.59 (d, J 
= 7.5 Hz, 2H), 7.47 (t, J = 7.6 Hz, 2H), 7.38 (t, J = 7.5 Hz, 1H), 7.17 (d, J = 8.5 Hz, 2H), 
7.08 (d, J = 9.3 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 163.45, 154.24, 142.81, 140.17, 138.68, 129.11, 129.05, 
127.65, 127.15, 126.13, 120.94, 117.31. 
 
 
[1,1'-Biphenyl]-4-yl allyl carbonate (S47) The title compound was prepared according 
to general procedure B in THF. The title compound was purified by column chromatography 
on silica gel (50% DCM/hexanes) to give a white solid in 67% yield (0.85 g). 
1H NMR (600 MHz, CDCl3) δ 7.59 (AA’BB’, J = 8.4 Hz, 2H), 7.57 – 7.56 (m, 2H), 7.45 – 
7.43 (m, 2H), 7.37 – 7.34 (m, 1H), 7.26 (AA’BB’, J = 8.4 Hz, 2H), 6.06 – 5.99 (m, 1H), 
5.47 – 5.44 (m, 1H), 5.36 – 5.34 (m, 1H), 4.77 – 4.76 (m, 2H).  
13C NMR (151 MHz, CDCl3) δ 153.68, 150.66, 140.40, 139.40, 131.25, 128.96, 128.37, 
127.57, 127.28, 121.45, 119.76, 69.39. 
HRMS (APCI) calculated for C16H14O3 [M+H]+ = 255.1016; found 255.1012. 
 
 
O-[1,1'-Biphenyl]-4-yl S-methyl carbonothioate (S48) The title compound was 













4-ol (1.70 g, 10 mmol) and sulfur powder (321 mg, 10 mmol) in DMF (20 mL) was added 
DBU (1.5 mL, 10 mmol). The mixture was sparged with CO for 5 minutes and then stirred 
vigorously at room temperature under a CO balloon for 9 hours. The reaction mixture was 
then sparged with argon for 5 minutes and was cooled to 0 °C. Methyl iodide was added 
slowly and the mixture was stirred at room temperature overnight. 1M HCl was then added, 
the mixture was extracted with diethyl ether (x3), the combined organic phase dried 
(MgSO4) and concentrated to give a brown solid. The title compound was purified by column 
chromatography on silica gel (2% to 5% ethyl acetate/hexanes) to give a white solid in 
27% yield (0.66 g). 
1H NMR (600 MHz, CDCl3) δ 7.58 (AA’BB’, J = 9.0 Hz, 2H), 7.57 – 7.56 (m, 2H), 7.45 – 
7.43 (m, 2H), 7.37 – 7.34 (m, 1H), 7.23 (AA’BB’, J = 9.0 Hz, 2H), 2.45 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 150.81, 140.37, 139.46, 128.97, 128.37, 127.59, 127.27, 
121.70, 13.90 (one peak missing or overlapping). 
HRMS (APCI) calculated for C14H12O2S [M+H]+ = 245.0631; found 245.0627. 
 
 
4-([1,1'-Biphenyl]-4-yloxy)benzaldehyde (S49) The title compound was prepared 
according to a published procedure; spectra data are in agreement with literature values.27 
1H NMR (600 MHz, CDCl3) δ 9.94 (s, 1H), 7.87 (d, J = 8.8 Hz, 2H), 7.63 (d, J = 8.5 Hz, 
2H), 7.59 (d, J = 7.9 Hz, 2H), 7.46 (td, J = 7.7, 1.5 Hz, 2H), 7.37 (td, J = 7.3, 1.3 Hz, 1H), 
7.16 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.8 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 190.96, 163.30, 154.68, 140.32, 138.18, 132.14, 131.46, 







[1,1'-Biphenyl]-4-yl tert-butyl carbonate (S50) To a solution of [1,1'-biphenyl]-4-ol 
(1.19 g, 7.0 mmol), DMAP (8.6 mg, 70 µmol) and TEA (0.97 mL, 7.0 mmol) in DCM (7 mL) 
was added Boc2O (1.99 g, 9.1 mmol) at rt. The mixture was stirred overnight then ethyl 
acetate was added and the mixture was washed with dilute aqueous NaHCO3 solution (x2), 
water (x1), brine (x1), dried (MgSO4) and concentrated to give a white solid. Trituration 
with DCM/hexanes gave the title compound as a white powder in 12% yield (0.22 g). 
Additional precipitate was observed in the filtrate but was not re-isolated. 
1H NMR (600 MHz, CDCl3) δ 7.58 (AA’BB’, J = 9.0 Hz, 2H), 7.56 – 7.55 (m, 2H), 7.45 – 
7.42 (m, 2H), 7.36 – 7.33 (m, 1H), 7.24 (AA’BB’, J = 9.0 Hz, 2H), 1.58 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 152.10, 150.64, 140.55, 139.08, 128.94, 128.28, 127.48, 
127.28, 121.70, 83.81, 27.87. 
HRMS (APCI) calculated for C17H18O3 [M+H]+ = 271.1329; found 271.1454. 
 
 
[1,1'-Biphenyl]-4-yl prop-1-en-2-yl carbonate (S-51) The title compound was 
prepared according to general procedure B in DCM. The title compound was purified by 
column chromatography on silica gel (10% ethyl acetate/hexanes) to give a white solid in 
92% yield (0.47 g). 
1H NMR (600 MHz, CDCl3) δ 7.61 (AA’BB’, J = 9.0 Hz, 2H), 7.58 – 7.56 (m, 2H), 7.46 – 
7.43 (m, 2H), 7.37 – 7.34 (m, 1H), 7.29 (AA’BB’, J = 9.0 Hz, 2H), 4.96 – 4.95 (m, 1H), 
4.79 (m, 1H), 2.07 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 153.08, 151.53, 150.47, 140.34, 139.54, 128.98, 128.40, 










HRMS (APCI) calculated for C16H14O3 [M]+⦁ = 254.0943; found 254.0934. 
 
 
[1,1'-Biphenyl]-4-yl methyl carbonate (S52) The title compound was prepared 
according to general procedure B in THF. The title compound was purified by column 
chromatography on silica gel (50% DCM/hexanes) to give a white solid in 71% yield (1.14 
g). 
1H NMR (600 MHz, CDCl3) δ 7.59 (AA’BB’, J = 9.0 Hz, 2H), 7.57 – 7.56 (m, 2H), 7.45 – 
7.43 (m, 2H), 7.37 – 7.34 (m, 1H), 7.25 (AA’BB’, J = 9.0 Hz, 2H), 3.93 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 154.46, 150.67, 140.38, 139.41, 128.96, 128.38, 127.57, 
127.28, 121.44, 55.60. 
HRMS (APCI) calculated for C14H12O3 [M+H]+ = 229.0859; found 229.0856. 
 
 
[1,1'-Biphenyl]-4-yl acetate (S-53) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.28 
 
 
[1,1'-Biphenyl]-4-yl methanesulfonate (S54) The title compound was prepared 














[1,1'-Biphenyl]-4-yl 4-methylbenzenesulfonate (S55) The title compound was 




4-Methoxy-1,1'-biphenyl (S56) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.31 
 
 
4-Chloroanisole (S57) The authentic standard was obtained from Oakwood Chemical. 
 
 
4-Methoxybenzyl acetate (S58) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.32 
 
 
3,4-Dimethoxybenzyl acetate (S59) The title compound was prepared according to a 














D.4 Preparation of Authentic Fluoroarene Standards 
 
4-Fluorophenyl pivalate (6.6-Std) To a dry, clean round-bottomed flask equipped with a 
stir bar was added I-4 (336.3 mg, 3.0 mmol, 1.0 equiv) and DCM 10 mL. The reaction was 
then cooled to 0 ºC before sequential dropwise addition of triethylamine (0.83 mL, 6.0 mmol, 
2.0 equiv) and pivaloyl chloride (0.44 mL, 3.6 mmol, 1.2 equiv). The reaction was stirred for 
1 hr. at 0 ºC before it was warmed up to room temperature and stirred overnight. Upon 
completion of the reaction, the mixture was quenched with DI water and diluted with 20 mL 
of DCM. The layers were separated and the aqueous layer was extracted (x2) with two 10 mL 
portions of DCM. The organic layers were combined, washed with saturated bicarbonate 
solution and brine, dried over MgSO4 and concentrated under reduced pressure. The title 
compound was purified by column chromatography on silica gel (5% to 20% ethyl 
acetate/hexanes) to give a clear oil in 90% yield (529.3 mg). 
1H NMR (600 MHz, CDCl3) δ 7.05 (t, J = 8.5 Hz, 2H), 7.01 (dd, J = 9.1, 4.6 Hz, 2H), 1.35 
(s, 9H). 
13C NMR (151 MHz, CDCl3) δ 177.30, 160.25 (d, J = 243.7 Hz), 147.01 (d, J = 2.8 Hz), 
123.00 (d, J = 8.6 Hz), 116.12 (d, J = 23.3 Hz), 39.19, 27.24. 
19F NMR (376 MHz, CDCl3) δ -117.42 (tt, J = 8.6, 4.7 Hz). 
 
 
1-Chloro-4-fluorobenzene (6.7-Std) The authentic standard was obtained from 
Oakwood Chemical and 19F spectral data are provided herein. 










1-Fluoro-2-methoxy-4-vinylbenzene (I-37) The title compound was prepared according 
to a published procedure; spectra data are in agreement with literature values.34 
19F NMR (376 MHz, CDCl3) δ -135.91 (ddd, J = 12.2, 8.1, 4.4 Hz). 
 
 
4-Ethyl-1-fluoro-2-methoxybenzene (6.8-Std) To a clean, dry 25 mL round bottomed 
flask equipped with a stir bar was added 1-fluoro-2-methoxy-4-vinylbenzene (0.136 g, 
0.895 mmol, 1 equiv), which was dissolved in 9 mL of a THF:EtOH solution (2:1). 10% 
palladium on carbon (0.029 g, 0.269 mmol, 0.3 equiv) was added to the solution and the 
reaction was placed under N2. The solution was evacuated and backfilled with H2 three times 
before being placed under a H2 atmosphere (1 atm) overnight. Upon reaction completion, 
the solution was run through a plug of celite, eluted with EtOAc, and concentrated in vacuo 
to afford 4-ethyl-1-fluoro-2-methoxybenzene (83.0 mg, 60%) as a clear, colorless liquid. 
1H NMR (600 MHz, CDCl3) δ 6.98 (dd, J = 11.4, 8.2 Hz, 1H), 6.79 (dd, J = 8.3, 2.1 Hz, 
1H), 6.70 (ddd, J = 8.1, 4.2, 2.0 Hz, 1H), 3.89 (s, 3H), 2.61 (q, J = 7.6 Hz, 2H), 1.23 (t, J 
= 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 150.77 (d, J = 242.3 Hz), 147.30 (d, J = 10.6 Hz), 140.63 
(d, J = 3.7 Hz), 119.84 (d, J = 6.6 Hz), 115.73 (d, J = 17.9 Hz), 113.10 – 113.02 (m), 
56.25, 28.73, 15.93. 






2-Fluoro-1-methoxy-4-vinylbenzene (I-38) The title compound was prepared according 
to a published procedure; spectra data are in agreement with literature values.35 
19F NMR (376 MHz, CDCl3) δ -135.40 (dd, J = 12.5, 8.7 Hz). 
 
 
4-Ethyl-2-fluoro-1-methoxybenzene (6.9-Std) To a clean, dry 100 mL round bottomed 
flask equipped with a stir bar was added 2-fluoro-1-methoxy-4-vinylbenzene (0.287 g, 1.88 
mmol, 1 equiv), which was dissolved in 18 mL of a THF:EtOH solution (2:1). 10% palladium 
on carbon (0.060 g, 0.566 mmol, 0.3 equiv) was added to the solution and the reaction was 
placed under N2. The solution was evacuated and backfilled with H2 three times before being 
placed under a H2 atmosphere (1 atm) overnight. Upon reaction completion, the solution 
was run through a plug of celite, eluted with EtOAc, and concentrated in vacuo to afford 4-
ethyl-2-fluoro-1-methoxybenzene (249.6 mg, 86%) as a clear, colorless liquid. 
1H NMR (600 MHz, CDCl3) δ 6.93 (d, J = 13.0 Hz, 1H), 6.90 – 6.85 (m, 2H), 3.87 (s, 3H), 
2.58 (q, J = 7.6 Hz, 2H), 1.20 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 152.25 (d, J = 244.8 Hz), 145.42 (d, J = 10.7 Hz), 137.43 
(d, J = 6.0 Hz), 123.19 (d, J = 3.4 Hz), 115.55 (d, J = 17.7 Hz), 113.25 (d, J = 1.7 Hz), 
56.36, 27.95, 15.65. 




5-Bromo-2-fluoroanisole (288-4) (6.10-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.08 (dd, J = 7.6, 2.3 Hz, 1H), 7.01 (ddd, J = 8.6, 4.1, 2.5 
Hz, 1H), 6.95 (dd, J = 10.9, 8.5 Hz, 1H), 3.88 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 151.74 (d, J = 246.2 Hz), 148.53 (d, J = 11.6 Hz), 123.71 
(d, J = 6.6 Hz), 117.39 (d, J = 19.6 Hz), 116.86 (d, J = 2.0 Hz), 116.46 (d, J = 3.9 Hz), 
56.50. 
19F NMR (376 MHz, CDCl3) δ -136.85 (ddd, J = 11.1, 7.4, 4.1 Hz). 
 
 
5-Chloro-2-fluoroanisole (288-3) (6.11-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.00 (dd, J = 10.9, 8.6 Hz, 1H), 6.94 (dd, J = 7.4, 2.5 Hz, 
1H), 6.86 (ddd, J = 8.6, 3.8, 2.5 Hz, 1H), 3.88 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 151.22 (d, J = 245.5 Hz), 148.30 (d, J = 12.0 Hz), 129.24 
(d, J = 3.7 Hz), 120.63 (d, J = 6.7 Hz), 116.84 (d, J = 19.8 Hz), 113.99 (d, J = 2.0 Hz). 
19F NMR (376 MHz, CDCl3) δ -137.47 (ddd, J = 11.0, 7.4, 4.0 Hz). 
 
 
3-Chloro-4-fluoroanisole (288-9) (6.12-std) The authentic standard was obtained from 








1H NMR (600 MHz, CDCl3) δ 7.05 (t, J = 8.8 Hz, 1H), 6.92 (dd, J = 6.0, 3.1 Hz, 1H), 6.75 
(ddd, J = 9.1, 3.7, 3.1 Hz, 1H), 3.78 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.95 (d, J = 2.2 Hz), 152.85 (d, J = 240.6 Hz), 121.18 (d, 
J = 19.2 Hz), 116.86 (d, J = 22.6 Hz), 115.56, 113.65 (d, J = 6.7 Hz), 56.04. 
19F NMR (376 MHz, CDCl3) δ -126.73 (ddd, J = 9.4, 6.1, 3.8 Hz). 
 
 
2-Chloro-5-fluoroanisole (288-5) (6.13-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.29 (dd, J = 8.7, 6.0 Hz, 1H), 6.67 (dd, J = 10.3, 2.8 Hz, 
1H), 6.62 (ddd, J = 8.7, 7.8, 2.8 Hz, 1H), 3.88 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 162.17 (d, J = 245.7 Hz), 155.99 (d, J = 10.3 Hz), 130.59 
(d, J = 9.8 Hz), 117.54 (d, J = 3.9 Hz), 107.81 (d, J = 22.6 Hz), 100.57 (d, J = 27.1 Hz), 
56.40. 
19F NMR (376 MHz, CDCl3) δ -112.25 (dt, J = 10.2, 6.9 Hz). 
 
4-Fluoro-3-methoxybenzaldehyde (6.14-std) The authentic standard was obtained 
from Oakwood Chemical and 19F spectral data are provided herein. 











1-(4-Fluoro-3-methoxyphenyl)ethan-1-ol (I-39) The title compound was prepared 
from 6.14-std according to a procedure adapted from a literature protocol.3 
1H NMR (600 MHz, CDCl3) δ 7.04 – 6.90 (m, 2H), 6.81 (ddd, J = 8.4, 4.4, 2.1 Hz, 1H), 
4.80 (q, J = 6.7 Hz, 1H), 3.85 (s, 3H), 2.49 (s, 1H), 1.43 (d, J = 6.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 151.60 (d, J = 244.7 Hz), 147.55 (d, J = 10.9 Hz), 142.33 
(d, J = 3.4 Hz), 117.61 (d, J = 7.0 Hz), 115.73 (d, J = 18.3 Hz), 110.53 (d, J = 2.1 Hz), 
69.95, 56.18, 25.36. 
19F NMR (376 MHz, CDCl3) δ -137.20 (ddd, J = 11.9, 8.2, 4.4 Hz). 
 
 
1-(4-Fluoro-3-methoxyphenyl)ethan-1-one (6.15-std) The title compound was 
prepared from I-39 according to a procedure adapted from a literature protocol.3 
1H NMR (600 MHz, CDCl3) δ 7.61 (dd, J = 8.4, 2.1 Hz, 1H), 7.53 (ddd, J = 8.3, 4.3, 2.1 
Hz, 1H), 7.14 (dd, J = 10.6, 8.3 Hz, 1H), 3.95 (s, 3H), 2.59 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 196.79, 155.77 (d, J = 254.9 Hz), 148.10 (d, J = 11.0 Hz), 
133.98 (d, J = 3.4 Hz), 122.60 (d, J = 8.2 Hz), 115.96 (d, J = 19.1 Hz), 112.62 (d, J = 3.3 
Hz), 56.38, 26.61. 












4-Fluoro-3-methoxybenzonitrile (6.17-std) (288-7) The authentic standard was 
obtained from Oakwood Chemical and 19F spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.29 – 7.23 (m, 1H), 7.21 (dd, J = 7.7, 2.0 Hz, 1H), 7.16 
(dd, J = 10.6, 8.3 Hz, 1H), 3.92 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 155.26 (d, J = 256.8 Hz), 148.47 (d, J = 11.5 Hz), 126.04 
(d, J = 8.1 Hz), 118.33, 117.28 (d, J = 19.8 Hz), 116.76 (d, J = 3.2 Hz), 108.57 (d, J = 4.3 
Hz), 56.57. 
19F NMR (376 MHz, CDCl3) δ -124.70 (ddd, J = 11.5, 7.9, 4.3 Hz). 
 
 
4-Fluoro-3-methoxybenzyl alcohol (I-40) The title compound was prepared according 
to a published procedure; spectra data are in agreement with literature values.36 
 
 
4-Fluoro-3-methoxybenzyl acetate (6.19-std) To a dry, clean round-bottomed flask 
equipped with a stir bar was added I-40 (780.8 mg, 5.0 mmol, 1.0 equiv) and DCM 10 mL. 
The reaction was then cooled to 0 ºC before sequential addition of pyridine (0.61 mL, 7.5 
mmol, 1.5 equiv) and acetyl chloride (0.61 mL, 5.5 mmol, 1.1 equiv). The reaction was 
stirred for 1 hr. at 0 ºC before it was warmed up to room temperature and stirred overnight. 
Upon completion of the reaction, the mixture was quenched with DI water and diluted with 
20 mL of DCM. The layers were separated and the aqueous layer was extracted (x2) with 










bicarbonate solution and brine, dried over MgSO4 and concentrated under reduced pressure. 
The title compound was purified by column chromatography on silica gel (5% to 20% ethyl 
acetate/hexanes) to give a clear oil in 95% yield (939.6 mg). 
1H NMR (600 MHz, CDCl3) δ 7.05 (dd, J = 11.0, 8.1 Hz, 1H), 6.96 (dd, J = 8.1, 2.0 Hz, 
1H), 6.89 (ddd, J = 8.2, 4.4, 2.1 Hz, 1H), 5.04 (s, 2H), 3.89 (s, 3H), 2.10 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 170.97, 152.38 (d, J = 246.9 Hz), 147.74 (d, J = 11.3 Hz), 
132.34 (d, J = 4.4 Hz), 121.09 (d, J = 7.3 Hz), 116.11 (d, J = 18.2 Hz), 113.71, 66.03, 
56.33, 21.15. 
19F NMR (376 MHz, CDCl3) δ -135.51 (ddd, J = 11.8, 8.1, 4.4 Hz). 
 
 
4-Fluorobenzyl alcohol (I-41) The title compound was prepared according to a published 
procedure; spectra data are in agreement with literature values.37 
 
 
4-Fluorobenzyl acetate (6.21-std) To a dry, clean round-bottomed flask equipped with a 
stir bar was added I-41 (505 mg, 4.0 mmol, 1.0 equiv) and DCM 10 mL. The reaction was 
then cooled to 0 ºC before sequential addition of pyridine (0.48 mL, 6.0 mmol, 1.5 equiv) 
and acetyl chloride (0.31 mL, 4.4 mmol, 1.1 equiv). The reaction was stirred for 1 hr. at 0 
ºC before it was warmed up to room temperature and stirred overnight. Upon completion of 
the reaction, the mixture was quenched with DI water and diluted with 20 mL of DCM. The 
layers were separated and the aqueous layer was extracted (x2) with two 10 mL portions of 
DCM. The organic layers were combined, washed with saturated bicarbonate solution and 






purified by column chromatography on silica gel (5% to 20% ethyl acetate/hexanes) to give 
a clear oil in 97% yield (649.7 mg). 
The title compound was prepared according to a published procedure; spectra data are in 
agreement with literature values.38 
 
 
4'-Fluoro-2,3,4,5-tetrahydro-1,1'-biphenyl (I-42) The title compound was prepared 
according to a published procedure; spectra data are in agreement with literature values.39 
 
1-Cyclohexyl-4-fluorobenzene (6.25-std) The title compound was prepared from I-42 
according to a published procedure3; Spectra data are in agreement with literature values.40 
19F NMR (376 MHz, CDCl3) δ -117.96 (dh, J = 8.6, 4.5, 4.0 Hz). 
 
 
2-(4-Fluorophenyl)tetrahydro-2H-pyran (6.27-std) Procedure adapted from literature 
protocol (45%, 0.122 g).41 Spectra data are in agreement with literature values.42 
19F NMR (376 MHz, CDCl3) δ -115.51 (dq, J = 9.4, 5.9, 4.7 Hz). 
 
2-Fluoro-4,5-dimethoxybenzaldehyde (6.29-std) The authentic standard was obtained 








19F NMR (376 MHz, CDCl3) δ -128.22 (dt, J = 10.4, 4.4 Hz). 
 
 
4-Fluoro-N-phenylaniline (I-43) The title compound was prepared according to a 
published procedure; spectra data are in agreement with literature values.43 
19F NMR (376 MHz, CDCl3) δ -121.94 (dp, J = 8.9, 4.2 Hz). 
 
 
3-Fluoro-9H-carbazole (I-44) The title compound was prepared according to a published 
procedure; spectra data are in agreement with literature values.44 
19F NMR (376 MHz, CDCl3) δ -124.38 (dh, J = 8.9, 4.1 Hz). 
 
 
tert-Butyl 3-fluoro-9H-carbazole-9-carboxylate (6.30-std) 
To a clean, dry round-bottomed flask equipped with a stir bar was added I-44 (80.0 mg, 
0.43 mmol, 1.0 equiv) and 10mL DCM. DMAP (70 mg, 0.57 mmol, 1.1 equiv) and Boc2O 
(160 mg, 0.73 mmol, 1.7 equiv) were sequentially added and the solution was stirred at 
room temperature for 0.5 h. Upon completion of the reaction, DCM (50mL) was added and 
the mixture was washed with aqueous HCl (1N). The layers were separated and the 
aqueous layer was extracted with DCM (2 x 10 mL). The organic fractions were combined, 











purified by column chromatography on silica gel (100% hexanes to 5% EtOAc:Hex) to give 
a pale yellow solid in 92% yield (113 mg). 
1H NMR (600 MHz, CDCl3) δ 8.28 (d, J = 9.7 Hz, 2H), 7.93 (dt, J = 7.7, 1.0 Hz, 1H), 7.62 
(dd, J = 8.3, 2.7 Hz, 1H), 7.49 (ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.36 (td, J = 7.5, 1.0 Hz, 
1H), 7.18 (td, J = 9.0, 2.7 Hz, 1H), 1.76 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 159.41 (d, J = 240.5 Hz), 151.06, 139.28, 134.81, 127.82, 
127.00 (d, J = 9.4 Hz), 125.25 (d, J = 3.7 Hz), 123.17, 119.96, 117.48 (d, J = 8.4 Hz), 
116.58, 114.45 (d, J = 24.2 Hz), 105.74 (d, J = 23.8 Hz), 84.28, 28.51. 
19F NMR (376 MHz, CDCl3) δ -120.12 (dt, J = 9.5, 5.0 Hz). 
 
 
5-Fluoro-2-methoxypyridine (6.31-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 2.9 Hz, 1H), 7.32 (ddt, J = 8.8, 7.4, 2.8 Hz, 
1H), 6.70 (dd, J = 9.1, 3.7 Hz, 1H), 3.90 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 160.44, 155.51 (d, J = 245.0 Hz), 133.21 (d, J = 25.9 Hz), 
126.69 (d, J = 21.4 Hz), 111.62 (d, J = 4.6 Hz), 53.93. 
19F NMR (376 MHz, CDCl3) δ -139.59 (dq, J = 7.5, 3.3 Hz). 
 
 
3-Fluoro-2-methoxypyridine (6.32-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.92 (dt, J = 5.1, 1.4 Hz, 1H), 7.36 – 7.27 (m, 1H), 6.84 






13C NMR (151 MHz, CDCl3) δ 153.52 (d, J = 11.0 Hz), 147.73 (d, J = 258.3 Hz), 141.41 
(d, J = 6.5 Hz), 123.05 (d, J = 15.4 Hz), 116.99 (d, J = 2.0 Hz), 53.82. 
19F NMR (376 MHz, CDCl3) δ -139.59 (dd, J = 10.2, 3.2 Hz). 
 
 
2-Fluoro-3-methoxypyridine (6.33-std) The authentic standard was obtained from 
Oakwood Chemical and spectral data are provided herein. 
1H NMR (600 MHz, CDCl3) δ 7.70 (t, J = 4.2 Hz, 1H), 7.27 (dd, J = 9.8, 6.0 Hz, 1H), 7.11 
(q, J = 4.5, 4.0 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 153.56 (d, J = 238.2 Hz), 142.97 (d, J = 25.4 Hz), 137.04 
(d, J = 13.2 Hz), 121.64 (dd, J = 67.0, 4.4 Hz), 56.08. 





Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoate (I-45) 
The title compound was prepared according to an adapted procedure (92%, 1.45 g).45 
1H NMR (600 MHz, CDCl3) δ 7.08 (t, J = 8.3, 5.4 Hz, 2H), 6.98 (t, J = 8.6 Hz, 2H), 4.98 
(d, J = 8.1 Hz, 1H), 4.56 (q, J = 8.4, 5.9 Hz, 1H), 3.71 (s, 3H), 3.10 (dd, J = 14.0, 5.8 Hz, 




13C NMR (151 MHz, CDCl3) δ 172.22, 161.99 (d, J = 245.3 Hz), 155.03, 131.74 (d, J = 
3.3 Hz), 130.80 (d, J = 8.1 Hz), 115.40 (d, J = 21.4 Hz), 80.04, 54.41, 52.32, 37.63, 
28.30. 




carboxamido)propanoate (6.36-std) The title compound was prepared according to an 
adapted procedure (64%, 85.6 mg).46 
1H NMR (600 MHz, CDCl3)  δ 7.03 (dd, J = 8.5, 5.5 Hz, 2H), 6.97 (t, J = 8.7 Hz, 1H), 
5.89 (d, J = 7.6 Hz, 1H), 4.86 (dt, J = 7.6, 5.6 Hz, 1H), 3.73 (s, 3H), 3.14 (dd, J = 14.0, 
5.8 Hz, 1H), 3.05 (dd, J = 14.0, 5.5 Hz, 1H), 2.01 (tt, J = 12.2, 3.5 Hz, 1H), 1.92 – 1.81 
(m, 1H), 1.80 – 1.74 (m, 1H), 1.45 – 1.33 (m, 3H), 1.05 (dddd, J = 11.7, 8.6, 5.4, 2.7 Hz, 
1H), 1.01 – 0.92 (m, 2H), 0.85 (d, J = 6.8 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 175.52, 172.04, 161.91 (d, J = 245.4 Hz), 131.55 (d, J = 
3.3 Hz), 130.71 (d, J = 8.1 Hz), 115.29 (d, J = 21.2 Hz), 52.65, 52.32, 45.40, 43.09, 
36.99, 32.67, 29.73, 29.39, 28.87, 28.78, 19.65. 




Methyl (S)-2-amino-3-(4-fluorophenyl)propanoate (I-46) The title compound was 





carboxamido)propanoate (6.37-std) The title compound was prepared from I-46 
according to a peptide-coupling procedure adapted from a literature protocol.21 
1H NMR (600 MHz, CDCl3) δ 7.03 (ddd, J = 8.5, 5.4, 2.9 Hz, 2H), 6.97 (t, J = 8.7 Hz, 
2H), 5.91 (d, J = 7.6 Hz, 1H) + rotamer at 6.07 (d, J = 7.5 Hz), 4.86 (dt, J = 7.7, 5.7 Hz, 
1H), 3.73 (s, 3H), 3.14 (dd, J = 13.9, 6.0 Hz, 1H), 3.06 (dd, J = 14.0, 5.3 Hz, 1H), 2.01 
(tq, J = 12.2, 3.9 Hz, 1H), 1.87 (ddt, J = 21.4, 12.9, 3.0 Hz, 2H), 1.81 – 1.71 (m, 2H), 
1.48 – 1.34 (m, 3H), 1.08 – 0.92 (m, 2H), 0.85 (d, J = 6.7 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 175.79, 172.28, 162.13 (d, J = 245.5 Hz), 131.75 (d, J = 
3.1 Hz), 130.93 (d, J = 8.1 Hz), 115.51 (d, J = 21.4 Hz), 52.87, 52.55, 45.62, 43.31, 
37.20, 32.88, 29.94, 29.60, 29.09, 28.99, 19.87. 














fluorophenyl)-propanoate (6.38-std) The title compound was prepared from I-45 
according to an adapted procedure (99%, 1.28 g).46 
1H NMR (600 MHz, CDCl3) δ 7.11 – 7.03 (m, 2H), 6.98 – 6.91 (m, 2H), 6.51 (d, J = 7.7 
Hz, 1H), 5.10 (d, J = 8.9 Hz, 1H), 4.82 (q, J = 6.2 Hz, 1H), 3.94 – 3.83 (m, 1H), 3.68 (s, 
3H), 3.09 (dd, J = 14.1, 5.8 Hz, 1H), 3.02 (dd, J = 14.0, 6.2 Hz, 1H), 2.04 (dd, J = 16.0, 
8.8 Hz, 1H), 1.42 (s, 9H), 0.90 (d, J = 6.8 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 171.62, 171.44, 162.00 (d, J = 245.4 Hz), 155.78, 131.47 
(d, J = 3.3 Hz), 130.80 (d, J = 7.9 Hz), 115.45 (d, J = 21.4 Hz), 79.89, 59.96, 53.16, 
52.38, 37.15, 30.81, 28.30, 19.18, 17.81. 




std) The title compound was prepared according to a published procedure; spectra data are 
in agreement with literature values.48 















Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-fluorophenyl)propanoate (6.39-std) 
The title compound was prepared according from I-46 according to a procedure adapted 
from a literature protocol (1.48 g, 92%).22 
1H NMR (600 MHz, CDCl3) δ 7.79 (dd, J = 5.5, 3.1 Hz, 2H), 7.70 (dd, J = 5.5, 3.0 Hz, 
2H), 7.17 – 7.01 (m, 2H), 6.87 (t, J = 8.6 Hz, 2H), 5.11 (dd, J = 11.3, 5.3 Hz, 1H), 3.78 (s, 
3H), 3.56 (dd, J = 14.5, 5.3 Hz, 1H), 3.51 (dd, J = 14.5, 11.3 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.32, 167.56, 161.86 (d, J = 245.0 Hz), 134.35, 132.47 
(d, J = 3.3 Hz), 131.59, 130.48 (d, J = 7.9 Hz), 123.68, 115.59 (d, J = 21.3 Hz), 53.29, 
53.09, 33.99. 




(I-47) The title compound was prepared according to a procedure adapted from a literature 
protocol (93%, 1.51 g).3 
1H NMR (600 MHz, CDCl3) δ 7.25 – 7.18 (m, 2H), 7.09 (ddd, J = 8.4, 4.6, 1.9 Hz, 1H), 
7.05 (dd, J = 10.8, 8.4 Hz, 1H), 6.27 (bs, 1H), 3.88 (s, 3H), 3.85 (s, 3H), 1.40 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 166.10, 152.75 (d, J = 250.9 Hz), 152.76, 147.57 (d, J = 
11.0 Hz), 130.86 (d, J = 3.9 Hz), 129.66, 124.01, 123.20 (d, J = 7.1 Hz), 116.17 (d, J = 
18.7 Hz), 114.46, 81.25, 56.20, 52.85, 28.25. 













(I-48) The title compound was prepared from I-47 according to a procedure adapted from 
a literature protocol (95%, 1.45 g).3 
1H NMR (600 MHz, CDCl3) δ 6.98 (dd, J = 11.2, 8.2 Hz, 1H), 6.72 (dd, J = 8.1, 2.1 Hz, 
1H), 6.63 (ddd, J = 8.3, 4.2, 2.0 Hz, 1H), 4.99 (d, J = 8.3 Hz, 1H) + rotamer at 4.72 (s), 
4.57 (q, J = 6.7 Hz, 1H) + rotamer at 4.36 (s), 3.86 (s, 3H), 3.72 (s, 3H), 3.08 (dd, J = 
13.9, 5.9 Hz, 1H), 3.00 (dd, J = 14.0, 6.2 Hz, 1H), 1.42 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.35, 155.13, 151.71 (d, J = 244.6 Hz), 147.55 (d, J = 
10.7 Hz), 132.42 (d, J = 3.9 Hz), 121.59 (d, J = 6.7 Hz), 116.04 (d, J = 18.2 Hz), 114.42, 
80.19, 56.26, 54.50, 52.45, 38.16, 28.43. 
19F NMR (376 MHz, CDCl3) δ -137.76 (t, J = 9.5 Hz) + rotamer at -137.57 (bs). 
 
 
Methyl 2-amino-3-(4-fluoro-3-methoxyphenyl)propanoate (I-49) The title compound 
was prepared according to a procedure from I-48 adapted from a literature protocol (90%, 
155.1 mg).3 
1H NMR (600 MHz, CDCl3) δ 6.96 (dd, J = 11.3, 8.2 Hz, 1H), 6.76 (dd, J = 8.2, 2.1 Hz, 
1H), 6.67 (ddd, J = 8.2, 4.2, 2.1 Hz, 1H), 3.83 (s, 3H), 3.70 – 3.66 (m, 4H), 3.00 (dd, J = 










13C NMR (151 MHz, CDCl3) δ 175.35, 151.45 (d, J = 244.4 Hz), 147.47 (d, J = 10.6 Hz), 
133.55 (d, J = 3.8 Hz), 121.42 (d, J = 6.6 Hz), 115.93 (d, J = 18.2 Hz), 114.28 (d, J = 1.7 
Hz), 56.15, 55.81 (d, J = 1.2 Hz), 52.06, 40.65. 




(6.40-std) The title compound was prepared from I-49 according to a procedure adapted 
from a literature protocol (97%, 0.2011 g).22 
1H NMR (600 MHz, CDCl3) δ 7.77 (dt, J = 4.9, 2.4 Hz, 2H), 7.69 (dd, J = 5.6, 3.0 Hz, 
2H), 6.85 (dd, J = 11.2, 8.3 Hz, 1H), 6.73 (dd, J = 8.1, 2.1 Hz, 1H), 6.65 (ddd, J = 8.3, 
4.2, 2.0 Hz, 1H), 5.13 (dd, J = 11.4, 5.3 Hz, 1H), 3.76 (s, 3H), 3.70 (s, 3H), 3.54 (dd, J = 
14.5, 5.3 Hz, 1H), 3.48 (dd, J = 14.4, 11.6 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.24, 167.49, 151.34 (d, J = 244.8 Hz), 147.45 (d, J = 
10.6 Hz), 134.34, 132.97 (d, J = 3.8 Hz), 131.52, 123.59, 121.13 (d, J = 6.7 Hz), 116.02 
(d, J = 18.3 Hz), 113.72 (d, J = 1.6 Hz), 56.04, 53.05, 53.03, 34.30. 




(I-50) The title compound was prepared according to a procedure adapted from a literature 












1H NMR (600 MHz, CDCl3) δ 7.40 (dd, J = 12.8, 2.2 Hz, 1H), 7.29 – 7.18 (m, 2H), 6.94 
(t, J = 8.6 Hz, 1H), 6.31 (s, 1H), 3.92 (s, 3H), 3.86 (s, 3H), 1.45 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 166.18, 152.63, 151.99 (d, J = 245.4 Hz), 148.58 (d, J = 
11.0 Hz), 129.67, 127.33, 127.32 (d, J = 10.4 Hz), 123.04, 116.85 (d, J = 19.8 Hz), 




(I-51) The title compound was prepared from I-50 according to a procedure adapted from 
a literature protocol (98%, 2.06 g).3 
1H NMR (600 MHz, CDCl3) δ 6.95 – 6.64 (m, 3H), 4.98 (d, J = 8.3 Hz, 1H), 4.54 (d, J = 
7.1 Hz, 1H), 3.87 (d, J = 2.7 Hz, 3H), 3.73 (d, J = 2.6 Hz, 3H), 3.01 (ddd, J = 49.0, 14.2, 
5.6 Hz, 2H), 1.43 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 172.29, 155.16, 152.25 (d, J = 246.5 Hz), 146.77 (d, J = 
10.6 Hz), 129.03 (d, J = 6.0 Hz), 125.11 (d, J = 3.5 Hz), 117.14 (d, J = 18.3 Hz), 113.48, 
80.20, 56.36, 54.49, 52.47, 37.55, 28.43. 
 
 
Methyl 2-amino-3-(3-fluoro-4-methoxyphenyl)propanoate (I-52) The title compound 











1H NMR (600 MHz, CDCl3) δ 6.89 (d, J = 12.2 Hz, 1H), 6.86 – 6.83 (m, 2H), 3.82 (d, J = 
1.6 Hz, 3H), 3.67 (s, 2H), 3.64 (dd, J = 7.7, 5.3 Hz, 1H), 2.96 (dd, J = 13.7, 5.1 Hz, 1H), 
2.76 (dd, J = 13.7, 7.7 Hz, 1H), 1.48 (s, 2H). 
13C NMR (151 MHz, CDCl3) δ 175.33, 152.15 (d, J = 245.8 Hz), 146.45 (d, J = 10.7 Hz), 
130.14 (d, J = 6.2 Hz), 124.97 (d, J = 3.6 Hz), 116.84 (d, J = 18.1 Hz), 113.36 (d, J = 2.1 
Hz), 56.20, 55.72, 52.03, 39.99. 




(6.42-std) The title compound was prepared from I-52 according to a procedure adapted 
from a literature protocol (87%, 739 mg). 
1H NMR (600 MHz, CDCl3) δ 7.71 (dt, J = 7.1, 3.5 Hz, 3H), 7.62 (dt, J = 7.0, 3.4 Hz, 3H), 
6.84 (dd, J = 12.0, 2.1 Hz, 1H), 6.83 – 6.80 (m, 1H), 6.71 (t, J = 8.6 Hz, 1H), 5.06 (dd, J 
= 11.4, 5.1 Hz, 1H), 3.70 (s, 3H), 3.68 (s, 3H), 3.47 (dd, J = 14.5, 5.1 Hz, 1H), 3.41 (dd, J 
= 14.4, 11.5 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 169.05, 167.32, 151.87 (d, J = 245.9 Hz), 146.27 (d, J = 
10.6 Hz), 134.16, 131.33, 129.46 (d, J = 6.1 Hz), 124.48 (d, J = 3.3 Hz), 123.40, 116.39 
(d, J = 18.2 Hz), 113.21, 55.84, 52.99, 52.79, 33.59. 









D.5 Experimental Procedures: Methods for Photoredox-Catalyzed Cation Radical 
Accelerated Nucleophilic Deoxyfluorination 
D.5.1 Experimental Conditions (General Procedure E)  
To a clean, dry 2 dram vial containing a Teflon-coated magnetic stir bar was added 
380.0 mg of cesium fluoride (0.500 mmol, 5 equiv) under an inert atmosphere. The vial was 
then removed from the inert atmosphere and a series of reagents were added: 0.0100 
mmol of 1 (0.05 equiv), tetrabutylammonium hydrogensulfate (0.075 mmol, 0.75 equiv), 
and arene (0.100 mmol, 1.0 equiv). The reagent mixture was then dissolved in solvent (1.2 
mL, 0.083 M) and DI water (0.05 mL, 0.5 M) was subsequently added. The vial was then 
sealed with a Teflon-lined septum screw cap and stirred rapidly for approximately 1 minute. 
The vial was positioned on a stir plate approximately 3-4 cm from a Kessil PR160-427 LED 
Photoredox Light supplying blue light (λ = 427 nm) and irradiated for a designated time. 
The crude reaction mixture was then concentrated in vacuo and purified by flash 
chromatography or reverse-phase flash liquid chromatography (conditions noted in each 
entry). Isolation yields were obtained on a 0.20 mmol scale while 19F NMR yields are 




4-Fluoro-1,1'-biphenyl (6.2) The title compound was synthesized according to general 
procedure E. The title compound was purified by column chromatography on U60 (10 – 30 
µm) silica gel (hexanes) to give a white solid in 78% yield (27.0 mg). The 19F NMR yield of 
the crude reaction mixture is 79%. 
1H and 13C NMR spectra are in agreement with literature values49 






2-Fluoro-1,1'-biphenyl (6.3) The title compound was synthesized according to general 
procedure E. The title compound was purified by column chromatography on U60 (10 – 30 
µm) silica gel (pentanes to 1:1 pentanes:hexanes to hexanes) to give a white solid in 60% 
yield (20.8 mg). The 19F NMR yield of the crude reaction mixture is 76%. 
1H and 13C NMR spectra are in agreement with literature values50 
19F NMR (376 MHz, CDCl3) δ -118.04 (tdd, J = 9.6, 7.6, 3.3 Hz). 
 
 
3-Chloro-4-fluoro-1,1'-biphenyl (6.4) The title compound was prepared according to 
general procedure E. The title compound was purified by column chromatography on U60 
(10 – 30 µm) silica gel (pentane) to give a clear colorless oil in 66% yield (27.3 mg). The 
19F NMR yield of the crude reaction mixture is 64%. 
1H NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 7.0, 2.5 Hz, 1H), 7.53 – 7.51 (m, 2H), 7.46 – 
7.42 (m, 3H), 7.39 – 7.36 (m, 1H), 7.21 (t, J = 8.5 Hz, 1H). 
19F {1H} NMR (565 MHz, C₆H₅F) δ -118.35. 
13C NMR (151 MHz, CDCl3) δ 157.79 (d, J = 249.2), 139.17, 138.64 (d, J = 3.8 Hz), 
129.40, 129.10, 127.96, 127.13, 126.91, (d, J = 7.1 Hz), 121.39 (d, J = 18.0 Hz), 116.95 
(d, J = 21.3 Hz). 









2-Chloro-4-fluoro-1,1'-biphenyl: (6.5) 07-154-B The title compound was prepared 
according to general procedure E. The title compound was prepared according to general 
procedure E. The title compound was purified by flash LC (55% acetonitrile:water with 0.1% 
TFA) to give a colorless oil in 26% yield (10.9 mg). The 19F NMR yield of the crude reaction 
mixture is 40%. 10% of 4-chlorofluorobenzene was observed in the crude mixture. 
1H NMR (600 MHz, CDCl3) δ 7.46 – 7.36 (m, 5H), 7.31 (dd, J = 8.6, 6.1 Hz, 1H), 7.23 
(dd, J = 8.6, 2.6 Hz, 1H), 7.04 (td, J = 8.3, 2.6 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 161.84 (d, J = 249.4 Hz), 138.61, 136.87 (d, J = 3.6 Hz), 
133.33 (d, J = 10.4 Hz), 132.37 (d, J = 8.7 Hz), 129.93 (d, J = 24.8 Hz), 129.61, 128.27, 
127.87, 119.61 (d, J = 167.0 Hz), 117.26 (d, J = 24.7 Hz), 114.22 (d, J = 21.0 Hz). 
19F NMR (376 MHz, CDCl3) δ -113.38 (q, J = 8.4 Hz). 
 
 
1-Chloro-4-fluorobenzene (6.6) The title compound was synthesized according to 
general procedure E in 60% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 
sample (Oakwood Chemical, 6.6-std). 









4-Fluorophenyl pivalate (6.7) The title compound was prepared according to general 
procedure E. The title compound was purified by silica gel column chromatography on silica 
gel (hexanes to 5% ethyl acetate:hexanes) to give a clear colorless oil containing the title 
compound in 41% yield (16.1 mg) alongside S7 (38.7% recovered) and 4-chlorophenol 
(20%). The 19F NMR yield of the crude reaction mixture is 64%. Product was also confirmed 
via comparison to the synthesized standard (6.7-std). 
1H NMR (600 MHz, CDCl3) δ 7.11 – 7.00 (m, 4H), 1.39 (s, 9H). 
19F NMR (376 MHz, CDCl3) δ -117.11 – -117.79 (m). 
 
 
4-Ethyl-1-fluoro-2-methoxybenzene (6.8) The title compound was synthesized 
according to general procedure E in 37% yield as determined by 19F spectroscopic analysis 
of the crude reaction mixture. The 19F NMR spectral data are in agreement with that of 
synthesized standard (6.8-std).  
19F NMR (376 MHz, CDCl3) δ -140.05 (ddd, J = 12.0, 8.1, 4.3 Hz). 
 
 
4-Ethyl-2-fluoro-1-methoxybenzene (6.9) The title compound was synthesized 
according to general procedure E in 12% yield as determined by 19F spectroscopic analysis 
of the crude reaction mixture. The 19F NMR spectral data are in agreement with that of 
synthesized standard (6.9-std).  








5-Bromo-2-fluoroanisole (6.10) The title compound was synthesized according to 
general procedure E in 74% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 
sample (Oakwood Chemical, 6.10-std). 
19F NMR (376 MHz, CDCl3) δ -136.79 (ddd, J = 11.4, 7.5, 4.1 Hz). 
 
 
5-Chloro-2-fluoroanisole (6.11) The title compound was prepared according to general 
procedure E. The title compound was purified by silica gel column chromatography on silica 
gel (hexanes to 5% ethyl acetate:hexanes) to give a clear colorless oil containing the title 
compound in 60% yield (19.3 mg) alongside 4-chlorophenol (60%). The 19F NMR yield of 
the crude reaction mixture is 77%. Product was also confirmed via comparison to the 
authentic sample (Oakwood Chemical, 6.11-std). 
1H NMR (500 MHz, CDCl3) δ 7.05 – 6.99 (m, 1H), 6.96 (dt, J = 7.6, 2.3 Hz, 1H), 6.89 
(ddt, J = 8.4, 4.3, 2.1 Hz, 1H), 3.90 (d, J = 1.8 Hz, 3H). 
19F NMR (376 MHz, CDCl3) δ -137.49 (td, J = 8.4, 8.0, 4.0 Hz). 
 
 
3-Chloro-4-fluoroanisole (6.12) The title compound was synthesized according to 
general procedure E in 45% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 








19F NMR (565 MHz, CDCl3) δ -126.83. 
 
 
2-Chloro-5-fluoroanisole (6.13) The title compound was synthesized according to 
general procedure E in 47% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 
sample (Oakwood Chemical, 6.13-std). 
19F NMR (565 MHz, CDCl3) δ -112.41. 
 
 
4-Fluoro-3-methoxybenzaldehyde (6.14) The title compound was synthesized 
according to general procedure E in 36% yield as determined by 19F spectroscopic analysis 
of the crude reaction mixture. The 19F NMR spectral data are in agreement with that of an 
authentic sample (Oakwood Chemical, 6.14-std). 7% of 4-chlorofluorobenzene was 
observed in the crude mixture. 
19F NMR (376 MHz, CDCl3) δ -123.72. 
 
 
1-(4-Fluoro-3-methoxyphenyl)ethan-1-one (6.15) The title compound was 













spectroscopic analysis of the crude reaction mixture. The 19F NMR spectral data are in 
agreement with that of synthesized standard (6.15-std). 
19F NMR (376 MHz, CDCl3) δ -127.06. 
 
 
Methyl 4-fluoro-3-methoxybenzoate (6.16) The title compound was prepared according 
to general procedure E. The title compound was purified by column chromatography on U60 
(10 – 30 µm) silica gel (5% diethyl ether/pentane) to give a white solid in 51% yield (18.8 
mg). The 19F NMR yield of the crude reaction mixture is 80%. 
1H NMR (400 MHz, CDCl3) δ 7.66 – 7.61 (m, 2H), 7.11 (dd, J = 10.8, 8.4 Hz, 1H), 3.93 
(s, 3H), 3.91 (s, 3H). 
19F {1H} NMR (376 MHz, C₆H₅F) δ -127.92. 
13C NMR (101 MHz, CDCl3) δ 166.34, 155.62 (d, J = 254.9 Hz), 147.72 (d, J = 10.9 Hz), 
126.72 (d, J = 3.6 Hz), 123.20 (d, J = 7.9 Hz), 116.03 (d, J = 19.2 Hz), 114.59 (d, J = 3.1 
Hz), 56.40, 52.41. 
HRMS (APCI) calculated for C9H9FO3 [M+H]+ = 185.0608; found 185.0606. 
 
 
4-Fluoro-3-methoxybenzonitrile (6.17) The title compound was synthesized according 
to general procedure E in 22% yield as determined by 19F spectroscopic analysis of the 
crude reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (6.17-std). 









Major: ethyl (E)-3-(4-fluoro-3-methoxyphenyl)acrylate (6.18-a); minor: ethyl (Z)-
3-(4-fluoro-3-methoxyphenyl)acrylate (6.18-b) (07-199) The title compound was 
prepared according to general procedure E. The title compound was purified by flash LC with 
(40% acetonitrile:water with 0.1% TFA) to give an off-white solid in 17% yield (7.80 mg, 
4:1 E/Z ratio). The 19F NMR yield of the crude reaction mixture is 26%. 
Major (6.18-a): 
1H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 15.9 Hz, 1H), 7.12 – 7.10 (m, 1H), 7.09 – 7.06 
(m, 2H), 6.35 (d, J = 16.0 Hz, 1H), 4.26 (q, J = 7.1 Hz, 2H), 3.92 (s, 3H), 1.34 (t, J = 7.1 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 166.98, 153.78 (d, J = 251.5 Hz), 148.09 (d, J = 11.1 Hz), 
143.79, 131.20 (d, J = 4.0 Hz), 121.69 (d, J = 7.2 Hz), 118.18 (d, J = 2.6 Hz), 116.57 (d, J 
= 18.9 Hz), 112.22 (d, J = 2.3 Hz), 60.73, 56.32, 14.46. 




1H NMR (600 MHz, CDCl3) δ 7.62 – 7.57 (m, 1H), 7.11 – 7.01 (m, 2H), 6.84 (d, J = 12.8 
Hz, 1H), 5.92 (d, J = 12.8 Hz, 1H), 4.18 (q, J = 7.2 Hz, 3H), 3.91 (s, 2H), 1.27 (t, J = 7.1 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 166.16, 152.78 (d, J = 250.1 Hz), 147.05 (d, J = 10.8 Hz), 
142.40, 131.24 (d, J = 4.2 Hz), 123.68 (d, J = 6.9 Hz), 119.43 (d, J = 2.0 Hz), 115.52 (d, J 
= 18.7 Hz), 115.10 (d, J = 2.3 Hz), 60.42, 56.20, 14.19. 












4-Fluoro-3-methoxybenzyl acetate (6.19) The title compound was synthesized 
according to general procedure E in 42% yield as determined by 19F spectroscopic analysis 
of the crude reaction mixture. The 19F NMR spectral data are in agreement with that of 
synthesized standard (6.19-std). 
19F NMR (376 MHz, CDCl3) δ -135.53 (ddd, J = 11.8, 8.2, 4.3 Hz). 
 
 
4-(4-Fluoro-3-methoxyphenyl)butan-2-one (6.20) The title compound was prepared 
according to general procedure E. The title compound was purified by flash LC with (40% 
acetonitrile:water with 0.1% TFA) to give a colorless oil in 33% yield (6.40 mg). The 19F 
NMR yield of the crude reaction mixture is 25%. 
1H NMR (600 MHz, CDCl3) δ 6.97 (dd, J = 11.3, 8.2 Hz, 1H), 6.79 (dd, J = 8.2, 2.1 Hz, 
1H), 6.68 (ddd, J = 8.2, 4.2, 2.1 Hz, 1H), 3.87 (s, 3H), 2.85 (t, J = 7.5 Hz, 2H), 2.75 (t, J 
= 7.5 Hz, 2H), 2.15 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 207.78, 150.98 (d, J = 243.6 Hz), 147.37 (d, J = 10.6 Hz), 
137.34 (d, J = 3.8 Hz), 120.27 (d, J = 6.6 Hz), 115.85 (d, J = 18.1 Hz), 113.62 (d, J = 1.9 
Hz), 56.21, 45.24, 30.20, 29.36. 









4-Fluorobenzyl acetate (6.21) The title compound was synthesized according to general 
procedure E in 11% yield as determined by 19F spectroscopic analysis of the crude reaction 
mixture. The 19F NMR spectral data are in agreement with that of synthesized standard 
(6.21-std). 8% of 4-chlorofluorobenzene was observed in the crude mixture. 




one (6.22) The title compound was prepared according to general procedure E. The title 
compound was purified by silica gel column chromatography on silica gel (1 to 5% ethyl 
acetate:DCM) to give an off-white solid containing the title compound in 54% yield (38.8 
mg) alongside S22 (27%). The 19F NMR yield of the crude reaction mixture is 76%. 1H and 
19F NMR spectra are in agreement with literature values.10 
1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 8.5 Hz, 2H), 7.68 (d, J = 8.6 Hz, 2H), 7.58 (dd, 
J = 8.6, 5.6 Hz, 3H), 7.18 (t, J = 8.6 Hz, 2H), 4.55 (dt, J = 4.8, 2.2 Hz, 2H), 2.83 (dd, J = 
16.5, 4.5 Hz, 4H), 2.48 – 2.28 (m, 2H), 1.86 – 1.70 (m, /2H), 1.65 – 1.54 (m, 2H). 













3-(4-Fluorophenyl)pyridine (6.23) The title compound was prepared according to 
general procedure E. The title compound was purified by silica gel column chromatography 
on silica gel (20 to 50% ethyl acetate:hexanes) to give an off-white solid containing the title 
compound in 60% yield (20.7 mg) alongside S23 (35%). The 19F NMR yield of the crude 
reaction mixture is 54%. 1H and 19F NMR spectra are in agreement with literature values51 
1H NMR (600 MHz, CDCl3) δ 8.82 (s, 1H), 8.60 (s, 1H), 7.83 (d, J = 8.6 Hz, 2H), 7.61 – 
7.46 (m, 2H), 7.40 – 7.36 (m, 1H), 7.17 (t, J = 8.4 Hz, 2H). 
19F NMR (376 MHz, CDCl3) δ -114.13 (td, J = 8.6, 4.3 Hz). 
 
 
5-(4-Fluorophenyl)pyrimidine (6.24) The title compound was prepared according to 
general procedure E. The title compound was purified by silica gel column chromatography 
on silica gel (20 to 50% ethyl acetate:hexanes) to give an off-white solid containing the title 
compound in 40% yield (13.9 mg) alongside S24 (59%). The 19F NMR yield of the crude 
reaction mixture is 32%. 1H and 19F NMR spectra are in agreement with literature values52 
1H NMR (600 MHz, CDCl3) δ 9.20 (s, 1H), 8.92 (s, 2H), 7.59 – 7.50 (m, 2H), 7.22 (t, J = 
8.5 Hz, 2H). 







1-Cyclohexyl-4-fluorobenzene (6.25) The title compound was synthesized according to 
general procedure E in 35% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (6.25-std). 
19F NMR (376 MHz, CDCl3) δ -117.91 (ddd, J = 14.3, 8.9, 5.4 Hz). 
  
 
Benzyl 4-(4-fluorophenyl)piperidine-1-carboxylate (6.26) The title compound was 
prepared according to general procedure E. The title compound was purified by flash LC with 
(60% acetonitrile:water with 0.1% TFA) to give a white solid in 31% yield (19.1 mg). The 
19F NMR yield of the crude reaction mixture is 33%. 
1H NMR (600 MHz, CDCl3) δ 7.40 – 7.35 (m, 4H), 7.35 – 7.29 (m, 2H), 7.24 – 7.18 (m, 
1H), 7.17 – 7.11 (m, 1H), 6.99 (t, J = 8.7 Hz, 1H), 5.18 (s, 2H), 4.33 (d, J = 39.8 Hz, 2H), 
2.88 (bs, 2H), 2.66 (dtd, J = 15.9, 8.2, 7.2, 4.8 Hz, 1H), 1.83 (bs, 2H), 1.61 (bs, 2H). 
13C NMR (151 MHz, CDCl3) δ 161.54 (d, J = 244.3 Hz), 155.42 (d, J = 3.8 Hz, 2 
rotamers), 145.67, 141.33 (d, J = 3.2 Hz), 136.97 (d, J = 6.7 Hz, 2 rotamers), 128.65 (d, J 
= 6.1 Hz, 2 rotamers), 128.22 (d, J = 7.8 Hz), 128.12 (d, J = 3.8 Hz, 2 rotamers), 128.04 
(d, J = 2.6 Hz, 2 rotamers), 126.72 (d, J = 50.5 Hz), 115.40 (d, J = 21.0 Hz), 67.22 (d, J = 
4.9 Hz, 2 rotamers), 44.70 (d, J = 10.4 Hz, 2 rotamers), 42.36 (d, J = 109.9 Hz, 2 
rotamers), 33.40 (d, J = 35.8 Hz, 2 rotamers). 







2-(4-Fluorophenyl)tetrahydro-2H-pyran (6.27) The title compound was synthesized 
according to general procedure E in 7% yield as determined by 19F spectroscopic analysis of 
the crude reaction mixture. The 19F NMR spectral data are in agreement with that of 
synthesized standard (6.27-std). 
19F NMR (376 MHz, CDCl3) δ -115.74. (proton decoupled spectrum) 
 
 
4-Fluoro-3-methoxyphenyl pivalate (6.28) The title compound was prepared according 
to general procedure E. The title compound was purified by flash LC with (40% 
acetonitrile:water with 0.1% TFA) to give a white solid in 42% yield (19.0 mg). The 19F NMR 
yield of the crude reaction mixture is 72%. 
1H NMR (600 MHz, CDCl3) δ 7.05 (dd, J = 10.9, 8.7 Hz, 1H), 6.67 (dd, J = 7.2, 2.7 Hz, 
1H), 6.57 (dt, J = 8.8, 3.2 Hz, 1H), 3.87 (s, 3H), 1.35 (s, 10H). 
13C NMR (151 MHz, CDCl3) δ 177.27, 150.10 (d, J = 243.3 Hz), 148.08 (d, J = 12.1 Hz), 
147.17 (d, J = 3.0 Hz), 116.03 (d, J = 20.3 Hz), 113.29 (d, J = 6.8 Hz), 107.50 (d, J = 2.2 
Hz), 56.43, 39.21, 27.25. 
19F NMR (376 MHz, CDCl3) δ -138.92 (ddd, J = 10.8, 7.2, 3.7 Hz). 
 
 
2-Fluoro-4,5-dimethoxybenzaldehyde (6.29) The title compound was synthesized 









of the crude reaction mixture. The 19F NMR spectral data are in agreement with that of an 
authentic sample (Acros Organics, 6.29-std). 
19F NMR (376 MHz, CDCl3) δ -128.17 (dd, J = 11.7, 6.7 Hz). 
 
 
tert-Butyl 3-fluoro-9H-carbazole-9-carboxylate (6.30) The title compound was 
synthesized according to general procedure E in 37% yield as determined by 19F 
spectroscopic analysis of the crude reaction mixture. The 19F NMR spectral data are in 
agreement with that of synthesized standard (6.30-std). 
19F NMR (376 MHz, CDCl3) δ -120.06 (td, J = 8.7, 4.6 Hz). 
 
 
5-Fluoro-2-methoxypyridine (6.31) The title compound was synthesized according to 
general procedure E in 30% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 
sample (Oakwood Chemicals, 6.31-std). 
19F NMR (376 MHz, CDCl3) δ -139.62 (dd, J = 7.8, 3.6 Hz). 
 
 
3-Fluoro-2-methoxypyridine (6.32) The title compound was synthesized according to 









reaction mixture. The 19F NMR spectral data are in agreement with that of an authentic 
sample (Oakwood Chemicals, 6.32-std). 
19F NMR (376 MHz, CDCl3) δ -139.56 (dd, J = 10.3, 3.3 Hz). 
 
 
2-Fluoro-3-methoxypyridine (6.33) The title compound was synthesized according to 
general procedure E in 9% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (Oakwood Chemicals, 6.33-std) 
19F NMR (376 MHz, CDCl3) δ -84.37. 
 
 
4-(Benzyloxy)-3-fluoropyridine (6.34) The title compound was synthesized according to 
general procedure E in 24% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. 19% of 4-chlorofluorobenzene was observed in the crude mixture. The 
title compound was purified by flash LC with (20% acetonitrile:water with 0.1% TFA) to give 
an off-white, low-melting solid in 20% yield (8.30 mg). 
1H NMR (600 MHz, CDCl3) δ 8.38 (s, 1H), 8.26 (s, 1H), 7.46 – 7.34 (m, 5H), 6.94 (t, J = 
6.3 Hz, 1H), 5.20 (s, 2H). 
13C NMR (151 MHz, CDCl3) δ 152.86 (d, J = 8.6 Hz), 147.01 (d, J = 5.5 Hz), 138.33 (d, J 
= 20.5 Hz), 135.13, 128.95, 128.73, 127.56, 127.44 (d, J = 5.4 Hz), 109.89, 70.90. 









2,4-Di-tert-butoxy-5-fluoropyrimidine (6.35) The title compound was prepared 
according to general procedure E. The title compound was purified by silica gel column 
chromatography on silica gel (2 to 5% ethyl acetate:hexanes) to give an off-white solid 
containing the title compound in 68% yield (32.9 mg) alongside S35 (26%) and 4-
chlorophenol (17%). The 19F NMR yield of the crude reaction mixture is 80%. 1H and 19F 
NMR spectra are in agreement with literature values53 
1H NMR (500 MHz, CDCl3) δ 8.00 (d, J = 2.7 Hz, 1H), 1.65 (s, 9H), 1.58 (s, 9H). 




carboxamido)propanoate (6.36) The title compound was synthesized according to 
general procedure E in 14% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (6.36-std) 










carboxamido)propanoate (6.37) The title compound was synthesized according to 
general procedure E in 11% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (6.37-std) 




fluorophenyl)-propanoate (6.38) The title compound was synthesized according to 
general procedure E in 14% yield as determined by 19F spectroscopic analysis of the crude 
reaction mixture. The 19F NMR spectral data are in agreement with that of synthesized 
standard (6.38-std) 
19F NMR (376 MHz, CDCl3) δ -115.47. 
 
 
Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoate (6.39) 



















as determined by 19F spectroscopic analysis of the crude reaction mixture. The 19F NMR 
spectral data are in agreement with that of synthesized standard (6.39-std) 
19F NMR (376 MHz, CDCl3) δ -115.76. 
 
 
Methyl (S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-fluorophenyl)propanoate (6.40) The 
title compound was synthesized according to general procedure E in 29% yield as 
determined by 19F spectroscopic analysis of the crude reaction mixture. The 19F NMR 
spectral data are in agreement with that of synthesized standard (6.40-std). 5% of 4-
chlorofluorobenzene was observed in the crude mixture. 




(6.41) The title compound was synthesized according to general procedure E in 22% yield 
as determined by 19F spectroscopic analysis of the crude reaction mixture. The 19F NMR 
spectral data are in agreement with that of synthesized standard (6.41-std) 















(6.42) The title compound was synthesized according to general procedure E in 9% yield as 
determined by 19F spectroscopic analysis of the crude reaction mixture. The 19F NMR 
spectral data are in agreement with that of synthesized standard (6.42-std) 
19F NMR (376 MHz, CDCl3) δ -134.92. (proton decoupled spectrum) 
 
D.6 Electrochemical Measurements  
Electrochemical half peak redox potentials (Ep/2) were estimated from cyclic 
voltammograms obtained by the method described previously.54,55 Measurements were 
performed in acetonitrile with tetrabutylammonium hexafluorophosphate (0.1 M) as the 
electrolyte, and the cyclic voltammograms were collected using a glassy carbon working 
electrode, a platinum wire counter electrode, and an Ag/AgCl reference electrode in 
saturated NaCl. The observed half peak potential was referenced to SCE by addition of 30 
mV to the value obtained vs. Ag/AgCl. For a typical measurement, the potential was 
increased from an initial potential of 0.5 V to a vertex potential of 2.8 V, then returning to a 
final potential of 0.5 V. With these parameters, all compounds listed in Table D.2. exhibited 




















































Figure D.2. Cyclic voltammogram of S56 in acetonitrile. 
 







Figure D.4. Cyclic voltammogram of S2 in acetonitrile.  
 








Figure D.6. Cyclic voltammogram of S21 in acetonitrile. 
 
 









Figure D.8. Cyclic voltammogram of S19 in acetonitrile. 
 
 
D.7 Experimental Procedures for Radiochemistry 
Procedures and radio-HPLC traces for the analogous 18F-labeled arenes are available 
upon request. 
D.8 NMR Spectra of New Compounds 
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